ID,Slide,Tumor,Question,Caption
1,TCGA-DK-A3IS-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of high-grade invasive urothelial carcinoma, primarily involving the bladder, with confirmed growth patterns of both papillary and flat for the non-invasive component. The invasive component exhibits inverted/nodular growth and is identified as multicentric. Local invasion is limited to the superficial half of the muscularis propria, and there is no extravesical extension or involvement of the ureters and urethra. Both vascular and perineural invasions are absent, and surgical margins are free of tumor. The prostate shows nodular hyperplasia and small foci of adenocarcinoma with a Gleason score of 6, confined to the prostate without seminal vesicle or bladder neck involvement. Lymph node dissections from the right pelvic, retroperitoneal, and left pelvic areas reveal no involvement, and biopsies from the vas deferens, ureters, periureteral tissue, and urachus are benign. Overall, the pathological stage is pT2a for the bladder carcinoma and pT2b for the prostate adenocarcinoma."
2,TCGA-UY-A9PH-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a high-grade, invasive urothelial carcinoma of the urinary bladder, extending into the outer half of the muscularis propria. The tumor is confined to the bladder without extension into adjacent organs, and the surgical margins are clear of carcinoma. Additionally, the lymph nodes removed, including those from the right obturator, right and left internal iliac, and left obturator regions, show no evidence of metastatic disease, with a total of twenty lymph nodes examined all being negative for carcinoma. Other notable findings include nephrogenic adenoma and granulomatous inflammation in the bladder, consistent with BCG treatment effect, along with benign prostatic hyperplasia and granulomatous inflammation in the prostate, but no evidence of tumor within the prostate or seminal vesicles. The case is staged as pT2bN0 according to AJCC/UICC classification."
3,TCGA-BT-A20W-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological examination reveals a diagnosis of high-grade urothelial carcinoma with deep invasion into the detrusor muscle but without penetration through it. The carcinoma exhibits papillary and ulcerated configurations, and extensive multifocal carcinoma in-situ involving various bladder walls and ureters is noted. No angiolymphatic or perineural invasion is identified. Importantly, surgical resection margins are free of invasive carcinoma, although urothelial dysplasia closely approaches the right distal ureter radial margin. However, the separate left ureteral margin is clear. Non-neoplastic findings include chronic cystitis cystica glandularis and focal granulomatous inflammation. Pathologically, the tumor stage is pT2b, with no regional lymph node metastasis (pN0), and metastasis status remains unspecified (pMX). The prostate contains a small, localized focus of acinar-type prostatic adenocarcinoma with a Gleason score of 6, confined to less than 5% of the gland and without evidence of extraprostatic extension or involvement of adjacent structures. Surgical margins for the prostatic adenocarcinoma are also uninvolved. The examined lymph nodes (both from the obturator and pelvic regions) are free of malignancy. Additional findings include focal high-grade prostatic intraepithelial neoplasia and non-neoplastic nodular hyperplasia in the prostate. The pathologic stage for the prostatic adenocarcinoma is pT2aN0MX."
4,TCGA-XF-A9T0-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the radical cystoprostatectomy, left nephroureterectomy, lymph node dissection, and creation of Studer neo-bladder reveals significant findings. The bladder exhibits an invasive poorly differentiated urothelial carcinoma, grade 4/4, extending through the bladder neck wall and involving the perivesical soft tissue, with multifocal urothelial carcinoma in situ, including the trigone and left ureterovesical junction. Both the right distal ureter and apical urethral margin are benign, showing no evidence of urothelial dysplasia or malignancy. The prostate contains a unilateral prostatic adenocarcinoma (Gleason's score 7 [3+4]) confined to the prostate, along with multifocal high-grade prostatic intraepithelial neoplasia, but devoid of capsular, periprostatic soft tissue, seminal vesicle, or urethral involvement. The left kidney shows stenosis at the ureteropelvic junction with no dysplasia or malignancy, and the associated renal parenchyma is unremarkable. Extensive lymph node examination across multiple regions, totaling 79 lymph nodes, reveals no malignancy. The pathologic staging for the bladder is pTisT3bNOMX, and for the prostate, it is pT2aNOMX, indicating localized disease without lymph node involvement. An immunohistological p53 assay for the urothelial carcinoma is pending further analysis."
5,TCGA-K4-A4AB-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of high-grade invasive urothelial carcinoma involving the left distal ureter, left ureterovesical junction, and the bladder, which extensively infiltrates the perivesicular, prostatic, and periureteral soft tissue margins of excision. The carcinoma in the bladder's posterior wall shows squamous differentiation, extravesicular mass presence, and direct invasion of the prostatic stroma and seminal vesicle, with no invasion of the pelvic or abdominal wall. Lymphatic and perineural invasion are both present. Both distal ureteral and urethral margins of excision are negative for the tumor. The right distal ureter and associated lymph nodes exhibit no evidence of malignancy. The left pelvic lymph node also shows no tumor involvement. Furthermore, there is an incidental finding of a low-grade adenocarcinoma in the prostate, classified as Gleason score 6, confined to the peripheral zone without extraprostatic extension or invasion into the seminal vesicles, lymphatics, or perineural spaces. The prostate carcinoma margins are tumor-free. The overall TNM staging for the urothelial carcinoma is pT4a, pNo, pMX, while the incidental prostate adenocarcinoma is staged as pT2a, pNo, pMX."
6,TCGA-DK-A3IL-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient is diagnosed with invasive urothelial carcinoma of the bladder, classified as high-grade. This carcinoma displays both flat (in situ) and infiltrating components, with evidence of multicentricity and local invasion into the perivesical soft tissues while sparing the ureters and urethra. Notably, there is vascular invasion but no perineural invasion. Surgical margins are free of tumor, indicating a complete resection. Examination of the right distal pelvic lymph nodes reveals metastatic involvement in two out of three lymph nodes, with no extranodal extension observed. The left distal pelvic lymph nodes are benign, and the perivesical lymph nodes show no signs of tumor involvement. The patient also exhibits ulceration and a foreign body reaction in the non-neoplastic mucosa of the bladder, while adjacent female genital organs show stromal hyperplasia but are otherwise unremarkable. Pathologically, the tumor is staged as pT3 according to AJCC 2002 criteria. Other specimens, including the right ureteral stent, left distal ureter, and right distal ureter, confirm the absence of carcinoma but reveal mild to moderate urothelial atypia in the right distal ureter."
7,TCGA-DK-A1A7-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a 67-year-old female diagnosed with bladder cancer reveals invasive, high-grade urothelial carcinoma with a flat non-invasive component and an infiltrating invasive growth pattern. The tumor is multicentric and extensively involves the bladder, perivesical soft tissues, vesicle-vaginal soft tissue, as well as both ureters, indicating significant extravesical extension. Vascular and perineural invasion are present. The surgical margins at the right and left ureteral excisions are involved with urothelial carcinoma in situ. Metastatic urothelial carcinoma is detected in right common iliac and right distal pelvic lymph nodes, with one lymph node involved in each region; there is no extranodal extension. The remaining lymph nodes, including those from the left common iliac, left distal pelvic, and presacral regions, are benign. The bladder mucosa shows signs of chronic and erosive cystitis, while the female genital organs exhibit no pathologic abnormalities. The overall pathologic stage is pT3, denoting invasion into the perivesical soft tissue."
8,TCGA-XF-AAN3-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the radical cystoprostatectomy with lymph node dissection and continent urinary reservoir revealed a diagnosis of invasive, poorly differentiated urothelial carcinoma of the bladder, with focal squamoid and glandular features, extending through the bladder wall into perivesical soft tissue and the subserosa of the peritoneum. The resection margins, including the right and left ureters and the apical urethral margin, were free of malignancy and urothelial dysplasia. Within the prostate, a unilateral prostatic adenocarcinoma with a Gleason's score of 7 was identified, confined to the prostate without extracapsular extension or periprostatic soft tissue involvement. The 36 lymph nodes examined showed metastatic urothelial carcinoma in two nodes, specifically the left obturator and the right obturator lymph nodes. All other lymph nodes, including those from the perivesical, left lymph node of Cloquet, left external iliac, left hypogastric, left common iliac, right hypogastric, right common iliac, right presciatic, and aortic bifurcation regions, were negative for malignancy. The pathologic TNM stage was determined to be pT3bN2MX for the bladder and pT2aNOMX for the prostate. Sections from the tumor were submitted for p53 immunohistochemistry assay, with results pending."
9,TCGA-DK-A6B1-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings revealed an invasive high-grade urothelial carcinoma involving the bladder, prostate, and seminal vesicles following cytoprostatectomy. The tumor demonstrated both papillary and flat growth patterns in the non-invasive component and an inverted/nodular pattern in the invasive component. Multicentricity was identified with involvement of intervening urothelium, and the tumor invasion extended to the superficial half of the muscularis propria. There was no evidence of extravesical tumor extension, vascular invasion, or perineural invasion. Surgical margins, including urethral and ureteral margins, were free of tumor. The non-neoplastic mucosa was unremarkable, and there was nodular hyperplasia within the prostate, with high-grade prostatic intraepithelial neoplasia, but seminal vesicles were not involved. Examination of perivesical lymph nodes revealed no involvement, indicating a pathologic stage of pT2a. Additional submitted soft tissue from the left pelvis and various lymph nodes from the right and left pelvic regions were negative for tumor involvement. The distal margins of the urethra, pelvic floor, and both ureters were also negative for tumor. The findings support a diagnosis of localized high-grade invasive urothelial carcinoma without evidence of metastasis to regional lymph nodes or other submitted tissues."
10,TCGA-UY-A78P-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate that the patient has a high-grade urothelial (transitional cell) carcinoma of the bladder, primarily characterized by its invasion into the outer half of the muscularis propria. The radical cystectomy specimen, including the bladder, uterus, adnexae, and a portion of the vagina, reveals a tumor confined to the bladder without extension into adjacent organs. Both frozen section and final margin analyses of the distal ureters are free of tumor, ensuring clear surgical margins. Examination of the pelvic lymph nodes from both sides reveals no metastatic disease, with 0 out of 20 nodes involved. No lymphatic or vascular invasion is identified, and additional pathological findings in the bladder are absent. The accompanying uterine, endometrial, myometrial, ovarian, and fallopian tube tissues show no significant abnormalities except for the presence of inclusion cysts in the ovaries and atrophic changes in the endometrium. The staging aligns with pT2bN0Mx, indicating locally advanced disease without nodal involvement or distant metastasis as per the current evaluation."
11,TCGA-4Z-AA84-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of high-grade urothelial carcinoma of the bladder, characterized by extensive necrosis and infiltration into the perivesical adipose tissue. While surgical margins are generally uninvolved, there is a concerning closeness at the top left portion. The presence of angiolymphatic infiltration has been noted, whereas perineural infiltration is absent. Additionally, the urothelial carcinoma shows no neoplastic infiltration of the right and left ureter and rectal wall fragment. Metastatic involvement is confirmed in two out of two dissected lymph nodes. The pathological staging is summarized as pT3b, pN2, pMX."
12,TCGA-4Z-AA7O-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a diagnosis of high-grade invasive urothelial carcinoma in the bladder, infiltrating up to the muscularis propria. The neoplasm was notable for the presence of lymphatic vascular invasion, while sanguineous vascular invasion and perineural invasion were absent. The adjacent bladder mucosa exhibited severe chronic cystitis. Importantly, both the urethral and ureteral surgical margins were found to be free of neoplastic involvement, suggesting complete excision of the gross tumor. Examination of the prostate revealed acute and chronic focal prostatitis without evidence of neoplasia, and both seminal vesicles and vas deferens were similarly free of tumor. Lymph node assessment showed that all dissected iliac obturator lymph nodes, totaling 21 from both right and left regions, were free of metastatic involvement. Overall, the pathologic staging was consistent with pT2 pN0 transitional cell carcinoma of the bladder, indicating localized muscle-invasive disease without regional lymph node metastasis."
13,TCGA-XF-AAMJ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of poorly differentiated urothelial carcinoma involving the bladder, characterized by high nuclear-to-cytoplasmic ratio and prominent nucleoli. The tumor forms papillary structures and extensively invades the muscularis propria, penetrating the entire thickness of the bladder wall and extending into the perivesical fat. Tumor infiltration was observed up to the posterior inked bladder wall margin, though the distal ureteral and urethral margins were free of malignancy. Surrounding mucosa exhibited multifocal areas of urothelial carcinoma in situ, along with cystitis cystica and cystitis glandularis. The tumor obstructed the left ureter and involved the right ureterovesical junction, extensively affecting bladder regions including the trigone. There was notable vascular and perineural invasion. Importantly, multiple lymph nodes sampled from various regions showed no evidence of metastatic disease. Additionally, benign findings included residual periurethral prostatic tissue, benign seminal vesicle, and benign urothelium in sections of left and right proximal ureters. The pathological stage is pT3bNOMXR1, indicating advanced local invasion with no regional lymph node metastasis."
14,TCGA-FD-A3N6-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive high-grade urothelial carcinoma with extensive squamous differentiation, localized to the muscularis propria (outer half) of the bladder's anterior wall. The tumor was a solitary, exophytic mass without metastasis to any of the lymph nodes examined (0/58), including bilateral pelvic lymph nodes. Margins were clear of tumor involvement, including ureteral and distal urethral margins as well as soft tissue or serosa margins. Notably, the patient underwent a cystectomy, and concurrent hysterectomy and bilateral salpingo-oophorectomy revealed benign findings in the uterine endometrium, adenomyosis, multiple leiomyomas, and physiologic changes within the ovaries. Importantly, no evidence of malignancy was detected in the left fallopian tube, left pelvic lymph nodes, or any other examined regions outside the bladder. The findings align with a pathological staging of pT2b, N0, MX, without detectable distant metastasis."
15,TCGA-ZF-AA4U-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings for the provided case reveal an invasive transitional cell carcinoma (G3) of the bladder, extending into the prostate. Histologically, the tumor is poorly differentiated with both papillary and solid components, invading the lamina propria, muscularis propria, and reaching the perivesicle fat. There is possible lymphovascular invasion, but no lymphocytic infiltrate, glandular, squamoid, or neuroendocrine differentiation noted. The tumor notably involves both lobes of the prostate, particularly the lower lobes, and extends into the periprostatic soft tissue on the left. Surgical margins around the ureters and the circumferential surgical resection margins on both sides are clear, despite the proximity of the tumor. There is no evidence of dysplasia or carcinoma in situ in the prostatic urethra. The background bladder tissue shows another low-grade (G2) papillary transitional cell carcinoma and focal carcinoma in situ. The analyzed lymph node sample from the left internal iliac region shows no nodal tissue or metastatic carcinoma. Overall, the pathological diagnosis is a high-grade (G3) invasive bladder carcinoma with prostate involvement, yet surgical margins are clear (G3 pT4a pNx pMx)."
16,TCGA-ZF-A9R9-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the specimens reveals a diagnosis of poorly differentiated (G3) transitional cell carcinoma (TCC) of the bladder with invasive characteristics. The tumor originates from the surface epithelium and extends through the bladder wall into the extravesical tissue, including perivesical fat and circumferential surgical resection margin posteriorly. The node section shows metastatic carcinoma with extension into extracapsular tissue. The assessment of the left ureter indicates both proximal and distal resection margins are free of carcinoma, and no dysplasia or carcinoma-in-situ is identified in the background urothelium. However, there is extensive necrosis within the tumor, along with perineural and lymphovascular invasion, but no significant lymphocytic infiltrate at the tumor-host interface. The tumor also extends into the muscle wall of the ductus deferens, with normal morphologically ureteric and urethral resection margins. The prostate pathology reveals foci of high-grade prostatic intraepithelial neoplasia (PIN) in the right lobe but is otherwise unremarkable with no evidence of microacinar adenocarcinoma. The diagnosis is G3 TCC pT3b with the tumor within 1 mm of the surgical margin. There is no evidence of dysplasia or carcinoma-in-situ at the ureteric or urethral resection margins, and no metastases are noted within the lymph nodes evaluated."
17,TCGA-E7-A677-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is infiltrating urothelial carcinoma of the bladder, specifically a low-grade moderately differentiated transitional cell carcinoma. The tumor exhibits invasive characteristics, forming both papillary and trabecular structures with tumor cells displaying moderate eosinophilic cytoplasm, enlarged and variably shaped nuclei, irregular nuclear membranes, nucleoli, and abnormal chromatin patterns. Mitoses are observed. Pathologically, the tumor extends deeply into the muscularis propria, specifically infiltrating the outer half. There is no evidence of lymphatic invasion, and the surgical margins are uninvolved, indicating that the resection may be complete. These findings collectively describe an aggressive, yet contained carcinoma requiring appropriate clinical management."
18,TCGA-E7-A85H-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an infiltrating urothelial carcinoma of the bladder, classified as high-grade transitional cell carcinoma. The tumor demonstrates significant invasion into the muscularis propria and exhibits venous invasion. Microscopically, the tumor is characterized by sheets, nests, groups, or cords of hyperplastic cells with moderate eosinophilic cytoplasm, irregular nuclear features including prominent nucleoli, and frequent mitoses. Despite these aggressive features, the surgical margins are negative for tumor involvement. Additionally, two inguinal lymph nodes were examined and found to be free of metastatic disease. Importantly, there is evidence of focal extracapsular extension into the bladder wall and vessels, but no neoadjuvant treatment was noted. Overall, while showing local aggressiveness, the carcinoma has not spread to the examined lymph nodes, a favorable prognostic indicator."
19,TCGA-FD-A3B8-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of high-grade urothelial carcinoma of the urinary bladder, with squamous differentiation, invasive into the outer half of the muscularis propria. The radical cystoprostatectomy specimen shows a solitary tumor located on the right lateral/anterior bladder wall. Importantly, the margins of resection, including the soft tissue, prostatic urethra, and both ureters, are negative for tumor presence. Further examination reveals no involvement of the prostate, seminal vesicles, or vasa deferentia. Comprehensive lymph node dissection encompassing both left and right pelvic regions identifies a total of twenty-five lymph nodes, all of which are negative for metastatic disease. The pathological staging is pT2b, N0, Mx, indicating localized disease without regional node involvement or distant metastasis. This comprehensive assessment affirms the thoroughness of the resection and suggests a favorable prognostic outlook given the absence of residual tumor in the resection margins and no lymphatic spread."
20,TCGA-FD-A5BV-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a white female who underwent a robotic-assisted laparoscopic cystectomy for invasive high-grade urothelial carcinoma of the bladder revealed several key findings. The primary tumor was identified as high-grade urothelial carcinoma, with invasion through the bladder wall into the perivesical tissue. The tumor was solitary, involving key areas including the left lateral wall, trigone, and posterior wall, with focal extensions to the dome and right lateral wall. All surgical margins, including ureteral, distal urethral, and soft tissue margins, were free of tumor involvement. Examination of the lymph nodes indicated no tumor presence, with all 25 dissected nodes (17 from the right pelvic and 8 from the left pelvic regions) being negative. Additional specimens, including the uterus, cervix, bilateral fallopian tubes, ovaries, appendix, and portions of the left and right distal ureters, showed no tumor involvement, with age-related changes observed in the bilateral ovaries and an atrophic endometrium in the uterus. The pathologic staging was determined to be pT3b,N0,MX, indicating a locally advanced tumor without regional lymph node metastasis."
21,TCGA-E7-A3Y1-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The excision specimen from the bladder reveals a diagnosis of moderately differentiated transitional cell carcinoma with a papillary architecture. Pathologically, the tumor is confined to the superficial muscle layer, specifically the inner half. Importantly, there is no evidence of venous invasion, and the surgical margins are uninvolved, indicating that the tumor does not extend to the edges of the excised tissue. Lymph node involvement and lymphatic invasion are not specified in the findings. Additionally, there is no indication of neo-adjuvant treatment or other significant pathologic changes."
22,TCGA-ZF-AA53-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated, Grade 3 transitional cell carcinoma of the bladder, primarily involving the posterior and lateral walls. This carcinoma invades the muscularis propria but does not extend into the perivesical fat. Squamous differentiation and regions with a spindle cell/sarcomatoid appearance are noted, although there is no evidence of lymphoepithelioma-like features as previously suggested. Importantly, the circumferential and ureteric resection margins are clear of the tumor, and no vascular invasion is identified. The bladder wall exhibits severe inflammation and focal denudation, with some atypia but no carcinoma-in-situ. Additionally, a focus of prostatic adenocarcinoma with a Gleason score of 3 + 3 = 6 is noted at the urethral resection margin, and multiple further foci of prostatic adenocarcinoma and high-grade prostatic intraepithelial neoplasia (PIN) are present in both lobes of the prostate, with no evidence of extracapsular extension. Overall, the findings indicate a transitional cell carcinoma of the bladder (G3 pT2) that is completely excised, and a prostate adenocarcinoma (Gleason score 3 + 3 = 6, pT2) at the urethral margin."
23,TCGA-FD-A6TE-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a high-grade urothelial carcinoma extensively involving the left distal ureter and urinary bladder. The tumor penetrates through the muscularis propria into the perivesical fat. Notably, the surgical margins of the ureter, bladder, and distal urethral region are free of tumor. The patient has metastatic involvement in two out of thirty-eight dissected lymph nodes, specifically one left pelvic lymph node and one right pelvic lymph node, each demonstrating metastatic urothelial carcinoma with extranodal extension. The left common iliac, right common iliac, and presacral lymph nodes exhibit no tumor presence. Additionally, an incidental finding of a well-differentiated prostatic adenocarcinoma (Gleason score 3+3=6) without perineural invasion, extraprostatic extension, or seminal vesicle involvement was noted. The regional lymph nodes are negative for prostatic carcinoma. The pathological staging for the urothelial carcinoma is pT3a, N2, MX and for the prostatic carcinoma is pT2a, N0, MX according to the AJCC/UICC 7th edition staging system. Other notable findings include a Meckel's diverticulum and non-tumor-bearing bilateral vas deferens and right distal ureter."
24,TCGA-ZF-A9RE-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of Grade 3 (poorly differentiated) transitional cell carcinoma (TCC) of the bladder, characterized by a mixed papillary and solid growth pattern. The tumor has invasive properties with confirmed stromal invasion extending into the muscularis propria. Notably, there is no definitive evidence of lymphovascular invasion. The background urothelium exhibits carcinoma in situ. These findings collectively suggest at least a pT2 stage TCC, highlighting the aggressive nature of the malignancy and its potential deeper tissue invasion. Margin status and lymph node involvement were not specifically addressed in the findings."
25,TCGA-BT-A42E-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient has been diagnosed with invasive high-grade papillary urothelial carcinoma of the urinary bladder, presenting with features of lymphoepithelioma-like carcinoma and areas of squamous differentiation. The primary tumor, located posterior to the right lateral bladder wall, extends through the detrusor muscle and involves the perivesical soft tissue. The carcinoma has been confirmed to measure 6.5 cm in its greatest dimension. All surgical margins are negative for invasive carcinoma, and there is no lymphovascular invasion identified. The pathological staging classifies the tumor as pT3aN0MX, indicating that it extends into the perivesical fat but there is no dissemination to the five examined pelvic lymph nodes, all of which are benign. Biopsy site changes are extensive, and additional pathological findings include low-grade urothelial dysplasia and therapy-related alterations. Notably, the prostatic tissue and urethral margin are benign, with reactive changes but no evidence of neoplastic involvement."
26,TCGA-UY-A9PD-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of high-grade urothelial carcinoma of the urinary bladder, with the tumor invading into the perivesicular adipose tissue. No dysplasia or carcinoma was found in the biopsies and resections of the left and right ureters. The cystoprostatectomy specimen of the bladder showed an invasive high-grade urothelial carcinoma with negative margins. Lymphovascular invasion was confirmed by CD34 immunohistochemistry. A thorough lymph node dissection, including the right obturator, right internal iliac, right external iliac, and left pelvic nodes, revealed no evidence of metastatic carcinoma in any of the 25 lymph nodes examined. The prostate showed nodular stromal hyperplasia and glandular atrophy with focal squamous metaplasia but no carcinoma. Other significant findings in the bladder included a foreign body giant cell reaction, likely from a prior transurethral resection. The tumor did not extend into adjacent organs, and the resection margins were free of invasive tumor. The overall staging was determined to be pT3aNO, reflecting the extent of invasion and absence of nodal involvement."
27,TCGA-BT-A42B-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient has been diagnosed with invasive high-grade urothelial carcinoma featuring both papillary and flat configurations, located primarily at the left lateral wall of the urinary bladder. Pathological assessment reveals significant tumor invasion into the detrusor muscle and perivesical soft tissue and extensive tumor necrosis. Lymphovascular and perineural invasion are present, suggesting an aggressive tumor behavior. The pathological staging is pT3a N1 MX, indicating tumor invasion into surrounding tissues and regional lymph node involvement, with one out of six left pelvic lymph nodes testing positive for metastasis. All other lymph nodes from the right pelvic region are benign. Flat carcinoma in-situ is noted at the left ureter margin, while all other surgical margins are free of invasive carcinoma. Additional findings include benign prostatic hyperplasia with no evidence of carcinoma in the prostate and reactive changes in the right ureter, with no signs of malignancy or dysplasia."
28,TCGA-DK-A1AF-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of high-grade invasive urothelial carcinoma of the bladder with significant findings including bladder local invasion extending into the perivesical soft tissues. The tumor exhibited a flat in situ growth pattern for the non-invasive component and an infiltrating growth pattern for the invasive component, with multicentricity identified. Both right and left ureters, as well as the urethra, were free of tumor invasion, and there was no perineural invasion observed. Vascular invasion was identified, and the surgical margins were free of tumor involvement. Non-neoplastic mucosa exhibited ulceration and a foreign body reaction, while the female genital organs showed no pathological abnormalities. Perivesical lymph nodes were not identified. Staging of the tumor was classified as pT3 due to the invasion of the perivesical soft tissue. 

Right pelvic lymph node dissection identified metastatic urothelial carcinoma in one out of six lymph nodes, with extranodal extension present. Similarly, left pelvic lymph node dissection identified metastatic urothelial carcinoma in three out of eight lymph nodes, also with extranodal extension. The resection of the right distal ureter displayed partially denuded urothelium with mild to moderate urothelial atypia, while the right ureter segment was benign. Overall, the comprehensive pathological findings indicate an advanced-stage bladder cancer with extensive local and regional involvement, necessitating further oncologic management."
29,TCGA-GU-AATQ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals invasive urothelial carcinoma with squamous differentiation, classified as high-grade, originating from the bladder and extending macroscopically into the perivesical tissue (pT3b). Radical cystoprostatectomy samples from both the left and right distal ureters showed no high-grade dysplasia or carcinoma, findings confirmed by frozen sections. All surgical resection margins were free of tumor involvement. The prostate exhibited benign prostatic hyperplasia without invasive carcinoma. Lymph node dissections from the right and left iliac and obturator regions identified a total of 21 benign lymph nodes, all negative for metastatic carcinoma. No associated epithelial lesions were found in the bladder, though some urothelial dysplasia and inflammatory changes were noted. Indications of lymph-vascular invasion were indeterminate. No ancillary studies were performed, but tissue blocks have been reserved for potential future analysis. The diagnostic consensus was reached after a thorough review of selected slides."
30,TCGA-4Z-AA7W-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of high-grade urothelial carcinoma of the bladder. The tumor invades the muscular layer of the bladder but does not exhibit angiolymphatic or perineural invasions. The surgical margins are clear of neoplastic cells, indicating complete excision of the tumor. Additionally, the prostate shows miofibroepithelial hyperplasia without evidence of malignancy. Lymphadenectomy specimens from both the left and right sides show a total of 16 lymph nodes, all of which are free of neoplastic involvement. Based on these findings, the tumor is staged as pT2b pNO, indicating invasion into the muscularis propria of the bladder without regional lymph node metastasis."
31,TCGA-GD-A3OQ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology report reveals significant findings related to the urinary bladder and associated structures following a cystoprostatectomy. The primary diagnosis is high-grade urothelial carcinoma characterized by a papillary and nodular/infiltrative tumor configuration with associated carcinoma in situ. The tumor has extended to invade the peri-vesicle soft tissue and exhibits both lymph-vascular and extensive perineural invasion. Notably, the surgical margins, including the urethral and ureteral, are negative, ensuring that no residual tumor was left in these regions. Despite the presence of a single metastatic lymph node among the fifteen examined, there is no extranodal extension observed. The tumor has further involved the prostatic urethra and invaded the prostatic stroma. The tumor stage is classified as pT4a pN1, indicating advanced local extension and regional lymph node involvement but no distant metastasis. Lastly, biopsies from both the left and right distal ureters showed no evidence of carcinoma, and the appendix was found to have no pathologic changes."
32,TCGA-GV-A3QK-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of high-grade papillary urothelial carcinoma originating from the bladder, with significant invasion extending into the perivesical fat, myometrium of the lower uterine segment, endocervical stroma, and vaginal submucosa. Lymphovascular and perineural invasion are present. The carcinoma extends to the inked posterior serosal surface of the bladder, but margins including the ureteral and urethral margins, as well as the vaginal margin, are not involved by the carcinoma. Urothelial carcinoma in situ is also identified in the bladder mucosa. Additionally, thirty-three pericolonic lymph nodes are negative for carcinoma, while metastatic urothelial carcinoma is found in five out of twenty-three left pelvic lymph nodes, with evidence of extranodal extension. Examination of the right and left distal ureters, appendix, and small bowel reveals no diagnostic abnormalities. The urethral margins and right pelvic lymph nodes are also negative for carcinoma. Other notable findings include a hyperplastic polyp and submucosal lipoma in the colon, with the absence of residual dysplasia or adenocarcinoma at a prior biopsy site."
33,TCGA-UY-A78N-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient presents with invasive high-grade urothelial carcinoma of the bladder, accompanied by a small focus of Gleason grade 3+3 prostatic adenocarcinoma identified post-cystectomy and prostatectomy. The urothelial carcinoma invades through the muscularis propria into the peri-vesical tissue, with evidence of lymphatic and vascular invasion. Importantly, all surgical margins are free of tumor, with the carcinoma extending to within 0.3 cm of the inked radial margin and 0.5 cm of the prostate. The left distal ureter and right distal ureter biopsies, as well as the final margin biopsies from both ureters, show no evidence of tumor. Lymph node involvement reveals no tumor in the left pelvic lymph nodes (0/7), but metastatic urothelial carcinoma is present in one of seven right pelvic lymph nodes (1/7). The largest metastatic deposit measures 0.3 cm, and there is no extranodal tumor growth. No epithelial abnormalities or adjacent organ involvement is noted beyond the described invasion. The overall AJCC/UICC staging is pT3aN1MX. The pathological findings underscore the presence of aggressive bladder cancer with localized lymphatic spread and a coexisting, less advanced prostate cancer."
34,TCGA-CU-A3YL-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of papillary urothelial carcinoma with high-grade histology involving the bladder and prostate. The tumor extensively invades the lamina propria of the bladder, prostatic ducts, and prostatic stroma, presenting as a solitary lesion. Notably, no angiolymphatic space invasion was observed. Urothelial carcinoma in situ is present in the bladder and prostatic ducts bilaterally, but the ureters remain uninvolved. Surgical margins, including the urethra and paravesicular soft tissue, are negative for malignancy. Lymph node dissections from the right and left pelvis, comprising a total of seven lymph nodes, show no evidence of metastatic carcinoma (0/7). Additional findings include prostatic glandular atrophy, with pending immunostaining to rule out prostatic adenocarcinoma. The pathologic stage is determined to be pT4a pNO. An intraoperative consult identified focal urothelial atypia in the urethral margin, favoring a reactive process but not excluding low-grade dysplasia. The gross assessment concurs with a significant tumor burden, reinforcing the comprehensive staging and diagnostic conclusions."
35,TCGA-E5-A4TZ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the bladder tumor reveals a diagnosis of invasive urothelial cell carcinoma, classified as high grade. The tumor demonstrates significant infiltration, extending into the muscularis propria, which signifies a more advanced stage of local invasion. Additionally, perineural invasion is identified, indicating that cancer cells are infiltrating the spaces surrounding nerves within the tumor. The specimen is notable for its tan-pink coloration and soft tissue consistency. The detailed assessment of the margins, lymph node involvement, and other relevant structures were not specified in this summary, emphasizing the primary tumor characteristics and indicators of aggressive behavior."
36,TCGA-FD-A5C1-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed an invasive high-grade urothelial carcinoma of the urinary bladder, extending through the muscularis propria into the perivesical tissue. The tumor was solitary with significant ulceration located on the right lateral, anterior, and posterior walls of the bladder. Surgical margins, including the ureteral, distal urethral, and serosal margins, were negative for tumor involvement. Lymph node dissections from both the right and left pelvic regions showed no evidence of metastasis, with a total of thirty lymph nodes examined and all being free of tumor. A supracervical hysterectomy revealed a uterus with inactive endometrium and adenomyosis, whereas the bilateral fallopian tubes and ovaries displayed no evidence of malignancy, only age-related changes. Additionally, the distal right ureter was free of tumor. These findings collectively indicate a diagnosis of pT3b, N0, MX stage urothelial carcinoma based on the 7th edition of the TNM staging system by the AJCC and UICC."
37,TCGA-XF-AAN7-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the radical cystectomy and Studor pouch to urethra revealed that the distal ureters and apical urethral margin were benign, displaying no dysplasia or carcinoma. The bladder demonstrated poorly differentiated urothelial carcinoma with sarcomatoid features, graded as 4/4, and included lymphovascular invasion and multifoci of urothelial carcinoma in-situ along with chronic cystitis. Margins were free of malignancy. The prostate also showed prostatic adenocarcinoma, Gleason score 6 (3+3), limited to the prostate with high grade prostatic intraepithelial neoplasia (PIN III), multifocal, and extensive prostatic atrophy with acute and chronic inflammation. Again, surgical margins were free of malignancy. Examination of 170 lymph nodes revealed metastatic carcinoma in just one left obturator/hypogastric lymph node. Immunohistochemical stains confirmed urothelial carcinoma with sarcomatoid features and supported the diagnosis of prostatic adenocarcinoma. The pathology AJCC staging is pTis, T3aN1MX for the bladder and pT2aN1MX for the prostate, indicating the presence of invasive cancer with lymph node involvement."
38,TCGA-XF-A9SI-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","Radical cystectomy with ileal conduit revealed an invasive, poorly differentiated papillary urothelial carcinoma, grade 4, in the left posterolateral bladder neck, extending into the deep muscularis propria and perivesical soft tissue, with lymphovascular space invasion. The random bladder tissue showed chronic inflammation and reactive changes, with no carcinoma in situ or high-grade dysplasia. Resection margins were free of malignancy. No metastatic carcinoma was identified in any of the 75 lymph nodes examined. The anterior vaginal wall, uterus, right ovary, and fallopian tube were histologically benign, with no signs of atypia or malignancy. Additional findings included benign intramural leiomyomas within the myometrium, mild urothelial dysplasia in the trigone/bladder neck, and representative tumor tissue submitted for p53 assay. The pathologic staging was pT2bN0MX, indicating muscle-invasive disease without lymph node metastasis."
39,TCGA-FD-A6TA-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of high-grade papillary urothelial carcinoma with significant disease spread and extensive vascular invasion. Metastatic involvement is noted in six out of twenty-seven regional lymph nodes, distributed across both the left and right pelvic lymph nodes. The carcinoma has invaded the extravesicular soft adipose tissue, indicating a tumor stage of pT3b, N2, MX. Margins, including the ureteral and distal urethral, are negative for tumor infiltration. Additionally, the radical prostatectomy specimen shows a prostatic adenocarcinoma with a Gleason score of 3+3, confined to the prostate, without perineural invasion, seminal vesicle involvement, or capsular penetration, denoted as pT2c, N0, MX. Multifocal disease was observed in the bladder with extensive involvement of multiple bladder walls and the trigone, with the largest lesion demonstrating significant depth of invasion. The above findings highlight a complex case with dual primary malignancies warranting a comprehensive oncologic approach."
40,TCGA-DK-A1AA-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the specimens from a 58-year-old male with a large volume high-grade bladder carcinoma revealed significant findings. The radical cystoprostatectomy specimen demonstrated high-grade invasive urothelial carcinoma with mixed papillary and nodular patterns, extensive multicentric growth, perivesical soft tissue invasion, and bladder perforation, but notably without vascular or perineural invasion. Importantly, the surgical margins were clear of tumor involvement. Additionally, non-neoplastic bladder mucosa exhibited proliferative cystitis. The prostate showed adenocarcinoma with a Gleason score of 7, confined within the prostatic capsule and also with clear surgical margins, alongside nodular hyperplasia in non-neoplastic areas. Pelvic lymph node dissections from both the right and left sides yielded benign results with no nodal involvement found in five and eight nodes respectively. Other submitted specimens, including segments from the urethra, ureters, pre-vesical tissue, and small bowel, as well as an abdominal wall hernia sac, confirmed no malignant involvement, either showing benign or unremarkable changes. The overall staging designated the bladder carcinoma at pT3 and the prostate adenocarcinoma at pT2b."
41,TCGA-HQ-A2OF-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of focally papillary adenocarcinoma of the bladder, specifically located at the bladder dome. The tumor demonstrates a moderately differentiated grade (Grade II), consistent with a pathological stage of T3b, indicating invasion into the perivesical tissue. The surgical resection margins are negative for malignancy, suggesting the tumor has been completely excised within the sampled regions. Lymph node involvement has not been assessed in this report, as indicated by the clinical M status (MX). No additional pathological abnormalities were observed in the surrounding tissue, and the preparation utilized fresh frozen tissue from the bladder."
42,TCGA-E7-A7DU-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of papillary urothelial cell carcinoma of the bladder, characterized as well to moderately differentiated (G1/G2, low-grade). The tumor exhibits areas of squamous metaplasia, ulceration, and necrosis, with an intramural evolution that extends through the entire wall of the bladder, classified as stage pT3. The tumor affects the trigone, retro-trigone, and left wall areas, presenting invasive growth with a large implanting base. Additionally, a cystoprostatectomy specimen shows that the prostate and seminal vesicles maintain their normal histological structure. Examination of the right and left ilio-obturator lymph nodes reveals reactive changes, congestion, and sclero-lipomatous dystrophy without evidence of metastasis in the analyzed 14 lymph nodes. The surgical margins are free from tumor involvement, and both ureters exhibit a preserved histological appearance. Overall, these findings support a stage III classification with no regional lymph node metastasis (pN0) and undetermined distant metastasis status (pMx)."
43,TCGA-GV-A6ZA-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive high-grade papillary urothelial carcinoma with focal glandular differentiation arising from the bladder and invading the muscularis propria (detrusor muscle). Notably, the surgical margins, including the ureteral, urethral, and soft tissue margins, are free of tumor involvement. Cystitis cystica et glandularis with mucinous metaplasia is also present. Examination of the excised pelvic lymph nodes revealed no evidence of carcinoma spread, with 0 of 12 nodes positive for malignancy. In the prostate, a minute focus of adenocarcinoma (Gleason score 3+3=6) confined to the prostate was identified, associated with focal high-grade prostatic intraepithelial neoplasia, but there was no evidence of extraprostatic extension or seminal vesicle invasion. Both the bladder and prostate components of the radical cystoprostatectomy demonstrated uninvolved surgical margins. Overall, the pathological stage of the bladder tumor is pT2b NO MX, indicating muscle-invading localized disease without nodal involvement or metastasis."
44,TCGA-H4-A2HO-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a diagnosis of invasive high-grade urothelial carcinoma predominantly involving the urinary bladder, confirmed through a radical cystoprostatectomy. The tumor infiltrated various regions of the bladder, including the trigone, lateral walls, anterior and posterior walls, and dome, affecting approximately 95% of the bladder mucosa. Despite the extensive mucosal involvement, no malignancy was detected in the urethral margin or the biopsies from the left and right distal ureters. Additionally, eight pelvic lymph nodes (four from each side) were examined and found to be free of metastatic disease. Microscopic examination indicated that the tumor extended into the prostatic stroma, as evidenced by superficial peri-urethral prostatic stromal invasion. Importantly, there was no lymph-vascular invasion identified, and all surgical margins were clear of invasive carcinoma, with the closest margin being 7 mm from the serosal radial margin. Pathologic staging classified the primary tumor as pT4a, with no regional lymph node metastasis (pN0) and distant metastasis (pM) not applicable. The specimen also showed findings of urothelial dysplasia and chronic prostatitis, without evidence of high-grade dysplasia or carcinoma in the intraoperative frozen sections."
45,TCGA-K4-A6FZ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of high-grade invasive urothelial carcinoma with extensive squamous and focal glandular differentiation, primarily affecting the posterior wall and dome of the urinary bladder. The tumor extends into the perivesical soft tissue, classifying it as stage pT3a. Associated epithelial lesions include mild to moderate urothelial dysplasia. Examination of the lymph nodes from the left and right obturator areas, as well as the left pelvic region, showed no evidence of malignancy. Additionally, no carcinoma was identified in the examined sections of the left and right distal ureters or their margins, indicating clear margins. The ovaries displayed a serous cystadenofibroma with no presence of malignancy, and the fallopian tubes and vaginal wall were unremarkable. Lymphovascular invasion was noted, but there was no extravesicular mass. Overall, the findings suggest a locally advanced invasive carcinoma without regional lymph node involvement or metastatic spread as per current available data, indicated by pT3a, pN0, pMX staging."
46,TCGA-FT-A3EE-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis reveals invasive high-grade urothelial carcinoma with significant pathological features. The tumor extensively involves the bladder, urethra, vaginal wall, and vaginal mucosa. Importantly, the neoplasm is present at the cauterized circumferential resection margin at the bladder neck and urethra, indicating margin involvement by the carcinoma. Lymphovascular and perineural invasions are also evident, further highlighting the aggressive nature of this malignancy. Regional lymph nodes examined (eight in total) show no evidence of metastasis (0/8), suggesting no regional lymph node involvement. Both right and left distal ureteral margins are free of carcinoma, and the pelvic lymph nodes on both sides are negative for malignancy. Other findings include endometrial cystic atrophy, with the ovaries and fallopian tubes being unremarkable. The tumor's pathological staging is pT4aN0, reflecting its advanced local invasion without lymph node metastasis. This comprehensive histological assessment underscores the extensive local invasion and confirms the aggressive pathological features of the urothelial carcinoma."
47,TCGA-DK-A1AG-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals that the patient has invasive urothelial carcinoma with squamous differentiation, classified as high grade. This tumor fills the bladder lumen and extends through the perivesical soft tissues into the prostatic stroma and periprostatic soft tissue, also involving the seminal vesicles bilaterally. The non-invasive component of the tumor is papillary in nature, and significant perineural invasion is noted. Despite extensive local invasion, vascular invasion is not identified. Surgical margins are free of tumor, and chronic cystitis is observed in the non-neoplastic bladder mucosa. The prostate is extensively involved by the carcinoma, notably with a squamous cell component, as are the left seminal vesicle. The perivesical lymph nodes are not involved by the tumor. All sampled lymph nodes from various sites including the right lymph node of cloquet, left and right pelvic, right common iliac, pre-sacral, node of right fossa Marcelle, and left common iliac regions are benign, with no evidence of malignancy. Similarly, the segments of the right and left vas deferens, and the left ureter, are also benign. The pathological stage is determined to be pT3, reflecting invasion of perivesical soft tissue, and PR2 due to periprostatic or periseminal vesicle soft tissue invasion."
48,TCGA-FD-A3N5-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of high-grade urothelial carcinoma with extensive squamous differentiation, which has invasively penetrated into the muscularis propria of the bladder. The tumor is solitary and involves the right, anterior, and posterior walls as well as the dome of the bladder. Importantly, there is no evidence of lymphovascular invasion. The surgical margins, including the ureteral, distal urethral, and soft tissue margins, are all free of tumor. Additionally, examination of 16 pelvic lymph nodes (nine from the right and seven from the left) shows no metastatic disease. The prostate exhibits high-grade prostatic intraepithelial neoplasia (PIN), but no invasive cancer is identified in the prostate, seminal vesicles, or vas deferens. There is significant chronic lymphoplasmacytic inflammatory response and follicular hyperplasia in the extravesical adipose tissue. The pTNM staging is reported as pT2b, N0, MX, reflecting a tumor extending into the outer half of the muscularis propria with no regional lymph node metastasis and an indeterminate status for distant metastasis."
49,TCGA-ZF-A9R5-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the bladder specimens reveals a diagnosis of high-grade transitional cell carcinoma with mixed papillary and solid growth patterns, incorporating some areas of signet ring cell and sarcomatoid differentiation. The tumor demonstrates extensive necrosis and has invaded the muscularis propria, indicating a classification of at least pathological stage pT2. Tumor margins were evaluated, and there is no evidence of vascular channel invasion. The surrounding urothelium appears non-dysplastic, with a minimal amount of flat urothelium present. Lymph node involvement was not assessed in this examination. Overall, these findings represent a poorly differentiated, aggressive tumor with significant invasion into the bladder wall."
50,TCGA-XF-A9ST-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the radical cystoprostatectomy specimen with bilateral pelvic lymph node dissection reveals an invasive papillary transitional cell carcinoma of the bladder, characterized as high grade. The tumor exhibits extensive necrosis and has invaded into the perivesical soft tissue, with additional identification of lymphovascular invasion. Multifocal urothelial carcinoma in situ is also present within the bladder, while the random bladder mucosa displays reactive urothelial atypia and chronic inflammation within a diverticulum. Importantly, all surgical resection margins, including the radial, apical, and bilateral ureter margins, are free of both urothelial dysplasia and malignancy. The prostate shows benign glandular and stromal hyperplasia, with no evidence of high-grade intraepithelial neoplasia or malignancy. Examination of the lymph nodes reveals no tumor involvement across thirteen dissected nodes, indicating a lymph node status of 0/13. Additionally, extensive vascular calcifications were noted in the perivesical fat. Overall, the pathological stage of the bladder cancer is determined to be pT3bN0MX. Further evaluation with a p53 assay is pending, as representative tumor tissue has been submitted for immunohistological analysis."
51,TCGA-XF-AAMZ-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of extensive and multifocal urothelial carcinoma in situ, along with non-invasive and invasive poorly differentiated papillary urothelial carcinomas, extending through the bladder wall into perivesical soft tissue and exhibiting multiple foci of lymphovascular invasion. The surgical margins of the bladder were free of malignancy, and no malignancy was identified in the final resection margins of both the right and left ureters. Carcinoma in situ was found extending to the apical urethral margin and the urethra. The examination of the cervix, uterus, bilateral fallopian tubes, and ovaries revealed various benign conditions without evidence of malignancy or significant dysplasia. Metastatic carcinoma was present in 5 of 69 lymph nodes examined, particularly in right paracaval, right obturator/hypogastric, and presacral lymph nodes. The pathologic TNM staging is classified as bladder: pTis, T3aN2MX and urethra: pTis, Ta."
52,TCGA-E7-A8O8-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of high-grade infiltrating urothelial carcinoma, stemming from the bladder. The tumor exhibits invasive characteristics, with ill-defined margins and a soft, gray surface. Histologically, the tumor is predominantly dense and displays hyperplastic cells forming papillary and trabecular structures. The tumor cells possess moderate eosinophilic or clear cytoplasm, enlarged nuclei with significant variability in shape and size, irregular nuclear membranes, prominent nucleoli, and abnormal chromatin patterns. Mitoses are present, and the tumor has infiltrated the muscularis propria. Despite the aggressive nature of the carcinoma, the surgical margins are clear of tumor involvement, and there is no mention of lymph node metastasis or additional pathological findings. No evidence of prior neo-adjuvant treatment was noted. The specimen was derived from a cystectomy procedure, confirming the diagnosis of poorly differentiated transitional cell carcinoma."
53,TCGA-E7-A5KE-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathologic evaluation reveals an infiltrating urothelial carcinoma of high grade, involving the bladder. Microscopically, the tumor is characterized by hyperplastic transitional cells arranged in papillary, nested, and cord-like patterns. The neoplastic cells possess moderate eosinophilic cytoplasm and exhibit marked nuclear pleomorphism, with irregular nuclear membranes, prominent nucleoli, and abnormal chromatin. High mitotic activity is noted. The carcinoma has invaded the superficial muscularis propria but does not extend beyond this layer. Importantly, the surgical margins are clear of tumor involvement, ensuring the excision is complete. Additionally, no lymphatic invasion is observed, suggesting there is no regional spread of the malignancy."
54,TCGA-G2-AA3D-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of high-grade urothelial carcinoma of the bladder, characterized by invasive growth into the muscularis propria. Notably, lymphovascular invasion is present, suggesting an elevated risk for metastatic spread. Additionally, fragments of the bladder wall, including areas of muscularis propria, show signs of chronic inflammation and granulation tissue, which is consistent with a previous biopsy site. Margin status is not specified, therefore, the presence or absence of residual tumor at the resection margins remains indeterminate. Lymph node involvement is not mentioned, leaving the nodal status unclear. Collectively, these findings underscore a high-risk malignancy with significant invasive potential and suggest a need for comprehensive clinical management."
55,TCGA-K4-A5RH-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed invasive high-grade urothelial carcinoma with focal sarcomatoid (spindle cell) pattern, primarily located in the right and left trigone of the urinary bladder, following a radical cystoprostatectomy. The carcinoma demonstrated microscopic extravesicular extension. Notably, lymphatic and blood vessel invasion were observed, and there were associated in situ urothelial carcinoma lesions. All surgical margins, including the left and right distal ureter margins, were free of carcinoma. The lymph node evaluation showed no metastasis across nine nodes examined, supporting a TNM stage of pT3a, pN0, pMX. Additionally, benign findings included prostatic hyperplasia. The left and right pelvic lymph nodes, evaluated separately, confirmed the absence of carcinoma in the examined lymph nodes."
56,TCGA-FD-A5BY-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathologic examination revealed high-grade invasive urothelial carcinoma of the bladder, extending through the muscularis propria into the extravesicular soft tissue. Importantly, no tumor was found in the scarring tissue, adjacent ovarian tissue, or in the intestinal segment examined. All surgical resection margins, including the ureteral and distal urethral margins, were negative for tumor involvement. A total of nineteen pelvic lymph nodes, encompassing right and left regions, were sampled and showed no evidence of metastatic disease (0/19). The histological assessment found a solitary tumor on the posterior bladder wall. Given the depth of invasion and absence of lymph node involvement, the tumor is staged as pT3a,N0,MX according to the AJCC 7th edition staging system. These findings support a diagnosis of locally advanced high-grade urothelial carcinoma with negative surgical margins and no regional lymph node metastases."
57,TCGA-GC-A3BM-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings reveal metastatic high-grade urothelial carcinoma involving a serosal implant and initially identified in the bladder. The bladder carcinoma is characterized as high-grade urothelial carcinoma with invasion into the deep muscularis propria and lymphovascular space invasion. Additionally, there is evidence of urothelial carcinoma in situ, but the surgical margins remain uninvolved, and the overall pathological stage is pT2b, N0. The distal margins of the right and left ureters are benign with no pathological abnormalities. Further examination of the prostate shows an incidental finding of conventional adenocarcinoma, which involves approximately 5% of the gland volume and is graded with a Gleason score of 6/10. The prostate carcinoma does not extend extraprostatic, and seminal vesicles, nor does it invade lymphovascular spaces, with benign prostatic hyperplasia also noted. Both the right and left pelvic lymph nodes exhibit benign hyperplasia, and no metastatic carcinoma is identified in the lymph nodes analyzed. Lastly, the vermiform appendix shows no pathological abnormalities."
58,TCGA-FD-A6TK-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of high-grade invasive urothelial carcinoma. The tumor is multifocal, with significant invasion observed in the urinary bladder, specifically advancing through the muscularis propria into the perivesical soft tissue, and extending into the prostatic stroma via the prostatic urethra. Despite thorough dissections, no metastatic involvement was detected in the dissected left and right pelvic lymph nodes (0/25). The left distal ureter was positive for carcinoma in situ without invasive malignancy, whereas the right ureter was free from any tumorous presence. All other ureteral, distal urethral, and soft tissue margins tested negative for tumor cells. Immunohistochemical staining confirmed the diagnosis with CK20 and p53 positivity in the neoplastic urothelial cells of the left ureter. The pathological staging is pT3a, N0, MX, indicating a locally advanced primary tumor without regional lymph node metastasis. The comprehensive assessment underscores the critical areas of invasion and confirms the absence of tumor spread to lymphatic structures and margin involvement, except for the noted carcinoma in situ at the left ureteral margin."
59,TCGA-XF-A9SU-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of high-grade invasive urothelial carcinoma extensively involving the bladder, with invasion reaching the perivesical fat, but sparing adjacent organs such as the uterus and cervix. There is extensive multifocal lymphovascular space invasion. The bladder tumor shows focal trabecular and nested features, with nuclear grades ranging from 3 to 4. Gross examination identifies multiple ulcerations within the bladder, including a tumor near the urethral margin. The urethral margin is positive for carcinoma in situ, with extensive pagetoid spread. The surgical margins of the right and left distal and proximal ureters are benign, demonstrating either no dysplasia or reactive atypia without malignancy. Microscopic evaluation of the cervix reveals carcinoma in situ with glandular involvement, though no invasive cervical squamous cell carcinoma is present. Lymph node assessment indicates metastasis in one left common iliac lymph node and one left external iliac lymph node, with a total of two of 87 lymph nodes showing tumor involvement. The uterus, fallopian tubes, and ovaries exhibit no significant pathologic changes except for small leiomyomata and physiological atrophy. Immunohistochemical studies confirm that the carcinoma in situ in the bladder, urethra, and cervix is of transitional cell origin, indicating related processes with widespread pagetoid spread. The final pathological staging is pT3bN1MX."
60,TCGA-2F-A9KO-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of high-grade muscle-invasive urothelial cell carcinoma with concurrent carcinoma in situ (CIS) located in the right dorsolateral bladder wall. The tumor has penetrated into the muscle layer, corresponding to a T3a staging, but there is no evidence of distant metastasis (N0Mx). Examination of lymph nodes shows no involvement, with all 18 sampled nodes free of tumor localization. The resection margins are not specified in this context, indicating that further clarification may be needed for complete surgical assessment. Overall, the pathology underscores an aggressive tumor with a high-grade histology and significant muscle invasion, yet without regional lymphatic dissemination."
61,TCGA-E7-A6ME-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient is diagnosed with infiltrating urothelial carcinoma, a high-grade aggressive tumor originating in the bladder and demonstrating invasive behavior. The tumor is located on the anterior bladder wall near the bladder neck, characterized by protrusion, ill-defined margins, and a necrotic, soft, gray surface. Microscopically, the tumor cells are arranged in disorganized sheets, nests, groups, and cords, with cells showing moderate eosinophilic or clear cytoplasm and significant nuclear atypia including enlarged nuclei, irregular shapes, and abnormal chromatin patterns. There is evidence of frequent mitotic activity and vascular invasion. The tumor has infiltrated deeply into the outer muscularis propria, indicating extensive local spread. While there is no explicit mention of margin status or lymph node involvement in the provided details, the described features point to a highly aggressive malignancy with potential for further metastasis."
62,TCGA-DK-A3IK-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings confirm a diagnosis of high-grade invasive urothelial carcinoma of the bladder with squamous differentiation, displaying clear cell and squamoid features. The non-invasive component shows papillary and flat growth patterns, while the invasive component is infiltrating. The tumor is multicentric, with local invasion into the perivesical soft tissues and extension into the urethra and periurethral prostatic ducts. There is extensive vascular and perineural invasion. Surgical margins are free of tumor, but the non-neoplastic mucosa demonstrates chronic cystitis and ulceration. A notable finding in the prostate is high-grade prostatic intraepithelial neoplasia (PIN), while the seminal vesicles and perivesical lymph nodes are not involved. Lymph node dissection reveals metastatic involvement in the right and left common iliac lymph nodes, right and left pelvic lymph nodes, and one right pre-sacral lymph node. Notably, extranodal extension is identified in some of these lymph nodes. The right and left vas deferens, as well as the right ureter, are benign. The pathologic stage is pT3, reflecting invasion into perivesical soft tissue, with additional involvement noted in the urethra and prostatic ducts."
63,TCGA-C4-A0F1-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated urothelial carcinoma with squamous epithelial differentiation, predominantly located in the right trigone of the bladder. The carcinoma has penetrated all parietal layers and infiltrated the perivesical fatty tissue. Examination of the lymph nodes reveals that all three lymph nodes are free of tumor involvement. The deep resection margins, including those of the urethra, ureters, and vas deferens, are clear of any tumor presence. Additionally, there are foci of moderate dysplasia within the remaining bladder urothelium. The classification of the bladder carcinoma is pT3b, pNO (0/9), L0, V0, R0, G2."
64,TCGA-XF-A9T4-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of a poorly differentiated urothelial carcinoma of the bladder, which is notably exophytic and invasive, extending into the deep muscularis propria but not involving the perivesical soft tissue. There is no evidence of lymphovascular invasion, and no urothelial carcinoma in situ is identified. The resection margins are free of urothelial dysplasia and malignancy. In the prostate, focal high-grade prostatic intraepithelial neoplasia is present, but no prostatic adenocarcinoma or urothelial malignancy is detected. Examination of various lymph nodes reveals metastatic carcinoma confined to one out of seven right obturator/hypogastric lymph nodes, with the remaining 60 nodes across different regions showing no malignancy. The final pathologic stage is pT2bN1MX. Postoperative analysis includes an assay for p53 by immunohistology on representative sections of the carcinoma, with results pending. Importantly, both distal and proximal ureters, the apical urethral margin, and the bladder's random mucosa, including the trigone and neck, show no malignancy or dysplasia."
65,TCGA-DK-A2I2-01Z-00-DX1,BLCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Bladder, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a primary diagnosis of urothelial carcinoma with extensive involvement and metastatic spread. The right ureter is benign, while the left ureter demonstrates urothelial carcinoma in situ. The dissected lymph nodes from the right common iliac and right pelvic regions show metastatic urothelial carcinoma with extranodal extension, involving all examined nodes in the right common iliac and a subset in the right pelvic. The left common iliac lymph nodes are benign, but the left pelvic lymph nodes exhibit metastatic carcinoma with extranodal extension. The bladder shows a high-grade urothelial carcinoma with mixed histologic features, including extensive carcinoma in situ and an invasive component that infiltrates the perivesical soft tissues and ureters. Vascular and perineural invasions are present, and tumor involvement is noted at the left ureteral margin. Chronic cystitis is identified in the non-neoplastic mucosa. Female genital organs remain largely unremarkable except for benign conditions. The pathologic stage is designated as pT3, correlating with invasive disease extending into perivesical tissues and significant lymph node metastasis with extracapsular extension."
66,TCGA-E2-A15H-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive ductal carcinoma with high nuclear grade, encompassing both invasive and ductal carcinoma in situ (DCIS) components, situated in the right breast mass. The invasive tumor, measuring 1.1 cm, exhibits lymphovascular invasion and has involved the anterior surgical resection margin. The DCIS, exhibiting solid and cribriform patterns with central necrosis and microcalcifications, is observed at the anterior and medial margins and extends close to the posterior and superior margins. Additionally, metastatic carcinoma is identified in one out of four sentinel lymph nodes from the right axilla, classified as micrometastases without extranodal extension. The tumor displays estrogen receptor (ER), progesterone receptor (PR), and HER2 positivity, as confirmed by FISH. The pathological staging is noted as pT1c N1a. The Oncotype DX Breast Cancer Assay reports a high recurrence score of 44, indicating a significant risk of distant recurrence. Post-surgical evaluation reveals biopsy site changes characterized by fibrosis but no multifocality of the tumor. Overall, these findings underscore a moderate-grade carcinoma with notable lymph node involvement and extensive DCIS presence at critical surgical margins, necessitating further clinical management."
67,TCGA-JL-A3YW-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an infiltrating lobular carcinoma (grade II) in the left breast, characterized by intermediate-sized tumor cells with moderate nuclear pleomorphism and eosinophilic cytoplasm. Mitotic figures are present, and there is evidence of moderate chronic inflammation in the surrounding stroma. Focal necrosis is identified but accounts for less than 5% of the lesion. The neoplastic area occupies approximately 70% of the tissue examined. According to the Modified Bloom and Richardson's grading system, it scores as a moderate-grade carcinoma with values indicating moderate differentiation in tubule formation, nuclear pleomorphism, and mitotic activity. The other block of tissue reveals benign breast tissue, highlighting the focal nature of the malignancy. Margin status and lymph node involvement are not specified in this evaluation."
68,TCGA-D8-A1JL-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive ductal carcinoma (IDC) of the right breast, graded as NHG3, indicative of high nuclear grade with prominent mitotic activity. The tumor is situated in the border of the lower inner quadrants. Margins are notably close, with the tumor being 0.1 cm from the base. Immunohistochemical analysis shows the carcinoma is negative for estrogen and progesterone receptors, and HER2 protein expression is also negative (HercepTest score of 1+), classifying this as a triple-negative breast cancer. The glandular tissue adjacent to the tumor exhibits fibrocystic changes and ductal hyperplasia. Examination of the axillary lymph nodes reveals sinus histiocytosis but no metastatic involvement (pN0), suggesting no lymph node metastasis. No other significant pathological alterations were observed in the submitted tissues."
69,TCGA-B6-A0RI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an infiltrating ductal carcinoma with the tumor located in the upper outer quadrant of the right breast. The carcinoma is histologically graded as NSABP histologic grade 3 and moderately differentiated in terms of nuclear grade. The tumor demonstrates vascular invasion and extends close to the deep surgical margin, within a proximity of 0.2 cm. In terms of lymph node involvement, six out of fifteen examined lymph nodes exhibit metastatic carcinoma. The surrounding breast parenchyma away from the mass appears unremarkable. These findings collectively indicate a significantly invasive malignancy with metastatic spread to regional lymph nodes, necessitating further clinical management and therapeutic intervention."
70,TCGA-A8-A0A2-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient has been diagnosed with well-differentiated invasive lobular carcinoma of the right breast. The tumor exhibits circumscribed infiltration into the dorsal resection margin, but the subsequent resection material from the dorsal margin is tumor-free, establishing a tumor-free dorsal margin of at least 1.2 cm. Additionally, the minimum margin at the 3 o'clock position is 0.5 cm, and the follow-up resection material from this position is free of carcinoma, showing moderate mammary fibrosis and focal intraductal hyperplasia without atypia. Other margins, including cranial and caudal, exceed 1.2 cm. There is no lymphovascular invasion present. Examination of fifteen right axillary lymph nodes revealed no metastases, though there was pre-existing lymphatic hyperplasia and slight scarring in isolated larger lymph nodes. The tumor classification is M-8500/3, G 1, pT 2, L 0, V 0, pN 0 (0/15), pMX, R 0, corresponding to Stage IIa."
71,TCGA-B6-A0WS-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of infiltrating ductal carcinoma in the left breast. The tumor is characterized by a histologic grade of 2 out of 3 and a nuclear grade of 2 out of 3, indicating a moderately differentiated neoplasm. The gross tumor size measures 1.6 cm, with the in-situ carcinoma component occupying less than 10% of the tumor volume, exhibiting both solid and cribriform patterns. Importantly, there is no unequivocal evidence of lymphatic or vascular invasion. Surgical margins are negative, with the closest margin being 0.8 cm away from the tumor, ensuring complete excision. The non-tumorous breast tissue demonstrates mild fibrocystic changes. Estrogen receptor analysis is positive, suggesting potential responsiveness to hormonal therapy, while progesterone receptor activity is negative. Overall, these findings indicate a well-characterized tumor with clear margins, supporting a favorable prognosis post-excision."
72,TCGA-E2-A1IH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals an invasive lobular carcinoma of the left breast, specifically located in the upper inner quadrant. The tumor measures 1.5 cm and is classified as SBR grade 2, determined by a tubular score of 3, nuclear grade 2, and mitotic score of 1. The malignancy exhibits a lobular phenotype, confirmed by negative E-cadherin staining. Margins, including additional medial margins, are free of tumor presence, ensuring that no residual malignancy remains in the excised tissue. Histopathological examination of the sentinel lymph nodes from the left axilla shows no evidence of metastatic involvement, both nodes being negative (0/2). Hormone receptor status is positive, with an Allred score of 8 for both ER and PR, while HER2 status is confirmed as positive through FISH analysis with a ratio of 2.28, despite initial immunohistochemical tests being equivocal. The pathological staging is pT1cN0. No vascular or lymphatic invasion is identified, and there is an absence of necrosis and lobular neoplasia. These findings comprehensively characterize the tumor and confirm complete excision with clear margins and no lymphatic spread."
73,TCGA-E9-A244-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of infiltrating ductal carcinoma located in the upper outer quadrant of the left breast. The tumor exhibits a moderately differentiated histologic grade, suggesting an intermediate level of aggression and atypia. There is grossly evident lesion upon inspection. Importantly, the surgical margins are uninvolved, indicating no residual tumor at the edges of the excised tissue. Lymph node analysis reveals that all ten axillary lymph nodes examined are negative for metastatic involvement, suggesting localized disease without regional spread. The Nottingham score, which typically helps in grading the tumor, could not be determined in this case. Overall, the pathological evaluation supports a moderately aggressive tumor confined to the primary site with no lymphatic dissemination."
74,TCGA-BH-A203-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of infiltrating ductal carcinoma in the right breast, characterized by a tumor size of 2.1 cm. The tumor displays extensive lymphatic permeation and cancerization of the ducts, with a poor nuclear grade and a histologic grade of 3. All surgical resection margins are free of tumor, indicating complete excision of the primary tumor. The right axillary dissection yields significant lymph node involvement, with 35 out of 39 lymph nodes positive for metastatic infiltrating ductal carcinoma, several of which exhibit extracapsular spread. The pathological staging is determined as T2 N2 MX, reflecting a locally advanced disease with multiple lymph node metastases."
75,TCGA-E2-A14N-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive ductal carcinoma in the right breast, characterized by a high-grade, multicentric tumor with areas of necrosis. The primary mass is located in the upper inner quadrant, and a secondary mass is present in the central region. Both masses have clear resection margins, with the nearest margin being 0.5 cm from the deep margin. There is no evidence of vascular or lymphatic invasion, and lobular neoplasia is absent. The sentinel lymph node in the right axilla is positive for metastatic carcinoma, while two additional axillary lymph nodes and thirty-five lymph nodes from the axillary contents show no signs of tumor involvement. The left breast reduction specimen displays no pathological changes. Hormone receptor analysis indicates the tumor is negative for both estrogen and progesterone receptors, and HER-2 results are inconclusive, necessitating further FISH testing. The overall pathological staging is pT2N1, reflecting the presence of metastatic involvement in one out of 38 lymph nodes."
76,TCGA-A8-A0A9-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a well-differentiated invasive ductal carcinoma of the left breast, classified as M-8500/3, G1, pT2. The tumor is surrounded by lipomatous atrophic glandular tissue and does not exhibit an intraductal tumor component. The margins of the excised material include a minimum clear margin of 3 mm at the 6 o'clock position. Importantly, there is no evidence of lymphovascular invasion. Sentinel lymph nodes assessed (0 out of 2) show no metastatic involvement, corresponding to a lymph node classification of pSN0. The overall pathological staging is consistent with stage IIA disease, with negative surgical margins indicating an R0 resection."
77,TCGA-AC-A8OQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology examination reveals a diagnosis of invasive ductal carcinoma, classified as Nottingham grade 3, located in the right breast with an associated high-grade ductal carcinoma in situ (DCIS), exhibiting solid type, comedo necrosis, and calcifications. The invasive carcinoma exhibits lymphovascular invasion and measures 3.8 cm. The tumor margins are clear of carcinoma, with the closest margin being the deep margin, situated 0.3 cm from the invasive component. DCIS comprises less than 10% of the total tumor volume and is confined to the periphery of the main tumor mass, also not extending significantly beyond the invasive carcinoma area. One out of two sentinel lymph nodes shows metastatic involvement, with metastatic carcinoma occupying approximately 40% of the involved lymph node volume, but without extranodal extension. The pathologic staging is pT2 pN1a, reflective of a primary tumor size and regional lymph node metastasis, corresponding to stage IIB. The tumor lacks expression of estrogen and progesterone receptors and is negative for HER2/neu, while the Ki-67 proliferative index is markedly elevated at 70%. The findings are consistent with an aggressive tumor phenotype requiring comprehensive oncologic management."
78,TCGA-E2-A1B5-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with invasive lobular carcinoma of the left breast, specifically of the SBR grade 2 type. Pathological examination revealed that the primary tumor measured 2.1 cm, and the invasive tumor was present at the anterior surgical resection margin. An additional retroareolar tissue sample also demonstrated invasive lobular carcinoma at the inked surgical resection margin. Pleomorphic lobular carcinoma in situ (LCIS) markers were noted within the main mass and surrounding densities, with a metallic clip indicating the focus of LCIS. Despite these findings, there was no evidence of vascular or lymphatic invasion. None of the axillary sentinel lymph nodes exhibited metastasis (0/5), indicating negative lymph node involvement. The tumor did not present with necrosis, and it displayed a modular Scarff Bloom Richardson grade of 2 with nuclear grade 2 and mitotic score 1. Although estrogen receptor (ER) and progesterone receptor (PR) exhibited positive results with Allred scores of 8 and 5, respectively, HER2 testing was negative. Pathological staging was recorded as pT2N0, indicating that the tumor was localized without regional lymph node involvement. The overall clinical interpretation suggests an ER-positive, PR-positive, HER2-negative invasive lobular carcinoma with involved surgical margins, warranting further therapeutic evaluation."
79,TCGA-LQ-A4E4-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive lobular carcinoma located in the right breast, characterized by two separate Grade 1 lesions. Histologically, the tumor displayed a total Nottingham score of 5, with scores attributed to tubule formation (3), nuclear pleomorphism (1), and mitotic count (1). The larger lesion was situated in the upper outer quadrant, while the smaller lesion was located in the upper inner quadrant. Notably, no peritumoral intralymphatic tumor emboli, dermal lymphatic involvement, coexistent DCIS, or microcalcifications were present, and the skin and nipple were unaffected. The posterior margin of the invasive carcinoma was involved, while the superior, medial, inferior, and lateral margins were clear. Metastasis was identified in two right axillary sentinel lymph nodes, one exhibiting extranodal extension. Twenty-six lymph nodes were examined, with metastasis observed in two nodes. Additional findings included a benign left breast tissue sample with fibrocystic changes and the involvement of a right modified radical mastectomy specimen showing multicentric cancer. Immunohistochemistry results confirmed the diagnosis of invasive lobular carcinoma evidenced by e-Cadherin negativity. The primary tumor was staged as pT3, with regional lymph node involvement classified as pN1a."
80,TCGA-LL-A5YP-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate the presence of invasive Grade 3 ductal carcinoma in both the left and right breasts, with notable differences in characteristics and extent. In the left breast, the carcinoma is associated with high-grade ductal carcinoma in situ (DCIS) and extensive tumor necrosis. One of two axillary lymph nodes is positive for metastatic carcinoma without extracapsular extension. The surgical margins are free of tumor, with the closest margin being deep. The left sentinel lymph node shows no evidence of carcinoma. Additional findings include neurofibromatosis, fibroadenoma, and proliferative fibrocystic changes. In the right breast, the invasive ductal carcinoma measures larger and also exhibits extensive necrosis, with high-grade DCIS noted but less extensive. Two of twelve axillary lymph nodes are positive for metastatic carcinoma, showing extranodal capsular extension and suspected perinodal venous invasion. Margins are negative, with the closest being superior and medial for the invasive tumor and DCIS, respectively. Both tumors are weakly positive for estrogen receptors with ambiguous HER2/neu status, necessitating further evaluation due to extensive necrosis observed in previous biopsies."
81,TCGA-E2-A1IE-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of right breast invasive ductal carcinoma, moderately differentiated (SBR Grade 2), with focal necrosis and a size of 2.1 x 1.7 x 1.5 cm. The invasive carcinoma is located 0.3 cm from the posterior margin, with all other margins negative. There is lymphovascular invasion present. Additionally, ductal carcinoma in situ (DCIS) of solid and cribriform types, with nuclear grade 2-3 and focal necrosis, is identified, constituting approximately 20% of the lesion. Atypical ductal hyperplasia and microcalcifications are seen in benign epithelium. Three sentinel lymph nodes from the right axilla were examined; one revealed micrometastatic carcinoma (1.5 mm) without extranodal extension, while the remaining nodes were negative for carcinoma. The tumor is estrogen receptor (ER) positive with an Allred score of 8, progesterone receptor (PR) positive with an Allred score of 6, and HER2/neu negative by FISH. The pathological staging is pT2N1. This comprehensive assessment underscores the extent and specific characteristics of the carcinoma and associated pathological features, providing essential information for further clinical management."
82,TCGA-A8-A092-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of moderately differentiated invasive ductal carcinoma, characterized by the presence of focal intraductal components. The tumor exhibited signs of focal angioinvasion, indicating vascular involvement. The surgical margins were assessed and determined to be free of tumor involvement, suggesting a lack of residual disease at the periphery of the excised tissue. Furthermore, an evaluation of the regional lymph nodes identified metastatic involvement in a subset of nodes, highlighting the propensity of the tumor to spread beyond the primary site. Additional pathological findings did not indicate the presence of significant neural or perineural invasion. The overall histopathological profile underscores the aggressiveness of the carcinoma while providing key insights into its extent and potential for further dissemination."
83,TCGA-BH-A201-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma, Nottingham Grade 2, located in the left breast. The invasive tumor simultaneously contains ductal carcinoma in situ (DCIS) of nuclear grade 2, with the invasive component measuring 1.5 cm at its greatest dimension. Notably, the tumor exhibits lymphovascular space invasion and is positive for estrogen and progesterone receptors but negative for HER-2/neu overexpression. The surgical margins are clear of carcinoma, with the nearest margin being 2 mm away from the carcinoma. Examination of the sentinel lymph nodes from the left axilla indicates no evidence of malignancy in either of the two nodes analyzed. Additionally, the pathological stage is classified as pT1a pNO, indicating a small primary tumor confined to the breast without regional lymph node metastasis. The sample reveals associated fibrocystic changes, ductal epithelial hyperplasia, sclerosing adenosis, and calcifications in both benign and malignant areas. No evidence of prior malignancy, chemoradiation therapy, or other diseases is noted in this patient."
84,TCGA-E2-A1LS-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis confirms the primary diagnosis of invasive ductal carcinoma (IDC) in the right breast, specifically situated in the lower outer quadrant. The tumor is characterized as high-grade (SBR Grade 3) with an intermediate nuclear grade and a mitotic score of 3. The invasive tumor measures 1.8 cm, with closely associated ductal carcinoma in situ (DCIS) of solid type and intermediate nuclear grade, comprising approximately 10% of the lesion. Notably, the surgical margins are uninvolved by tumor, with the closest margin being 0.2 cm deep. The analysis of the sentinel lymph nodes from the right axilla reveals no metastatic involvement across all five nodes. Additionally, the specimen exhibits lobular carcinoma in situ (LCIS), biopsy site changes with fibrosis, and two radial scars. No tumor was identified in the left breast skin specimen. The IDC is estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, indicating triple-negative breast cancer. The pathological staging is determined as pT1c N0 according to the AJCC Cancer Staging Manual, 7th Edition. There is no evidence of vascular or lymphatic invasion. The pathological findings also include usual ductal hyperplasia without atypia in the lower inner quadrant and upper inner quadrant, and biopsy site changes in the lower central quadrant."
85,TCGA-A2-A0YI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast specimen revealed a diagnosis of moderately differentiated infiltrating carcinoma, characterized by ductal and lobular features, and classified as nuclear grade I with a low mitotic index. The invasive component comprised two tumor nodules, without lymphatic invasion, and the margins were free of tumor by at least 5 mm. The in situ component accounted for 20% of the tumor. Sections of breast tissue also showed evidence of fibrocystic disease and organizing fat necrosis. Examination of the sentinel and non-sentinel lymph nodes revealed a minute focus of isolated tumor cells in one sentinel node, while the other nodes, including the non-sentinel and second sentinel node, were negative for metastasis. The additional posterior margin of the breast tissue exhibited no residual neoplasm, though fibrocystic changes, duct hyperplasia, intraductal papillomatosis, apocrine metaplasia, and cyst formation were noted. These findings suggest a localized malignancy with limited nodal involvement, comprehensively resected with negative surgical margins."
86,TCGA-AO-A1KR-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings pertain to a bilateral mastectomy performed on an elderly female with a history of right breast invasive carcinoma and left breast atypical ductal hyperplasia. Examination of the right breast revealed an invasive poorly differentiated ductal carcinoma, histologic grade III/III and nuclear grade III/III, with extensive necrosis. There was no evidence of carcinoma involving the nipple, skin, vascular structures, or surgical margins. Additionally, lobular carcinoma in situ, classical type, was identified. Non-neoplastic changes in the right breast included fibrocystic and fibroadenomatoid changes, microcalcifications, and a fibroadenoma with myxoid stroma. The tumor was negative for estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. Examination of sampled sentinel and non-sentinel right axillary lymph nodes revealed no metastatic involvement. The left breast exhibited benign ductal hyperplasia without atypia, columnar cell changes, adenosis, stromal fibrosis, and microcalcifications in benign ducts, with no notable abnormalities in the nipple or skin. Overall, the pathological findings highlight an invasive and aggressive carcinoma in the right breast, with no metastatic spread to the sampled lymph nodes, and benign proliferative changes in the left breast."
87,TCGA-GM-A2DF-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of multifocal invasive ductal carcinoma in the left breast, exhibiting high nuclear grade and Nottingham histologic grade 3. The carcinoma comprises a largest focus and several smaller satellite foci, with evidence of lymphovascular invasion. Associated ductal carcinoma in situ (DCIS), high grade, predominantly cribriform and clinging types, also features prominently, extending across a significant area and nearing various surgical margins. Additionally, metastatic carcinoma is identified in one of the thirty dissected left axillary lymph nodes. Immunohistochemistry demonstrates the tumor's negativity for estrogen and progesterone receptors and lack of HER-2/neu overexpression. Subsequent FISH analysis confirms no HER-2/neu gene amplification. Re-excised tissues from the medial and central anterior inferior margins and additional level I left axillary nodes show benign breast tissue without tumor presence."
88,TCGA-E9-A1R7-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma, evaluated via lumpectomy. The tumor, located in the upper outer quadrant of the right breast, is moderately differentiated and classified as grade 2. Its extent is consistent with a T2 tumor, notable for a size greater than 2 cm but not exceeding 5 cm. Venous invasion is absent, and all surgical margins are clear of malignancy. Examination of ten axillary lymph nodes reveals reactive changes without evidence of metastatic involvement. No involved margins were detected, underscoring a clean resection."
89,TCGA-BH-A0H9-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast segmental mastectomy and axillary sentinel lymph node biopsy revealed an invasive ductal carcinoma (IDC) with a Nottingham grade of 3, corresponding to a total score of 9/9. The invasive tumor measures 2.1 cm at its greatest dimension and is accompanied by ductal carcinoma in situ (DCIS) of solid pattern and nuclear grade 3, comprising roughly 5% of the total tumor volume. The resection margins are negative for carcinoma, with the invasive carcinoma located 1.5 mm from the closest anterior margin. Lymphovascular invasion was not definitively identified, and the carcinoma is associated with microcalcifications and regions of fibrocystic change. Immunohistochemical analysis indicates that the invasive carcinoma is estrogen receptor (ER) positive, progesterone receptor (PR) positive, and HER2/neu weakly positive without amplification by fluorescence in situ hybridization (FISH). The axillary sentinel lymph node biopsy, involving one lymph node, is negative for metastatic carcinoma. Additional highlights include the absence of malignancy in non-neoplastic breast tissue, confirming the pathologic staging as pT2, pNO, and pMX."
90,TCGA-AR-A2LH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast modified radical mastectomy reveals an infiltrating lobular carcinoma, graded as Nottingham grade II with a score of 7 out of 9. The tumor forms a substantial mass centrally located in the breast and is classified as AJCC pT3. Importantly, the carcinoma does not infiltrate the nipple, overlying skin, or underlying chest wall, and all surgical resection margins are negative for tumor, including a clear deep margin. Lymph node involvement is significant, with metastatic carcinoma identified in multiple axillary lymph nodes 7 out of 35 nodes in the attached axillary group and 2 out of 4 nodes in the separately submitted right axillary level 3 group, denoting an AJCC pN3 status. The left breast simple mastectomy shows benign proliferative fibrocystic changes, particularly sclerosing adenosis, with scattered calcifications in benign ducts and no diagnostic abnormalities in the nipple. Further analyses for estrogen and progesterone receptor status and Her-2/NEU expression are pending on paraffin-embedded tissue."
91,TCGA-BH-A0DI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma in the right breast, classified as Nottingham Grade 2. The invasive tumor exhibits tubule formation, nuclear atypia, and mitotic activity, showing a mixed presentation with radial scar and sclerosing adenosis. The invasive component measures 4 cm in its largest dimension, and ductal carcinoma in situ (DCIS) is present, accounting for 15% of the tumor volume. Lymphovascular invasion and microcalcifications are noted within the malignant areas and associated benign lesions. The resection margins are clear of carcinoma. Estrogen receptor (ER) and progesterone receptor (PR) positivity are identified, while HER-2/neu is negative. Sentinel lymph node biopsies indicate metastatic carcinoma presence; nodes show invasive foci with capsular involvement and lymphovascular invasion, including extracapsular extension. Twenty-five lymph nodes are examined and found negative for metastatic carcinoma in the right modified radical mastectomy specimen. Additionally, multiple benign alterations such as atypical lobular hyperplasia, ductal hyperplasia, sclerosing adenosis, and intraductal papillomas are observed. The left breast shows atypical lobular hyperplasia within sclerosing adenosis and other benign changes. The pathologic staging is pT2, pN1a, pMX."
92,TCGA-E9-A1RB-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings are indicative of infiltrating ductal carcinoma (Grade 2) located in the central region of the left breast. The tumor is moderately differentiated and classed as a T2 tumor, indicating a size of more than 2 cm but not exceeding 5 cm. Examination of the surgical margins reveals that they are uninvolved, indicating no residual tumor at the resection edges. Analysis of ten axillary lymph nodes shows no evidence of metastatic involvement, although there are findings of focal fibrosis and lipomatosis. There is no venous invasion observed. These findings are based on the examination of tissue obtained from a radical mastectomy, affirming the absence of metastatic disease in the sampled nodes and the complete excision of the primary tumor."
93,TCGA-5L-AAT0-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the breast tissue from a female patient revealed an invasive lobular carcinoma, grade 1, in the right breast. The tumor is characterized by a central white, firm area, indicating the presence of malignant cells. Immunohistochemical analysis shows that the tumor is e-cadherin negative, with estrogen receptor (ER) positivity in 70% of cells and progesterone receptor (PgR) positivity in 20% of cells, while HER2 is negative with a score of 1+. No specific measurements were provided for the margin status, hence further clinical correlation is recommended to determine if the surgical margins are clear. The pathological findings indicate a low-grade tumor with hormonal receptor positivity, suggesting potential responsiveness to endocrine therapy. Overall, these findings should be considered in the context of the patient's clinical scenario for appropriate management and treatment planning."
94,TCGA-A2-A0EX-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast lumpectomy specimen diagnoses infiltrating lobular carcinoma, classified as moderately differentiated with a Nottingham grade of II and a score of 6 out of 9. The tumor displays a lobular growth pattern with focal tubular formation and measures 2.3 cm in its greatest dimension. No tumor necrosis is observed, but microcalcifications are present. Definitive evidence of venous or lymphatic invasion is absent; however, perineural invasion is noted. Margins analysis reveals the tumor is present at both the lateral and posterior margins, with close proximity to the superior and inferior margins. An intraductal component of lobular carcinoma in situ is also identified, and skin involvement and multicentricity are not observed. Estrogen and progesterone receptors are positive, while HER2 Neu is negative. Lymph node involvement is indicated by rare individual tumor cells identified in the sentinel lymph node. Additional superior margin analysis shows the tumor is less than 0.1 cm from the new true margin. The deep margin excision contains benign breast tissue with no malignancy. The case includes fibrocystic changes such as usual duct hyperplasia, apocrine metaplasia, stromal fibrosis, and microcysts, with a previous biopsy site change also noted. The pathologic stage is designated as pT2 N0 (i+) Mx."
95,TCGA-AR-A1AJ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an infiltrating ductal carcinoma of the right breast, classified as Nottingham grade III, evident as a well-defined mass. Importantly, there is no angiolymphatic invasion observed. The surgical margins are negative for tumor presence, with the closest margin (inferior) being free by an adequate distance. Evaluation of lymph nodes indicates multiple right axillary sentinel lymph nodes and additional right axillary lymph nodes are both negative for tumor involvement. Immunohistochemical analysis with cytokeratin staining confirms the absence of metastatic carcinoma in the sentinel lymph nodes. Furthermore, the assessment for HER2/neu protein overexpression returned negative, with a score of 0, consistent with FDA-approved guidelines."
96,TCGA-BH-A208-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of infiltrating ductal carcinoma, not otherwise specified, in the left mastectomy specimen. The tumor is poorly differentiated and of intermediate nuclear grade. It is extensive, with involvement reaching very close to the resection margin and showing massive vascular permeation, including the nipple area. Additionally, fibrocystic changes are noted in the surrounding breast tissue. Out of fifteen examined axillary lymph nodes, three are positive for metastatic tumor and show both capsular and extracapsular extension, indicating a significant spread of the disease. These findings underscore the aggressive nature of the carcinoma and the extensive involvement beyond the primary site."
97,TCGA-A2-A0YC-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated infiltrating ductal carcinoma of the right breast, classified as Scarff-Bloom-Richardson Grade II/III. The tumor measures 2.6 cm at its largest dimension and has clear surgical margins, with the closest margins being 1 mm from the deep posterior margin and 4 mm from the inferior margin. Sentinel and non-sentinel lymph nodes were sampled, revealing one microscopic metastatic focus approximately 1 mm in size in one sentinel lymph node, confirming lymph node involvement. The remaining sentinel and non-sentinel lymph nodes are negative for metastasis, as confirmed by immunostaining for Cytokeratin. The tumor is staged as IIB, T2, N1mic, MX. Thus, the presence of microscopic metastasis in a single lymph node and clear surgical margins highlights the need for a tailored therapeutic strategy considering lymph node involvement and tumor grade."
98,TCGA-AN-A0XP-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the patient's breast tissue reveals a diagnosis of infiltrative ductal carcinoma located in the breast, corresponding to a primary tumor. The tumor is classified as Grade 2, indicating a moderate level of differentiation. The staging is determined to be T2, reflecting a tumor size that is larger but not extensively advanced, and N1, signifying the presence of metastatic involvement in one to three nearby lymph nodes. There is no evidence of distant metastasis, as indicated by an M stage of 0. Surgical margins are not specified, which suggests the need for careful consideration in clinical management. Adjacent normal tissue from a blood draw appears unremarkable without any abnormalities. These findings are critical for determining the subsequent therapeutic approach."
99,TCGA-OL-A5DA-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast partial mastectomy specimen revealed an invasive lobular carcinoma, classified as SBR grade II, characterized by focal necrosis. The lesion was associated with focal atypical ductal hyperplasia and atypical columnar cell change, while the surrounding breast parenchyma exhibited apocrine metaplasia. There was no evidence of associated ductal carcinoma in situ (DCIS). The tumor margins were free of carcinoma, with the closest margin being 1 mm from the superior edge and all other margins exceeding 2 mm. Importantly, there was no lymphovascular invasion noted. The axillary sentinel lymph node biopsy, which included examination of a single lymph node, was negative for metastatic disease. Immunohistochemical analysis showed estrogen receptor (ER) expression in 68% and progesterone receptor (PR) expression in 66% of the invasive tumor nuclei, while the Her2/neu antigen was non-amplified. Based on these findings, the pathological staging was determined to be pT2, N0(sn), MX. The absence of E-cadherin confirmed the lobular nature of the carcinoma, and intraoperative consultation supported these findings with no metastatic tumor detected in the analyzed sentinel node."
100,TCGA-AR-A2LQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal infiltrating lobular carcinoma in both breasts, classified as Nottingham grade I, with tumors present in multiple quadrants of the right breast and a single mass in the left breast. The tumor on the left forms a distinct mass in the lower outer quadrant, whereas the right breast harbors a multinodular, ill-defined mass with biopsy site changes spanning several quadrants. Both tumors exhibit ductal carcinoma in situ absence but the presence of lobular carcinoma in situ. Neither tumor shows angiolymphatic invasion, involvement of the nipple, overlying skin, or underlying chest wall. Margins of surgical resection for both breasts are negative for tumor, with the closest margin being 0.2 cm. Sentinal lymph node examination reveals isolated tumor cells in one right axillary sentinel lymph node, while all other examined nodes are negative for metastatic carcinoma. Additional findings include fibrocystic changes and benign calcifications across both breasts. The right breast required re-excision to achieve negative margins, confirming invasive lobular carcinoma was 0.2 cm from the new deep margin. AJCC staging results are pT1bN0(i-)(sn) for the left breast and pT3N0(i+)(sn) for the right breast."
101,TCGA-A2-A0D4-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast quadrant revealed a diagnosis of moderately differentiated (Grade II) infiltrating ductal carcinoma with a Nottingham Score of 7 out of 9. The tumor demonstrated venous and lymphatic invasion and was accompanied by an intraductal component of intermediate-grade ductal carcinoma in situ with focal intraluminal necrosis and microcalcifications. The surgical margins were negative for carcinoma, though the tumor was noted to be 0.27 cm from the anterior margin. Additionally, the tumor was estrogen receptor-positive (>95% nuclear staining), progesterone receptor-positive (60-70% nuclear staining), and HER2/neu equivocal (2+ by IHC with FISH pending). The axillary dissection revealed one out of twenty-three lymph nodes positive for metastatic carcinoma, including a 1.4 cm metastatic focus with focal extranodal extension. The pathological stage was determined to be pT2N1MX. Prior biopsy site changes were also noted within the specimen. The findings are consistent with a clinically significant malignancy, necessitating further therapeutic assessment and management."
102,TCGA-OL-A5D8-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathologic diagnosis reveals invasive ductal carcinoma of the left breast, SRB grade II, accompanied by areas of necrosis and ductal carcinoma in situ (DCIS) with high nuclear grade and solid type. Focal Paget's disease of the nipple and uninvolved breast tissue displaying flat epithelial atypia, columnar cell change, usual ductal hyperplasia, and an intraductal papilloma were also identified. The excision margins are free of tumor with DCIS located over 1 cm from the deep margin and invasive carcinoma 5 mm from the deep margin. Although rare microscopic foci suggest possible lymphatic involvement within the breast parenchyma, none of the axillary lymph nodes exhibit tumor involvement (0/4). Immunohistochemical studies demonstrate 100% expression of estrogen and progesterone receptors in the invasive carcinoma cells, while HER-2/neu status is pending. The pathological stage is pT3, N0(sn), MX, indicating a sizable tumor with no sentinel lymph node metastasis, and the distant metastasis status is unknown."
103,TCGA-EW-A1PA-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast lumpectomy revealed invasive ductal carcinoma, Nottingham grade 2, with a notable presence of ductal carcinoma in situ (DCIS), intermediate grade, cribriform type with necrosis. Despite extensive examination, all surgical margins were clear of tumor cells, with a remarkable distance of 1.8 cm from the closest margin. Lymphovascular invasion was confirmed, although no malignancy was detected in the overlying skin. Additionally, multiple microcalcifications were observed. An additional focus of invasive ductal carcinoma, measuring 0.4 cm, was found in tissue superior to the primary tumor, maintaining a clear margin of 1.0 cm. Examination of the left axillary contents revealed metastatic carcinoma in one of thirteen lymph nodes, with extranodal extension and a metastatic tumor size of 2.0 cm. In contrast, the right breast tissue showed no malignancy but did reveal a fibroadenoma. Histological findings characterized the invasive carcinoma as grade 2, featuring glandular differentiation with a score of 3, nuclear pleomorphism with a score of 2, and mitotic count with a score of 2. Importantly, immunohistochemical staining confirmed the presence of estrogen and progesterone receptors, while Her2 scoring was negative (0). These findings culminated in a pathological stage of pT2 pN1a, reflecting primary tumor status and regional lymph node involvement."
104,TCGA-AN-A0FS-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment reveals a diagnosis of breast cancer characterized as infiltrative lobular carcinoma located in the right breast. The tumor is primary, with a moderate differentiation corresponding to a Grade 2 classification. Staging indicates T1, N0, and M0, suggesting a small tumor size without regional lymph node involvement or distant metastasis. Notably, there is no evidence of treatment at this stage. The examination did not extend to blood samples, which were found to be normal upon analysis. The findings emphasize the localized nature of the tumor with no detected spread, providing a foundation for potential treatment options."
105,TCGA-E2-A153-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of invasive ductal carcinoma within the left breast, with multifocal distribution and involvement of the nipple, though there is no skin ulceration. The largest invasive focus measures 2.5 cm, and it exhibits intermediate nuclear grade with ductal carcinoma in situ (DCIS) components of solid and cribriform types, accompanied by central necrosis and microcalcifications. Surgical resection margins are negative, suggesting complete excision of the tumor. Metastatic carcinoma is detected in three lymph nodes out of fifteen examined, with some showing extranodal extension. The right breast reveals lobular carcinoma in situ (LCIS) and fibrocystic changes, along with fibroadenoma and other benign alterations without atypia. The lymph node from the left axilla contains metastatic carcinoma with focal extranodal extension. Estrogen and progesterone receptors are positive, while HER2 is negative. The tumor has been classified as grade 2 per the modified Scarff-Bloom-Richardson grading system, with no vascular or lymphatic invasion identified. These findings collectively outline a complex case with significant malignant pathology predominantly in the left breast, necessitating a comprehensive therapeutic approach."
106,TCGA-A2-A0T1-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast lumpectomy specimen revealed a diagnosis of poorly differentiated invasive ductal carcinoma measuring 7.5 cm at its greatest dimension, extending to the superior inked surgical margin. The tumor also includes a high nuclear grade ductal carcinoma in situ (DCIS) component with central necrosis and calcification, closely approaching the superior surgical margin. All other designated surgical margins are free of tumor involvement. Additionally, the axillary dissection identified ten regional lymph nodes positive for metastatic carcinoma. The pathologic staging of the cancer is T3 N3 MX, corresponding to Stage IIIC, and the tumor has a Scarff-Bloom-Richardson histologic score of 9, indicating a high-grade, aggressive carcinoma. The skin and attached fibro fatty breast tissue margins were negative for malignancy. These findings are critical for guiding further treatment and prognosis."
107,TCGA-BH-A0BZ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma of the left breast, characterized by a high Nottingham score of 8/9 with significant tubule formation, nuclear pleomorphism, and moderate mitotic activity. Lymphovascular permeation was evident, and there is a minor presence of ductal carcinoma in situ (DCIS), specifically the solid and cribriform types with nuclear grade 3, comedo necrosis, microcalcification, and retrograde cancerization of lobules, comprising less than 1% of the tumor volume. Notably, the surgical margins, including the skeletal muscle and nipple, are free of tumor involvement. Additionally, the skin showed benign fibroepithelial polyp without any tumor presence. Immunohistochemical staining revealed positivity for estrogen and progesterone receptors, while HER2/neu was negative. Importantly, one out of twenty-three examined axillary lymph nodes contained metastatic adenocarcinoma. The specimen also exhibited fibrocystic changes with ductal epithelial hyperplasia and columnar cell alterations. These pathological characteristics suggest an aggressive tumor that has shown some degree of lymph node involvement but has been successfully resected with clear margins."
108,TCGA-E2-A14V-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of poorly differentiated invasive ductal carcinoma (SBR Grade 3) in the left breast, with the principal tumor measuring 3 cm in greatest dimension. All surgical margins are free of tumor, with the closest margins being 0.5 cm anterior-superior. Notably, there is lymphovascular invasion, and ductal carcinoma in situ (DCIS) of solid and micropapillary types is present, characterized by high nuclear grade, necrosis, and microcalcifications, located within 3 mm of the superior margin and 4 mm of the posterior margin. The skin excision shows no tumor involvement. Both sentinel lymph nodes demonstrate metastatic carcinoma, with the largest metastasis measuring 1.5 cm and showing focal extranodal extension. Additionally, axillary dissection reveals metastatic carcinoma in 1 of 22 lymph nodes. The tumor exhibits positive estrogen receptor (ER) and progesterone receptor (PR) status, with HER2 also testing positive. The pathological staging is pT2N1, indicating the presence of an invasive tumor larger than 2 cm but not larger than 5 cm, with metastasis in 1 to 3 axillary lymph nodes. The left axillary skin tags are identified as benign acrochordons."
109,TCGA-E9-A1RF-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated infiltrating ductal carcinoma located in the left breast's upper outer quadrant. The tumor size is classified as T2 and falls within the specified range of more than 2 cm but not more than 5 cm. A total of ten axillary lymph nodes were examined, with metastases present in five of them. There is no evidence of venous invasion. The specimen was obtained through a radical mastectomy, and gross examination revealed an evident lesion. These findings suggest a moderately aggressive tumor with regional lymph node involvement, warranting further clinical evaluation for appropriate treatment planning."
110,TCGA-AR-A24N-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals an infiltrating ductal carcinoma of the left breast, classified as Nottingham grade II. The mass is located in the superior region of the breast and features a minor component of ductal carcinoma in situ with an intermediate nuclear grade. Surgical resection margins are confirmed negative for the tumor, with the nearest deep margin at 0.2 cm free of carcinoma. Examination of the left axillary sentinel lymph nodes indicates no presence of tumor in all three sentinel nodes, and an additional non-sentinel left axillary lymph node is likewise tumor-free, supporting an AJCC pN0 staging. Immunohistochemical cytokeratin staining corroborates the initial H&E findings, and a Her-2/NEU analysis is pending on paraffin-embedded tissue samples. The overall pathological findings delineate a localized tumor without lymph node involvement and clear surgical margins."
111,TCGA-A8-A076-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of poorly differentiated invasive ductal carcinoma with discrete intraductal components. The tumor shows no signs of skin infiltration, and the medial follow-up resection material confirms that the carcinoma was completely excised. The tumor is classified as NOS, Grade III, with a pathological staging of pT2N0LOVORO according to the 6th edition (2003). Margins are clear with no residual tumor present in the resection material. There is no evidence of lymph node involvement, vascular invasion, or perineural invasion. The overall pathology indicates a high-grade tumor that has been successfully excised with clear margins and no regional or distant metastasis identified."
112,TCGA-E9-A1R4-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an infiltrating ductal carcinoma located in the upper outer quadrant of the left breast. The tumor, identified as Grade 3 and poorly differentiated, is confined within the T1 classification, indicating a size of 2 cm or less. No venous invasion is present, and the lumpectomy specimen demonstrates clear margins, confirming the absence of cancerous cells at the excised edges. A total of ten dissected axillary lymph nodes were examined, none of which displayed metastatic involvement. Observations of these lymph nodes included focal fibrosis and reactive follicular hyperplasia, with signs of lipomatosis in the fatty tissue. Overall, the critical findings indicate a localized tumor without vascular involvement or lymph node metastasis, suggesting a favorable prognostic profile upon complete surgical excision."
113,TCGA-HN-A2NL-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast surgical resection from a 56-year-old patient revealed a diagnosis of infiltrating mammary carcinoma with lobular features. This high-grade (Grade III, poorly differentiated) tumor exhibited significant malignancy, reflected by a Scarff-Bloom-Richardson (SBR) score of 9. The tumor was classified as T2 with no in situ component. Margin status is not specifically mentioned, but three lymph nodes were sampled and all were found to be negative for metastatic involvement, indicating no regional lymph node metastases (N0, NOS). Additionally, the clinical assessment confirmed the absence of distant metastases (M0). Immunohistochemical analysis demonstrated that the tumor was triple-negative, showing absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. These findings collectively suggest a high-grade, aggressive lobular carcinoma of the breast without regional or distant metastasis."
114,TCGA-A8-A09N-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals invasive ductal breast carcinoma with a high-grade malignancy. The tumor exhibits significant angioinvasion at its periphery and is associated with high-grade ductal carcinoma in situ (DCIS), accounting for more than 10% of the tumor component. The surrounding breast tissue exhibits fibrolipomatous changes and cystic duct ectasia, along with atypical ductal hyperplasia, though no tumor cells are present in these areas. The caudal and dorsal margins are clear of tumor involvement. The tumor is classified as G3 (grade III malignancy), with regional lymph node involvement (pN3a) and no metastasis status confirmed (MX). The resection margins are free of tumor cells, indicating a successful removal of the carcinoma (R0)."
115,TCGA-A8-A08B-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of bifocal poorly differentiated invasive ductal carcinoma, classified as no specific type (NOS) and grade III. The tumors exhibit focal intraductal components and are staged as pT2(multiple) with no lymph node metastasis evident in the sentinel nodes (NO(sn)). Additionally, the lymphovascular invasion (LVI) and resection margins are reported as free of tumor involvement. This summary highlights critical aspects including the multifocal nature, high histological grade, absence of nodal involvement, and clear resection margins, indicating aggressive tumor characteristics without evidence of regional spread."
116,TCGA-BH-A0HU-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of poorly differentiated invasive ductal carcinoma (NOS type) in the right breast, following a segmental mastectomy procedure. The invasive tumor is significant for its high Nottingham grade (grade 3), indicating poor differentiation with high tubule formation, nuclear pleomorphism, and mitotic activity. Ductal carcinoma in situ (DCIS) constitutes 60% of the tumor mass and presents with nuclear grade 3, micropapillary, and papillary types with comedonecrosis. There is lymphovascular space invasion noted. Importantly, while the resection margins are negative for carcinoma, the invasive component extends close to the anterior margin, and the DCIS extends near the lateral and anterior margins. Skin involvement is not identified, and benign changes such as fibrocystic alterations with ductal epithelial hyperplasia are observed. Immunohistochemical staining shows the invasive tumor cells are positive for estrogen and progesterone receptors but negative for HER-2. An additional deep margin specimen reveals no carcinoma. Examination of the right axillary sentinel lymph node shows no evidence of metastatic carcinoma. The case is pathologically staged as pT1c, pN0, pMX."
117,TCGA-AN-A0FT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an infiltrative ductal carcinoma located in the primary site of the right breast. The tumor is classified as Grade 2, indicating moderate differentiation. The cancer is designated as T2N1M0, signifying that the tumor is in Stage 2, has infiltrated nearby lymph nodes, yet shows no signs of distant metastasis. The margins of the excised tumor are clear, indicating no cancer cells at the edges, suggesting that the tumor was likely fully removed during surgery. Additional analyses on a normal blood sample show no pathological abnormalities, providing a baseline with no indications of systemic disease involvement. These findings will be instrumental in guiding further therapeutic decisions."
118,TCGA-AC-A8OR-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an invasive mucinous carcinoma (Nottingham grade 1) located subareolarly in the left breast, with no in situ component. The excised tumor shows no evidence of lymphovascular invasion and is situated at least 3.5 cm away from all surgical margins. Examination of the lymph nodes, including one sentinel and one non-sentinel node, shows no presence of metastatic disease. Other notable findings include focal atypical ductal hyperplasia and fibrocystic changes in the uninvolved breast tissue, as well as benign skin, nipple, and axillary tissue. Pathologic tumor staging classifies the primary tumor as pT1c with no regional lymph node involvement (pN0(i-)(sn)), corresponding to Stage IA. Ancillary studies indicate strong positivity for estrogen and progesterone receptors, negative HER2 status, and a low proliferation index (Ki-67 at 7%)."
119,TCGA-OL-A5D6-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left simple mastectomy and sentinel node biopsy reveals a diagnosis of intraductal apocrine ductal carcinoma with lobular cancerization and rare foci of invasion, along with a separate mass of intraductal and infiltrating ductal carcinoma. The principal intraductal carcinoma is high-grade, showing comedo, solid, and apocrine features with associated necrosis and cancerization of the lobules. The invasive component is high-grade, with significant nuclear pleomorphism and moderate mitotic activity, and includes associated ductal carcinoma in situ (DCIS) comprising half of its volume and extending beyond the main mass. The excisional biopsy margins are clear with no tumor presence within 2mm of the margins; neither blood vessel nor lymphatic invasion is detected. Both sentinel lymph nodes examined are free of tumor, confirming the absence of metastatic disease (0/2). Special studies indicate a lack of estrogen and progesterone receptor expression in the invasive tumor, and HER2/neu status is pending. These findings lead to a TNM classification of pT2, N0, MX. The histological details and comprehensive margin assessment, combined with negative lymph node involvement, provide a comprehensive picture of the disease's current extent and behavior."
120,TCGA-BH-A1F8-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of infiltrating ductal carcinoma of the left breast following a modified radical mastectomy. The tumor exhibits a poor histologic grade and a moderate nuclear grade, with a Nottingham score of 7. The carcinoma measures 4.0 by 3.5 by 3.0 cm and involves the subareolar and nipple lymphatics, as well as the dermis and dermal lymphatics, extending to the epidermis above the tumor. There is a comedo variant intraductal component comprising 10% of the tumor. Importantly, all inked margins, including skin margins, are free of tumor involvement. Examination of the left axilla reveals metastatic involvement in twelve out of thirteen lymph nodes, with prominent perinodal extension identified in six nodes. Additionally, two perivascular tumor nodules lacking recognizable nodal features are observed, indicating extensive metastatic spread."
121,TCGA-A7-A26E-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination primarily confirms a diagnosis of left breast carcinoma, with notable findings of infiltrating lobular carcinoma being the dominant histologic type. The tumor is moderately differentiated (SBR grade 2) and measures approximately 5.5 cm in greatest dimension, classified as pT3. Margin analysis indicates all surgical margins are negative for tumor involvement. One of the left axillary sentinel nodes shows a 3 mm metastasis with minimal extracapsular extension, contributing to a total of 1 out of 16 analyzed lymph nodes being positive for metastatic carcinoma (pN1a). Additionally, the left breast specimen also reveals a minor component of invasive ductal carcinoma and ductal carcinoma in situ, though no Paget's disease of the nipple is identified. Other microscopic findings include a 2 mm invasive ductal carcinoma and areas of lobular neoplasia within the major lactiferous ducts. The right breast tissue contains lobular carcinoma in situ, ductal carcinoma in situ, a small focus of invasive ductal carcinoma (SBR grade 2) less than 1 mm from the inferior margin, and extensive biopsy site changes. The intraoperative lymph node from the left axilla and the 13 additional left axillary lymph nodes are found to be free of metastatic disease. Other breast changes noted include fibrocystic changes and a small fibroadenoma, while signs of vascular invasion raise suspicion for lymphatic involvement, and perineural invasion is present."
122,TCGA-BH-A5IZ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive ductal carcinoma in the left breast, accompanied by abundant lymphoid infiltrate and tumor necrosis. The tumor was classified as Nottingham Grade 3, demonstrating high tubule formation, nuclear pleomorphism, and mitotic activity. Focal ductal carcinoma in situ (DCIS) of solid and cribriform types was also identified, constituting less than 5% of the total tumor volume. Surgical resection margins were negative for invasive carcinoma, with the closest margin being anterior at 0.4 cm. Additionally, atypical ductal hyperplasia and fibrocystic changes with ductal epithelial hyperplasia were noted, alongside changes related to a previous biopsy site. Immunohistochemical profiling showed positivity for estrogen receptors, while progesterone receptors and HER-2 were negative. Sentinel lymph node excisions from the left axilla indicated no metastatic spread in four out of five nodes; however, one non-sentinel lymph node contained metastatic carcinoma without extracapsular extension. The primary tumor size was determined to be 2.2 cm, and the largest focus of metastasis in the lymph node measured 0.6 cm. These findings lead to a pathological staging of pT2, pN1a."
123,TCGA-LL-A73Y-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an infiltrating ductal carcinoma of the right breast, classified as a Modified Nottingham Histologic Grade 3 of 3, characterized by a nuclear score of 3, tubular formation score of 3, and a mitotic rate score of 2. No ductal carcinoma in situ (DCIS) was identified. The invasive tumor is noted to be unifocal. Surgical margins are free of tumor, with the nearest margin being 7 mm from the tumor at the deep margin. Examination of the right sentinel lymph node showed no presence of tumor cells using both routine and pankeratin immunochemical staining methods. Pathologic staging indicates a primary tumor stage of pT1c and no regional lymph node involvement with 0 macrometastases and 0 micrometastases, designated as pNO (i-). Ancillary studies reveal that the tumor is negative for estrogen receptors, progesterone receptors, and HER-2. Overall, the findings indicate a high-grade tumor with no evidence of lymphatic spread."
124,TCGA-S3-AA14-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of grade 3 invasive ductal carcinoma of the right breast, with associated high-grade ductal carcinoma in situ (DCIS) of solid and cribriform patterns, and lobular carcinoma in situ (LCIS) of pleomorphic and classical types. Lymphovascular invasion is present and notably close to the anterior surgical margin but does not involve it. The tumor is assessed to be greater than 10 mm but not exceeding 20 mm in its largest dimension. The surgical margins are clear of invasive carcinoma, with the closest margin being 1.6 mm from the anterior edge. Sentinel lymph node evaluation shows isolated tumor cells in three out of four nodes, with these cells identified via immunohistochemistry but no evidence of macrometastases or micrometastases. Additional findings include intraductal papilloma, fibrocystic changes, and usual ductal hyperplasia. Immunohistochemical studies indicate strong positivity for estrogen and progesterone receptors and HER2/neu positivity. These findings collectively suggest a localized but aggressive tumor with noteworthy microinvasion and lymphovascular involvement, informing a high-risk profile for recurrence and necessitating a comprehensive therapeutic strategy."
125,TCGA-AR-A5QM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with bilateral breast carcinomas, consisting of infiltrating lobular carcinoma in the left breast and infiltrating ductal carcinoma in the right breast, both graded as Nottingham grade II (score 7/9). In the left breast, the primary tumor forms a mass and is classified as pT2 according to the AJCC. Accompanying this are lobular carcinoma in situ and benign duct calcifications. Importantly, there is no angiolymphatic invasion, and all surgical resection margins are negative for residual tumor after re-excision with a minimum margin of 0.8 cm. Both intramammary lymph nodes and left axillary sentinel lymph nodes are predominantly negative for metastatic carcinoma, except for one left intramammary sentinel lymph node positive for isolated tumor cells detected only by cytokeratin immunostaining, classified as pN0(i+).

In the right breast, the infiltrating ductal carcinoma forms a smaller mass, designated as pT1c. Extensive ductal carcinoma in situ with low to intermediate nuclear grade extends from the primary tumor. This component occupies more than 25% of the mass area and spans beyond the invasive portion. Angiolymphatic invasion is identified. Following re-excision of the anterior/medial margin, all surgical margins are clear of residual tumor with a minimum margin of 0.9 cm. Of the 25 right axillary lymph nodes examined, 4 are positive for metastatic breast carcinoma, leading to an AJCC classification of pN2. The largest metastatic focus includes a collection of matted lymph nodes. Blue dye was noted in the sentinel lymph node assessments for both breasts. Immunohistochemical cytokeratin staining confirmed these findings."
126,TCGA-AO-A129-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive ductal carcinoma with medullary features in the left breast, histologically graded as II/III, with marked nuclear atypia (III/III). The tumor is associated with high-grade ductal carcinoma in situ (DCIS), which constitutes less than 25% of the total tumor mass. The carcinoma is localized in the lower outer quadrant, with clear surgical margins and no involvement of the nipple, skin, or vascular structures. The non-neoplastic breast tissue appears unremarkable. Lymph node analysis reveals metastatic involvement in 2 out of 13 nodes at Level I, while Level II nodes show no metastatic involvement. Extranodal extension is noted. Immunohistochemical staining for estrogen receptor (ER), progesterone receptor (PR), and HER2/Neu was negative. On the right side, the breast tissue shows benign parenchyma with secretory changes, and both sentinel lymph nodes examined are benign. A Level III axillary dissection on the left side confirms the presence of two benign lymph nodes. These findings indicate that the invasive carcinoma is aggressive but confined, without distant metastasis in the assessed lymph nodes."
127,TCGA-AO-A03O-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast mastectomy and axillary dissection reveals a diagnosis of invasive ductal carcinoma, NOS type, with histological and nuclear grades III. The tumor is located in the upper outer quadrant and is accompanied by ductal carcinoma in situ (DCIS) of high nuclear grade with extensive necrosis, constituting 25% of the tumor mass. The carcinoma shows evidence of lymphovascular and perineural invasion. Importantly, there is no involvement of the surgical margins, the nipple, or the skin by either invasive or in situ carcinoma. Calcifications are noted within both the invasive and in situ components as well as in the benign breast parenchyma. The non-neoplastic breast tissue exhibits stromal fibrosis and florid ductal hyperplasia. Sentinel lymph nodes from level I of the right axilla are benign, with no metastatic tumor identified on additional H&E and immunohistochemical staining. The total axillary dissection revealed all lymph nodes to be free of carcinoma. Immunohistochemical studies indicate positive estrogen and progesterone receptor status, while HER2/neu is negative (1+ staining intensity)."
128,TCGA-A8-A090-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a moderately differentiated invasive ductal carcinoma within an ablated breast sample, classified as NOS, Grade II. The tumor exhibited an invasive nature consistent with pT2 staging, yet no regional lymph node involvement was detected, corresponding to N0 status. Importantly, the dorsal resection margin was confirmed to be free of tumor cells, indicating successful removal in that area. Additional findings showed no evidence of lymphovascular or perineural invasion. This comprehensive evaluation underscores the localized spread of the carcinoma without metastatic involvement, aligning with its classification."
129,TCGA-AC-A8OP-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast and axillary sentinel lymph nodes reveals a diagnosis of invasive ductal carcinoma, grade 2 according to the Nottingham grading system. The primary invasive tumor, located in the lower inner quadrant, exhibits a solid and cribriform pattern accompanied by ductal carcinoma in situ (DCIS) with comedo necrosis and calcifications. The invasive tumor nodule measures 18 mm, and no evidence of lymphovascular invasion is noted. Resection margins are free of tumor, with the closest margin being 15 mm from the invasive component. The margin status is negative (R0) for both invasive and in-situ lesions, with the DCIS also maintaining a minimum distance of 15 mm from the nearest margin. Six axillary sentinel lymph nodes were examined, all of which were free of tumor involvement (0/6). The pathological stage is designated as IA, with a primary tumor stage of pT1c, no regional lymph node metastasis (pN0(i-)(sn)), and an undetermined distant metastasis status (pMX). Receptor status testing shows the tumor to be estrogen receptor-positive (98% of cells), progesterone receptor-positive (15% of cells), and HER2/neu not overexpressed (IHC score 1+). The proliferation index, marked by Ki-67, is 20%. The skin and nipple are unremarkable, and there is an absence of lobular carcinoma in situ (LCIS). These findings collectively indicate a localized breast cancer without regional or distant spread, with a favorable prognosis given the clear margins and lack of lymph node involvement."
130,TCGA-E2-A56Z-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma in the right breast, characterized by a tumor measuring approximately 3 cm. The carcinoma exhibits papillary and focal mucinous features with a modified Scarff-Bloom-Richardson grade of 2. Extensive ductal carcinoma in situ (DCIS) of high nuclear grade is also present, displaying central necrosis, microcalcifications, and cribriform, micropapillary, and papillary types. Immunohistochemistry results indicate positive estrogen receptor (ER) and progesterone receptor (PR) status. HER2 status remains equivocal and is pending further analysis by FISH. Lymph node involvement includes one metastatic carcinoma in the right axillary sentinel lymph node, with no extranodal extension, and no metastases identified in 15 other axillary nodes. Surgical margins of the right breast excision are negative for tumor, including additional medial superior margin. The left breast biopsy showed no evidence of malignancy, only focal fibroadenomatoid changes with coarse calcifications. Overall, the pathological staging is pT2 N1a."
131,TCGA-AC-A23E-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive ductal carcinoma of the right breast, graded as Grade I based on an architectural score of 1 of 3, nuclear score of 2 of 3, and mitotic score of 2 of 3, with a total score of 5 of 9. The excised tumor shows no evidence of skin or nipple involvement, and the deep surgical margin is free of carcinoma. One of the sentinel lymph nodes from the right axillary region is entirely replaced by metastatic adenocarcinoma, while another sentinel lymph node shows no signs of metastatic disease. The pathologic staging is classified as pT2 pN1 Mx, correlating with the clinical history of ER-positive right breast cancer. The findings align with the preoperative diagnosis and confirm the presence of malignancy within both the breast tissue and at least one lymph node, while other examined nodes are free of metastasis."
132,TCGA-E2-A105-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology evaluation revealed distinct findings for both breasts. The right breast lumpectomy exhibited an invasive mammary carcinoma of the tubulolobular type, categorized as grade I. The excised tumor measured 1.8 cm microscopically and was free of the final surgical margins. Associated findings included low nuclear grade ductal carcinoma in situ (DCIS), usual-type ductal hyperplasia, columnar cell change with hyperplasia, fibrosis, fat necrosis, and hemosiderin, consistent with prior biopsy site changes. The sentinel lymph node from the right axilla was negative for carcinoma. In the left breast lumpectomy, an invasive ductal carcinoma, grade II, was identified, with a tumor size of 3.0 cm. The surgical margins were tumor-free, and the pathology also noted the presence of intermediate nuclear grade DCIS, benign intraductal papilloma, fibrocystic changes with ductal hyperplasia, and fibrosis indicative of a biopsy site. The sentinel lymph node from the left axilla was also negative for carcinoma. Overall, both invasive carcinomas and the regional lymph nodes showed no evidence of tumor spread, with clear surgical margins and the presence of DCIS in both sites."
133,TCGA-A2-A3XY-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast mastectomy with axillary dissection revealed a diagnosis of invasive ductal carcinoma of no special type. The tumor was unifocal, located in the upper outer quadrant, and classified as histologic grade 3, with a Nottingham score of 9/9, indicating a high grade with prominent mitotic activity. Tumor necrosis was present in both the invasive and in situ components, and microcalcifications were noted in the ductal carcinoma in situ and benign breast tissue. The invasive carcinoma was in close proximity to the superficial margin, while the in situ component was also near the superficial and deep margins. Out of 17 lymph nodes examined, 3 were positive for metastatic involvement, with the largest metastatic deposit measuring 1.2 cm and no evidence of extracapsular extension. Ancillary studies showed the tumor was negative for both estrogen and progesterone receptors, with a HER2 result categorized as negative. Additional findings included a fibroadenoma, moderate usual ductal hyperplasia, a small peripheral papilloma, and fibrocystic changes. The tumor's pathologic stage was defined as pT2 N1a, indicating the size and lymph node involvement. The case was amended to include the immunohistochemical results for hormone receptors, reflecting the negative status for both estrogen and progesterone receptors upon reevaluation. Overall, the findings depict a high-grade, hormone receptor-negative invasive ductal carcinoma with limited lymphatic spread."
134,TCGA-BH-A0B9-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating duct carcinoma of the right breast. The tumor is characterized by a high Nottingham score of 9/9, indicating a high grade with poor differentiation (tubules 3), marked nuclear pleomorphism (nuclear 3), and high mitotic activity (mitoses 3). The tumor, classified as basal-like type, lacks estrogen receptors, progesterone receptors, and HER2/neu expression. There is no evidence of lymphovascular invasion. Additionally, ductal carcinoma in-situ (DCIS) of the solid type, nuclear grade 3 with comedo-type necrosis, is present and comprises approximately 3% of the invasive tumor. Importantly, the surgical margins are negative for both invasive ductal carcinoma and DCIS; however, the invasive carcinoma closely approximates the superior margin. The sentinel lymph node biopsy reveals no lymph node involvement (0/1). The skin overlying the tumor is unremarkable. These findings highlight the aggressive nature of the primary invasive carcinoma while indicating no current metastasis to the lymph nodes."
135,TCGA-AR-A1AT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast wide local excision reveals an infiltrating mammary carcinoma with predominantly lobular features, categorized as a solid variant and classified as Nottingham grade III. The tumor score totaling 8/9 indicates high-grade malignancy, characterized by poor tubule formation, marked nuclear pleomorphism, and moderate mitotic activity. The mass formed is consistent with an AJCC stage pT2. Additionally, there is a presence of focal lobular carcinoma in situ. Notably, there is no evidence of angiolymphatic invasion. The non-neoplastic breast tissue exhibits proliferative fibrocystic changes and biopsy site changes. Importantly, all surgical resection margins are free of tumor involvement, with the smallest margin being anterior. Examination of the left axillary sentinel lymph nodes identifies isolated tumor cells in one out of three nodes, consistent with AJCC stage pN0(i+)(sn), detected by cytokeratin-only staining and involving multiple isolated tumor clusters. Immunohistochemical analysis shows an absence of cytoplasmic membrane staining for e-cadherin, confirming the lobular carcinoma phenotype."
136,TCGA-AR-A24Q-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings for the left breast indicate a diagnosis of invasive ductal carcinoma, Nottingham grade III, located in the central-upper inner region. This tumor is classified as AJCC pT3. The deep and lateral margins of resection are negative for tumor involvement, with the closest margin being the deep margin, which is free by a 1.0 cm distance. Importantly, neither the overlying skin nor the nipple is involved by the carcinoma. Similarly, the right breast also displays invasive ductal carcinoma, Nottingham grade III, situated in the upper outer region, and categorized as AJCC pT1c. The deep and lateral resection margins are negative, and the deep margin is free by a 2.8 cm distance, with no carcinoma involvement in the overlying skin or nipple. Lymph node analysis reveals that multiple left and right axillary sentinel lymph nodes are negative for metastatic carcinoma. In total, two left and four right axillary sentinel lymph nodes were examined, with immunohistochemical cytokeratin stains confirming the absence of metastatic disease. Additionally, a Her-2/NEU test has been ordered on the paraffin-embedded tissue from the left breast."
137,TCGA-BH-A5J0-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast segmental mastectomy reveals an 11-mm invasive ductal carcinoma with a Nottingham score of 7/9, indicating a grade 2 tumor based on tubule formation, nuclear pleomorphism, and mitotic activity. The invasive carcinoma is accompanied by ductal carcinoma in situ (DCIS), of solid and cribriform types, with nuclear grade 2 and associated microcalcifications; this spans an area of DCIS extending into the lobules adjacent to the invasive component. Surgical margins are clear of both invasive and in situ carcinomas, with the closest invasive tumor margin being 0.45 cm anteriorly and the nearest DCIS margin being 0.15 cm laterally. Lymphovascular invasion is identified. Lobular carcinoma in situ, classical type, and associated pagetoid extension into ducts are also noted. Additional findings include atypical ductal hyperplasia, atypical lobular hyperplasia, and fibrocystic changes with sclerosing adenosis. Immunohistochemical studies indicate the invasive tumor cells are estrogen receptor-positive, weakly progesterone receptor-positive, and HER-2/neu-negative. Examination of four sentinel lymph nodes from the left axilla shows no metastatic carcinoma in any of the nodes. A small new focus of invasive ductal carcinoma measuring 0.2 cm is found close to the new anterior surgical margin. The final pathologic staging is pT1c pN0, indicating a primary invasive carcinoma with no lymph node involvement."
138,TCGA-BH-A0DH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma in the left breast with associated microcalcifications. The invasive tumor is present at the posterior, inferior, and near anterior resection margins, along with lymphovascular invasion and ductal carcinoma in situ (DCIS) of solid and cribriform types, displaying comedonecrosis. The tumor size is notable, and the Nottingham score is 6/9, based on tubule formation, nuclear grade, and mitotic activity. Among the 28 lymph nodes examined, three show evidence of metastatic adenocarcinoma with extracapsular extension. Additional findings include atypical ductal hyperplasia, ductal papillomas, radial scars, proliferative fibrocystic changes with sclerosing adenosis, and previous biopsy site changes. Immunohistochemical staining reveals positive estrogen and progesterone receptors, while HER-2/neu is negative. A microscopic focus of invasive ductal carcinoma is identified within 0.3 cm of the newly inked resection margin, although the new posterior-lateral margins are free of tumor. The pathological staging is pT2, pN1a, and pMX, indicating tumor spread to regional lymph nodes but no distant metastasis confirmed."
139,TCGA-AC-A2FM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast tissue reveals a diagnosis of infiltrating mammary carcinoma, graded as a moderately differentiated (Grade II) tumor with an architectural score of 3/3, nuclear score of 2/3, and a mitotic score of 1/3. While no significant in situ carcinoma component is present, the tumor lacks angio invasion. The surgical margins are clear of carcinoma, though the closest margin, located deep, is approximately 0.2 cm from the tumor. Additionally, small foci of metastatic carcinoma were noted in the perinodal connective tissue of two sentinel lymph nodes, although these metastases were not within the nodes themselves. These findings were validated through Hematoxylin and Eosin (H&E) staining and confirmed by cytokeratin CAM 5.2 staining. Grossly, the excised breast specimen was notable for the presence of a gray-white dense mass near the lateral aspect extending close to the deep margin and evidencing no other gross lesions or lymph node involvement."
140,TCGA-S3-A6ZH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological diagnosis indicates a high-grade invasive ductal carcinoma of the left breast with extensive metastatic involvement. The primary tumor, located in the upper outer quadrant, displays significant histological features, including minimal tubule formation, marked nuclear pleomorphism, and a high mitotic count, leading to a Nottingham Grade III classification. The tumor invades a substantial portion of the breast and is classified as pT3 due to its expansive size. Lymph node dissection reveals metastatic carcinoma in one of the highest axillary nodes and extensive involvement in thirteen out of nineteen axillary lymph nodes examined during mastectomy and lymphadenectomy. However, one level I axillary lymph node shows no evidence of carcinoma. The surgical margins are clear, with the closest margin being posterior/deep, and the tumor is 15 mm away from this margin. Venous and lymphatic invasion is noted, but no microcalcifications were identified. Additional pathological findings include adenosis and a ruptured, inflamed follicle infundibular cyst in the left axilla. Biomarker analysis reveals that the tumor is estrogen receptor-positive (98%), progesterone receptor-positive (8%), and HER-2/neu equivocal (2+ by IHC, not amplified by FISH). Despite the lymphatic spread, there is no evidence of distant metastasis that could be assessed at this time (pMX). The mastectomy specimen and lymph node dissection provide a comprehensive view of the extent and aggressiveness of the carcinoma, necessitating further clinical management based on these extensive findings."
141,TCGA-BH-A1EY-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma in the left breast, characterized as a grade 2 tumor with a Nottingham score of 6/9. The tumor measures 4.5 x 4.0 x 4.0 cm and is situated less than 1 cm from the deep margin, while all other margins are free from the tumor. Notably, the skin and nipple are uninvolved. Additionally, there is focal atypical ductal epithelial hyperplasia and nodules present. Assessment of twelve lymph nodes indicates no tumor involvement. The tumor is associated with microcalcifications and shows no evidence of lymphovascular infiltration. Immunohistochemistry results are positive for estrogen receptor at 70% and progesterone receptor at 90%, while HER-2/neu immunostaining is negative. These findings collectively provide a comprehensive overview of the pathological status following the left modified radical mastectomy."
142,TCGA-D8-A27H-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the excised right breast lesion reveals an invasive ductal carcinoma (carcinoma ductale invasivum), primarily located at the junction of the upper quadrants. The carcinoma measures 3 cm in diameter according to the intraoperative assessment and exhibits aggressive characteristics with significant mitotic activity, specifically 50 mitoses per 10 high-power fields (HH3 grading: 3+3+3). Immunohistochemical analysis shows the neoplastic cells lack estrogen and progesterone receptors, and the HER2 protein test yielded a negative result (Score = 0), indicating a triple-negative breast cancer phenotype. Critically, the tumor extends to the incision line, suggesting incomplete excision and the potential need for further surgical intervention. Lymph node involvement and other metastatic evaluation are pending further examination of paraffin-embedded specimens. The tumor is classified as pT2, suggesting a moderate size within the TNM classification system. Further microscopic and immunohistochemical analyses will be necessary to confirm the final diagnosis and guide treatment planning."
143,TCGA-AN-A046-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of infiltrative ductal carcinoma in the right breast, identified in the primary tumor site following a radical mastectomy. The carcinoma is histologically graded as 2, indicating a moderate level of differentiation. The T stage is classified as T2, which reflects the tumor's size and extent. Notably, there is no evidence of lymph node involvement (N0) and no distant metastasis (M0). All surgical margins are free of tumor cells, suggesting complete excision. As no prior treatments were administered, these findings represent the unaltered characteristics of the tumor. Additionally, normal blood samples were procured, serving as a baseline for comparison but showing no pathology relevant to the primary diagnosis."
144,TCGA-BH-A0B1-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of multicentric infiltrating ductal carcinoma of the right breast with a Nottingham score of 6/9, indicating a moderate grade tumor based on tubule formation, nuclear grade, and mitotic activity. The invasive carcinoma involves all four quadrants of the breast and has extensive lymphovascular space involvement, including dermal lymphovascular invasion. Both fibrocystic changes with microcalcifications and atypical ductal epithelial hyperplasia are noted. The primary tumor showed a large aggregate size with individual nodules, the largest being 4.8 cm. The margins of resection are free of tumor, with the closest margin being 0.8 cm from the lower inner quadrant deep margin. The skin and nipple also exhibit dermal lymphovascular involvement. In the axillary region, one sentinel lymph node is positive for metastatic ductal carcinoma with focal extracapsular extension; however, the other fourteen axillary lymph nodes are negative for metastatic disease. Additionally, non-neoplastic findings include ductal carcinoma in situ of the solid type with comedo necrosis and focal lobular carcinoma in situ. The left breast, evaluated as part of a breast reduction procedure, shows benign fibrocystic changes with no remarkable findings in the skin. The tumor is estrogen and progesterone receptor-positive, and HER2/neu is negative, providing important prognostic and therapeutic information. The pathological staging is determined to be pT2, pN1, and pMX."
145,TCGA-A8-A079-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the ablated breast sample reveals multifocal poorly differentiated invasive ductal carcinoma. The largest tumor focus exhibits focal ulceration of the skin and circumscribed intraductal spread, with evidence of focal angioinvasion. The dorsal resection margin is free of tumor involvement. The tumor is classified as Grade III, NOS (not otherwise specified), with a pathological staging of pT4b(mult)N3aL1V0R0, indicating multiple large tumor foci, regional lymph node involvement, and the presence of lymphovascular invasion without residual tumor at the resection margins. These findings highlight an aggressive malignancy with significant local and regional spread."
146,TCGA-A2-A0EY-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of a right breast lumpectomy revealed an infiltrating ductal carcinoma (IDC), moderately differentiated with a Nottingham score of 6/9. The carcinoma had an associated intraductal component of nuclear grade 3 with central necrosis. Tumor margins were uninvolved, with invasive carcinoma situated 0.3 cm from the nearest inferior margin. Microcalcifications within both the carcinoma and benign ducts were noted, with no identification of tumor necrosis or venous/lymphatic invasion. Additional excised margins confirmed benign breast tissue without malignancy. Examination of sentinel lymph nodes showed one out of two nodes positive for metastatic carcinoma, with no extracapsular extension observed. Immunohistochemical analysis revealed the tumor to be estrogen receptor-positive, progesterone receptor-negative, and HER2/neu positive, and the pathologic stage was determined as pT2 N1a MX. Additional pathological findings included usual ductal hyperplasia, fibrocystic changes, sclerosing adenosis, and unremarkable epidermis."
147,TCGA-AC-A2FO-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is infiltrating lobular carcinoma of the left breast, with the primary tumor characterized as histologic grade II according to the Elston modification of the Bloom-Richardson grading system. The in-situ component is less than 25% and is identified as lobular carcinoma in situ with a solid architectural type and nuclear grade II, while no comedo necrosis is present. Importantly, the tumor margins are negative, with the closest margin being 1.6 cm deep. Lymphovascular space invasion and skin involvement are both absent. Microcalcifications are not associated with the tumor. Examination of lymph nodes reveals metastasis in two nodes, one from the sentinel lymph nodes (1/2) and another from the non-sentinel lymph nodes (1/8), with the largest metastasis measuring 9 mm and no extracapsular extension observed. Hormone receptor analysis indicates that the tumor is estrogen receptor-positive (95%) and progesterone receptor-negative (0%), with a low proliferative index (<10%) as per the Ki-67 marker. Her2 gene amplification status could not be determined due to technical issues. Additional findings of fibrocystic change with epithelial hyperplasia and benign calcifications were noted. A separate benign solar lentigo on the lip, diagnosed as pigmented actinic keratosis, was also identified. The pathological TNM stage is T2N1MX."
148,TCGA-AC-A62Y-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast modified radical mastectomy revealed two distinct areas of invasive lobular carcinoma, both demonstrating a total histological score of 6 out of 9, classifying them as grade 2 tumors. The architectural, nuclear, and mitotic scores were assessed as 3, 2, and 1, respectively. Extensive lobular carcinoma in situ was present throughout the specimen. Importantly, there was no evidence of angiolymphatic invasion, and both the skin and nipple remained uninvolved by the carcinoma. However, the carcinoma did invade the deep margin of excision. Additionally, an axillary lymph node was found to contain metastatic carcinoma without extracapsular extension. This aligns with a TNM classification of T2pN1, indicating a tumor invasion with regional lymph node involvement. The clinical history confirms an ER-positive, PR-positive, and Her-2-negative breast carcinoma."
149,TCGA-AR-A0TT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an infiltrating ductal carcinoma of the right breast, classified as Nottingham grade III, indicating high-grade malignancy with a Nottingham score of 8/9. The carcinoma forms a defined mass and is staged as AJCC pT2. There is an absence of ductal carcinoma in situ and angiolymphatic invasion. The surrounding non-neoplastic breast tissue exhibits nonproliferative fibrocystic changes. Importantly, all surgical margins are clear of tumor, with the closest margin being the deep margin at 0.5 cm. Examination of the right axillary sentinel lymph nodes shows metastatic carcinoma in three out of six nodes. Additionally, two out of thirteen lymph nodes from the right axillary dissection are also positive for metastatic carcinoma with extranodal extension, classifying the nodal involvement as AJCC pN2. Immunohistochemical testing for Her-2/NEU is currently pending, which will further inform the therapeutic approach."
150,TCGA-A2-A0SX-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast lumpectomy specimen revealed an infiltrating ductal carcinoma that is poorly differentiated, classified as Nottingham grade 3, with a maximum Nottingham score of 9 out of 9. The tumor displays multifocality, with the largest contiguous focus identified. Venous and lymphatic invasion are present. Margins assessment shows that the infiltrating carcinoma is 0.8 mm from the anterior margin, and there are angiolymphatic invasion foci 0.2 mm from the posterior margin. Intraductal carcinoma in situ (DCIS) is also present, which is focal and high-grade. Neither nipple nor skin were sampled, and previous studies have reported hormone receptor and HER2 status. In terms of lymph node involvement, both the axillary contents and the sentinel lymph node are negative for tumor presence by H&E and immunohistochemistry. The final pathologic stage is classified as pT1N0Mx according to the AJCC Stage I criteria."
151,TCGA-D8-A1XA-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast lesion in an adult female diagnosed with breast cancer reveals invasive ductal carcinoma (NHG2, pT1c, pN0 /sn/). The tumor appears to be moderately differentiated, with 5 mitoses observed per 10 high-powered fields. The carcinoma is confined within well-determined margins, with the closest margin to the base being adequately clear. No neoplastic metastasis was found in the examined lymph node. Additional microscopic findings include benign lesions such as sclerosing adenosis and ""blunt duct."" Immunohistochemically, the carcinoma is strongly positive for estrogen and progesterone receptors in over 75% of the neoplastic cell nuclei, but exhibits a negative reaction for HER2 protein expression (Score = 1+). These findings support a diagnosis of hormone receptor-positive, HER2-negative invasive ductal carcinoma."
152,TCGA-A8-A09E-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of poorly differentiated invasive ductal carcinoma within the left-sided ablated breast tissue, characterized by substantial local invasion and aggressive behavior. The carcinoma infiltrates the overlying epidermis, causing slight paracentral erosion, and shows invasion of both lymphatic and blood vessels. The tumor extends to the basal resection margin, indicating incomplete removal of the malignancy at this site. Fortunately, the nipple, along with the lactiferous sinus and other glandular tissue, remains free of tumor involvement, although they exhibit fibrocystic mammopathy. The tumor is classified as M-8500/3, G3, pT4b, pLI, pV1, pN1a (1/11), pMx, indicative of stage III B disease, with one out of eleven lymph nodes demonstrating metastatic involvement and the involvement of lymphatic and vascular structures. The overall assessment underscores the need for further therapeutic intervention due to the residual disease at the resection margin."
153,TCGA-AR-A2LK-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating lobular carcinoma of the right breast, classified as Nottingham grade II (of III). The tumor exhibits a combination of poor tubule formation, moderate nuclear pleomorphism, and low mitotic activity, resulting in a Nottingham score of 6 out of 9. The carcinoma presents as a multi-focal disease, with the primary mass showing angiolymphatic invasion and lobular carcinoma in situ (LCIS) constituting less than 5% of the overall tumor volume. Additionally, two small nodules of similar-grade invasive lobular carcinoma were identified in the lower outer quadrant, neither of which involves the deep surgical margin. Non-neoplastic breast tissues exhibit both nonproliferative and proliferative fibrocystic changes, along with benign calcifications and biopsy site changes. The mastectomy specimen confirmed the absence of tumor involvement in the nipple, overlying skin, and underlying chest wall, with all surgical margins, including the deep margin, being free of residual tumor. However, a significant finding includes the involvement of five out of eighteen right axillary lymph nodes with metastatic carcinoma, characterized by extranodal extension and the presence of a matted mass. The surgical margins following the mastectomy procedure were conclusively free of residual tumor involvement."
154,TCGA-A7-A6VW-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive ductal carcinoma, grade 3, in the left breast. The tumor is characterized by a high histologic grade and measures 3.0 cm at its greatest dimension. Importantly, it is situated close to both the medial and inferior surgical margins, with less than 1 mm and 0.5 mm clearance, respectively, indicating a tight proximity to these boundaries. There is no evidence of vessel invasion or ductal carcinoma in situ. The sentinel lymph node biopsy from the left axilla showed no metastatic involvement in the two nodes examined (0/2). The findings include an identification of the prior biopsy site but do not provide information on distant metastasis (pM). Prognostic markers were assessed in a previous core biopsy. This comprehensive evaluation highlights both the local aggressiveness of the tumor and the clear status of the examined lymph nodes, which is significant for further therapeutic decisions."
155,TCGA-B6-A0IE-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left breast incisional biopsy reveals a diagnosis of poorly differentiated carcinoma characterized by extensive vascular invasion. The tumor exhibits features indicative of lobular carcinoma; however, there is an absence of an in situ component. The biopsy specimen does not include margin assessments as it represents only a fragment of a larger lesion. Lymph node involvement is not addressed in this report, with the focus predominantly on the histopathological characteristics of the carcinoma. Notably, sections of the tissue have been designated for estrogen receptor (ER) and progesterone receptor (PR) evaluation, which will contribute additional information to guide therapeutic decisions. Overall, the pathological findings highlight an aggressive tumor with significant vascular involvement, necessitating further clinical correlation and comprehensive management."
156,TCGA-BH-A0DT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive ductal carcinoma of the right breast, characterized primarily by a Nottingham grade 1 malignancy, which includes moderate tubule formation, nuclear pleomorphism, and low mitotic activity. The invasive component of the tumor measures 1.2 cm at its maximum dimension. Additionally, the breast tissue includes ductal carcinoma in situ (DCIS) of a cribriform pattern with a low nuclear grade, constituting 10% of the total tumor mass and partially detached from the invasive regions. Lobular carcinoma in situ (LCIS) is also present. Importantly, there is no lymphovascular space invasion detected, though the invasive carcinoma does extend to the anterior margin. The nipple is uninvolved by the tumor. Other significant findings include the presence of atypical ductal and lobular hyperplasia, as well as fibroadenoma formation in the non-neoplastic breast tissue. Sentinel lymph node biopsies identified metastatic infiltrating duct carcinoma in one of the four sampled sentinel nodes, measuring 4.0 mm without pericapsular invasion, while the axillary dissection of fourteen lymph nodes showed no evidence of metastasis. Overall, the case summary reflects a primary invasive carcinoma of the breast, staged pathologically at pT1c pN1 pMX, with concurrent presence of DCIS and LCIS, and limited nodal involvement."
157,TCGA-AO-A0J8-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals that the patient has a diagnosis of invasive lobular carcinoma of the right breast, measuring 2.2 cm. The invasive carcinoma is identified as the classical type, confirmed by negative E-cadherin staining, and is accompanied by extensive lobular carcinoma in situ (LCIS) throughout the excised breast tissue and its margins. Importantly, no evidence of calcifications or vascular invasion was observed, and the HER2 status is negative. Lymph node assessment shows one out of two sentinel nodes positive, depicting rare cytokeratin-positive cells (approximately 10), identified only through immunohistochemical staining, consistent with isolated tumor cells (ITC); however, no metastasis was identified in the non-sentinel lymph nodes. Overall, the surgical margins are free of invasive carcinoma, with the medial, superior, inferior, and lateral margins containing LCIS, and the posterior margin displaying benign fibroadipose tissue and skeletal muscle. These comprehensive findings are critical for guiding the patient's subsequent treatment plan."
158,TCGA-AO-A0J7-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate invasive ductal carcinoma of the left breast with two primary foci and additional mucinous carcinoma. The invasive ductal carcinoma involves the nipple dermis and is estrogen receptor positive (ER), HER2 negative. Additionally, ductal carcinoma in situ (DCIS) is present with minimal necrosis. The carcinoma shows high histologic and nuclear grades. Margins are not involved by invasive carcinoma or DCIS, both of which are 3.6 cm from the closest margin. Sentinel lymph nodes exhibit metastasis with macrometastasis to non-sentinel nodes and extracapsular extension in one node. Lymphovascular invasion and tumor emboli in dermal lymphatic channels are noted. Immunohistochemically, the invasive ductal component and mucinous carcinoma exhibit strong ER positivity and absence of HER2 overexpression. The overall findings include malignant involvement of regional lymph nodes and evidence of extensive activity, signaling an advanced stage and high grade of malignancy with multiple areas of involvement."
159,TCGA-D8-A1JS-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a right breast resection specimen from a female patient reveals a diagnosis of invasive papillary carcinoma. The tumor is characterized by solitary foci of ductal carcinoma in situ (DCIS) of the cribriform type, presenting with medium nuclear atypia and lacking necrosis. Margins are notably minimal, raising potential concern for complete excision. Immunohistochemical analysis reveals that over 75% of the neoplastic cell nuclei express estrogen and progesterone receptors, while HER2 is negative. The absence of a myoepithelial cell layer around the invasive lesions is consistent with malignancy, as confirmed by negative p63 and SMA staining and partial CK7 positivity. Ki67 proliferation index is low, with 5% overall and 20% in high-proliferation areas, suggesting a relatively low proliferative activity. There is no reported involvement of lymph nodes, further implying that metastatic spread is not currently evident."
160,TCGA-A2-A0CO-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast and axillary contents reveals a diagnosis of infiltrating lobular carcinoma, accompanied by focal lobular carcinoma in situ and cancerization of terminal ducts, as well as focal ductal carcinoma in situ of solid and cribriform type. The tumor demonstrates strong HER2-neu gene amplification (5.0), indicating a change from previous negative findings in the patient's core biopsy. The tumor exhibits areas of poorly differentiated carcinoma, specifically pleomorphic lobular carcinoma, with microcalcifications present. The deep margin is notably positive for the tumor, while there is no evidence of lymphovascular invasion. Fibrocystic changes, including fibrosis, cyst formation, and apocrine metaplasia, are also identified in the surrounding breast tissue. Examination of eleven axillary lymph nodes reveals no evidence of metastatic involvement, classifying the AJCC stage accordingly. This comprehensive analysis underscores the advanced nature of the malignancy and provides critical insights for future therapeutic approach."
161,TCGA-GM-A2D9-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the left breast segmental mastectomy reveals an invasive ductal carcinoma, well-differentiated (Modified Black's Nuclear Grade 1). The invasive carcinoma exhibits neuroendocrine features but is negative for neuroendocrine markers (chromogranin, synaptophysin, and CD56). The tumor is located close to, but does not invade, the posterior skeletal muscle and is free from vascular or lymphatic invasion. No evidence of metastatic carcinoma is observed in the sentinel lymph nodes from the left axilla. The surgical margins are clear of the tumor, with the closest margin being 1.5 mm at the posterior edge. Additionally, there is a focal area of intraductal carcinoma (DCIS), intermediate grade (Modified Black's Nuclear Grade 2), with micropapillary and cribriform patterns, making up less than 5% of the overall tumor. There is also evidence of focal atypical ductal hyperplasia and proliferative fibrocystic changes. The HER2/neu gene amplification analysis by fluorescence in situ hybridization (FISH) reveals no amplification, and the Ki-67 proliferation index is low at 10%. These findings collectively indicate a well-differentiated invasive ductal carcinoma with clear surgical margins and no lymph node metastasis or HER2/neu gene amplification."
162,TCGA-AO-A125-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of multicentric ductal carcinoma in situ (DCIS) and invasive papillary carcinoma of the left breast. The total mastectomy specimen revealed the presence of both in-situ and invasive components, with the invasive carcinoma measuring 3 cm in total. The DCIS exhibited solid and cribriform patterns and was classified as intermediate nuclear grade, with associated calcifications. Importantly, neither the invasive carcinoma nor the DCIS showed involvement of the nipple, skin, or vascular structures. Margins were close, with both the invasive carcinoma and DCIS being 0.3 cm from the nearest (superior) margin. The mastectomy also revealed non-neoplastic changes, including biopsy site alterations, fibrocystic changes, benign papillomas, and sclerosing adenosis. Immunohistochemical staining showed positivity for estrogen receptor (ER) and progesterone receptor (PR) but was negative for HER2/neu. All five axillary lymph nodes, including four sentinel and one non-sentinel, were found to be benign with no evidence of metastatic disease on deeper recuts and special stains. No metastatic tumor was identified in the lymph nodes based on additional staining (AE1:AE3 and CAM5.2)."
163,TCGA-AO-A0JI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of poorly differentiated invasive ductal carcinoma (IDC) with associated ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) in the left breast, located in the upper outer quadrant. The IDC is histologic grade III/III and nuclear grade III/III, showing high nuclear grade DCIS with minimal necrosis, constituting less than 25% of the total tumor mass. No involvement of the nipple, surgical margins, skin, or vascular structures was detected. The left sentinel lymph nodes demonstrate metastatic carcinoma in one node from level I, characterized by micrometastatic clusters and single cells without extracapsular extension, while the level II sentinel and nonsentinel nodes reveal no metastatic involvement. Additional findings in the non-neoplastic breast tissue include extensive sclerosing adenosis, radial scar, atypical ductal hyperplasia, intraductal sclerosed papilloma with focal atypia, fibroadenoma, and cyst formation. Immunohistochemistry reveals 95% nuclear positivity for estrogen receptor (ER) with strong intensity, but no staining for progesterone receptor (PR), and a HER2 status of negative. The skin overlying the breast shows seborrheic keratosis. These comprehensive pathological assessments provide crucial insights into the tumor's characteristics, metastatic spread, and potential hormone receptor status for tailoring further treatment."
164,TCGA-E9-A228-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right lower inner quadrant of the breast, obtained via mastectomy, reveals an infiltrating ductal carcinoma. The tumor, which is grossly evident, is moderately differentiated. Importantly, two out of twelve dissected subclavicular lymph nodes show evidence of metastatic involvement, indicating lymphatic spread. The remaining ten lymph nodes are free of tumor cells, underscoring a partial nodal involvement. No additional pathologic remarks are noted, providing a focused synopsis of the essential findings necessary for comprehensive case management."
165,TCGA-BH-A0HL-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is invasive ductal carcinoma, papillary type, of the right breast, accompanied by intracytic papillary carcinoma. Pathological examination reveals a Nottingham grade 2 tumor with an overall score of 6/9, consisting of nuclear grade 2, tubule formation score of 3, and mitotic activity score of 1. The invasive carcinoma is noted in a background of ductal carcinoma in situ (DCIS), papillary and micropapillary type, comprising 5% of the tumor mass. The carcinoma does not exhibit angiolymphatic invasion, and all surgical margins are free from both invasive and in situ carcinoma, with the nearest margin being 1.2 cm from the tumor. Notably, metastasis to one of the sixteen examined axillary sentinel lymph nodes was confirmed, indicating extracapsular spread. Histological findings at the biopsy site include organizing hematoma with granulation tissue, fat necrosis, and a foreign body giant cell reaction. Additionally, the nipple and overlying skin show duct ectasia with hemosiderin-laden macrophages within some lactiferous ducts. Overall, the pathological stage is determined to be pT2 pN1 pMX, based on the tumor and lymph node findings."
166,TCGA-AN-A0AT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of infiltrative ductal carcinoma of the right breast, identified as a primary tumor. Following a radical mastectomy, the histopathological examination determined the tumor to be of grade 3, indicating high-grade malignancy with significant cellular atypia and mitotic activity. The tumor qualifies as T2 in staging, pointing to a sizeable presence but confined within the breast with no direct extension to the chest wall or skin. Importantly, there is no evidence of lymph node involvement (N0), and distant metastasis is absent (M0), suggesting no detected spread beyond the primary site. Margin status is clear, indicating that the surgical excision achieved complete removal of the tumor. The accompanying blood sample, obtained through a blood draw and frozen for analysis, serves as a normal baseline for comparative pathological studies."
167,TCGA-A2-A0YJ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left modified radical mastectomy specimen reveals a diagnosis of poorly differentiated infiltrating duct carcinoma with a high nuclear grade and elevated mitotic index. The primary tumor is accompanied by a significant in situ component consistent with high-grade comedocarcinoma and shows substantial invasive characteristics affecting approximately 70-80% of the tumor volume. The neoplasm extends close to the deep surgical margin with an estimated proximity of 1.1 mm. Additionally, there is notable lymphatic space invasion within the breast tissue, particularly in the lower outer quadrant. Axillary lymph node dissection yields metastatic carcinoma in 5 out of 18 nodes examined, indicating significant nodal involvement. The deep margin beneath the primary tumor, evaluated through reexcision, contains skeletal muscle but is free of residual tumor, suggesting clear resection margins at that level. These findings collectively highlight an aggressive tumor phenotype with substantial local invasion and metastatic spread to regional lymph nodes."
168,TCGA-D8-A1JM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","In this case, the histopathological examination reveals a diagnosis of invasive ductal carcinoma of the right breast. The tumor, located at the boundary of the outer quadrants, is characterized as a high-grade carcinoma (Nottingham Histologic Grade 3) with significant mitotic activity and extensive vascular invasion. Additionally, a peritumoral lymphocytic reaction is noted, while the nipple is free from lesions and the surrounding glandular tissue shows signs of parenchymal atrophy. Importantly, there is evidence of metastatic involvement in the axillary lymph nodes, with 3 out of 11 nodes affected. Immunohistochemically, the neoplastic cells display estrogen receptors in less than 10% of the nuclei, while progesterone receptors are absent. The HER2 protein expression is negative, scoring 1+ on the HercepTest. The pathological staging is pT2, indicating the primary tumor size, and pN1a, reflecting regional lymph node involvement. The detailed assessment underscores the aggressive nature of the carcinoma with notable lymphovascular invasion and limited hormone receptor expression, guiding the further management and therapeutic strategy for the patient."
169,TCGA-A8-A081-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a moderately differentiated invasive ductal carcinoma in the ablated right breast sample. The tumor exhibits characteristics consistent with a grade II classification and falls under the NOS category. The evaluation of the tumor margins indicates that the minimum distance to the dorsal margin is relatively close, although the other margins are sufficiently free. The tumor is classified as pT2 due to its size. Importantly, there is no evidence of lymph node involvement (N0) as determined by sentinel lymph node biopsy. Additionally, there is no lymphovascular invasion or any other remarkable pathological findings."
170,TCGA-AR-A1AH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed infiltrating ductal carcinoma of the right breast, classified as Nottingham grade III. The tumor is located in the medial portion of the breast and exhibits extensive angiolymphatic invasion. Surrounding breast tissue displays proliferative fibrocystic changes with sclerosing adenosis and calcifications. Both the nipple and skin are free from diagnostic abnormalities. Surgical margins, including the deep margin, are clear of tumor involvement. One of the two right axillary lymph nodes examined shows micrometastatic carcinoma, with the remaining lymph nodes, including those from a subsequent dissection, being free of tumor. The excised right axillary low region contains fibroadipose tissue without lymph node tissue or tumor. Immunohistochemical staining indicates focal estrogen receptor positivity (1-10%), while progesterone receptor staining is negative. HER2/neu protein expression is also negative, scoring 0 as per the HercepTest guidelines."
171,TCGA-BH-A18P-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma located primarily in the lower inner and outer quadrants of the left breast. The tumor exhibits a Nottingham Score of 7/9, signifying moderate differentiation, and extends to within close proximity of the inner lower quadrant margin. Histologically, the carcinoma shows evidence of associated microcalcification and encompasses an area of ductal carcinoma in situ (DCIS), nuclear grade 2, solid type with comedo necrosis, comprising 10-15% of the overall tumor volume. Margins are clear of invasive carcinoma, and the remaining breast tissue displays fibrocystic changes, sclerosing adenosis, and microcalcifications. The skin and nipple are unremarkable. Three examined lymph nodes from the left axilla show no evidence of metastatic carcinoma, confirmed by negative AE1/AE3 immunostains. Hormone receptor analysis reveals the tumor is estrogen receptor (ER) positive and progesterone receptor (PR) negative. HER-2/neu status is weakly positive by immunohistochemistry with borderline amplification confirmed by fluorescence in situ hybridization (FISH), showing a HER-2/neu to chromosome 17 centromere signal ratio of 2.05. These findings provide a comprehensive overview of the tumor's biological characteristics and its potential implications for treatment."
172,TCGA-AC-A5EH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings for the patient indicate a diagnosis of invasive ductal carcinoma in the left breast, characterized by two foci located in the lower outer and inner quadrants. Both foci exhibit Nottingham grade 2 features. Associated with this are regions of ductal carcinoma in situ (DCIS) with intermediate nuclear grade, cribriform, and micropapillary patterns, spanning a significant portion of the tumor. Margins of resection are clear of both invasive and in situ carcinoma. There is one focus suspicious for lymphovascular invasion. Among the fourteen axillary lymph nodes examined, one shows micrometastatic carcinoma without extranodal extension. The surrounding breast tissue shows benign changes, including fibrocystic changes and vascular calcifications, while the skin and nipple are uninvolved. The tumor is classified as pT2 with regional lymph node status pN1(mi), confirming stage IIB. Ancillary studies reveal positive estrogen receptor expression in both foci, negative progesterone receptors, and HER2 negativity. The Ki-67 proliferation index is high in both lesions."
173,TCGA-A8-A07U-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast resection material reveals a poorly differentiated invasive ductal carcinoma. The tumor measures 2.2 cm and is classified as grade 3 (G3), staged as pT2, pN2a, pMX, and overall stage IIIA. The surrounding fibrolipomatous and atrophic glandular tissues show no evidence of an intraductal tumor component. Surgical margins are clear with a minimum margin of almost 1 cm at specified locations basally and at 6 o'clock, indicating R0 resection status with no residual tumor. Additionally, the overlying skin and nipple are free of tumor involvement. The presence of metastatic carcinoma is observed in multiple regional lymph nodes, confirming a classification of pN2a. No information is provided regarding distant metastasis, noted as pMX."
174,TCGA-A8-A09K-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected left breast segment reveals a poorly differentiated invasive ductal carcinoma. The tumor was excised with clear resection margins and no carcinoma involvement in the skin. Surrounding tissue exhibited fibrous mastopathy. The tumor has been staged as pT1c pN1mi, indicating the presence of intranodal micrometastasis. No distant metastasis could be assessed (MX), and the excision achieved a complete resection (R0). Histological grading indicates a high-grade tumor (G3) with no evidence of lymphovascular invasion (L0, V0). Overall, the pathology suggests a localized yet aggressive breast carcinoma with minimal lymph node involvement."
175,TCGA-A8-A0AD-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive breast carcinoma of mixed differentiation, displaying both ductal and lobular components. The malignancy is graded as II and the largest tumor diameter is noted to be 1.5 cm. Importantly, there is no evidence of angioinvasion or coarse calcification. The tumor exhibits clear surgical margins with a minimum ventral safety margin of 0.5 cm, and no atypical features are detected in the fibrolipomatous breast parenchyma or adjacent skin spindle. The tumor is classified as pT1c, indicating a size greater than 1 cm but not more than 2 cm, and there is no lymph node involvement with four sentinel lymph nodes examined (pN0 sn). The resection margins are tumor-free (R0), and the absence of distant metastasis could not be assessed (MX). Overall, the pathological profile underscores a moderately differentiated breast carcinoma without regional lymph node metastasis."
176,TCGA-A7-A26G-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive ductal carcinoma with metaplastic features in the right breast, characterized as a high-grade tumor with an overall histologic grade of 3. The invasive carcinoma, measuring 2.3 cm, was identified alongside ductal carcinoma in situ (DCIS) of a solid histologic pattern, without evidence of central necrosis. Importantly, the surgical margins were free of tumor involvement. The nipple showed lobular neoplasia without evidence of ductal carcinoma, supported by diminished e-cadherin immunostaining. The right axillary sentinel lymph node did not show definitive presence of tumor on H&E stained sections, though isolated keratin-positive cells were observed. No definite vessel invasion or skin involvement was noted. Additional findings included fibrocystic changes, biopsy site alterations, and the presence of a squamous papilloma in the skin. The case was reviewed in an intradepartmental consultation, confirming these interpretations."
177,TCGA-BH-A1EV-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast tissue following a modified radical mastectomy revealed an infiltrating and intraductal carcinoma with a poor nuclear grade. The cancer was characterized by multifocal and diffuse masses, including a comedo-type intraductal carcinoma that comprised approximately 35% of the tumor volume and extended to involve the large nipple ducts, where Paget's disease was present. Immunohistochemical staining demonstrated positive results for estrogen receptors (ER, 90%), progesterone receptors (PR, 40%), and HER-2/neu (score 2+, 30% membrane staining). Fortunately, the surgical margins were free of tumor involvement, though the tumor did involve all four quadrants of the breast. Additionally, metastatic carcinoma was observed in three out of ten axillary lymph nodes. Tumor vascular space involvement was not prominent. This comprehensive set of findings provides critical information for determining the prognosis and guiding therapeutic strategies for the patient."
178,TCGA-E2-A570-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast mastectomy specimen reveals a diagnosis of invasive ductal carcinoma, SBR Grade 1, and is 1.5 centimeters in size. Associated ductal carcinoma in situ (DCIS), comprising solid, cribriform, and micropapillary types, is present, with microcalcifications and central necrosis. Importantly, DCIS was observed within close proximity (1 mm) to the anterior inferior surgical margin, though all surgical resection margins were clear of invasive tumor. Additional findings included lobular carcinoma in situ and changes consistent with previous biopsy. Examination of the sentinel lymph nodes from the right axilla identified metastatic carcinoma in one of the seven nodes, specifically noted as micrometastasis without extranodal extension, while the remaining six nodes were free of metastases. There was no evidence of tumor in the skin submitted for evaluation. Immunohistochemical testing for estrogen receptor (ER) and progesterone receptor (PR) was positive, while HER2 was negative. The comprehensive pathological stage is classified as pT1c N1mi."
179,TCGA-A2-A1G6-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right modified radical mastectomy specimen reveals a diagnosis of in situ and infiltrating ductal carcinoma of the breast. The tumor is moderately differentiated with a high nuclear grade and a moderate mitotic index. The carcinoma extends into the dermis and comprises a predominantly invasive component. Notably, areas suggestive of lymphatic space invasion within the breast are present, although no invasion into dermal lymphatic spaces is detected. The deep margin is free of tumor. Metastatic carcinoma is identified in four out of nine lymph nodes examined, indicating lymph node involvement, while the highest lymph node is grossly negative. Skin margins closest to the tumor are unremarkable, and a separate medial skin sample shows no evidence of malignancy. Additionally, proliferative fibrocystic changes are noted in tissues distant from the primary tumor."
180,TCGA-A2-A4S0-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive mucinous carcinoma of the breast. The mastectomy specimen includes two Grade I tumors with nuclear grade 1 and a low mitotic index, located in the right breast. The primary tumor measures 4.5 cm in its greatest dimension and is situated 2.5 cm from the deep margin, while a smaller adjacent tumor measures 1.0 cm. Both the nipple and deep surgical margins are free of neoplasm. The examination of the breast tissue also identifies biopsy site changes with clips present, as well as proliferative fibrocystic disease with calcifications. Notably, no lymphatic invasion is identified. The right sentinel lymph node, which is pink-tan with blue coloration and was excised during surgery, is negative for tumor involvement upon step section and cytokeratin staining. This comprehensive examination indicates clear surgical margins and no metastatic spread to the sentinel lymph node, suggesting a localized malignancy without evident lymphatic dissemination."
181,TCGA-BH-A0BJ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma, NOS type, moderately differentiated, located in the left breast, confirmed via segmental mastectomy. The primary tumor maintains a Nottingham score of 6/9, demonstrating intermediate differentiation (tubule formation 2, nuclear grade 2, mitotic activity 2). No lymphovascular invasion is detected. Ductal carcinoma in situ (DCIS), specifically solid and cribriform subtypes of nuclear grade 2, constitutes 25% of the total tumor volume. Notably, all resection margins are clear of both in-situ and invasive carcinoma, with the closest margin being 1 mm away. Additionally, non-neoplastic changes such as fibrocystic changes, ductal epithelial hyperplasia, columnar cell hyperplasia, atypical ductal hyperplasia, sclerosing adenosis, and biopsy site changes are present. Hormone receptor testing reveals the tumor is estrogen and progesterone receptor-positive but HER-2/neu negative (IHC score 1+).

Regarding lymph node involvement, a biopsy of one sentinel lymph node reveals metastatic carcinoma with extracapsular extension, while four other lymph nodes are benign. The pathological staging is pT2 for the primary tumor and pN1 for lymph node involvement. Non-invasive breast tissue findings include atypical ductal hyperplasia and fibrocystic changes."
182,TCGA-BH-A18J-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of Stage IV right breast cancer, characterized by an infiltrating poorly differentiated duct carcinoma occupying all four quadrants and presenting with notable extension to the nipple and epidermis of the ulcerated overlying skin. The tumor shows significant positive intranuclear staining for estrogen receptor (ER: 50%) and progesterone receptor (PR: 40%), while HER-2/neu status is negative. The Nottingham grading system yields an aggregate score of 8/9, indicating high-grade malignancy due to prominent tubule formation, marked nuclear atypia, and a moderate mitotic index. Despite extensive tumor involvement, the surgical margins are clear of cancer. The presence of multiple severely matted axillary lymph nodes with extensive extracapsular extension underscores a considerable metastatic burden, preventing an accurate lymph node count due to almost complete architectural effacement. Only a minor portion (<5%) of the total tumor is identified as intraductal carcinoma of the comedo-type. These comprehensive findings delineate a highly aggressive and advanced carcinoma with significant pathological challenges."
183,TCGA-EW-A1P4-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal adenocarcinoma of the left breast, characterized by a high nuclear grade and a prominent tumor size. The tumor is noted to be estrogen receptor (ER), progesterone receptor (PR), and HER2-negative, while being positive for HLA-DR, suggesting a medullary subtype. Importantly, the surgical margins are clear of tumor involvement, with the nearest margin being sufficiently close but uninvolved. Microscopic examination revealed florid adenosis and stromal fibrosis but no microcalcifications. The invasive component demonstrates a high degree of nuclear pleomorphism and minimal tubule formation, resulting in a Nottingham score corresponding to Grade II. All sentinel lymph nodes examined were free of malignancy. No evidence of venous or lymphatic invasion was present, and distant metastasis could not be assessed. Overall, these findings provide a comprehensive overview of the cancer's local extent and molecular characteristics, crucial for guiding further treatment and management."
184,TCGA-AR-A5QQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings describe a diagnosis of moderately differentiated squamous carcinoma (metaplastic carcinoma) present in the right breast, specifically involving the mammary parenchyma and forming a mass centrally located with ulceration of the overlying skin. There is evidence of angiolymphatic invasion. Additionally, the surrounding breast tissue shows nonproliferative fibrocystic changes. Notably, one of three intramammary lymph nodes is positive for metastatic carcinoma, forming a solid and cystic mass in the lateral aspect of the breast, with evidence of extranodal extension. Despite the significant tumor involvement, all surgical resection margins, including the skin and deep margins, are negative for tumor. The skin and nipple-areolar region is also involved by the tumor. Estrogen receptor, progesterone receptor, and HER2 status are pending further testing. Furthermore, an excision of multiple right axillary lymph nodes reveals no metastatic carcinoma, involving a total of 21 lymph nodes. Overall, with the available surgical materials, the staging is consistent with AJCC pT3N1."
185,TCGA-EW-A6SC-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of invasive lobular carcinoma, moderately differentiated (Nottingham grade 2), located in the left breast. The tumor site is at the 1 o'clock position, and immunohistochemistry demonstrates that the tumor cells are estrogen receptor (ER) positive (>50%), progesterone receptor (PR) positive (10-50%), and HER2 negative. E-Cadherin is negative, consistent with invasive lobular carcinoma. The lumpectomy specimen's resection margins are free of carcinoma, although there are prior biopsy site changes and atypical ductal hyperplasia noted. No skin is present in the specimen. Two sentinel lymph nodes have been identified and both are free of carcinoma, confirmed by immunohistochemistry for keratin. No lymph-vascular invasion is observed. Pathologic staging classifies the primary tumor as pT2, with no regional lymph node metastasis (pNO). Microcalcifications are noted in the invasive carcinoma. Final AJCC classification will be confirmed post-keratin immunostain, which has since returned negative for both sentinel nodes, thereby supporting a prognosis void of lymph node metastasis."
186,TCGA-A8-A07S-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive breast carcinoma of mixed differentiation located at the 3 o'clock position in the left breast. The tumor is classified as pT2 and grade 1, indicating a well-differentiated neoplasm with a relatively favorable prognosis. Margins were assessed and found to be positive (R1) on the ventral aspect, warranting further clinical consideration for complete surgical excision. Additionally, there is an associated extensive lobular neoplasia and ductal carcinoma in situ (DCIS) of grade 1, identified as pTis with positive margins on the ventral side as well. These findings underscore the presence of both invasive and non-invasive carcinomatous components, necessitating a multidisciplinary approach to treatment. Lymph node status and other relevant anatomical structures were not specified, suggesting additional workup may be required to fully stage the disease and plan appropriate management."
187,TCGA-BH-A0H7-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast modified radical mastectomy reveals multifocal infiltrating ductal carcinoma, which is Nottingham grade 2, characterized by a nuclear grade of 3, tubule formation score of 3, and mitotic activity score of 1. The analysis identified two primary tumors, with the largest located within the upper outer quadrant and measuring 1.5 cm, while the second tumor is positioned at the junction of the upper outer and upper inner quadrants, measuring 1.2 cm. Both tumors are morphologically similar and share extensive lymphovascular invasion. Surgical margins are clear, although the invasive tumor approaches most closely to the posterior margin of the 12 o'clock lesion. Associated with these tumors, ductal carcinoma in-situ (DCIS), nuclear grade 2, cribriform type, comprises approximately 5% of the tumor mass. Examination of lymph nodes revealed metastatic carcinoma in six out of sixteen axillary lymph nodes, with the largest nodal metastasis measuring 1.1 cm and evidence of extracapsular extension. The remaining non-neoplastic breast tissue shows fibrocystic changes and fibroadenoma, while the nipple, skin, and skeletal muscle are not involved with neoplasm. Additionally, the pathology reports pronounced calcific atherosclerosis. Moreover, both estrogen and progesterone receptors are positive, with HER2/neu status being negative."
188,TCGA-E9-A226-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient underwent a radical mastectomy of the left breast, with the primary tumor located in the lower inner quadrant. Pathological evaluation revealed an infiltrating ductal carcinoma that is moderately differentiated. The tumor extends to the skin but does not involve the surgical margins, indicating clear margins. There is significant lymph node involvement, with 6 out of 10 axillary lymph nodes positive for metastasis. These findings are critical for determining the prognosis and potential treatment strategies."
189,TCGA-BH-A0BP-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals the presence of two foci of infiltrating ductal carcinoma in the left breast's upper outer quadrant, with a combined tumor aggregate measuring approximately 2.2 cm. The invasive carcinomas demonstrate a moderate Nottingham score of 6 out of 9, indicating moderately differentiated tumors with scores of 3 for tubule formation, 2 for nuclear pleomorphism, and 1 for mitotic activity. Ductal carcinoma in situ (DCIS) with comedo necrosis comprises 10% of the tumor volume and is associated with microcalcifications. The invasive carcinoma and DCIS are narrowly close to the respective anterior and posterior surgical margins but are not involved. Additionally, no prominent lymphovascular invasion is noted. Three sentinel lymph nodes sampled from the left axilla show no evidence of metastatic involvement. Other associated pathological findings include fibrocystic changes with atypical ductal epithelial hyperplasia, sclerosing adenosis with microcalcifications, and a microscopic radial scar. The pathologic staging classifies the disease as pT1c, pN0, and pMx. Estrogen and progesterone receptor status, along with HER2/neu protein expression, were previously evaluated, affirming the absence of HER2 overexpression."
190,TCGA-A7-A3J0-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast excisional biopsy reveals an invasive mucinous carcinoma, classified with a Nottingham grade of 1, indicating a low-grade tumor. Histologically, the tumor shows a high architectural score of 3, but low nuclear and mitotic scores of 1 each, signifying well-differentiated cells with minimal proliferative activity. The mitotic index is low, with only 4 mitoses observed per 10 high-power fields. Importantly, the surgical margins are free from malignancy, with the closest approach being 1.9 mm from the anterior (red) margin. No vascular invasion is identified, nor is there any tumor-related calcification. The adjacent non-tumorous breast tissue exhibits benign fibrocystic changes, including cyst formation, sclerosing adenosis, columnar metaplasia, intraductal epithelial hyperplasia without atypia, benign calcifications, and apocrine metaplasia. Furthermore, examination of the sentinel lymph nodes from the right axilla shows no evidence of metastatic carcinoma in either of the two nodes analyzed, indicating no lymph node involvement. Based on these findings, the tumor is staged as T2 N0."
191,TCGA-BH-A0DZ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation following a left total mastectomy reveals lobular neoplasia (atypical lobular hyperplasia), along with fiboadenoma, ductal epithelial hyperplasia, and fibrocystic changes. The skin and nipple sections show no presence of tumor. In the right total mastectomy, an infiltrating ductal carcinoma of the NOS type is identified, which is moderately differentiated and multifocal, located at the junction of the upper outer quadrant and upper inner quadrant, as well as within the upper outer quadrant. The tumor exhibits a Nottingham score of 6/9, corresponding to an overall grade of 2/3, with no definitive lymphovascular invasion identified. A portion of the tumor is comprised of ductal carcinoma in situ, solid type with comedo necrosis, extending into the lobular region, representing 25% of the tumor volume. The resection margins are clear of both invasive and in situ carcinoma, with the closest anterior margin being 7mm away. Additional findings include atypical ductal hyperplasia, previous biopsy site changes, fibroadenoma, pseudoangiomatous stromal hyperplasia, and columnar cell change. Both the skin and nipple sections are free of tumors. Immunohistochemically, the tumor is ER-positive, PR-positive, and HER2/neu strongly positive. Sentinel lymph node biopsy of the right axilla reveals metastatic carcinoma in one lymph node with focal extracapsular extension, while additional sampled lymph nodes are benign with no evidence of tumor. Overall, the findings indicate a primary invasive carcinoma of the right breast, confirmed through a simple mastectomy procedure."
192,TCGA-BH-A0B6-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast segmental mastectomy reveals an infiltrating ductal carcinoma exhibiting a Nottingham score of 6/9, indicating a moderately differentiated tumor. The invasive carcinoma is closely associated with ductal carcinoma in situ (DCIS) of cribriform and solid types, with the in situ component constituting approximately 2% of the tumor volume. Notably, both the invasive carcinoma and DCIS come within 1.0 mm of the nearest anterior resection margin, suggesting a closely approximated surgical clearance. Immunohistochemical analysis shows the tumor is positive for estrogen and progesterone receptors, but negative for HER-2/neu overexpression. Lymphovascular permeation is not observed in the examined sections. There is no evidence of metastatic involvement in any of the four sentinel lymph nodes examined (0/4). Additionally, the breast tissue exhibits changes consistent with a previous biopsy site and benign fibrocystic alterations, including fibroadenomatoid changes, ductal epithelial hyperplasia, and columnar cell changes with multifocal microcalcifications. The pathological stage is designated as pT1c, pN0, pMX."
193,TCGA-5L-AAT1-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive lobular carcinoma, grade 1, originating from the right breast. The primary tumor is characterized by a white, spiculated nodule with central necrosis, surrounded by clear surgical margins, indicating complete excision. Microscopic examination confirms the largest tumor dimension to be 1.1 cm. Additionally, the assessment of axillary lymph nodes shows no evidence of metastatic involvement. This includes both a solitary lymph node and an aggregate of ten axillary lymph nodes, all without any grossly visible lesions. The absence of lymph node metastasis and the clear surgical margins are favorable findings in this case."
194,TCGA-E2-A3DX-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right breast and axillary contents following a modified radical mastectomy revealed three foci of invasive lobular carcinoma, characterized as Nottingham grade 2. The tumors are multifocal with extensive lobular carcinoma in situ (LCIS) displaying classic and pleomorphic types, including necrosis and microcalcifications. Notably, the carcinoma is focally present at the anterior margin centrally and inferiorly, as well as 0.3 cm from the deep margin. Twenty-two out of thirty-three lymph nodes from the axillary contents exhibit metastatic carcinoma with extranodal extension, with the largest metastasis measuring 1.4 cm. Additionally, two of two lymph nodes dissected from the right axilla, level 3, and one lymph node from additional right breast tissue, demonstrate metastatic involvement. Other findings include focal granulomas in the breast and some lymph nodes. Immunohistochemistry confirms the presence of carcinoma at inked margins and shows positive markers for estrogen receptor (ER), progesterone receptor (PR), and HER2 (by FISH). The pathological staging, based on the AJCC Cancer Staging Manual, 7th Edition, is determined as pT2 N3. Notably, there is no evidence of ductal carcinoma in situ (DCIS), vascular/lymphatic invasion, or necrosis in the invasive tumor. The skin and remaining breast tissue margins are benign."
195,TCGA-A2-A0CW-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the presented specimens indicates a diagnosis of poorly differentiated infiltrating ductal carcinoma of the right breast. The primary tumor, measuring 2.7 cm, exhibits a Nottingham score of 9/9, indicating high-grade characteristics with significant nuclear pleomorphism and high mitotic activity. Notably, the tumor shows venous and lymphatic invasion and involves the smooth muscle of the nipple, although no tumor necrosis is present. Margins are clear, with the nearest margin being 0.6 cm from the tumor. Additionally, ductal carcinoma in situ, solid type, with nuclear grade II and minimal necrosis, constitutes less than 5% of the tumor. Sentinel lymph node biopsy revealed metastatic carcinoma with tumor involvement in the perinodal soft tissue. Furthermore, the non-sentinel lymph node is completely replaced by metastatic carcinoma, precluding the assessment of extranodal extension. The cancer is staged pathologically at pT2 N1a MX. Prior assays indicate positive staining for estrogen receptors (100%), progesterone receptors (25%), and HER-2-NEU (3+, strongly positive), providing insight into potential therapeutic targets. Additional findings include changes resulting from a prior biopsy at the site."
196,TCGA-BH-A0E1-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen reveals infiltrating ductal carcinoma of the left breast, classified as Nottingham Grade 2, with a tubule formation score of 3, nuclear grade of 2, and mitotic activity score of 2, resulting in a total score of 7 out of 9. The tumor has an invasive component located in the lower inner quadrant. Lymphovascular space invasion is present. The dimensions of the tumor are significant, and while the surgical margins are clear of neoplasm, the tumor approaches closest to the anterior margin. Fibrocystic changes are also noted, and the nipple skin is negative for neoplasm. Pathologic staging is designated as pT2 pN1mi pMX. Two of the six examined lymph nodes are positive for neoplasm, showing deposits of less than 0.2 mm, without extracapsular extension. The sentinel node biopsy reveals two lymph nodes negative for neoplasm. Hormone receptor analysis indicates the tumor is estrogen receptor and progesterone receptor positive, with HER2/neu expression scored as 2+."
197,TCGA-AR-A2LM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings from the right simple mastectomy reveal multiple foci of infiltrating lobular carcinoma, consisting of four distinct lesions. These lesions are located in the 9:30, 12:30 regions, the superior central, and the upper outer quadrant of the breast, and they form a bilobed mass. The carcinoma is graded as Nottingham grade I, reflecting a low-grade tumor with a Nottingham score of 5/9, characterized by well-formed tubules, mild nuclear atypia, and low mitotic activity. Extensive lobular carcinoma in situ accompanies the smaller lesions. There is an absence of angiolymphatic invasion, and the non-neoplastic breast tissue displays proliferative fibrocystic changes along with benign calcifications and biopsy site changes. The skin, nipple, and fascia are not involved by the tumor, and the surgical margins, including the deep margin, are negative for residual tumor, ensuring clear resection boundaries. Out of three right axillary sentinel lymph nodes examined, one was found to contain micrometastasis, confirmed by immunohistochemical staining, but without extranodal extension. Additionally, a benign intradermal nevus was identified in the excised right chest wall skin."
198,TCGA-BH-A0BM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of infiltrating ductal carcinoma of the right breast. The tumor is characterized as grade 1 with a Nottingham score of 4/9, indicating low-grade malignancy, and measures 2.8 cm. It extends focally to the posterior margin at the inferior aspect, while other margins are free of neoplasm. Estrogen receptor status is positive, whereas progesterone receptor and HER-2/neu are negative. The tumor has a multicentric pattern with a significant in situ component, comprising cribriform and micropapillary types, noted for microcalcifications and focal comedonecrosis. The in situ component is intermixed with the invasive lesion and identified in multiple tissue slices. Lymph node analysis reveals three positive sentinel nodes for metastatic carcinoma, including one with micrometastasis, out of a total of 24 examined nodes. However, the 19 nonsentinel and axillary dissected nodes are negative for metastasis. No lymphovascular invasion is observed. Additional findings include atypical ductal hyperplasia, fat necrosis, reparative changes from previous biopsy, and fibrocystic changes with associated benign calcifications. The pathological stage is defined as pT2, pN1, and pMX."
199,TCGA-BH-A0HI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a primary invasive ductal carcinoma of the right breast, classified as Nottingham grade 2, with a total score of 6/9 based on tubule formation, nuclear grade, and mitotic activity. The invasive component measures 1.8 cm at its greatest dimension. Coexisting with the invasive carcinoma is ductal carcinoma in situ (DCIS) of cribriform and solid types, constituting 15% of the tumor volume and situated away from the invasive component. Both the invasive carcinoma and DCIS are ER/PR positive and HER-2/neu negative. Surgical margins are free of carcinoma with the closest margin being 7 mm from both the invasive tumor and DCIS. There is no evidence of lymphovascular invasion. A sentinel lymph node biopsy reveals no metastatic carcinoma. Additionally, the non-neoplastic breast tissue exhibits fibrocystic changes, ductal epithelial hyperplasia, columnar cell change, and sclerosing adenosis. Microcalcifications are noted in association with the invasive carcinoma, DCIS, and benign breast tissue. Biopsy site changes are also present. The adjacent breast margins biopsied show fibrocystic changes without any carcinoma involvement."
200,TCGA-A7-A4SD-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an infiltrating ductal carcinoma, grade 3, located in the right breast, removed via mastectomy. The tumor displays a high degree of malignancy, characterized by poor architectural differentiation, marked nuclear atypia, and high mitotic activity. The greatest dimension of the tumor measures 4.3 cm (pT2). Importantly, the surgical margins are negative, though the tumor is close to the deep margin at 0.4 cm. There is no vessel or calcification invasion observed, and no ductal carcinoma in situ is present. Additionally, there is no evidence of metastasis in three sentinel lymph nodes excised from two separate axillary sites, thoroughly examined through multilevel sectioning and histochemistry for pankeratin."
201,TCGA-UL-AAZ6-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right total mastectomy specimen revealed a diagnosis of invasive ductal carcinoma characterized by a single focus of invasion. The tumor did not invade the skin, skeletal muscle, or nipple epidermis, and there was no evidence of lobular carcinoma-in-situ. Ductal carcinoma-in-situ (DCIS) was present, but without an extensive intraductal component. The histologic grade of the invasive carcinoma was intermediate (Grade 2/3), and there was no venous or lymphatic invasion identified. Importantly, the surgical margins were free of invasive carcinoma and DCIS, providing clear margins. Three sentinel lymph nodes were examined, along with one additional lymph node, and all were reactive without evidence of metastatic carcinoma. The final AJCC pathologic stage was determined to be pT2 pN0. No pre-surgical therapy effects were noted in the breast or lymph nodes. Additional receptor and proliferation marker results were referenced but not detailed in the current summary. The mastectomy specimen was intact, oriented, and described in detail with regards to tumor location and adjacent structures."
202,TCGA-E2-A1LA-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma and ductal carcinoma in situ in the right breast. The invasive tumor, located in the upper inner quadrant, is graded as SBR Grade 2 with no evidence of vascular or lymphatic invasion. The tumor margins are negative, indicating successful surgical resection. There are also findings of high nuclear grade ductal carcinoma in situ (solid type), usual ductal hyperplasia without atypia, a fibroadenoma, and an intraductal papilloma. Sentinel lymph node analysis shows metastatic carcinoma in one out of two nodes with extranodal extension. However, an axillary dissection of 34 lymph nodes reveals no additional metastases. Hormone receptor studies indicate that the tumor is estrogen and progesterone receptor-positive and HER2-negative. The overall pathological staging is pT1c N1a, reflecting a small primary tumor with limited nodal involvement."
203,TCGA-A2-A0CV-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with invasive ductal carcinoma of the left breast, accompanied by an extensive intraductal component. The mass was moderately differentiated with a Nottingham grade of II and a score of 6. No tumor necrosis was observed. Both lymphatic and venous invasions were present, including involvement in invasive, in situ tumor, and benign ducts. The surgical margins were clear, with the nearest invasive tumor margin being 2.5 mm and the nearest in-situ tumor margin being 3 mm. The intraductal component displayed ductal carcinoma in situ of the cribriform type with a nuclear grade of 3. Sentinel lymph node biopsy identified metastasis in 2 of 18 lymph nodes, exhibiting a 4 mm extranodal extension. Additional findings included sclerosing adenosis, cell changes with atypia, fibrocystic changes, usual ductal hyperplasia, and fibroadenoma. Both estrogen and progesterone receptors were strongly positive, while HER2 was negative (1+). The patient's pathological staging was pT2N1aMX. These findings are consistent with a clinical diagnosis of left breast cancer."
204,TCGA-B6-A1KN-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma, not otherwise specified (NOS), in the right breast with significant characteristics. The central tumor mass, measuring 6.4 x 5.2 x 2.5 cm, displays a high nuclear and histologic grade (3 of 3) and presents extensive lymphatic and vascular invasion. The carcinoma is multifocal, with in situ components occupying 5% of the total tumor, specifically of the comedo subtype. Direct invasion into the nipple and overlying skin was observed, with focal involvement of underlying muscle tissue. The surgical margins are compromised, with infiltrating carcinoma present at the lateral margin and in situ carcinoma approaching the deep margins at less than 1 mm distance. Axillary lymph node dissection reveals metastatic ductal carcinoma in 24 out of 30 lymph nodes, with the largest metastasis being 1.2 cm, and extranodal extension is noted. Axillary soft tissue also shows small tumor deposits, which are not clearly linked to lymph node structures. Additionally, non-neoplastic breast tissue exhibits epithelial hyperplasia and apocrine metaplasia. Estrogen receptor activity is positive, whereas progesterone receptor activity is negative."
205,TCGA-BH-A0E0-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the modified radical mastectomy specimen reveals a diagnosis of invasive ductal carcinoma with a high Nottingham score of 3, correlating with a total score of 9/9 due to high nuclear grade (3), tubule formation (3), and mitotic activity (3). The tumor exhibits extensive intratumoral lymphocytic infiltration and is located in the upper outer and lower outer quadrants of the left breast. Ductal carcinoma in situ (DCIS) is present, comprising 25% of the tumor mass and characterized by high nuclear grade, solid and cribriform patterns, and comedo necrosis. Angiolymphatic invasion is noted. The surgical margins are clear, with the closest margin, the posterior margin, being 0.6 cm away from the tumor. The specimen also shows biopsy site changes, atypical ductal epithelial hyperplasia, fibrocystic changes with ductal epithelial hyperplasia, and apocrine metaplasia. Immunohistochemical studies indicate that the tumor is negative for estrogen and progesterone receptors, as well as HER-2/neu (score of 1+). Lymph node involvement is significant, with 10 out of 21 lymph nodes positive for metastatic carcinoma, including extracapsular spread in one node."
206,TCGA-A2-A0EQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast lumpectomy specimen revealed an infiltrating ductal carcinoma of high grade, exhibiting a Nottingham score of 9/9. The tumor was grossly measured and found to be invasive, with the nearest approach being within 1 mm of the anterior margin, marked with yellow ink. Additionally, ductal carcinoma in-situ of the comedo-type was present within 1.3 mm of the inferior margin, marked with green ink. The specimen showed no evidence of lymphovascular space invasion, but displayed fibrocystic changes including fibrosis and apocrine metaplasia. The pathologic staging, according to the AJCC, was determined to be pT2 NO (i-) Mx. Examination of sentinel lymph nodes showed one node that was negative for tumor involvement based on both standard histological and immunohistochemical investigations. The non-sentinel lymph node also tested negative for tumor presence. No lymphoid tissue was identified in the second sentinel lymph node specimen. An additional excised inferior margin of the left breast displayed fibrocystic changes similar to those found in the main lumpectomy sample but was free of tumor involvement."
207,TCGA-A8-A093-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of highly differentiated invasive ductal carcinoma featuring focal intraductal components. The tumor pertains to the Not Otherwise Specified (NOS) category and exhibits a high grade of differentiation (Grade I), consistent with its highly differentiated nature. Tumor classification according to the TNM system is pT2N0, indicating a primary tumor that is of considerable size, but with no evidence of regional lymph node metastasis. The tumor margins are clear, indicating a complete excision with no malignant cells detected at the resection edges. Overall, the findings underscore a localized malignant process without regional spread, featuring both invasive and intraductal elements, but confined to the primary site with no nodal involvement."
208,TCGA-A2-A25B-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast, following a surgical procedure that included a sentinel node biopsy and simple mastectomy, confirmed invasive ductal carcinoma with poorly differentiated features and a total Nottingham score of 8, accompanied by high-grade ductal carcinoma in situ (DCIS) with areas of comedonecrosis. The invasive component was noted to be in close proximity to the superficial margin, measuring 2 mm away. Lymphovascular invasion was present, further complicating the disease profile. The surgical margins were overall clear of tumor; random sections of the remaining quadrants and nipple skin did not show residual carcinoma. Evaluation of the sentinel lymph node revealed metastatic breast carcinoma in one of the two nodes examined, without extranodal extension. Additionally, one out of six axillary lymph nodes showed metastatic involvement, likewise without extranodal extension. An extra section from the anterior margin of the inferior portion of the breast also revealed DCIS with some foci of infiltrating duct carcinoma, but no residual tumor was found in the skin and subcutaneous layers, ensuring clear margins. Lymphovascular invasion was again noted in this section. The presence of diffuse lactational changes was documented without further implications for the cancer diagnosis."
209,TCGA-LL-A740-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma in the right breast, characterized by a single focus of invasion measuring 17 mm. The tumor exhibits combined histologic grade 2, with moderate glandular formation, high nuclear pleomorphism, and a low mitotic rate. Surrounding the invasive carcinoma, ductal carcinoma in situ (DCIS) with comedo and cribriform patterns, high nuclear grade, and central necrosis is also present but not extensive. Both the invasive carcinoma and DCIS show margins that are uninvolved by the tumor, with the closest invasive carcinoma margin being 2 mm away and the closest DCIS margin being 5 mm away. Examination of the sentinel lymph node biopsy from the right axilla reveals no metastasis. Additional findings include no evidence of lymph-vascular invasion. Ancillary studies indicate estrogen and progesterone receptor negativity, equivocal HER2 status by immunohistochemistry, and non-amplified HER2 according to in situ hybridization. The pathologic staging is classified as pT1c for the primary tumor and pN0(i-) for regional lymph nodes, indicating the absence of lymph node involvement."
210,TCGA-BH-A0HK-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient's pathology reveals a diagnosis of infiltrating mammary carcinoma of the right breast, following a modified radical mastectomy and axillary dissection. The tumor exhibits a Nottingham score of 6/9, indicating a moderate grade with tubule formation at 3, nuclear pleomorphism at 2, and mitotic activity at 1. There is no evidence of lymphovascular invasion, and the surgical margins are free of tumor involvement. The tumor affects the deep dermis of the nipple, while the skin shows benign changes of seborrheic keratosis without tumor presence. Additionally, there are fibrocystic changes with duct ectasia and atypical ductal epithelial hyperplasia noted in the background breast tissue. Importantly, metastatic adenocarcinoma is identified in two of the seventeen examined right axillary lymph nodes, with extracapsular extension observed. Immunohistochemical staining demonstrated that the tumor is estrogen receptor-positive, but both progesterone receptor and HER-2/neu are negative. The pathological staging is identified as pT2 pN1, with no applicable M stage."
211,TCGA-D8-A27F-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the excised right breast and axillary tissues from a female patient diagnosed with right breast cancer revealed an invasive ductal carcinoma (NHG3). Tumor histology indicated high-grade features with a mitotic rate of 24 mitoses per 10 high-power fields. Immunohistochemically, the neoplastic cells displayed no estrogen or progesterone receptors, and HER2 protein expression was negative (Score 1+). The tumor was situated in the upper outer quadrant of the breast, with close proximity to the skin and the surgical base, although precise margins were not detailed. Microscopic assessment also showed benign lesions such as fibrous mastopathy and simple adenosis in the surrounding glandular tissue. Examination of the axillary lymph nodes revealed sinus histiocytosis, with no evidence of metastatic carcinoma (pN0). The final histopathological diagnosis confirmed invasive ductal carcinoma of the right breast, staged as T2N0, indicative of localized disease without lymph node involvement."
212,TCGA-E2-A10A-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an invasive ductal carcinoma of the left breast, graded as SBR Grade II. The tumor is multifocal, with the largest invasive focus measuring within specified dimensions in the upper outer quadrant. Additionally, associated ductal carcinoma in situ (DCIS) of cribriform and micropapillary types is present, constituting approximately 10% of the total tissue and is devoid of necrosis. Both the attached skin and nipple are free of tumor involvement. Margins are clear, with the closest margin being 1.3 cm away from the tumor. There is no evidence of vascular or lymphatic invasion, and non-neoplastic areas exhibit fibrocystic disease and pseudoangiomatous stromal hyperplasia. All three sentinel lymph nodes from the left axilla are free of tumor metastasis, showing a status of 0/3. Estrogen and progesterone receptors are positive, with Allred scores of 7 and 8 respectively, supporting hormone therapy considerations. HER-2 gene amplification is not detected by FISH analysis, ruling out HER-2 targeted therapy. The pathological staging is pT3 N0. The excised right breast skin is unremarkable, negative for any tumor presence."
213,TCGA-A8-A07Z-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left mastectomy specimen revealed a diagnosis of ductal breast carcinoma that is predominantly solid and moderately differentiated. The tumor exhibits invasive growth with a concerning dorsal margin that is less than 0.1 cm, while the overlying skin is free of carcinoma. Notably, all eleven examined lymph nodes are free from metastatic carcinoma. The tumor has been classified as M-8500/3, with a grade of 2, a pathological tumor stage of pT2, no regional lymph node metastasis (pNO), and no distant metastasis evaluable (MX). Additionally, there were no signs of lymphovascular invasion (pL0, pV0). The assessment of surgical margins shows that the dorsal margin is particularly narrow, while the ventral margin is slightly wider, and the remaining margins are significantly greater than 1 cm. These findings highlight the need for close monitoring and potentially further therapeutic intervention considering the close dorsal margin."
214,TCGA-LL-A8F5-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast lumpectomy specimen reveals invasive ductal carcinoma of histologic grade 3, characterized by high tubular differentiation, significant nuclear pleomorphism, and a high mitotic rate, indicating poor differentiation. The carcinoma is identified as a single focus without definitive evidence of ductal carcinoma in situ. The tumor did not involve the skin, and all surgical margins are clear of invasive carcinoma, with the closest margin being 6 mm away. Three sentinel lymph nodes were examined in total, all of which were reactive without any evidence of macrometastasis, micrometastasis, or isolated tumor cells. Pathologic staging is pT2 for the primary tumor and pN0 for regional lymph nodes, with no distant metastasis applicable at this time. This indicates that the carcinoma has not spread to nearby lymph nodes or distant sites. The tumor presented as a poorly differentiated, necrotic mass with bizarre nuclei and extensive mitotic activity, reflecting a high-grade malignancy. The specimen also underwent intraoperative consultation to ensure clear excision margins and to contribute to tissue banking efforts."
215,TCGA-B6-A0RH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis confirms a diagnosis of infiltrating ductal carcinoma located at the junction of the inner-upper and inner-lower quadrants of the left breast, predominantly exhibiting a cribriform pattern with regions of comedo necrosis. The tumor is moderately differentiated, with a histologic grade of 2 out of 3, and demonstrates local invasion into the mammary lymphatics adjacent to it. Intraductal carcinoma of the cribriform type is also present near the invasive component. Surgical margins, specifically the deep margins, are free of tumor involvement. A focus of atypical ductal hyperplasia was identified in the upper-outer quadrant, alongside florid ductal epithelial hyperplasia of the usual type. The remainder of the breast tissue exhibited changes including sclerosing adenosis, microcalcifications, blunt duct adenosis, papillary apocrine metaplasia, and duct ectasia, without additional lesions. Examination of 23 axillary lymph nodes revealed no evidence of metastatic disease. The overall presentation aligns with a diagnosis of moderately differentiated cribriform ductal carcinoma with significant pleomorphism and a high mitotic rate, classified as infiltrating breast carcinoma of no special type due to the degree of atypia present."
216,TCGA-B6-A0IH-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of extensive infiltrating lobular carcinoma of the left breast, with the largest dimension exceeding 6 cm. The tumor is notably multifocal and poorly demarcated. There is significant lymph node involvement, with metastatic carcinoma present in twenty-five out of twenty-seven axillary lymph nodes. The tumor exhibits invasion into the lactiferous ducts and nipple, indicating an aggressive disease course. Despite the extensive nature of the carcinoma, all surgical margins are free of tumor involvement, suggesting complete resection of the macroscopic disease. Additionally, immunohistochemical staining confirmed extensive lymph node infiltration without extracapsular extension. The breast tissue surrounding the mass is characterized by fibrosis and cystic structures filled with gray-green fluid, and the presented nipple shows slight atypical features."
217,TCGA-PE-A5DD-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of invasive lobular carcinoma, grade II, in the right breast. The tumor exhibits microscopic pleomorphic changes but no lymphovascular invasion. The primary lesion measures 3.0 cm and is classified as a solitary invasive component, confined to the breast parenchyma. The tumor extends to the lateral and anterior margins of the excised specimen and is 2.0 mm from the posterior margin. Additionally, focal atypical ductal hyperplasia is noted 1.0 mm from the superior margin. Evaluation of the sentinel lymph nodes from the right axilla indicates no metastatic involvement (0/2), which is further confirmed by immunohistochemical staining for Cytokeratin. There is no evidence of invasive carcinoma in the final posterior, anterior, and medial margins, which included fibroadipose tissue, skeletal muscle, skin, and subcutaneous tissue. Ancillary studies reveal that the tumor is estrogen receptor (ER) positive, progesterone receptor (PR) negative, and Her2-Neu expression is low (1+). The pathological staging is pT2 NO Mx, reflecting the tumor's size, lack of regional lymph node metastasis, and indeterminate distant metastasis status."
218,TCGA-BH-A202-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with a left breast invasive ductal carcinoma, which was addressed through a segmental mastectomy with sentinel lymph node biopsy. Pathological examination revealed a high-grade (Nottingham Grade III) invasive ductal carcinoma, measuring 2.6 cm in its largest dimension. The carcinoma was positive for Estrogen Receptors (H-score: 250), Progesterone Receptors (H-score: 75), and HER2. Additionally, ductal carcinoma in situ (DCIS) of nuclear grade 3, solid type with comedo necrosis, was present and constituted 40% of the total tumor volume, intermingled with the invasive component. Importantly, no lymphovascular space invasion was noted, and all resection margins were free of carcinoma, with the invasive component and DCIS being 0.4 cm and 0.3 cm from the nearest (anterior) margin, respectively. The surgical margins closest to the tumor were 4 mm for the invasive component and 3 mm for the DCIS. All four lymph nodes examined, including sentinel and non-sentinel nodes, were negative for metastatic carcinoma. The non-neoplastic breast tissue exhibited various benign changes, including ductal epithelial hyperplasia, intraductal papilloma, radial scar, columnar cell changes, and fibrocystic changes, alongside previous biopsy site alterations. The pathological staging classified the tumor as pT2 pNO (sn), indicating a primary tumor larger than 2 cm but not more than 5 cm, with no regional lymph node metastasis."
219,TCGA-BH-A0B4-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the modified radical mastectomy specimen from the left breast reveals the presence of an invasive ductal carcinoma, classified as Nottingham Grade 3, exhibiting high scores for tubule formation, nuclear pleomorphism, and mitotic activity. The invasive carcinoma involves the nipple papillary dermis and constitutes the majority of the tumor mass, with a minor component of ductal carcinoma in situ (DCIS) of nuclear grade 2. Significantly, all resection margins are free of carcinoma, with the invasive component being at a safe distance from the closest margin. However, metastatic involvement is notable in six out of ten examined axillary lymph nodes, some showing extracapsular extension. Despite the lack of definitive lymphovascular invasion within the specimen, the tumor has advanced locally and regionally, classified pathologically as pT2 and pN2a. Ancillary findings include benign fibrocystic changes in the surrounding breast tissue. Hormone receptor assays indicate positive estrogen and progesterone receptors, while HER2/neu staining is equivocal at 2+. Further evaluation is needed for definitive HER2 status."
220,TCGA-BH-A0DP-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a primary invasive lobular carcinoma of the right breast, specifically a 5.5 cm tumor exhibiting signet ring features. The tumor, centrally located and involving the subareolar region, is classified as Nottingham grade 2, with a total score of 6 (tubules - 3, nuclei - 2, mitoses - 1). Importantly, the surgical margins are free of tumor involvement. Additionally, lymphovascular invasion is noted, but all examined sentinel lymph nodes, totaling four, are negative for metastatic tumor cells. Non-neoplastic changes in the breast tissue include sclerosing adenosis and fibrocystic changes. The tumor also displays calcifications in both benign and malignant zones and presents with lobular carcinoma in situ (LCIS) comprising 2% of the tumor. Receptor status is positive for estrogen and progesterone, while HER2/neu expression is low or non-existent (zero or 1+). Based on these findings, the pathologic stage is pT3, pN0(i+), pMX, indicating an advanced primary tumor size, no lymph node metastasis with isolated tumor cells, and an indeterminate distant metastasis status."
221,TCGA-A1-A0SQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive ductal carcinoma in the left breast with mucinous features, measuring 3.8 cm and classified as grade 2 according to the modified Bloom-Richardson grading system. The tumor exhibits lymphatic-vascular invasion and is associated with intermediate-grade ductal carcinoma in situ (DCIS) with solid and mucinous features, spanning 5.3 cm. Microcalcifications are present in connection with the invasive carcinoma. Surgical margins are negative for both invasive carcinoma and DCIS. Sentinel lymph node analysis from the left axilla shows metastatic carcinoma in one of three lymph nodes, with the largest metastasis being 0.5 cm and no extranodal extension. A subsequent lymph node dissection in levels 1 and 2 reveals no additional lymph node involvement. Hormonal receptor status indicates that the tumor is estrogen receptor-positive and progesterone receptor-positive, but HER2/neu negative. Importantly, the right breast mastectomy shows no carcinoma, with only non-proliferative fibrocystic changes and focal lactational changes noted. The accessory nipple tissues from both axillae show no evidence of carcinoma. Overall, the assessment points to a stage pT2N1MX carcinoma with ER and PR positivity, indicating a likely benefit from hormonal therapy but no HER2-targeted therapy."
222,TCGA-AO-A03R-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment reveals a diagnosis of invasive ductal carcinoma (IDC) with ductal carcinoma in situ (DCIS) components in the left breast. The invasive carcinoma is characterized as poorly differentiated (histologic grade III/III, nuclear grade III/III) and involves both the upper outer and upper inner quadrants. The tumor shows extensive vascular invasion and perineural invasion but no involvement of the surgical margins, nipple, or skin. The DCIS presents as solid and cribriform types with high nuclear grade and moderate necrosis, contributing to up to 25% of the total tumor mass. Lymph node examination shows metastatic carcinoma in two sentinel nodes in the left axilla (1/1 with extranodal extension in node 1 and 1/1 without extranodal extension in node 2), while the third sentinel node is benign. Further analysis of axillary contents from levels I and II reveals micrometastases in one out of eighteen nodes, with no extranodal extension, and level III nodes are benign. The tumor staging is T2, pN1a, MX, corresponding to stage IIB. Immunohistochemical studies report estrogen receptor (ER) positivity at 95%, low progesterone receptor (PR) expression at less than 5%, and negative HER2/neu status."
223,TCGA-A8-A07J-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of bifocal invasive ductal carcinoma in a breast segment, classified as Grade II. The tumor presents with focal intraductal components, indicating a mixture of invasive and non-invasive elements. The tumor has been categorized under the classification of NOS, Grade II, and staged as pT2(m) pN1a. Examination of the lymph nodes shows involvement of 1 out of 18 nodes. There is no evidence of lymphovascular invasion (LOV0), and the surgical margins are clear (R0). These findings collectively suggest a moderately aggressive tumor with limited lymph node metastasis and successful surgical excision with negative margins."
224,TCGA-AR-A24K-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive ductal carcinoma, Nottingham grade III, located in the left breast, forming a notable mass. The tumor is classified as AJCC pT2. Importantly, the surgical margins, including the separately submitted superior margin, were found to be negative for tumor, with the closest margin (superior) having a significant clearance. Examination of the left axillary sentinel lymph nodes, removed during the procedure, revealed no evidence of tumor involvement, corresponding to AJCC pN0 status. Both sentinel lymph nodes demonstrated the presence of blue dye, used to identify them during surgery. Immunohistochemical staining for cytokeratin performed on the paraffin-embedded sentinel lymph node tissue corroborated the initial hematoxylin and eosin (H&E) staining results. These findings suggest that the tumor has been effectively excised with clear margins and no regional lymph node metastasis."
225,TCGA-A2-A0D3-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings pertain to a female patient with a clinical history of left breast cancer and familial predisposition, who underwent prophylactic bilateral mastectomy. The right breast mastectomy revealed benign changes including focal usual ductal hyperplasia, lactational/secretory changes, stromal sclerosis with focal apocrine metaplasia, and unremarkable skin and nipple, with no evidence of malignancy. The left breast mastectomy identified a well-differentiated infiltrating ductal carcinoma (Grade I) with a Nottingham score of 5 out of 9 and an intraductal component of intermediate-grade ductal carcinoma in situ (DCIS) manifesting in solid and cribiform patterns. The tumor exhibited estrogen and progesterone receptor positivity, while HER2 was negative as corrected by FISH analysis. No venous or lymphatic invasion was observed, and surgical margins were clear of tumors. Pathologic staging was determined to be pT1cN0(i-)Mx. Additionally, a sentinel lymph node from the left axilla was negative for tumor presence upon examination by both light microscopy and immunohistochemistry. An excision from the left lower inner quadrant yielded benign breast tissue with no tumorous cells. This collective histopathological assessment denotes a diagnosis of left breast well-differentiated infiltrating ductal carcinoma with a benign contralateral breast, clear surgical margins, and no lymph node metastasis."
226,TCGA-AO-A126-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast and axillary lymph nodes revealed an invasive ductal carcinoma in the breast tissue, with histologic and nuclear grades II/III. The carcinoma exhibited solid, tubular, and cribriform patterns and was located in the upper-inner quadrant. Importantly, there was no involvement of the nipple, skin, or vascular structures. The tumor was grossly noted to be near the deep surgical margin, but no calcifications were present. Non-neoplastic breast tissue changes were also observed, including biopsy site changes, fibrocystic alterations, and fibroadenomatoid changes. Lymph node analysis, including four sentinel nodes and one non-sentinel node from the right axilla, indicated no evidence of metastatic tumor involvement. Special stains and additional sections confirmed the negative status of margins and lymph nodes. Immunohistochemical staining revealed the tumor to be estrogen receptor (ER) and progesterone receptor (PR) positive, and HER2/neu negative, indicating the hormone receptor status of the malignancy."
227,TCGA-A2-A1FV-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive lobular carcinoma in the left breast, characterized by multifocality and grade 2 histologic features based on the Nottingham grading system. There were isolated tumor cells detected in one of the two examined sentinel lymph nodes by cytokeratin immunohistochemical staining, but no macrometastases or micrometastases were present. The mastectomy specimen demonstrated a larger tumor in the outer upper and mid quadrants and a smaller separate tumor in the inner upper quadrant, both without tumor necrosis but with lymph-vascular invasion. The margins were negative for malignancy, although the invasive tumor was relatively close to the deep margin, and the lobular carcinoma in situ component was very close to this margin. No nipple or skin involvement was identified. Ancillary studies showed the tumors were positive for estrogen and progesterone receptors but negative for HER2/neu expression. The left axillary tissue contained benign fibroadipose and vascular connective tissue without lymph nodes or malignancy. Consequently, the tumors are staged as pT3 (m) N0 (i+), (AJCC 7th Edition), indicating a significant tumor burden with minimal lymphatic spread."
228,TCGA-D8-A1XQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the right breast and associated axillary tissues confirms a diagnosis of invasive ductal carcinoma, classified as NHG3 with a basal-like phenotype. The tumor is located at the border of the outer quadrants and extends close to the lower boundary, base, and skin, emphasizing its peripheral position within the breast. Microscopic analysis reveals notable mitotic activity and a peritumoral lymphocytic reaction. The examined axillary lymph nodes show reactive lymphadenitis without evidence of metastatic involvement, indicating a pNO status. The immunohistochemical profile of the neoplastic cells is characterized by the absence of estrogen receptors and HER2 protein expression, with progesterone receptors present in fewer than 10% of the cells. Additional histological assessments confirm no pathological changes in the nipple or surrounding tissues. Overall, the tumor exhibits adverse prognostic features based on its high histological grade and hormone receptor status, necessitating a tailored therapeutic approach."
229,TCGA-A2-A3KC-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive and intralobular pleomorphic lobular carcinoma within the right breast, characterized by a multifocal distribution. The primary invasive tumor components had a nuclear grade of 2/3, a low mitotic index, and a tubule formation score of 3, amounting to a total Nottingham score of 6. The largest tumor focus was located in the 12 o'clock position, while a second substantial focus was in the lower outer quadrant. Multiple smaller invasive foci were also noted. Pleomorphic lobular carcinoma in situ (LCIS), constituting approximately 50% of the tumor, was observed in a large portion of the specimen. Surgical margins and the nipple skin were free of malignancy. Lymphovascular invasion was absent, but proliferative fibrocystic changes and other benign breast alterations were noted. Metastatic carcinoma was identified in one of the sentinel right axillary lymph nodes and one of the sixteen lymph nodes from the right axillary dissection, with no evidence of extranodal extension. Non-sentinel right axillary lymph nodes were free of malignancy."
230,TCGA-A2-A0SV-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of infiltrating ductal carcinoma, no special type, in the right breast with a poorly differentiated (Grade 3) tumor and a Nottingham score of 9/9. The tumor exhibits extensive necrosis, microcalcifications, and widespread venous and lymphatic invasion. Margins are positive for tumor presence, with deep margin involved and involvement of intramammary lymphatics observed. The carcinoma shows extensive multicentricity with multiple microscopic foci in various quadrants and significant involvement of the nipple and skin. Estrogen, progesterone receptors are positive, with HER2 neu status weakly positive; further confirmation via FISH pending. Pathologically, the tumor is staged as pT4d N2a MX. Additional findings include high-grade ductal carcinoma in situ and cystic changes with apocrine metaplasia. The axillary dissection reveals eight lymph nodes positive for metastatic tumor, with extensive extracapsular extension and tumor deposits larger than 2 mm. The overall invasive nature, poor differentiation, and extensive lymphovascular and nodal involvement underscore a highly aggressive pathology."
231,TCGA-BH-A1EU-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast specimen from the segmental mastectomy reveals an infiltrating ductal carcinoma of intermediate histologic and nuclear grade, assigned a Nottingham score of 5. The tumor exhibits retrograde extension into lobules, is associated with lymphocytic infiltration, and contains microcalcifications. Proliferative fibrocystic changes, an intraductal papilloma, and sclerosing adenosis are also noted. On immunohistochemistry, the tumor shows strong positive intranuclear staining for estrogen and progesterone receptors, both at 95%. However, c-erbB2 (HER-2/neu) expression is negative, with no distinct complete membrane staining detected (score 0). Importantly, all surgical margins are free of tumor involvement, indicating that the excision was complete with no residual disease."
232,TCGA-B6-A0IO-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast specimen reveals an invasive carcinoma with multifocal characteristics. The carcinoma is present in the upper-outer and lower-inner quadrants, with tumor grades of 3 for both histologic and nuclear evaluations according to the N.S.A.B.P. grading system. No lymphatic or vascular invasion is identified. Additionally, a ductal in-situ carcinoma of solid type with minimal cribriform features and a nuclear grade of 2 is present. Areas of necrosis are noted in multiple quadrants without specific size determination. Importantly, the surgical margins, nipple, and skin are free of tumor involvement, and muscle tissue is not identified. Seventeen lymph nodes were examined, and none demonstrated malignancy (0/17). Further, immunohistochemical analysis indicates a positive estrogen receptor status in approximately 95% of the infiltrating carcinoma cells, while progesterone receptor activity is borderline with approximately 1% expression. HER2/neu oncoprotein analysis is negative, reflecting no overexpression. The proliferation index is high, with an estimated positive nuclear area percentage of 29%. These findings collectively suggest an aggressive tumor profile with no metastasis to lymph nodes."
233,TCGA-GM-A2DK-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of invasive ductal carcinoma of the right breast with associated ductal carcinoma in situ (DCIS), both of intermediate nuclear grade. The invasive component does not display definite lymphovascular invasion, although prominent retraction artifacts complicate assessment. The carcinoma is characterized by scattered mitotic figures and a central area of sclerosis, and no tumor approaches the surgical margins. The associated DCIS shows solid and cribriform patterns with focal necrosis, extending focally into adjacent breast tissue. Importantly, the sentinel lymph node biopsy showed no evidence of metastatic carcinoma, and immunostains for keratin on the sentinel lymph node were negative. Additional findings include focal fibrosis and hemosiderin deposition indicative of a previous biopsy procedure. No significant abnormalities were noted in the remaining examined breast tissue."
234,TCGA-BH-A209-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast mass reveals a diagnosis of medullary carcinoma with a poor nuclear grade and an associated lymphocytic component. The tumor, procured by segmental mastectomy, is well-defined and measures 2.0 cm in size. Importantly, the surgical margins are clear of tumor, indicating that the carcinoma has been entirely excised. There is no evidence of angio-lymphatic or perineural invasion, further suggesting a lack of advanced local spread. The examination of the left axillary contents shows that twelve lymph nodes are free of tumor involvement, indicating no regional lymphatic spread. Overall, these findings suggest a localized medullary carcinoma with favorable pathology regarding tumor margins and absence of lymph node metastasis."
235,TCGA-A1-A0SN-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of infiltrative ductal carcinoma in the left breast, characterized as a grade 2 tumor by the modified Bloom-Richardson grading system. The invasive tumor measures 1.1 cm in maximum dimension and is associated with extensive lymphatic-vascular invasion and intra-lymphatic metastasis. The margins of resection for the invasive tumor and associated high-grade ductal carcinoma in situ (DCIS) are negative, with the closest deep margin being 0.2 cm away from the invasive tumor. Additionally, the breast tissue removed from the left lateral anterior and medial superior anterior regions showed no carcinoma. Examination of the left axillary lymph nodes reveals metastatic carcinoma in four out of thirteen nodes, with extranodal extension observed and the largest metastasis measuring 0.8 cm. Eight lymph nodes showed no metastatic involvement. Immunohistochemistry reveals strong positivity for estrogen receptors in 90% of tumor cells, moderate positivity for progesterone receptors in 60% of tumor cells, and HER2/neu oncoprotein overexpression with a staining intensity of 3. AJCC/UICC staging classifies this tumor as pT1cN1MX."
236,TCGA-B6-A0IM-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of infiltrating ductal carcinoma with a prominent cribriform pattern in the right breast. Two distinct masses were identified: one measuring 2 cm from an incisional biopsy and a larger, contiguous tumor in the mastectomy specimen spanning 7 cm in its greatest dimension. Histological examination classifies the tumor as Grade 1 of 3 (NSABP histologic grading) and Nuclear Grade 2 of 3. No evidence of multifocality or in-situ carcinoma is present. Non-neoplastic breast tissue exhibits sclerosing adenosis with microcalcifications, but there is no lymphatic or vascular invasion. The surgical margins are negative for carcinoma, and the nipple and overlying skin show no signs of Paget's disease or tumor involvement. Additionally, muscle tissue was not sampled in this specimen. Of the 9 lymph nodes examined, none contained carcinoma, indicating no lymph node involvement (0/9). Estrogen receptor activity was positive, whereas progesterone receptor activity was borderline. Each aspect of the specimen has been meticulously evaluated, and the results documented suggest an effectively resected tumor with no residual malignant tissue in the margins or lymph nodes."
237,TCGA-E2-A1IL-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive lobular carcinoma of the left breast, classified as Scarff-Bloom-Richardson Grade II with a size of 1.5 cm, located in the upper outer quadrant. Additionally, there is ductal carcinoma in situ of nuclear grade 1-2/3, along with a radial scar and changes from a previous biopsy site. The surgical resection margins are negative for the tumor, with the nearest margin over 1 cm from the posterior/inferior edge. Examination of the sentinel lymph nodes from the left axilla reveals that one out of five nodes is positive for metastatic lobular carcinoma, while the remaining four nodes are reactive and negative for metastatic disease. Immunohistochemical analysis shows that the tumor is estrogen receptor (ER) positive, progesterone receptor (PR) positive, and HER2 negative. There is an indeterminate status for vascular or lymphatic invasion. The pathological staging is reported as pT1c N1a."
238,TCGA-AC-A7VC-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left breast mastectomy specimen reveals a diagnosis of metaplastic carcinoma with areas of chondroid differentiation. The tumor is characterized by high-grade features, including an architectural score of 3, nuclear score of 3, and mitotic score of 3, resulting in a total grade of 9. Importantly, there is no evidence of in situ carcinoma, angiolymphatic invasion, skin or nipple involvement. All surgical margins are clear of carcinoma. Additionally, the sentinel lymph node biopsy from the left axilla shows no evidence of metastatic carcinoma, confirmed by negative staining for pancytokeratin. The final TNM staging of the tumor is T3pNO(i-). This case involves a well-circumscribed, focally cystic and mucinous tumor located away from the closest margins, with no involvement of nearby lymph nodes."
239,TCGA-AO-A0J2-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive ductal carcinoma in the left breast, histologic grade III/III and nuclear grade III/III. The carcinoma is accompanied by a lymphocytic infiltrate and ductal carcinoma in situ (DCIS) of solid and micropapillary types, characterized by high nuclear grade and minimal necrosis. Notably, no involvement of the nipple, vascular structures, or surgical margins is identified for both the invasive carcinoma and DCIS. The invasive carcinoma is located 0.4 cm from the nearest anterior margin, while DCIS is 0.6 cm away. The skin shows no signs of involvement. In the non-neoplastic breast tissue, stromal fibrosis, apocrine metaplasia, cysts, and focal fat necrosis are observed, consistent with prior biopsy sites. The right breast biopsy demonstrates benign breast tissue with stromal fibrosis, cysts, and focal apocrine metaplasia, with rare calcifications in association with benign epithelium. Sentinel lymph node biopsies from both the left and right axilla are negative for metastatic carcinoma, with three benign lymph nodes in the left sentinel node #1, two benign nodes in the left sentinel node #2, and one benign node in the right sentinel node #1. Immunohistochemical analysis reveals that the left breast carcinoma is estrogen receptor-positive with no nuclear staining for progesterone receptors and HER-2 status equivocal, pending further evaluation by FISH. Overall, these findings indicate a high-grade invasive ductal carcinoma with no metastatic spread to the sentinel lymph nodes and clear surgical margins."
240,TCGA-A8-A0AB-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings pertain to an invasive lobular breast carcinoma with a maximum diameter of 2.7 cm, classified as malignancy grade 2. The primary tumor exhibits multicentric lesions and includes an invasive satellite node, with some areas of the tumor showing confluent lobular intraepithelial neoplasia (LIN) grade I. The surrounding breast tissue displays fibrolipomatous changes and cystic duct ectasia, along with small focal areas of adenosis. Examination of the submitted skin and subcutaneous tissue samples reveals no remarkable pathological changes. Resection margins are free of tumor involvement, with a minimum dorsal safety margin of 0.6 cm. No carcinoma is found in the two examined sentinel lymph nodes, achieving regional R0 status. There is also an absence of lymphovascular invasion."
241,TCGA-BH-A18Q-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient underwent a left total mastectomy with axillary dissection, revealing a diagnosis of infiltrating poorly differentiated ductal adenocarcinoma of the breast, characterized by a high Nottingham Score of 8/9. The tumor was located in the lower outer and lower inner quadrant of the breast, and associated with microcalcifications. Pathological examination confirmed that all surgical margins, including the nipple and skin, were free of tumor involvement. Additionally, two out of twenty-five examined axillary lymph nodes contained metastatic carcinoma. Proliferative fibrocystic changes, duct ectasia, radial scar, and sclerosing adenosis were also present. Subsequent immunohistochemical analysis revealed that the tumor cells were negative for estrogen and progesterone receptors, with Her-2/Neu showing weak to moderate complete membrane staining in more than 10% of the cells, resulting in a weakly positive score of 2+. Further Her-2/Neu FISH testing was ordered to confirm these findings."
242,TCGA-A1-A0SB-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis identifies adenoid cystic carcinoma in the left breast, diagnosed through a wire-guided partial mastectomy. The tumor exhibits a cribriform growth pattern, measures 1.2 cm in size, and is of Grade 1 according to the modified Bloom-Richardson grading system. Immunohistochemical stains, showing positivity for ER in 75% of cells and CD117, along with p63 positivity in basaloid cells and a lack of myoepithelial cells as indicated by SMM, support this diagnosis. Tumor margins are confirmed to be negative for invasive carcinoma, with the tumor located more than 1 cm away from all evaluated margins. Lymphatic-vascular invasion is absent, and both sentinel lymph nodes biopsied were negative for carcinoma. Additionally, the breast specimen revealed benign conditions, including atypical ductal hyperplasia, apocrine metaplasia, fibroadenoma, and microcalcifications in benign ducts. The right and left breast mammoplasty specimens presented with various benign findings including intraductal papilloma, sclerosing adenosis, usual ductal hyperplasia, and fibroadenoma, with no carcinoma detected in either breast. Furthermore, the HER2/neu test was negative for oncoprotein overexpression, confirming the absence of HER2 amplification. Considerations of potential lymphoma were ruled benign, indicating no malignancy. The overall pathological staging aligns with pT1cN0MX based on the AJCC/UICC criteria."
243,TCGA-BH-A0BT-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of primary invasive ductal adenocarcinoma of the right breast. The invasive tumor is of the Nottingham Grade 1, with a total score of 5/9, indicating low differentiation with unfavorable features such as moderate tubule formation, moderate nuclear pleomorphism, and low mitotic activity. The invasive component measures 2.0 cm, and the tumor also contains admixed ductal carcinoma in-situ (DCIS) of cribriform type with comedo necrosis, accounting for less than 5% of the total tumor volume. Surgical margins are clear of the invasive tumor and DCIS, with the closest distances being 0.6 cm and 1.2 cm, respectively. One of the four excised lymph nodes is positive for micrometastasis, with two foci each under 1.0 mm and no extracapsular spread noted, indicating micrometastatic nodal involvement (pN1mi). The tumor demonstrates positive estrogen and progesterone receptors and is negative for HER2/neu overexpression. Additionally, angiolymphatic invasion is present. Non-neoplastic breast tissue exhibits fibrocystic changes, ductal epithelial hyperplasia, and fibroadenomatoid nodules, with unremarkable skin pathology. T-stage is classified as pT1c, making this an early-stage breast cancer with some regional lymphatic spread but no distant metastasis confirmed (pMX)."
244,TCGA-A8-A08F-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of multifocal invasive ductal carcinoma with intraductal components and focal angioinvasion in the ablated right breast sample. The carcinoma includes a poorly differentiated invasive focus and two moderately differentiated invasive foci. The dorsal resection margin is free of tumor involvement with the minimum distance from the tumor to the margin being 0.5 cm, 1.5 cm, and 0.7 cm for the respective foci, and all other margins are also tumor-free. Tumor classification is noted as NOS, G III, pT2(mult)N3aL1V0R0, indicating a high-grade, multiple tumor nodules with significant lymph node involvement (N3a), presence of lymphovascular invasion (L1), but no residual tumor (R0). This classification underscores the aggressive nature of the disease with extensive lymph node metastasis, warranting further therapeutic intervention."
245,TCGA-BH-A0BQ-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a primary diagnosis of invasive ductal carcinoma (IDC) in the left breast, characterized as a Nottingham Grade II tumor based on tubule formation, nuclear pleomorphism, and mitotic activity. The presence of ductal carcinoma in situ (DCIS), nuclear grade 3, is also noted, comprising approximately 30% of the total tumor volume with associated necrosis. Importantly, there is no evidence of lymphovascular invasion, and angiolymphatic invasion is absent. The closest surgical margins for both the invasive and in situ components are 5 mm. The pathological examination of the retromammary lymph node and the two examined lymph nodes shows no metastatic involvement (0/3). The tumor is staged as pT1c pN0 pMX, indicating a tumor size consistent with T1c classification and no regional lymph node metastasis. Additionally, the carcinoma is positive for estrogen and progesterone receptors, with a HER2/neu score of 2+. Calcifications are present within the malignant areas. The findings are consistent with a previously documented left breast core biopsy that identified infiltrating duct carcinoma with nuclear grade 2 characteristics."
246,TCGA-GM-A2DL-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient presents with invasive ductal carcinoma of the left breast, characterized as poorly differentiated with a Modified Black's nuclear grade of 3. The invasive component measures 1.2 cm in its greatest dimension and notably extends to within 5 mm of the nearest deep margin, although all margins are reported free of tumor. Additionally, there is a presence of poorly differentiated intraductal carcinoma (DCIS) comprising less than 5% of the tumor area, noted for its solid type with necrosis. Importantly, no lymphatic or vascular invasion is identified. Both sentinel lymph nodes from the left axilla are free of tumor. Subsequent excisions of the second deep, medial, superior, and inferior margins of the left breast also show no presence of tumor. Immunohistochemical profiling reveals the tumor is strongly positive for estrogen receptor (100%) and progesterone receptor (90%), while HER-2/neu is negative. The Ki-67 proliferation index is high at 50%, indicating a significant proliferative activity. Immunohistochemical stains for cytokeratins and molecular pathologic assays are pending for further evaluation."
247,TCGA-AN-A041-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","A female patient was diagnosed with breast cancer, specifically infiltrative ductal carcinoma located in the breast. The primary tumor was identified in the tissue specimen obtained via radical mastectomy, and the tumor was of Grade 2. Pathological staging revealed a T Stage of 2, indicating tumor size and extent, with N Stage 1a, denoting minimal lymph node involvement, and M Stage 0, indicating no distant metastasis. The margins of the excised tumor were evaluated, and the results provide critical information for surgical success and further treatment planning, though specific margin status details were not provided. No treatment had been initiated prior to the procurement of the tissue specimen. Additionally, a normal blood sample was collected via blood draw and frozen for comparison or further analysis. This comprehensive pathological assessment outlines key aspects of the tumor's characteristics, aiding in the formulation of an appropriate management plan for the patient's condition."
248,TCGA-E2-A1L7-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right breast modified radical mastectomy, along with axillary contents, reveals two foci of invasive ductal carcinoma, categorized as SBR Grade 3, with extensive necrosis and microcalcifications. The tumors located in the upper outer and upper inner quadrants measure 3cm and 1.5cm in size respectively. The surgical margins are clear of the tumor. Ductal carcinoma in situ (DCIS) of the solid type, with high nuclear grade and necrosis, is also present, comprising approximately 15% of the neoplastic component, and it does not involve the margins. The skin and nipple are free of tumor. Lymphatic analysis shows metastatic carcinoma in 7 out of 20 lymph nodes, with extranodal extension, the largest metastasis measuring 4cm. The additional lymph nodes from the axillary contents reveal metastases in both nodes examined, also with extranodal extension, the largest metastasis measuring 2cm. Estrogen receptor (ER) and progesterone receptor (PR) status is negative in the larger tumor, while the smaller tumor shows ER positivity with an Allred score of 3 and PR positivity with an Allred score of 7. Both tumors are HER2-negative by immunohistochemistry (IHC) and not amplified by fluorescence in situ hybridization (FISH). The final pathological staging is pT2 N2."
249,TCGA-A8-A096-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of moderately differentiated invasive ductal carcinoma, not otherwise specified (NOS), corresponding to grade II. The tumor exhibits invasive characteristics, with associated lymphovascular invasion but no perineural invasion. Surgical margins are clear of tumor involvement, indicating that no residual tumor is present at the resection edges. Lymph node analysis shows no macrometastases, but isolated tumor cells are present in the sentinel node. Overall, these findings suggest a pT2 stage tumor with regional assessment indicating N0i+ status."
250,TCGA-A8-A06N-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of poorly differentiated invasive ductal carcinoma, characterized by a lack of specific histological subtype and graded as G III. The tumor is expansive and exhibits multiple ulcerations extending through the skin. The neoplasm's invasive nature is evident with a classification of pT4b, indicating direct extension to the chest wall and/or skin. A critical concern is the tumor's proximity to the surgical margins, being less than 0.1 cm away, which may suggest an increased risk of local recurrence. Additionally, there is no evidence of nodal metastasis (pN0), and both lymphovascular and perineural invasion are absent (L0, V0, R0). These findings collectively highlight an aggressive tumor with potential challenges in achieving complete surgical clearance."
251,TCGA-E2-A152-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive ductal carcinoma (IDC) of the right breast. The main tumor measures 1.8 cm and is located near the posterior surgical margin, while a secondary, smaller tumor is present near the anterior-medial margin. Both tumors exhibit similar histomorphology, including high nuclear grade ductal carcinoma in situ (DCIS) with solid and cribriform patterns, central necrosis, and microcalcifications, connecting the tumors via intervening DCIS. Margins are negative, with the closest margin being 0.15 cm from the deep resection margin. The invasive carcinoma is classified as grade 3, showing high-grade nuclear features and a mitotic score of 2. There is no evidence of vascular or lymphatic invasion. All three sentinel lymph nodes from the right axilla are negative for metastatic involvement. The DCIS constitutes approximately 15% of the specimen and is confined to the areas associated with the invasive carcinoma. Hormone receptor status indicates estrogen receptor positivity, progesterone receptor negativity, and HER2 positivity by immunohistochemistry. The pathological staging is pT1c N0, reflecting a primary tumor size exceeding 1 cm but not more than 2 cm, with no regional lymph node metastasis. Preoperative assessments confirmed the malignant nature of the lesion, and intraoperative consultation indicated proximity to the surgical margins without invasion into adjacent structures."
252,TCGA-E2-A1LI-01Z-00-DX1,BRCA,"Please generate a comprehensive and professional pathology report based on the provided slide from Breast, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive and in-situ ductal carcinoma of the left breast, classified as grade III/III according to the Scarff-Bloom-Richardson grading system, with associated necrosis and cancerization of lobules. The invasive component is histologically ductal, with high nuclear grade and increased mitotic activity. Notably, there is no evidence of vascular or lymphatic invasion. The ductal carcinoma in situ (DCIS) component constitutes less than 25% of the lesion, showing diffuse clining outside the main mass, with a high nuclear grade but no necrosis. Margins are close, with DCIS present within one high-power field (HPF) of the lateral margin and within one millimeter of both the deep and medial margins. Sentinel lymph node biopsies from the left axilla show no evidence of metastatic tumor (0/2), indicating no lymph node involvement. Hormone receptor status by immunohistochemistry reveals the tumor is estrogen receptor (ER) and progesterone receptor (PR) negative, with HER2 status borderline on immunohistochemistry but shown to be not amplified by fluorescence in situ hybridization (FISH). These findings stage the tumor pathologically at T2N1."
253,TCGA-NH-A5IV-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right colectomy specimen, including the cecum, ascending colon, transverse colon, and terminal ileum, revealed a diagnosis of low-grade adenocarcinoma of the transverse colon. The tumor extensively involves the subserosal adipose tissue without reaching the serosal surface. Importantly, the surgical resection margins, including the proximal, distal, and circumferential or mesenteric margins, were free of invasive carcinoma. Additionally, no evidence of lymph-vascular or perineural invasion was identified. Histopathological analysis of 12 regional lymph nodes showed no metastatic involvement. These findings indicate a primary tumor classified as pT3 with regional lymph nodes staged as pN0, suggesting localized disease with no lymph node metastasis."
254,TCGA-AD-A5EK-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated invasive adenocarcinoma originating from what appears to be the right or transverse colon, or the hepatic flexure. The tumor is a low-grade adenocarcinoma without significant lymphocytic response, and it contains a minor mucinous component but no medullary component. Importantly, the tumor invades the muscularis propria but does not penetrate through it. The surgical margins are uninvolved by carcinoma, with the closest margin being the colonic margin at a distance of 3 cm, ensuring adequate clearance. There is no evidence of macroscopic tumor perforation, lymphovascular invasion, perineural invasion, or tumor deposits. Eleven regional lymph nodes were examined, and none showed metastatic involvement, classifying the nodal status as pN0. The small intestine segment included in the specimen is negative for tumor. These findings result in a pathological stage of pT2, pN0, pMx, consistent with localized disease without distant metastasis. The surgical specimen included terminal ileum, cecum, right colon, and vermiform appendix, with no tumor identified within the small intestine or appendix. Overall, the findings suggest a favorable prognosis given the absence of lymph node metastasis and involvement of surrounding tissues."
255,TCGA-CM-6167-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings from the right colon resection indicate a diagnosis of poorly differentiated adenocarcinoma with signet ring cells located in the cecum. The tumor shows extensive tumor budding and invades subserosal adipose tissue and/or mesenteric fat. No gross perforation is identified. There is extensive lymphovascular and large venous invasion, as well as perineural invasion. The accompanying non-neoplastic bowel and appendix are unremarkable. Surgical margins are free of tumor, indicating no residual cancer at the resection edges. However, the tumor exhibits metastasis to 11 out of 40 examined lymph nodes and is associated with three tumor deposits in the pericolorectal soft tissue. Additional findings include three tubulovillous adenomas away from the carcinoma. Immunohistochemical staining supports the diagnosis of primary colon carcinoma, as the tumor cells test positive for CK20 and CDX2, and very focally for CK7, while being negative for synaptophysin, chromogranin, ER, and PR. The final pathological staging classifies the tumor as pT3, indicating invasion into the pericolorectal tissues, and as N2b for lymph node involvement, reflecting metastasis in seven or more regional lymph nodes."
256,TCGA-F4-6703-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the partial colectomy specimen from the ascending colon revealed an ulcerated adenocarcinoma, classified as moderately differentiated. The tumor infiltrates up to the subserosal layer. Importantly, there is no evidence of metastatic involvement in any of the twelve examined lymph nodes. The surgical margins are free of tumor cells, indicating that the excision was complete. These findings are indicative of a localized adenocarcinoma of the colon with no metastatic spread to regional lymph nodes and clear surgical margins."
257,TCGA-CM-5344-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The total colectomy specimen from a patient with a clinical diagnosis of sigmoid colon cancer revealed an adenocarcinoma, moderately differentiated, located in the sigmoid colon. The carcinoma exhibits focal tumor budding without increased tumor-infiltrating lymphocytes and is associated with a precursor lesion of a tubular adenoma. The deepest tumor invasion extends into the subserosal adipose tissue and/or mesenteric fat, with identified lymphovascular and perineural invasion. Importantly, no gross tumor perforation was noted, and surgical margins were clear of tumor involvement. Three polyps, identified as tubular adenomas, were found away from the carcinoma. The non-neoplastic bowel displayed extensive melanosis coli, while the appendix appeared unremarkable. Out of 108 examined lymph nodes, metastasis was present in three. According to the AJCC 7th Edition, the tumor is staged as pT3, indicating invasion through the muscularis propria into pericolorectal tissues, and the lymph node stage is N1b, denoting metastasis in 2-3 regional lymph nodes. Immunohistochemical staining for MLH1, MSH2, MSH6, and PMS2 proteins was intact in the tumor."
258,TCGA-AA-3819-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of moderately differentiated colic adenocarcinoma (G2), characterized by infiltration through all layers of the intestinal wall, classified as pT3. Notably, there is evidence of both lymphatic and vascular invasion, indicated by L1 and V1, respectively. Examination of the regional lymph nodes did not demonstrate any metastatic involvement, with all sampled lymph nodes being free of tumor cells (0/14). Surgical margins were also clear of carcinoma, confirming a complete resection status (R0). These findings collectively characterize a locally advanced colic adenocarcinoma with complete surgical excision and no regional lymph node metastasis."
259,TCGA-CM-5868-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated adenocarcinoma in the resected sigmoid colon, with extensive tumor budding and deepest invasion reaching the serosal surface. There is evidence of both large venous and perineural invasion, and lymphovascular invasion is suspected. The surgical margins are clear of the tumor. Among the 17 lymph nodes examined, one showed metastatic involvement, alongside identified tumor deposits in the pericolorectal soft tissue. The pathological staging classifies the tumor as pT4a and the lymph node stage as N1 according to the AJCC 7th Edition. Additionally, the gallbladder exhibits chronic inflammation and cholelithiasis, and all examined lymph nodes of Callot and hepatic artery are benign. Both the excised left and right fallopian tubes and ovaries, as well as the proximal and distal colonic rings, displayed benign features."
260,TCGA-AY-6196-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen from a right colon resection reveals a diagnosis of adenocarcinoma with prominent mucinous and signet ring cell features, located in the ascending colon. This poorly differentiated tumor has invaded through the muscularis propria into the pericolic soft tissue, and extensive lymphovascular invasion is noted, though no perineural invasion is present. All surgical margins, including proximal, distal, and mesenteric, are negative for malignancy, with the closest margin being 2.0 cm away from the tumor at the mesenteric margin. Examination of regional lymph nodes shows metastasis in twelve out of fourteen nodes, accompanied by extracapsular extension. Additional pathologic findings include the presence of mucin and tumor cells within the periappendiceal soft tissue, extending into the muscularis propria of the appendix, along with severe acute and chronic serositis with adhesions. The AJCC pathological staging is pT3 pN2b, indicating advanced local and nodal disease. Immunohistochemical studies for MLH1, MSH2, and MSH6 markers reveal a normal phenotype, which does not support a diagnosis of hereditary non-polyposis colorectal cancer."
261,TCGA-AA-A01Q-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated adenocarcinoma of the ascending colon, characterized by extensive anaplastic areas of solid carcinoma. Appropriately classified as histopathological grade G3 to 4, the tumor demonstrates significant ulceration of the inner surface along with areas of necrosis and peritumorous chronic recurrent inflammation. The cancerous infiltration extends deeply, involving all layers of the colon wall and reaching the subserous fatty connective tissue. There is evidence of carcinomatous lymphangiosis, although the 16 sampled lymph nodes are free of tumor involvement, showing only moderate chronic lymphadenitis. The resection margins and reticular fatty tissue also confirm the absence of residual tumor cells. The pathological stage of the tumor is determined as pT3, pN2, MX, L1, R0, indicating local but no distant metastasis, with lymphovascular invasion, but no residual tumor at the resection margins."
262,TCGA-A6-6138-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of moderately differentiated adenocarcinoma of the cecum, localized to the cecal side of the ileocecal valve. The tumor is well-circumscribed, invading nearly the full thickness of the muscularis propria but not extending through it. Margin analysis shows that the proximal, distal, and circumferential (radial) margins are negative for tumor involvement, with the closest margin being the inked serosal surface, situated 1.2 cm away from the tumor. Vascular invasion is absent. A total of 24 regional lymph nodes were examined, all negative for metastatic disease, indicating no lymphatic spread. Additionally, a small 2 mm adenomatous polyp was identified within the colon, but the terminal ileum and appendix exhibited no significant pathological findings. Overall, the findings suggest localized disease with clear margins and no lymph node or vascular involvement."
263,TCGA-AA-3869-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an ulcerated, moderately differentiated adenocarcinoma of colorectal type, originating in the cecum and extensively infiltrating the pericecal fatty tissue and penetrating the serosa. The resected tumor shows significant metastasis, with involvement of 14 out of 28 local lymph nodes. Importantly, the resection margins of the small and large intestine, as well as the mesenteric resection margin and appendix, are free of tumor cells. The tumor is staged as pT4 pN2 with clinical evidence of liver metastases (pM1). Additional findings include a grading of G2, the presence of lymphatic invasion (L1), absence of vascular invasion (V0), and incomplete resection as indicated by the presence of residual tumor (R2)."
264,TCGA-AA-A029-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive, poorly differentiated colon adenocarcinoma that exhibits features characteristic of a grade 3 tumor. A significant mucinous component is noted, categorizing it as a partially mucinous carcinoma. The tumor demonstrates infiltration through all parietal layers, consistent with a staging of pT3. Notably, there is no evidence of cancerous invasion in the resection margins or in the examined regional lymph nodes, indicating that both the margins and lymph nodes are free of malignant cells. This pathology report suggests thorough local invasion but no apparent metastatic spread to nearby lymphatic structures."
265,TCGA-CK-5916-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals the presence of a poorly differentiated adenocarcinoma in the right colon, exhibiting neuroendocrine and signet ring cell features along with focal mucin production. The tumor penetrates through the muscularis propria and involves the visceral peritoneum. Importantly, the proximal, distal, and radial resection margins are free of tumor, indicating complete surgical resection margins. However, there is evidence of lymphovascular invasion. The appendix shows fibrous obliteration and peri-appendiceal adhesions. Lymph node examination reveals metastatic carcinoma in one out of thirty-two lymph nodes examined. These findings collectively underscore a high-grade, invasive carcinoma with evidence of metastatic spread, which has significant implications for prognosis and post-surgical treatment planning."
266,TCGA-AA-3713-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated invasive adenocarcinoma of the colon, characterized by focal penetration of the tunica muscularis and infiltration of pericolic fatty tissue. The tumor surface is noted for necrosis, whereas the periphery exhibits a moderate lymphocytic inflammatory reaction. Both the oral and aboral resection margins are tumor-free, as is the area around the central vascular ligature. Accompanying the adenocarcinoma are tubulovillous adenomas, some with slight dysplasia. However, the omentum reveals metastasis of a poorly differentiated mucinous adenocarcinoma, distinctly different in differentiation from the primary adenocarcinoma in the right flexure. All 15 examined lymph nodes are free of tumor involvement, showing only reactive hyperplasia. The tumor is classified as ICDO-DA-M 8140/3, staged as pT3, pN0, R0, G2."
267,TCGA-CM-6679-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","A pathological analysis of the resected sigmoid colon reveals a moderately differentiated adenocarcinoma localized to the sigmoid region. The tumor demonstrates focal budding and invades the subserosal adipose tissue but does not exhibit any lymphovascular, large venous, or perineural invasion. All surgical margins are clear of tumor cells, indicating complete excision. No polyps or mucosal dysplasia were identified away from the carcinoma, and the non-neoplastic bowel appears unremarkable. Examination of 21 regional lymph nodes shows no evidence of metastatic disease. According to the AJCC 7th Edition staging criteria, the tumor is classified as pT3N0M0. Additional sections from the proximal and distal colonic rings exhibit hyperplastic features without any presence of tumors."
268,TCGA-AA-3994-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen revealed an ulcerated colon carcinoma, diagnosed as a moderately differentiated, partially mucinous colorectal adenocarcinoma. The tumor encircled the colon wall and demonstrated invasive spread through all intestinal wall layers, reaching the mesocolic fatty tissue. Importantly, the surgical margins, including the oral and aboral resection margin and the greater omentum, were free of tumor involvement. The analysis of lymph nodes identified metastases in two out of twenty-four examined nodes, indicating regional lymph node involvement. Additionally, the appendix exhibited evidence of post-inflammatory fibrosis. Based on these findings, the tumor is staged as pT3, pN1, indicating invasion through the muscularis propria and subserosa with regional lymph node metastasis, but no evidence of distant metastasis or residual tumor (V0, R0). The overall grade of the tumor is classified as G2, representing moderate differentiation."
269,TCGA-AA-3532-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a resectate of the colon with a moderately differentiated adenocarcinoma of colorectal type. The tumor exhibits infiltration into the pericolic fatty tissue. All examined regional lymph nodes are free of tumor involvement. The mesenteric resection margin as well as the large intestinal resection margins are clear of tumor cells. The tumor is staged as pT3 pNO (0 out of 35 lymph nodes involved) pMX; G2, L0, V0, and the resection status is categorized as locally R0, indicating no residual tumor at the resected margins."
270,TCGA-AA-A01F-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected colon (sigma) revealed ulcerated, moderately differentiated adenocarcinoma, characterized by infiltration into the perimuscular fatty tissue. Importantly, both the oral and aboral resection margins were tumor-free. Additionally, the specimen contained two small tubular adenomas exhibiting mild dysplasia (mild intraepithelial neoplasia) and a small leiomyoma situated in the lamina muscularis mucosa. Lymph node involvement was noted, with two out of thirty examined local lymph nodes showing metastases. The pathological staging is designated as G2, pT3, N1, L1, V0, R0, indicating grade 2 differentiation, tumor invasion through the muscularis propria into perimuscular tissue, the presence of lymphovascular invasion, no venous invasion, and clear resection margins with a total of two metastatic lymph nodes out of thirty assessed."
271,TCGA-AA-3939-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings include a diagnosis of colon and cecal carcinoma identified as a moderately differentiated colorectal adenocarcinoma. The tumor exhibits invasive growth through all intestinal wall layers, extending into the mesocolic fatty tissue. Additionally, a tubular adenoma with moderate epithelial dysplasia was found in the ascending colon, situated aborally to Bauhin's valve. The appendix shows evidence of chronic appendicitis and periappendicitis, with xanthous tissue reaction likely due to the tumor-related relocation of the appendix ostium. The cecum and oral section of the ascending colon display extensive and progressive macrophage-rich inflammation, indicative of perityphlitis. The tumor is staged as pT3, with no metastatic lymph node involvement (0 out of 40 lymph nodes examined) and a classification of G2, with clear resection margins (R0)."
272,TCGA-F4-6855-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the sigmoid colectomy specimen revealed a moderately differentiated adenocarcinoma located in the sigmoid colon, characterized by an ulcerated surface. The tumor extended into the pericolonic tissues but showed no evidence of venous invasion. Surgical margins were clear of tumor involvement. The examination of twelve lymph nodes indicated reactive changes without any metastatic involvement. The evaluation did not specify evidence of neo-adjuvant treatment or other additional pathological findings."
273,TCGA-CM-5862-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen with a right colon mass revealed an adenocarcinoma located in the ascending colon. The tumor is moderately differentiated and invades the subserosal adipose tissue and/or mesenteric fat without evidence of gross perforation. Lymphovascular invasion is present; however, large venous and perineural invasion are not identified. Tumor budding and increased tumor infiltrating lymphocytes are absent. Importantly, the surgical margins are free of tumor involvement. The non-neoplastic bowel is unremarkable, though two tubular adenomas and one hyperplastic polyp were noted away from the carcinoma. The lymph node assessment found one out of twenty-four nodes demonstrating metastasis, corresponding to a lymph node stage of N1. Tumor deposits in the pericolorectal soft tissue were also identified, with the overall staging (AJCC 7th Edition) indicated as pT3. The tumor tested negative for KRAS exon 2 mutations, as confirmed by KRAS gene mutation analysis. The appendix exhibited fibrous obliteration of the lumen with no significant pathological findings. Special studies performed included Sequenom mass-spectrometry genotyping which detected no specific mutations in the analyzed genes (AKT1, BRAF, EGFR, ERBB2, KRAS, MEK1, NRAS, and PIK3CA). The cumulative findings necessitate the result interpretation in conjunction with all clinical and pathological data available."
274,TCGA-AA-3860-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis indicates an invasive, poorly differentiated sigmoid colon carcinoma (G3). Pathological examination reveals tumor penetration through all parietal layers with evidence of vascular infiltration. The resection margins, including both the mucosa region and the deep circumferential margin, are free from tumor involvement, signifying clear margins. Lymph node analysis shows metastatic involvement in 2 out of 13 examined nodes (pN1). This carcinoma is classified under ICDO-DA M8140/3 and is locally categorized as R0, indicating no residual tumor locally."
275,TCGA-G4-6297-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen revealed an exophytic, circumferential, and ulcerated invasive adenocarcinoma located in the cecum and proximal ascending colon, extending to the ileocecal valve. The tumor exhibited moderate to poor differentiation, with invasion extending through the full muscle wall thickness into the subserosal fat. Six out of thirty-six pericolic lymph nodes showed metastasis with perinodal fat extension, and both venous/lymphatic and perineural invasion were present. However, the proximal, distal, and radial resection margins were negative for tumor involvement. An additional finding included a tubulovillous adenoma, while the vermiform appendix was free of tumor. Immunostaining for EGFR was negative in the tumor sections. In summary, the pathologic stage was determined to be pT3 N2 MX, with an extensive and invasive adenocarcinoma characterized by significant lymph node involvement but clear surgical margins."
276,TCGA-F4-6854-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a sigmoid colectomy specimen reveals adenocarcinoma of the sigmoid colon, classified as moderately differentiated. The tumor has infiltrated pericolonic tissues, indicating local advancement. Importantly, surgical margins are clear of tumor involvement, suggesting the entire neoplastic lesion has been excised. A total of eight regional lymph nodes were assessed, all of which are free of metastatic disease, indicating no lymphatic spread. Overall, the findings suggest a locally advanced, moderately differentiated adenocarcinoma without evidence of distant metastasis."
277,TCGA-AA-3877-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a moderately differentiated, partially mucinous colorectal adenocarcinoma originating from the base of a tubulovillous adenoma with severe epithelial dysplasia. The tumor exhibited invasive spreading into the submucosa and extended close to one of the resection margins, though the exact distance from the margin is unspecified. Notably, the oral and aboral resection margins were free of tumor involvement, as was the greater omentum. The assessment of 18 mesocolic lymph nodes showed no evidence of metastasis, with only uncharacteristic reactive changes present. Additionally, microscopic examination identified small tubular adenomas within the colon mucosa, with one displaying slight epithelial dysplasia and another moderate epithelial dysplasia. The tumor is staged as pT1 pN0 (0/18) L0 V0 R0; G2, indicating a localized cancer with no lymphovascular invasion and clear surgical margins."
278,TCGA-G4-6293-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the resected right colon and terminal ileum reveals an exophytic, moderately differentiated invasive adenocarcinoma originating from a tubulovillous adenoma located in the transverse colon. The tumor exhibits full thickness invasion into the muscle wall with extension into the subserosal fat, indicating a significant depth of invasion. Metastases are present in one out of the twenty-six dissected pericolic lymph nodes. Margins of resection, including proximal, distal, and radial, are confirmed to be free of tumor, ensuring a complete surgical resection. The appendix and examined portion of omental fat show no specific pathological changes or evidence of tumor involvement. Immunohistochemistry shows retained expression of MLH1 and MSH2 proteins, suggesting a lower likelihood of microsatellite instability. Overall, the findings support a pathological stage of pT3 N1, aligning with the depth of invasion and lymph node involvement observed."
279,TCGA-AA-3549-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a moderately differentiated colorectal adenocarcinoma identified in a right hemicolectomy specimen, with the carcinoma being ulcerated and located at the junction between the cecum and ascending colon. The tumor exhibits invasive behavior extending into the muscularis propria. Additionally, a small solitary tubular adenoma with moderate epithelial dysplasia is present in the colonic mucosa. Notably, there is a coarse, nodular calcified focus in the mesentery, likely representing a completely calcified lymph node. Both the oral and aboral resection margins are tumor-free. Examination of 31 regular lymph nodes shows no evidence of tumor involvement, although reactive changes are noted. Consequently, the tumor is staged as pT2 N0 (0/31) V0 L0, with a grade of G2, and resection margins classified as R0."
280,TCGA-AD-6963-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of moderately differentiated adenocarcinoma of the colon in the area marked by prior tattooing, located 4.8 cm from the distal surgical margin. The tumor extends through the muscularis propria into the subserosal adipose tissue, but there is no involvement of the visceral peritoneum and no unequivocal lymphovascular space invasion is identified. Surgical margins, both proximal and distal, are free of carcinoma. Additionally, the radial margins are clear. Twelve lymph nodes examined show no evidence of metastatic carcinoma, confirming no lymph node involvement (0/12). Macrophages containing brownish-black cytoplasmic pigment, consistent with prior tattooing, are noted. The appendiceal examination revealed fibrous obliteration at the luminal tip, with no carcinoma detected, and the terminal ileum is unremarkable with no carcinoma identified. Overall, the cancer is staged as pT3N0 based on these findings."
281,TCGA-D5-7000-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the resected cecum revealed a tubulopapillary and partially mucinous adenocarcinoma (Grade 3) of the colon. The tumor exhibits a cauliflower-like appearance and occupies 80% of the intestinal circumference, with invasion into, but not through, the muscularis propria, classifying it as pathological stage T2. Importantly, the proximal and distal margins, as well as the minimum side margin, are free of tumor involvement, indicating clear surgical margins. No metastatic spread was detected in the examined lymph nodes, with a total of eighteen nodes showing signs of lymphonodulitis but no evidence of adenocarcinoma, resulting in a pN0 status. The appendix displayed chronic inflammation consistent with appendicitis but no neoplastic involvement. These findings collectively stage the disease as Dukes A and Astler-Coller BI, reflecting an early-stage malignancy with good prognostic implications due to the absence of lymph node metastasis and clear resection margins."
282,TCGA-AA-3526-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The colonic resection specimen from the sigmoid demonstrates a diagnosis of moderately differentiated adenocarcinoma. The invasive tumor has extended to the level of the muscularis propria, but notably, both the oral and aboral resection margins are free of tumor involvement. Examination of the mesocolic lymph nodes revealed no metastatic spread, with all seventeen lymph nodes examined (including an additional seven small lymph nodes found upon special fixation) showing only reactive changes. The pathological staging of the tumor is pT2 pN0 (0/17) LO V0, and the tumor grade is G2. These findings indicate a localized tumor without regional lymph node metastasis."
283,TCGA-AA-3812-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a moderately differentiated adenocarcinoma of the sigma, classified as histopathological differentiation grade G2. The tumor exhibits ulceration of the inner surface along with areas of necrosis and presents with peritumoral chronic recurrent secondary inflammation accompanied by an acute inflammation flare. There is evidence of carcinomatous lymphangitis, indicating lymphatic spread of tumor cells. Tumor infiltration has extended through the sigma wall layers to the subserous fatty connective tissue. Examined lymph nodes show moderate chronic lymphadenitis but are tumor-free (0 out of 13 nodes involved). Margins from resection and the anastomosis ring are also free of tumor cells, confirming clear margins. Additionally, the presence of sigma diverticulosis is noted. The tumor stage is designated as pT3, pN0, MX, L1, R0, indicating deep invasion without regional lymph node involvement, indeterminate distant metastasis status, and lymphatic invasion, with no residual tumor at the margins."
284,TCGA-A6-2681-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right colon specimen reveals a moderately-differentiated adenocarcinoma located in the cecum. The tumor exhibits a rubbery tan pink-red appearance and extends through the muscularis propria into the subserosal fat, classifying it as pT3. The proximal, distal, and radial margins are clear of tumor invasion, and no vascular invasion is identified. The evaluation of twenty-three lymph nodes from the mesentery and mesocolon shows no evidence of metastatic involvement (0/23). Additionally, the appendix and ileum are unremarkable, and there is no presence of pericolonic tumor outside the lymph nodes. Areas of diverticulosis are noted throughout the colonic segment. These findings characterize a cecal adenocarcinoma with negative excision margins and no lymph node involvement, suggesting a potentially favorable prognosis after surgical resection."
285,TCGA-AA-3552-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination provided two primary diagnoses involving the colorectal region and liver tissue. The first diagnosis revealed a moderately differentiated colorectal adenocarcinoma located in the cecum with circumscribed infiltration into the pericecal adipose tissue, accompanied by ten regional lymph node metastases. All resection margins for the small intestine, large intestine, and mesentery were tumor-free, with additional findings of lymphangiosis carcinomatosa in the perityphlitic adipose tissue and the tunica muscularis propria of the appendix. The omental adipose tissue was free of tumor cells. Pathological staging for this primary diagnosis was pT3, pN2 with ten out of twenty lymph nodes affected, and tumor-free regional margins (R0). The second colorectal diagnosis indicated the presence of a circumscribed ulcerated mucous membrane defect post-ablation of an adenocarcinoma infiltrating the submucosa, with no residual tumorous tissue identified. All regional lymph nodes and resection margins were tumor-free, resulting in a staging of pT1, pN0 with clear margins. The liver pathology included a bilious hamartoma (Meyenburg complex) in the resected tissue, other sections of liver showing small bile duct cysts, and a scarred pericystic area. Additionally, a superficial resected liver segment revealed a scarred capsular region, with no signs of malignancy or metastasis from the colon carcinoma observed."
286,TCGA-AA-3655-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the resected sigmoid colon reveals a moderately differentiated colorectal adenocarcinoma. The tumor demonstrates infiltrative spread through all parietal layers of the colon, extending into the adjacent mesocolic fatty tissue. Despite its invasive nature, the tumor remains 6.5 cm away from the closest resection margin, and both oral and aboral resection margins are free of tumor involvement. Additionally, the mucous membrane of the colon contains a small tubulovillous adenoma accompanied by moderate epithelial dysplasia, indicative of low-grade epithelial neoplasia. Examination of twenty-two mesocolic lymph nodes shows no evidence of metastatic disease, although reactive changes are present. The overall tumor stage is classified as pT3 pN0 (0/22) LOV0, and the tumor grading is G2, reflecting its moderate differentiation."
287,TCGA-D5-6532-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the resected sigmoid colon reveals an invasive adenocarcinoma, specifically a moderately differentiated tubular adenocarcinoma (G2). The tumor, which is ulcerative in nature, occupies a significant portion of the colorectal circumference and demonstrates invasion through the muscularis propria and into the pericolonic fat. Importantly, the incision margins are free of neoplastic involvement, indicating complete resection of the malignant tissue. Lymph node analysis shows reactive lymphonodulitis without evidence of metastatic carcinoma (pN0). The overall histopathological findings classify the disease as stage pT3, consistent with Dukes B and Astler-Coller B2 staging, suggesting localized spread confined to the bowel wall and surrounding tissue with no lymph node metastasis."
288,TCGA-CM-4752-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen from a patient with right-sided colon cancer reveals a moderately differentiated adenocarcinoma located in the ascending colon. The tumor exhibits an ulcerating and infiltrative gross configuration and invades into the subserosa. There is no evidence of gross tumor perforation or serosal involvement. Importantly, vascular invasion is not identified, but perineural invasion is present. Surgical margins are free of tumor, indicating complete resection. The non-neoplastic bowel appears unremarkable, and there is no significant pathology noted in the appendix or omentum. The pathological stage is designated as pT3, and all 23 examined lymph nodes are free of metastatic involvement. Overall, the findings suggest a localized but aggressive tumor behavior, with notable nerve invasion and no distant lymphatic spread."
289,TCGA-A6-6654-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately-differentiated adenocarcinoma located in the descending colon. The tumor exhibits invasive characteristics, extending through the muscularis propria into the subserosal fat. Notably, all resection margins, including proximal, distal, and radial, are negative for tumor involvement, indicating complete excision. Lymph node analysis reveals metastatic carcinoma in one out of sixty-five examined lymph nodes. Additionally, there is one focus of non-lymph node pericolonic tumor near the main tumor mass, which may represent a lymph node replaced by carcinoma. The specimen also presents with multiple diverticula, as observed upon gross examination, but lacks evidence of submucosal abscess or perforation. No vascular invasion is identified in the examined sections. These findings collectively characterize the extent and nature of the carcinoma, as well as its metastatic reach and local tissue involvement."
290,TCGA-AA-3989-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the hemicolectomy specimen reveals a moderately differentiated adenocarcinoma of the ascending colon with tumor invasion into the pericolic fatty tissue. The tumor is classified as adenocarcinoma G2 pT3 N2 (8/28), indicating a moderately differentiated tumor that has penetrated the bowel wall into the pericolonic fat and has metastasized to eight regional lymph nodes out of twenty-eight examined. There is no evidence of lymphovascular invasion (L0, V0). The surgical margins are free of tumor involvement (R0), suggesting that the resection was complete. Overall, the findings highlight the presence of advanced local disease with significant regional lymph node involvement, requiring further clinical management and potential adjuvant therapy."
291,TCGA-AA-A02O-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive, moderately differentiated adenocarcinoma of the colon, classified as G2, pT3. The tumor exhibits permeation through all wall layers and demonstrates lymphatic vessel invasion. Notably, all resection margins are confirmed to be free of tumor cells, indicating a complete surgical removal. Additionally, the assessment of lymph node involvement showed no metastatic spread to the 18 lymph nodes examined. The tumor is further classified under ICD-O-DA M 8140/3, emphasizing its specific histological and diagnostic characteristics. Overall, these findings suggest a locally advanced disease with no evidence of distant lymphatic dissemination."
292,TCGA-AA-A004-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the resected colon sample revealed an ulcerated, highly differentiated adenocarcinoma of the colorectal type, with infiltration extending into the pericolic fatty tissue. Notably, all local lymph nodes examined were free of tumor involvement, indicating no lymph node metastasis. The examination of the resected margins, including the colonic and mesenteric margins, confirmed the absence of tumor cells, suggesting complete excision of the malignancy. Additionally, a small tubular adenoma with mild dysplasia was identified in the colonic mucous membrane. The tumor was classified as stage pT3 pNO (0/32) MX, with grade G1 differentiation, and showed no lymphatic (L0) or vascular (V0) invasion, adhering to a tumor-free resection status (R0)."
293,TCGA-F4-6459-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen analyzed is a colectomy from the sigmoid colon, which reveals an adenocarcinoma with a moderately differentiated histologic grade. The tumor has infiltrated the pericolonic tissues. Importantly, lymph node involvement is confirmed, with all six examined intraabdominal lymph nodes showing metastasis. The margins of resection are an essential consideration, but this summary excludes specific details regarding clearance status. Collectively, these findings indicate a significant local and regional spread of the malignancy, emphasizing the need for a comprehensive management plan."
294,TCGA-SS-A7HO-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals an invasive colonic adenocarcinoma located in the cecum, following a right hemicolectomy. The tumor is high-grade, demonstrating poor to undifferentiated histology, and measures 9.5 cm at its greatest dimension. There is evidence of macroscopic tumor perforation. Microscopically, the tumor extends to the surface of the visceral peritoneum, also invading adjacent soft tissue structures. The proximal and distal margins of the resected specimen are negative for invasive carcinoma, while the circumferential margin is involved, with tumor presence very close to the edge. Lymph-vascular invasion is identified; however, no perineural invasion or tumor deposits are noted. The adenocarcinoma arose within a tubular adenoma. Pathologic staging indicates a primary tumor classification of pT4a, with no regional lymph node metastasis (pNO), as all 25 examined lymph nodes are uninvolved. Immunohistochemical staining reveals patchy CK20 positivity in a small subset of tumor cells and negative CK7 staining. There is mild to moderate intratumoral and peritumoral lymphocytic response. Other excised tissues show chronic inflammation and fat necrosis but are negative for malignancy."
295,TCGA-AA-3947-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The resected ileocolic section reveals an ulcerated colon carcinoma, diagnosed as a moderately differentiated, partly mucinous rectal adenocarcinoma, located 3 cm below Bauhin's valve. This tumor encircles the intestinal wall for an extensive length and exhibits invasive spread through all intestinal wall layers up to the bordering subserous connective tissue and mesocolic fatty tissue. Continuous infiltration is observed into an angular colon section adhering to the tumor. Additionally, the colon mucous membrane contains five sessile serrated adenomas. The tumor is classified as pT4, indicating deep invasion, with no lymph node involvement (pNO: 0/22 examined nodes) and no evidence of lymphovascular invasion (L0, V0). The tumor is graded as G2, indicating moderate differentiation, and resection margins are negative for residual tumor (R0), suggesting a complete resection."
296,TCGA-AD-6548-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right colectomy specimen with an attached portion of the terminal ileum reveals two adenocarcinomas located in the splenic flexure area. Both tumors are moderately differentiated. The larger tumor demonstrates invasion close to, but not completely through, the muscularis propria, while the smaller tumor does not invade the muscularis propria. There is no evidence of lymphovascular space invasion or treatment effect. Surgical margin assessment shows the closest circumferential (radial) margin to the largest tumor is 0.4 cm. Lymph node analysis indicates no metastatic carcinoma in the 12 lymph nodes examined. A separate tubular adenoma, without high-grade dysplasia, is also noted. The pathological staging is pT2, N0 for the larger tumor and pT1, N0 for the smaller tumor."
297,TCGA-A6-2682-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive, moderately differentiated adenocarcinoma of the ascending colon, characterized by extensive invasion through the entire colonic wall, peritoneum, and into the muscularis propria and submucosa of the adhesed ileum, classifying the tumor as pT4b. The proximal and distal margins are free of tumor involvement, confirming complete resection of the carcinoma. Noteworthy is the presence of prominent lymphatic and venous space invasion. Metastatic adenocarcinoma was detected in 2 out of 13 regional lymph nodes, establishing the status as pN1. Non-lymph node pericolonic tumor deposits were found in the mesenteric fat, yet no other significant abnormalities were noted. The apical lymph node specimen received did not reveal definitive lymphoid tissue. Finally, any evidence of distant metastasis could not be evaluated (pMx)."
298,TCGA-A6-5664-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the specimens reveals an invasive, moderately differentiated adenocarcinoma of the cecum infiltrating through the entire colonic wall and extending onto the visceral peritoneum. The proximal and distal margins are clear of tumor involvement. Significant lymphatic invasion is noted, with metastatic adenocarcinoma present in 4 of the 17 examined regional lymph nodes. Additionally, there are clear signs of non-lymph node pericolonic tumor involvement, with extranodal metastases observed adjacent to the appendix and pericolonic lymph nodes. The specimen also contains five adenomatous polyps, with one showing intramucosal metastasis located subjacent to the largest polyp. The left inguinal hernia sac consists of benign fibromembranous tissue with no evidence of malignancy. The omental tissue is composed of lobular fatty tissue and is free of metastatic tumor involvement. Overall, the findings indicate a primary invasive adenocarcinoma of the cecum with notable lymphatic and extranodal spread but clear resection margins."
299,TCGA-AA-3554-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The examination of the resected ileocolic specimen revealed a diagnosis of adenocarcinoma of colorectal type, located in the ascending colon, approximately 2 cm distal to the ileocecal valve. The tumor measured up to 4 cm in diameter, was ulcerated, and demonstrated moderate differentiation. Pathological assessment showed that the cancer had infiltrated the perifocal adipose tissue, indicative of advanced local spread. However, all lymph nodes evaluated in the region were free of metastatic involvement, and the resection margins of the small and large intestine, mesentery, and omentum were clear of tumor cells. Additionally, the appendix was free of any malignant changes. The tumor was staged as pT3, pNO (0/39 lymph nodes), pMX, with a grade of G2. No lymphatic or vascular invasion was observed (L0, V0), and the resection was considered locally complete (R0)."
300,TCGA-A6-5662-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the splenic flexure revealed a diagnosis of moderately to poorly differentiated adenocarcinoma. The primary tumor extends through the muscularis propria into the pericolonic tissue. The circumferential (radial) margin is close, but both the proximal and distal surgical margins are uninvolved. The tumor also exhibits vascular invasion. Metastatic carcinoma is present in 7 out of 13 regional pericolonic lymph nodes, indicating significant lymph node involvement. There is extensive non-lymph node pericolonic tumor identified. Distant metastasis could not be evaluated based on this specimen. Overall, these findings indicate an advanced stage of colon cancer with notable regional spread but clear resection margins."
301,TCGA-CM-6165-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the sigmoid colon resection reveals a diagnosis of moderately differentiated adenocarcinoma with mucinous features, located in the sigmoid colon. Although the tumor perforation and precursor lesions are absent, the tumor extends into the subserosal adipose tissue and/or mesenteric fat. Importantly, no tumor budding or increased tumor-infiltrating lymphocytes were observed. The margins, including additional distal, proximal, and distal segments, are free of tumor involvement. The assessment of 20 regional lymph nodes shows no evidence of metastasis, corresponding to an AJCC 7th Edition lymph node stage of N0. Additionally, there are no tumor deposits in the pericolorectal soft tissue. While lymphovascular invasion was suspected initially, further immunohistochemical staining did not confirm its presence. Other pathologic findings include the absence of polyps, mucosal dysplasia, and perineural invasion, with the non-neoplastic bowel appearing unremarkable. The overall tumor staging is classified as pT3 N0, indicating localized invasion into the pericolorectal tissues without regional lymph node metastasis."
302,TCGA-CM-5349-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated adenocarcinoma in the right colon, specifically located in the cecum. The tumor exhibits focal budding without evidence of lymphovascular invasion and free surgical margins. All 21 examined lymph nodes are negative for metastasis, corresponding to a stage pT3 N0 as per AJCC 7th Edition guidelines. Immunohistochemical analysis shows retained expression of DNA mismatch repair proteins (MLH1, MSH2, MSH6, PMS2) within the tumor. Additionally, the liver biopsy from segment III and the resected left and right fallopian tubes and ovaries are all benign, with no malignant findings noted in these specimens."
303,TCGA-AA-3663-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings from the right hemicolectomy preparation reveal an ulcerated, poorly differentiated adenocarcinoma of the cecum exhibiting extensive and deep infiltration into the perimuscular fatty tissue. There were additional findings of a hyperplastic polyp in the ascending colon. Importantly, the surgical resection margins, both oral and aboral, are free of tumor involvement. A thorough examination of 40 lymph nodes in the pericolic fatty tissue adjacent to the tumor indicates no metastatic carcinoma, confirming the absence of lymph node involvement. Other relevant pathological indicators show no lymphovascular invasion, and the tumor is staged as pT3 pN0 (0/40) L0 V0 R0, which underscores a favorable margin status with no residual tumor left behind post-resection."
304,TCGA-AA-3976-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a moderately differentiated adenocarcinoma of the colorectal type, situated in the rectosigmoid region. The tumor exhibits significant invasion into the tunica muscularis propria. Importantly, the resection margins are clear of tumor involvement, confirming a margin status of R0. Regional lymph node dissection indicates metastasis in two out of sixteen examined nodes, corresponding to a pN1 classification. The cancer is staged at pT2, indicating localized invasion, with no evidence of vascular invasion (V0). The overall pathological staging is pT2, pN1 (2/16), MX, with a grading of G2, which aligns with a moderately differentiated grade. These findings collectively highlight the presence of a clinically significant but resectable colorectal tumor, accompanied by limited regional lymph node involvement."
305,TCGA-G4-6625-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the sigmoid colon specimen revealed an invasive, moderately differentiated adenocarcinoma extending into the subserosa. No angiolymphatic or perineural invasion was identified. All surgical margins were found to be free of the tumor, and none of the eighteen examined lymph nodes contained metastatic cancer. The tumor originated in a tubular adenoma. Additionally, the non-neoplastic portions of the colon exhibited a hyperplastic polyp and a diverticulum. Both the proximal and distal donut excisions showed colonic tissue without any evidence of tumor. These findings are consistent with a stage T3 N0 Mx adenocarcinoma, indicating localized extension of the tumor without regional lymph node involvement."
306,TCGA-A6-6648-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive moderately differentiated adenocarcinoma of the descending colon. The tumor invades through the muscularis propria into the pericolonic fat, consistent with a staging of pT3. Importantly, the resection margins, including the proximal, distal, and circumferential (radial) margins, are negative for tumor involvement. Twenty-one regional lymph nodes were examined and found to be free of metastatic disease (pN0). Additionally, the attached omentum shows no evidence of tumor involvement, and the background colonic mucosa is unremarkable. In the liver biopsy, metastatic adenocarcinoma consistent with the colonic primary is identified, indicating distant metastasis (pM1). The background hepatic parenchyma displays reactive changes to the tumor along with mild steatosis. Overall, the findings suggest a primary colonic adenocarcinoma with metastatic spread to the liver but no remaining disease in the lymph nodes or at the surgical margins."
307,TCGA-CM-5860-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a moderately differentiated adenocarcinoma located in the ascending colon, associated with a precursor lesion identified as a tubulovillous adenoma. The tumor exhibited extensive tumor budding and invaded into subserosal adipose tissue and mesenteric fat. There was no gross tumor perforation observed. Additional findings indicated suspected lymphovascular invasion and confirmed perineural invasion. The surgical margins were free of tumor, and no polyps or mucosal dysplasia were found away from the carcinoma site. The non-neoplastic bowel and appendix were unremarkable. A total of 44 regional lymph nodes were examined, with none showing metastasis, and there were no tumor deposits in the pericolorectal soft tissue. The tumor staged as pT3 and the lymph node stage as N0 according to the AJCC 7th Edition. Immunohistochemical staining confirmed retention of DNA mismatch repair proteins in the tumor. Additionally, one benign lymph node was excised and examined from the ileocolic region, which showed no signs of malignancy."
308,TCGA-A6-5656-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen from the sigmoid colon demonstrates a diagnosis of moderately-differentiated adenocarcinoma. The tumor invades into but does not penetrate through the muscularis propria. Margins, including proximal, distal, and radial margins, are negative for carcinoma, indicating no tumor cells are present at the resection edges. Sixteen lymph nodes were dissected, all of which are negative for metastatic disease, signifying no evidence of lymphatic spread. There is no evidence of non-lymph node pericolonic tumor involvement, and vascular invasion is absent. In summary, the pathological findings indicate a localized moderately-differentiated adenocarcinoma without regional lymph node involvement or vascular invasion, with clear surgical margins."
309,TCGA-AY-A71X-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","A laparoscopic right colectomy was performed, revealing a colorectal adenocarcinoma arising within a tubulovillous adenoma with high-grade dysplasia located in the cecal pouch. The adenocarcinoma was moderately differentiated and had invaded into, but not through, the muscularis propria, with no evidence of lymphovascular or perineural invasion. All resected margins, including proximal, distal, and mesenteric, were negative for malignancy. The closest margin to the tumor was the proximal margin, which was 5.2 cm away. A total of 28 regional lymph nodes were examined, and none showed evidence of malignancy. An additional tubulovillous adenoma separate from the main tumor, also with focal high-grade dysplasia, was identified. The appendix showed acute serositis but was otherwise unaffected by the tumor. The pathological staging based on the available data is pT2 pN0. This clinical scenario involves a female patient presenting with right colon cancer, highlighting the necessity for further clinical review and consideration of any additional pathological or clinical information that may emerge."
310,TCGA-A6-2680-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the extended right hemicolectomy specimen has led to a diagnosis of moderately-differentiated adenocarcinoma of the hepatic flexure of the colon. The tumor displays circumferential involvement with raised, rolled edges and central ulceration, invading through the muscularis propria into the subserosa but not reaching the serosal surface, classifying it as a pT3 tumor. Importantly, the surgical margins are free of tumor involvement. All proximal, distal, and circumferential margins are negative, with the closest margin being 5.7 cm from the distal margin. Examination of the vascular structures reveals no evidence of blood vessel or lymphatic invasion. Additionally, a thorough assessment of the regional lymph nodes, totaling 34, found no evidence of metastatic disease (pN0). Analyzing the non-lymph node pericolonic tissue did not identify any tumor extension, further confirming the localized nature of the carcinoma within the primary site. These collective findings indicate successful surgical removal of the adenocarcinoma with clear margins and no lymph node involvement."
311,TCGA-QG-A5YX-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings pertain to an invasive adenocarcinoma located in the sigmoid colon. The tumor is a low-grade neoplasm, displaying well to moderately differentiated histology and extending through the muscularis propria into the subserosal adipose tissue. Importantly, all margins proximal, distal, and radial are free of invasive carcinoma, with the closest margin being 2 mm from the radial margin. Lymphovascular invasion is present, although perineural invasion and tumor deposits are not identified. Examination of thirteen lymph nodes reveals no metastatic carcinoma. Additional sections of the colon, including the new proximal margin, proximal donut, and distal donut, are unremarkable. The spleen shows benign parenchyma with a subcapsular hemorrhage. Pathologic staging of the tumor is pT3, pN0, indicating no regional lymph node metastasis and categorizing the stage as IIA. Microsatellite instability testing is positive for MSH-2, MSH-6, PMS-2, and MLH-1. Overall, the findings suggest a localized but invasive colon adenocarcinoma with significant lymphovascular invasion but no lymph node involvement."
312,TCGA-A6-4107-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive moderately differentiated adenocarcinoma in the right colon. The tumor is characterized by its circumferential, lobulated appearance and extends through the muscularis propria into the superficial pericolonic fat, classifying it as pT3. All resection margins, including the proximal, distal, and circumferential (radial) margins, are negative for tumor involvement, with the closest margin being 19 cm from the distal edge. There is no evidence of vascular invasion. Lymph node analysis reveals metastatic adenocarcinoma in 2 out of 28 regional lymph nodes, corresponding to a pN1b classification. Additionally, endometriosis is observed in the appendix, but there is no other pericolonic tumor involvement or distant metastasis that could be evaluated. MSI testing has been requested to further characterize the tumor."
313,TCGA-CM-6674-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the total abdominal colectomy specimen reveals a moderately differentiated adenocarcinoma with mucinous features at the hepatic flexure of the colon. The tumor invades the subserosal adipose tissue and mesenteric fat, but no lymphovascular or perineural invasion is identified. Importantly, the surgical margins are free of tumor. The non-neoplastic bowel and appendix are unremarkable. There are no signs of gross tumor perforation or polyps with mucosal dysplasia away from the carcinoma. Of the forty-three lymph nodes examined, none show metastasis. Overall, the tumor is staged as pT3N0 according to the AJCC 7th Edition, indicating significant invasion but no regional lymph node metastasis. Additionally, immunohistochemical staining for mismatch repair proteins demonstrates a loss of MLH1 and PMS2 expression, suggesting an underlying deficiency in DNA mismatch repair function, warranting clinical correlation. The proximal and distal anastomotic ring resections show no pathological diagnosis."
314,TCGA-AA-A02Y-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of a highly to moderately differentiated adenocarcinoma of the colon, potentially arising from a pre-existing tubulovillous adenoma. The tumor exhibits infiltration into the muscularis layer and evidence of both lymphatic and blood vessel invasion. Importantly, the resection margins are free of tumor cells, and the ligature region is clear, with no lymph node involvement detected. Additional findings include chronic appendicitis with partial scarring and the presence of a characteristic Meckel's diverticulum, consistent with the clinical data."
315,TCGA-AA-A02K-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings suggest a diagnosis of metastasis of poorly differentiated adenocarcinoma, with histopathological grade G3. The tumor exhibits extensive necrosis and peritumorous inflammation, with findings of vascularized fatty connective tissue showcasing moderate chronic inflammation and fibrosis. Both the cecum and ascending colon include regions affected by medium to poorly differentiated adenocarcinoma, graded as G2-3, exhibiting necroses, ulcerations on the inner tumor surface, carcinomatous lymphangitis, involvement of blood vessels (carcinosis), perineural carcinosis, and tumor infiltration through all parietal layers extending to the subserous fatty connective tissue. Lymphatic examination reveals metastases in seven out of twenty regional lymph nodes, alongside peritumorous chronic recurrent concomitant inflammation. Tumor-free sections were observed in all other designated parts, with chronic appendicitis also noted. The tumor spreads, from the histological preparations, correspond to a stage of pT3, pN2 (7/20), pM1 (HEP), L1, V1. Locally, the carcinoma was completely excised. The overall tumor classification is ICDO-DA M-8140/3 with a differentiation grade of G2-3."
316,TCGA-D5-5540-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of adenocarcinoma tubulare (G2) located in the cecum, within a right-sided hemicolectomy specimen. The tumor infiltrates the pericolonic adipose tissue, indicative of pT3 staging, without evidence of neoplastic lesions at the intestinal resection margins, suggesting clean surgical margins. Reactive lymphadenitis was noted in the lymph nodes, however, there is no indication of lymph node metastasis (pN0). The tumor is classified as Dukes B and Astler-Coller B2, confirming an intermediate stage of cancer with penetration through the muscular wall but no lymph node involvement. Other relevant pathological findings include the absence of neoplastic lesions at the proximal and distal intestinal ends."
317,TCGA-AD-5900-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the segmental resection of the right colon reveals an adenocarcinoma with focal mucinous features, located in the right colon. The tumor is moderately differentiated (low-grade) and penetrates into the superficial muscularis propria. Importantly, there is no lymphovascular space invasion, perforation of visceral peritoneum, or mesenteric deposits. Surgical margins are clear, with the proximal margin negative by 8.2 cm and the distal margin negative by 5.4 cm. The deep (radial) margin is not applicable as the tumor does not reach the serosal surface. All 11 examined lymph nodes are free of metastatic carcinoma. The tumor originates within a tubular adenoma with high-grade dysplasia, and the final TNM staging is T2 N0 MX."
318,TCGA-D5-6540-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the resected colon and caecum reveals a diagnosis of tubulopapillary and partially mucinous adenocarcinoma (G3) involving the caecum. The tumor demonstrates infiltration into the muscularis propria but remains confined without involvement of the outermost margins, as excision lines are free of neoplastic lesions. Adjacent to the primary tumor, small hyperplastic polyps and a tubulopapillary adenoma with low-grade dysplasia were identified. The minimal side margin from the tumor is 0.6 cm. Lymph node analysis shows sinus histiocytosis without evidence of metastatic carcinoma. The staging of the tumor is classified as Dukes B, Astler-Coller B1, pT2, pNO, indicating local invasion without lymph node metastasis."
319,TCGA-AA-3672-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right-sided hemicolectomy specimen reveals a moderately differentiated adenocarcinoma of the transverse colon, characterized by ulceration and infiltration into the perimuscular fatty tissue. Both the oral and aboral resection margins are free of tumor involvement. Lymph node assessment indicates that out of 21 sampled nodes, four show metastatic involvement, classifying the disease stage as pT3 pN1. No evidence of lymphovascular invasion or venous involvement is detected, and the resection margins are clear, denoted as R0. The comprehensive findings substantiate the diagnosis of a stage pT3, pN1, moderately differentiated adenocarcinoma of the colon, with significant nodal involvement but no residual tumor at the resection margins."
320,TCGA-AA-3556-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a moderately differentiated, partially mucus-producing colorectal adenocarcinoma located in the resected section of the sigmoid colon. The tumor exhibits invasive growth into the muscularis propria but does not involve the intestinal walls, which show signs of pseudodiverticula and chronic scarring due to peridiverticulitis. Both the oral and aboral margins of the resected material are clear of tumor involvement, confirming a tumor-free resection margin. None of the 22 examined mesocolic lymph nodes contain tumor cells, although they display reactive changes. The tumor is staged at pT2, pN0, L0, V0, indicating no lymph node involvement, lymphatic invasion, or venous invasion, with the tumor grade classified as G2 and the resection classified as R0, signifying that the resection margins are free of tumor cells."
321,TCGA-AA-3522-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen revealed an ulcerated, moderately differentiated adenocarcinoma of the ascending colon. The tumor exhibits infiltration of the perimuscular fatty tissue, indicative of advanced local invasion, and demonstrates lymphatic vessel invasion, suggesting a risk for potential dissemination through lymphatic channels. Importantly, the surgical resection margins are free of tumor involvement, indicating a complete excision of the malignant tissue. The assessment of regional lymph nodes showed no evidence of metastasis, with all examined nodes being negative for cancer. These findings classify the tumor as G2 (moderately differentiated) and stage pT3 (invasion through the bowel wall into perimuscular fat) without regional lymph node metastasis (pN0, 0/18), with lymphatic invasion present (L1), vascular invasion absent (V0), and resection margins clear (R0)."
322,TCGA-CM-6166-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen from a patient with a clinical diagnosis of transverse colon moderately differentiated adenocarcinoma revealed an adenocarcinoma located in the ascending colon. The tumor is moderately differentiated and exhibits invasion into the muscularis propria. There is no evidence of gross tumor perforation, serosal involvement, vascular invasion, or perineural invasion. The surgical margins are free of tumor, and no polyps were identified. Additionally, an incidental small schwannoma was found in the appendix. The non-neoplastic bowel appears unremarkable. Pathologic staging determined the tumor to be pT2, with no lymph node metastases identified among the 33 examined lymph nodes, resulting in a stage of pN0. Immunohistochemical analysis confirmed the presence of DNA mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 in the tumor, indicating that the mismatch repair system is intact."
323,TCGA-A6-3808-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right colon resection specimen revealed an invasive moderately-differentiated adenocarcinoma with mucinous differentiation. The tumor is well circumscribed, located within the cecal pouch, and extends through the muscularis propria into the pericolonic fat, classified as pT3. Importantly, the proximal, distal, and circumferential (radial) resection margins are negative for tumor involvement, indicating no residual carcinoma at the resection margins. Additionally, 24 mesenteric lymph nodes were examined, all of which were negative for metastatic carcinoma (pN0). There was no evidence of non-lymph node pericolonic tumor, and distant metastasis could not be assessed (pMx). The surrounding ileal and colonic mucosa appeared unremarkable, with no abnormalities observed. Overall, the findings indicate a localized adenocarcinoma with no lymphatic or vascular invasion and clear surgical margins."
324,TCGA-G4-6303-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of adenocarcinoma with multiple sites involved, including peritoneal and small bowel implants, both of which are positive for adenocarcinoma. The primary tumor is located in the sigmoid colon, characterized as a moderately differentiated, exophytic, ulcerated adenocarcinoma that invades the full thickness of the muscle wall and extends into the subserosal fat. Metastasis is evident in one out of twenty-five examined lymph nodes, along with tumor implants in the pericolic fat. The margins of resection for the sigmoid colon are negative for tumor involvement. Additional findings include venous and lymphatic invasion but no perineural invasion. Two ring segments of colonic tissue from rectal and colon donuts are both negative for the tumor. The pathological stage is classified as pT3 N1 Mx, with the presence of tubular adenoma in association with the carcinoma. The extent of resection is marked as complete (R0) with grossly and microscopically negative margins."
325,TCGA-AA-3971-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The resected colon sample revealed a centrally ulcerated, moderately differentiated adenocarcinoma of colorectal type, exhibiting broad infiltration into the pericolic fatty tissue. The tumor was accompanied by metastases to two nearby lymph nodes, although the overall lymph node sampling showed no additional metastatic involvement. Importantly, both the colon and mesenteric resection margins were tumor-free, indicating complete excision. The pathological examination also identified individual tubular adenomas within the colon mucosa, primarily exhibiting moderate dysplasia. The tumor was staged as pT2, pNO (0/27), pMX, with a grade of G2, and no evidence of lymphovascular or venous invasion, and negative resection margins."
326,TCGA-AA-3854-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of mucinous adenocarcinoma, characterized by infiltration into the muscularis layer and vascular structures. The tumor is classified as grade 3 (G3) and staged as pT2, indicating localized spread within the organ. Lymphovascular invasion is present, as evidenced by lymphatic (L1) and vascular (V1) involvement. Resection margins are clear, indicating no residual tumor at the surgical margins (R0), and all examined lymph nodes are free of metastatic disease (pNo, 0 of 12). Additionally, the anastomosis ring is free of malignancy. The examination also revealed fragments of a serrated adenoma, which display focal areas of severe chromatin disorders, aligning with features of a high-risk type. These findings collectively suggest a locally excised tumor with no regional lymph node involvement but with potential high-risk features in the serrated adenoma component."
327,TCGA-A6-5660-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the right colectomy specimen reveals an invasive poorly differentiated adenocarcinoma located in the cecal region. The primary tumor, characterized by grade 3 nuclei, measures approximately 9.0 X 5.5 cm and invades through the muscularis propria into the pericolonic fat, classifying it as a pT3 tumor. The proximal, distal, and circumferential radial margins are free of tumor involvement, indicating negative margins. There is significant lymphatic space invasion, and notable metastatic spread is observed in 11 out of 23 regional lymph nodes (pN2b), with extranodal extension of the tumor. Additionally, an adenomatous polyp is identified adjacent to the primary tumor, while the appendix and remaining sections of colon exhibit no remarkable histological abnormalities. Distant metastasis could not be evaluated based on the provided specimen."
328,TCGA-AA-A01D-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the resected rectosigmoid section revealed an ulcerated colon carcinoma, histologically characterized as a poorly differentiated, partially mucinous adenocarcinoma of the colorectal type. The tumor exhibited invasive spread through all layers of the intestinal wall, reaching the neighboring mesocolic fatty tissue, and included numerous lymphatic processes near the tumor margin. Importantly, both the oral and aboral resection margins were free of tumor involvement. Examination of the 12 local lymph nodes revealed metastatic carcinoma with some nodes showing tumor extension beyond the lymph node capsules. The remaining sections of the intestinal wall showed no relevant pathological findings, and there was no evidence of pseudodiverticula. The tumor was staged as pT3, pN2 with twelve out of twelve lymph nodes involved, L1 V0, G3, and R0, indicating poorly differentiated grade 3 tumor with clear resection margins."
329,TCGA-QL-A97D-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemicolectomy specimen reveals an invasive low-grade adenocarcinoma located in the cecum and ileum, which invades the muscularis propria without macroscopic perforation. The margins of resection, including the proximal, distal, and mesenteric margins, are free of carcinoma, with the closest margin being 8 mm from the invasive tumor. There is no evidence of lymph-vascular or perineural invasion. Thirteen regional lymph nodes were examined, and all were negative for metastatic carcinoma. Additionally, the specimen contains a tubular adenoma and a tubulovillous adenoma, with no diagnostic abnormalities identified in the small bowel. The pathological stage of the tumor is pT2 pN0, indicating the tumor's invasion into the muscularis propria and the absence of regional lymph node metastasis. No prior treatment effect is noted."
330,TCGA-CM-6170-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left colon following an extended hemicolectomy revealed a diagnosis of moderately differentiated adenocarcinoma located in the descending colon. The tumor originates from a tubulovillous adenoma and invades into the muscularis propria. Tumor size was noted but details on measurements are excluded here for brevity. No tumor budding, increased tumor infiltrating lymphocytes, gross tumor perforation, lymphovascular invasion, large venous invasion, or perineural invasion were observed. Importantly, all surgical margins were free of tumor involvement. Two additional tubular adenomas were identified away from the primary carcinoma site, while the rest of the non-neoplastic bowel appeared unremarkable. A total of twelve lymph nodes were examined, and none exhibited metastasis. No tumor deposits were found in the pericolorectal soft tissue. According to the AJCC 7th Edition staging guidelines, the tumor is classified as pT2, indicating invasion into the muscularis propria, with a lymph node stage of N0, indicating no regional lymph node metastasis."
331,TCGA-CM-6163-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology examination reveals a diagnosis of moderately differentiated adenocarcinoma located in the sigmoid colon. The adenocarcinoma demonstrates invasive characteristics, extending into the submucosa without perforating the tumor. Notably, lymphovascular and perineural invasions are present, but there is no evidence of tumor budding or increased tumor-infiltrating lymphocytes. Precursor lesions were not identified, and there were no gross tumor perforations. Surgical resection margins for both proximal and distal ends are free of tumor involvement, containing only benign colonic tissue. Additionally, there is a hyperplastic polyp and evidence of diverticulosis in the nonneoplastic bowel. Lymph node analysis shows no metastasis in the 23 examined nodes. Consequently, the tumor staging according to the AJCC 7th Edition is pT1, indicating submucosal invasion with no regional lymph node metastasis (N0)."
332,TCGA-AA-3509-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis illustrates two main findings. First, a small specimen excised from the peritoneum exhibited submesothelial fibrosis. Second, the portion of the sigmoid colon resected revealed an ulcerated moderately differentiated colon carcinoma. This carcinoma extended through all layers of the intestinal wall, reaching the neighboring mesocolic fatty tissue. Importantly, both the oral and aboral resection margins were free of tumor involvement. Examination of 27 mesocolic lymph nodes indicated no evidence of metastatic tumor cells, although reactive changes were observed. The tumor's stage is classified as pT3 pN0 (1/27), L0, V0, R0, G2, signifying a moderately differentiated tumor with no lymphovascular or venous invasion and clear surgical margins. These findings collectively characterize the carcinoma's pathological profile and extent of local spread."
333,TCGA-NH-A50U-01Z-00-DX1,COAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Colon, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with invasive low-grade adenocarcinoma of the right colon, specifically involving the cecum, with mucinous differentiation arising from a tubulovillous adenoma. The tumor has metastasized to the liver, as evidenced by the liver biopsy. The carcinoma extends through the visceral peritoneum and includes areas of higher histologic grade noted microscopically. While the margins are negative, indicating no residual tumor at the resection boundaries, the mesenteric/radial margin is the closest at 5 mm. Importantly, 17 regional lymph nodes were examined and found to be free of metastatic carcinoma, and no angiolymphatic invasion was identified, though perineural invasion is present. Additional findings include a separate sessile serrated adenoma and periappendiceal chronic inflammation. There was no evidence of prior treatment, and the tumor did not exhibit lymph-vascular invasion or deposits. The pathologic staging is pT4a, pNO, pM1a due to liver metastasis. Further molecular evaluation for KRAS mutation and mismatch repair defects is pending."
334,TCGA-08-0244-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an infiltrating glioblastoma multiforme (GBM), classified as grade IV according to the World Health Organization (WHO). The tumor demonstrates high cellularity with notable cytoplasmic and nuclear pleomorphism, including both fibrillary and gemistocytic features, indicative of aggressive astrocytic neoplasm. Noteworthy findings include extensive endothelial proliferation and areas of necrosis throughout the sampled regions, with some viable, atypical tumor cells identified adjacent to necrotic tissue. Immunohistochemical staining for glial fibrillary acidic protein (GFAP) is strongly positive, reinforcing the glial origin of the tumor. Although the majority of tissue in several biopsies is necrotic, the vascular proliferation and presence of atypical cells around vessels confirm the diagnosis of GBM. The adjacent cortical areas show infiltration by the tumor in some sections. The MIB-1 immunohistochemical labeling index is 13.04%, suggesting a high proliferative activity. Evaluation of additional markers such as p53 and EGFR is pending. No specific measurements were mentioned for tumor margins, and there is no information about lymph node involvement in this summary. The consistent finding across multiple biopsies corroborates the diagnosis of a highly malignant and invasive glioblastoma multiforme."
335,TCGA-06-5414-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of glioblastoma (WHO Grade IV) in the right cerebral hemisphere, confirmed through excision biopsy. Microscopically, the tumor exhibits a densely cellular glioma with moderate pleomorphism, frequent mitotic figures, prominent vascular proliferation, and areas of pseudopalisading necrosis. There are reactive changes indicative of prior surgical intervention. Immunohistochemical analysis shows that the tumor cells are diffusely positive for GFAP, with a high Ki-67 labeling index of up to approximately 30%, indicating a high proliferative rate. No lymph nodes were included in this specimen, hence lymph node involvement was not assessed. The MGMT promoter methylation status was negative, suggesting a lack of epigenetic silencing of the MGMT gene. The importance of negative and positive controls exhibiting appropriate immunoreactivity underscores the reliability of the immunohistochemical findings."
336,TCGA-27-1838-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of glioblastoma multiforme located in the left occipito-temporal region. The tumor exhibits classic histological features, including cellular pleomorphism, necrosis, and microvascular proliferation. Margin status analysis indicates that the resection margins are positive, suggesting residual tumor presence at the surgical boundaries. Lymph node involvement is not applicable in this intracranial tumor. Additionally, the presence of mitotic figures is notable, reflecting the high proliferative activity characteristic of this aggressive malignancy. The overall pathological profile indicates a high-grade astrocytoma with poor prognosis and a propensity for rapid progression."
337,TCGA-41-3392-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient's frontal brain tumor has been diagnosed as a WHO grade IV small cell and fibrillary astrocytoma, commonly known as glioblastoma multiforme. Pathological examination of the specimens revealed hallmark features including the presence of palisading necrosis. The tissues examined from various sections of the frontal brain, including irregularly shaped fragments and intact portions of cortex, exhibited significant areas of brown and creamy white discoloration, indicative of malignant transformation. This high-grade glioma is characterized by its aggressive nature and poor prognosis. Due to the malignant characteristics noted during frozen section analysis, further classifications were deferred to permanent sections. No specific mention of margin status or lymph node involvement is provided, but the high grade of the tumor suggests a likelihood of diffuse infiltration. Additional tissue procurement was carried out for possible future analysis or therapeutic considerations."
338,TCGA-06-0169-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of glioblastoma multiforme located in the left parietal region of the brain. The tumor demonstrates significant nuclear atypia, frequent mitotic figures, microvascular proliferation, and areas of necrosis. Immunohistochemistry reveals the presence of glial fibrillary acidic protein (GFAP) indicating fibrillogenesis, and CD34 and smooth muscle actin positivity highlighting microvascular cellular proliferation. The MIB-1 proliferation index is notable at 17%, indicating a high rate of cell proliferation within the tumor. Gross pathology describes the tumor fragments as soft, granular, and reddish-brown. The intraoperative consultation identified a high histological grade glioma. There is no information provided regarding the status of surgical margins or lymph node involvement, which may be of relevance for comprehensive treatment planning."
339,TCGA-26-A7UX-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the brain tumor from the left frontal lobe reveals a diagnosis of Glioblastoma Multiforme, classified as WHO Grade IV. The neoplasm is characterized by highly infiltrative glioma with areas of high cellularity, notable mitotic activity, and the presence of pseudopalisading necrosis. Specimen A predominantly shows extensive necrosis with only focal perivascular viable tumor, whereas Specimen B more comprehensively exhibits the tumor's pathology. Immunohistochemical studies indicate weak p53 protein expression at 5%, a negative IDH-1 result, and a high proliferation index with a Ki-67 positivity rate of 40%. Additionally, glial fibrillary acidic protein (GFAP) is strongly positive in the tumor cells and processes, confirming glial origin. No mention of lymph node involvement or specific margin status is provided, focusing the findings strictly on the local tumor characteristics within the cerebral tissue. The pathological findings collectively affirm the aggressive nature and poor prognosis associated with this high-grade glioma."
340,TCGA-19-5955-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right temporal neoplasm reveals a diagnosis of glioblastoma multiforme (WHO Grade IV), a highly aggressive and malignant brain tumor. The intraoperative consultation, including microscopic and touch imprint analysis, confirmed the presence of glioblastoma multiforme. The gross examination of the submitted specimens showed irregular fragments of white-pink soft tissue with cerebriform appearance, consistent with the tumor characteristics typically seen in glioblastomas. Margin status, lymph node involvement, and other specific details regarding metastasis or adjacent tissue infiltration were not addressed in the provided information. Overall, the collected pathological findings highlight the diagnosis of glioblastoma multiforme, indicating a high-grade, rapidly progressive neoplasm requiring prompt and aggressive treatment."
341,TCGA-06-0744-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the biopsy from the left parietal lobe of the brain revealed a diagnosis of glioblastoma multiforme, a highly aggressive and malignant tumor. The tumor exhibited frequent mitotic figures, significant vascular hyperplasia, and extensive necrotic areas. The proliferation index (MIB-1) was noted to be 20%, indicating a high rate of tumor cell proliferation. Molecular analysis demonstrated a methylated MGMT promoter, which has been detected through bisulfite treatment followed by PCR amplification. While the test results are informative, they are not intended as stand-alone diagnostic evaluations. The tissue samples comprised multiple irregular fragments of pale red-tan to gray-tan tissue, preserved in formalin, and sections were submitted for histological analysis. The findings suggest a characteristic histopathological profile of glioblastoma multiforme, emphasizing the malignant nature and the aggressive behavior of the tumor."
342,TCGA-19-1789-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The comprehensive pathological evaluation reveals a diagnosis of infiltrating glioma with a significant portion identified as malignant astrocytoma, and the most aggressive subset classified as glioblastoma multiforme (WHO Grade IV), small cell variant. Despite extensive examination across multiple biopsy specimens from the right occipital neoplasm, no primitive neuroectodermal differentiation markers were identified. Notably, the permanent tissue sections display cerebral cortex and white matter demonstrating focal hypercellularity consistent with infiltrating glioma, further confirmed by micropathological evaluation as a high-grade glial neoplasm. Margin status remains challenging to ascertain precisely due to the infiltrative nature of the tumor, though one specimen from the edge of the neoplasm suggests advanced and aggressive characteristics. There is no definitive mention of lymph node involvement, likely due to the anatomical constraints and natural spread patterns of central nervous system tumors. The gross pathological assessment aligns with the microscopic findings, demonstrating multiple irregular fragments of tan-pink and tan-brown neural tissue, providing a thorough representation of the malignancy's invasive properties. Overall, the findings confirm a highly aggressive central nervous system neoplasm, predominantly characterized by glioblastoma multiforme, requiring further clinical management and therapeutic intervention."
343,TCGA-19-5959-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of Glioblastoma Multiforme (WHO Grade IV) in the left parietal region, with sections demonstrating focal oligodendroglial differentiation. Examination of the tissue obtained from the left parietal mass and infiltrated brain confirms the presence of high-grade astrocytoma consistent with glioblastoma. The tumor specimens exhibit multiple pink-tan soft tissue fragments with irregular, opaque white to pink-tan to red characteristics. Margins of resection are not explicitly described in this summary, thus leaving the margin status undetermined. Lymph node involvement is not addressed in the provided data, suggesting no lymph nodes were submitted or involved in this resection. Overall, the specimen presentation and microscopic findings corroborate the diagnosis of an aggressive and infiltrative glioblastoma multiforme, further characterized by regional brain invasion."
344,TCGA-19-2623-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right frontal lobe tumor biopsy and removal reveals a diagnosis of glioblastoma multiforme (WHO Grade IV), a highly aggressive and malignant primary brain tumor. The intraoperative consultation confirmed the presence of a high-grade glioma. The gross analysis of the specimens showed irregular segments of red-tan, soft tissue, with varying fragments submitted for both frozen and permanent section analysis. Key findings include a heterogeneous histological appearance with necrotic areas and highly proliferative tumor cells. The excised tumor demonstrates infiltrative growth, characteristic of glioblastoma, complicating complete surgical removal and often leading to indistinct tumor margins. Lymph node involvement is not typically assessed in primary brain tumors and therefore isn't a factor in this diagnosis. These features collectively underscore the aggressive nature of the tumor and suggest a challenging prognosis."
345,TCGA-19-2631-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of glioblastoma multiforme (WHO Grade IV) in the right frontal lobe of the brain. This highly malignant tumor was confirmed through both biopsy and subsequent surgical removal of the tumor mass. The specimens comprised multiple irregular fragments of soft tissue ranging in color from tan-white to red-brown. Histological examination of these fragments reinforced the diagnosis of glioblastoma multiforme. The tumor was present in the primary tumor site as well as in the surrounding inferior white matter. There was no mention of the margin status or lymph node involvement within the provided data, suggesting that these may not have been focal points in this particular case. Overall, the findings highlight the aggressive nature and extensive involvement of the tumor in the right frontal lobe, confirming the diagnosis of WHO Grade IV glioblastoma multiforme."
346,TCGA-08-0246-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the brain tissue specimens from the left temporal region revealed a diagnosis of Glioblastoma Multiforme, grade IV according to the World Health Organization (WHO) classification. Histologically, the tumor exhibits notable nuclear atypia, marked hypercellularity, areas of tumor necrosis, and significant microvascular proliferation. Immunohistochemistry confirms the presence of glial fibrillary acidic protein within the neoplastic cells, while keratin staining remains largely negative, ruling out a metastatic origin. Both biopsy and excised specimens provide consistent findings supporting this diagnosis. The surgical margins and lymph nodes could not be commented on as lymphatic involvement is typically less relevant in primary central nervous system tumors and was not part of the sampled tissue. Overall, the examination consolidates the diagnosis of a highly aggressive and malignant glial tumor."
347,TCGA-08-0347-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis for the right temporal lobe biopsy is glioblastoma. Key pathological findings indicate that this is a grade IV glioblastoma, also referred to as glioblastoma multiforme, characterized by significant necrosis, mitotic activity, endothelial proliferation, and marked nuclear and cytoplasmic pleomorphism. The analysis is based on both gross and microscopic examinations of the biopsy specimens. The neoplasm displays aggressive features typical of high-grade gliomas, with no specific mention of margin status or lymph node involvement in the initial biopsy report, indicating that the primary focus was on the histopathological grading and morphological details of the tumor. These findings underscore the malignant and highly aggressive nature of the tumor, necessitating prompt and comprehensive therapeutic intervention."
348,TCGA-08-0355-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate the presence of glioblastoma multiforme (astrocytoma, WHO grade IV) in the right temporal lobe, identified through biopsy and excision, as well as in the CUSA contents. This high-grade infiltrating glioma, consistent with a high-grade astrocytoma, exhibits aggressive features characteristic of glioblastoma multiforme. The excised tumor fragments were unorientated and showed a mix of yellow-pink, tan-pink, and gray-white soft tissue. No specific mention of clear surgical margins or margins involving the lesion were noted, and lymph node involvement was not described, suggesting the primary focus of assessment on the brain tissue. The comprehensive pathological examination, incorporating both gross and microscopic analyses, was essential in confirming the diagnosis made by the attending pathologist."
349,TCGA-19-5956-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of glioblastoma multiforme, giant cell type (WHO Grade IV), in the left frontotemporal brain region. The tumor is characterized by its highly aggressive nature and distinctive giant cell histology. Examination of the resected specimen indicates multiple irregular fragments of soft tissue exhibiting light tan coloring. While the exact margin status is not explicitly stated, the submission of the entire specimen in cassettes suggests comprehensive examination for residual tumor cells. Key characteristics of this high-grade malignancy include rapid growth and infiltrative capacity, often necessitating thorough evaluation to guide further treatment. Lymph node involvement is not applicable in this context, given the intracranial location of the tumor."
350,TCGA-06-5416-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left temporal brain tumor reveals a diagnosis of glioblastoma, characterized by a highly cellular glial neoplasm with marked cytologic atypia and pleomorphism. The tumor demonstrates a high MIB-1 proliferation index of up to 50%, indicative of brisk mitotic activity. Immunohistochemical stains show strong positivity for GFAP, while NeuN is negative, confirming the glial origin of the tumor cells. Notably, there is some microvascular proliferation; however, frank tumor necrosis is absent. Genetic testing reveals partial loss of chromosome arm 1p but no allelic loss on chromosome arm 19q. Importantly, the tumor lacks methylation of the MGMT promoter and shows no evidence of the EGFRVIII mutation. These findings suggest a lower likelihood of response to alkylating agent therapy and may influence therapeutic decision-making. The surgical margins and lymph node status are not applicable in this context. Collectively, these pathological characteristics and molecular findings support the diagnosis of glioblastoma, necessitating comprehensive care and targeted therapeutic strategies."
351,TCGA-41-2571-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right frontal brain mass reveals a diagnosis of glioblastoma multiforme (GBM), a highly malignant type of brain tumor. Histologically, the tumor is characterized by marked nuclear pleomorphism, extensive mitotic activity, and areas of necrosis, which are hallmarks of this aggressive malignancy. Immunohistochemistry shows that the malignant cells are positive for glial fibrillary acidic protein (GFAP), affirming their glial origin, while being negative for pankeratin, ruling out epithelial origin. The submitted specimens from different sections of the right frontal mass do not contain any definitive information regarding margin status due to the nature of biopsy fragments. Lymph node involvement is not addressed in the report, likely due to the primary site being intracranial where routine lymph node assessment is not typically performed. The final diagnostic consensus confirms the initial impression from frozen section diagnosis, indicating the presence of malignant cells typical of glioblastoma multiforme."
352,TCGA-06-5415-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the excised brain specimen reveals characteristic features of a high-grade malignant glioma, consistent with glioblastoma. The tumor is distinguished by the presence of mitotic figures and microvascular proliferation, indicative of its aggressive nature. Notably, there is significant necrosis within the tumor, along with hyalinizing and reactive changes in the vasculature, which suggest prior radiation injury. Viable tumor areas exhibit prominent phagocytic activity, signaling ongoing tissue response and turnover. Although the exact margins and lymph node involvement are not detailed, the presence of necrotic and viable tumor fragments implies incomplete resection, suggestive of residual tumor. Overall, these findings underscore a high-grade neoplastic process with significant necrosis and radiation-induced vascular damage."
353,TCGA-26-1799-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of Glioblastoma Multiforme (WHO Grade IV astrocytoma) in the left temporal lobe of the brain. Two brain mass specimens were submitted, with one showing gross features consistent with malignant glioma upon frozen section analysis. The tissue sections presented a characteristic pattern of cortical gray matter and subcortical white matter with no discrete masses. Microscopic examination confirmed the diagnosis of Glioblastoma Multiforme for both specimens, indicating an aggressive and highly malignant tumor. There were no specific mentions of tumor margin status or lymph node involvement in the provided information. The diagnosis underscores a critical condition requiring immediate and thorough clinical intervention."
354,TCGA-19-1787-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left frontal lobe brain cystic lesion reveals a diagnosis of Glioblastoma Multiforme (WHO Grade IV) with noteworthy differentiation characteristics, including giant cell, granular cell, and papillary patterns. Immunohistochemical analysis indicates a strong positive reaction for glial antigens, while tests for epithelial and melanoma-related antigens returned negative results, confirming the glial origin of the tumor. Gross examination details multiple irregular fragments of soft tissue from the left frontal cystic mass and the brain tumor, submitted for extensive histological analysis. The findings also highlight the presence of giant cell glioblastoma from intraoperative touch imprint and microscopic evaluations. The surgical margins and lymph node involvement were not specified in the findings, which typically require further clinical correlation and intraoperative assessment. Overall, the diagnosis underscores a highly aggressive neoplasm of the central nervous system with distinct histopathological and immunohistochemical features."
355,TCGA-19-1386-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a left temporal lobe resection specimen from a male patient revealed a diagnosis of glioblastoma, small cell subtype (WHO Grade IV). The tumor exhibited characteristic features, including cellular infiltration, necrosis, and microvascular proliferation. Immunohistochemical staining demonstrated tumor cell positivity for GFAP, with scattered cells highlighted by the Ki-67 marker, indicating proliferation. Additionally, EGFR immunostain was strongly and diffusely positive, corroborating the glioblastoma diagnosis. Fluorescence in situ hybridization (FISH) studies confirmed intact chromosomes 1p and 19q and amplified EGFR. Gross examination of the submitted specimens showed irregular tan-red and tan-brown brain tissue fragments, with sections processed for frozen section and routine histology. The report does not provide explicit margin status or lymph node involvement, focusing instead on the intrinsic tumor pathology and molecular characteristics."
356,TCGA-27-2528-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of Glioblastoma Multiforme located in the right temporo-mesial region. The tumor displays characteristic histological features, including significant cellular atypia, pleomorphism, and areas of necrosis surrounded by pseudo-palisading cells. Additionally, there is evidence of microvascular proliferation and high mitotic activity, which are consistent with the aggressive nature of this neoplasm. Examination of the surgical margins indicates that the tumor extends to the resection edges, suggesting incomplete removal. No lymph node involvement is applicable in this intracranial location. Other pertinent findings include a notable presence of hemorrhage and edema within the tumor mass. Collectively, these findings are indicative of a high-grade, highly invasive brain tumor with a poor prognosis."
357,TCGA-08-0350-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","Glioblastoma multiforme, grade IV (WHO), is identified in the right parietal lobe based on both biopsy and resection samples. The tumor is composed of extremely pleomorphic, bizarre, and often multinucleated cells with densely eosinophilic cytoplasm, consistent with a gemistocytic phenotype. A high percentage of tumor cells stain strongly for GFAP. Pathological analysis reveals significant infiltration into the adjacent cortex, frequent mitoses including abnormal mitotic figures, and notable microvascular proliferation and focal necrosis. These findings meet the diagnostic criteria for glioblastoma multiforme, as well as for grade 4 astrocytoma. The immunohistochemical labelling index for MIB-1 is 24.58%. Importantly, no specific mention of the status of resection margins or lymph node involvement is provided in the examined specimens."
358,TCGA-26-1440-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the submitted brain tumor specimens has revealed a diagnosis of glioblastoma multiforme (WHO Grade IV astrocytoma) in all three samples. These tumors were characterized by aggregates of pink-tan soft tissue, with specimens demonstrating varying degrees of hemorrhage and necrosis. Notably, portions of the tumors were also submitted for future research studies to tumor banks. The examination did not specify the involvement of surgical margins or regional lymph nodes, as these were not part of the submitted specimens. The gross and histologic features were reviewed, confirming the aggressive nature of the tumors consistent with glioblastoma multiforme."
359,TCGA-19-5953-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final diagnosis reveals the presence of glioblastoma multiforme with significant spindle cell differentiation, classifying it as gliosarcoma (WHO Grade IV). The biopsies and removal from the right frontal lobe and a superficially labeled tumor also confirm this diagnosis. Intraoperative consultations showed touch imprints consistent with tumefactive demyelination for the initial biopsies and glioblastoma for later specimens. Gross examination of the specimens identified soft, tan-white to red-tan tissue fragments from various parts of the brain, all submitted for detailed analysis. There is no explicit mention of the margin status or lymph node involvement, but the diagnosis and tissue characteristics are consistent with aggressive gliosarcoma, a highly malignant form of glioblastoma. The diagnosis is corroborated by the clinical history of a high-grade glioma in the right brain, affirming the presence of a severe and malignant neoplasm."
360,TCGA-28-1746-01Z-00-DX1,GBM,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The excisional biopsy of the right temporal brain tissue reveals a diagnosis of glioblastoma multiforme, classified as WHO grade IV. The biopsies show a high tumor cell proportion, varying from 95% to 100% across different samples, with necrosis proportion ranging from 0% to 30%. The immunohistochemical profile indicates that 3% of tumor cells immunostain for MGMT, suggesting potential responsiveness to Temodar, while the loss of PTEN implies a lower probability of response to EGFR kinase inhibitors. Additionally, laminin beta-1 expression is upregulated, and laminin beta-2 shows focal loss, predicting a more aggressive tumor behavior. Notably, 10% of tumor nuclei and 15% of tumor cytoplasm are positive for phosphorylated pMAPK, indicating a likelihood of responsiveness to radiation therapy due to the large fraction of pMAPK-immunonegative cells. Microscopic examination shows diffuse infiltration of hyperchromatic elongate astrocytic nuclei with numerous mitotic figures, extensive infiltration, and focal extension to the pia. EGFR FISH analysis indicates no amplification but reveals a high level of polysomy with more than four copies of EGFR in over 72.5% of cells. These findings collectively suggest an advanced, aggressive glioblastoma multiforme with complex therapeutic considerations."
361,TCGA-CN-5359-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals an invasive, moderately differentiated squamous cell carcinoma originating in the floor of the mouth that has infiltrated the mandibular bone. The primary tumor measures 4 cm and demonstrates perineural invasion, although no angiolymphatic invasion is detected. Resection margins are tumor-free, indicating a successful surgical margin clearance. Examination of lymph nodes shows that two deep floor-of-mouth lymph nodes are free of tumor; however, three out of sixteen cervical lymph nodes on the left side exhibit metastatic squamous cell carcinoma, though without extracapsular extension. Eleven cervical lymph nodes on the right side are negative for tumor involvement. Additionally, both submandibular glands display chronic and focal acute sialadenitis. Pathologic staging is determined to be pT4 pN2b pMX, highlighting the advanced nature of the primary tumor with regional lymph node metastasis."
362,TCGA-CV-5444-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen reveals an invasive, poorly differentiated squamous cell carcinoma involving the larynx and extending into the thyroid gland. The tumor exhibits substantial local invasion and is located less than 0.1 cm from the anterior soft tissue edge. There is no evidence of perineural or lymphovascular invasion. Surgical margins show the tumor near but not breaching the superficial margin, notably anterior to the thyroid cartilage and behind the hyoid bone. Lymph node analysis reveals metastatic squamous cell carcinoma in three of twenty-one lymph nodes from the laryngectomy and subtotal thyroidectomy specimen, as well as in one paratracheal lymph node, making a total of four positive nodes. Extracapsular extension is noted in some involved nodes but not in the paratracheal node. Other lymph nodes from region-specific dissections, including levels 2B and 2 on the left and right sides respectively, are free of tumor involvement. The parathyroid gland is unaffected, and no diagnostic abnormalities were found in the addressed regions."
363,TCGA-CQ-A4C7-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of poorly differentiated squamous cell carcinoma originating in the left floor of the mouth, involving the body of the mandible. The tumor demonstrates perineural invasion without evidence of lymphovascular invasion, and all resection margins are free of carcinoma. Examination of the left perifacial lymph node shows metastatic carcinoma with focal extracapsular extension, while twenty-three additional lymph nodes from the left neck contents show no carcinoma involvement. Importantly, level IA lymph nodes are also negative for carcinoma. Seborrheic keratosis is identified in the left postauricular lesion. The left sublingual gland and various oral cavity margins, including the anterior and posterior floor of mouth, posterior buccal, and deep floor of mouth margins, are negative for carcinoma. Overall, the pathological staging indicates metastasis in a single ipsilateral lymph node with extracapsular extension, but no evidence of distant metastasis. The comprehensive examination and negative resection margins provide a clear context for staging and treatment planning."
364,TCGA-P3-A6T7-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated squamous cell carcinoma (SCC) with a primary tumor identified in the anterior mandible composite resection. The tumor exhibits extension within 0.1 cm of the posterior margin and 0.2 cm of the deep margin, while being greater than 0.5 cm from the anterior margin. Notably, there is no bone involvement, although lymphovascular and perineural invasion are present. The right neck dissection revealed metastatic SCC in 2 out of 39 lymph nodes, with extracapsular extension noted. The level IIB lymph nodes and salivary gland showed no evidence of carcinoma, and similarly, the additional margin biopsies (D-K) encompassing fibrofatty tissue, skeletal muscle, and bone were unremarkable for carcinoma. The minimal pathologic stage was determined to be pT3N2b, emphasizing the extent of regional lymph node involvement and tumor characteristics."
365,TCGA-MT-A67A-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals an invasive squamous cell carcinoma that is moderately to well-differentiated, located in the right glossectomy specimen. The primary tumor does not show evidence of perineural or vascular invasion. The tumor infiltrates deep into the tissue reaching the deep surgical margin, though subsequent re-resections confirmed the absence of malignancy in the remaining marginal tissue. Examination of the right superior, anterior, and deep margins shows benign tongue tissue with no evidence of malignancy, while the right inferior margin contains invasive squamous carcinoma and the right posterior margin exhibits mild dysplasia. Additionally, lymph node dissection from levels 1, 2A, 2B, and 3 on the right side shows no evidence of metastatic disease, with all examined nodes free of malignancy. Moderate dysplasia was observed in the initial right posterior re-resection, while further re-resections at the inferior margin showed no malignancy. The surgical procedure included a submental platysmal flap rotation to reconstruct the right lateral border of the tongue and floor of the mouth, ensuring thorough inspection and clearance of malignant tissue."
366,TCGA-CN-6023-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The detailed pathological examination identifies a diagnosis of larynx cancer, primarily presenting as invasive squamous cell carcinoma located in the right pyriform sinus, extending into the pre-epiglottic space. The tumor reveals non-keratinizing histological features and measures 4.6 cm. Margins from the larynx are clear of carcinoma. An additional finding includes a small focus of papillary thyroid microcarcinoma, measuring less than 0.1 cm, confined to the right thyroid lobe without vascular invasion. This multifocal lesion does not involve the surgical margins. The lymph node analysis shows metastatic squamous cell carcinoma in four out of thirty-one nodes, with no evidence of extracapsular extension. One left level 3 lymph node also contains laminated calcification indicative of a psammoma body, though further immunohistochemical staining shows no additional evidence of metastatic papillary thyroid carcinoma. Perineural and lymphovascular invasion are present, which corroborates the aggressive nature of the neoplasm. The overall pathologic staging categorizes the primary tumor as pT3 with regional lymph node involvement classifying as pN2c. Other inspected areas, including several pharyngeal and hypopharyngeal margins, showed no evidence of residual tumor, ensuring a clear margin status outside the primary affected region."
367,TCGA-CV-A45V-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right hemimandibulectomy specimen reveals the presence of an invasive, well-differentiated squamous carcinoma involving the cortical bone, as confirmed by decalcification of the mandibular bone. The tumor, characterized by an ulcerated and necrotic lesion, is predominantly located within the soft tissue attached to the mandibular segment. Importantly, all surgical margins, including the anterior and deep soft tissue margins, are free of tumor involvement, indicating that the resection was complete with clear margins. No lymph node involvement is specified in this case. The findings underscore the aggressive nature of the tumor with bone invasion but suggest a favorable prognosis due to the absence of residual tumor at the surgical margins."
368,TCGA-BA-5151-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The left cheek skin and mandible biopsies, as well as the en bloc resection of the left mandible, maxilla, and cheek, reveal invasive well-differentiated squamous cell carcinoma with the presence of carcinoma in situ (CIS). The tumor involves the buccal mucosa, submucosa, and invades the mandible, with close but negative soft tissue surgical margins. The margin closest to the tumor is less than 1 mm from the mid/inferior soft tissue margin, while other margins range from 4 mm to 9 mm. Bone invasion is observed in the mandible; however, the bone surgical margins are not involved. No angiolymphatic or perineural invasion is identified. Lymph nodes from the left neck levels 1 through 5 show no evidence of metastatic carcinoma, with 0/33 nodes positive. The thyroid parenchyma is benign without carcinoma. The tumor is staged as pT4a (invasion of the skin of the face) pN0 pMx, indicating there is skin involvement with no regional lymph node metastasis and undetermined distant metastasis. Two apparent lymph nodes adjacent to the resected mass do not show metastatic involvement. This well-delineated lesion is observed extending through the oral mucosa, soft tissues, and into the overlying skin, with periosteal erosion abutting the maxilla. The remainder of the uninvolved mucosa and skin appears normal, and there are no significant additional pathological findings noted."
369,TCGA-BA-A6DE-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathologic examination revealed a diagnosis of invasive squamous cell carcinoma originating from the right lateral tongue and floor of the mouth, with the tumor being moderately differentiated and unifocal. The surgical margins were clear of carcinoma, with the closest margin being 0.4 cm from the superior medial edge. Multiple lymph node dissections from various levels of the neck (right level 1B, midline level 1A, left level 1B, left level 2B, left level 2A, left level 3, left level 4, right level 2B, right level 4, right level 2A, and right level 3) showed no evidence of metastatic carcinoma. The submandibular glands were also free of invasive carcinoma. Ancillary studies, including immunohistochemistry for P16 and in situ hybridization for high-risk HPV, were negative, suggesting the absence of high-risk HPV infection. The case is staged as pT2 pN0 pMx according to the AJCC Pathologic Stage for the oral cavity, and no other significant findings were noted. This comprehensive analysis indicates a localized tumor without regional lymph node metastasis."
370,TCGA-CN-A63W-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of moderately differentiated invasive squamous cell carcinoma originating in the midline supraglottic region with extensions to the base of the tongue and hypopharynx. Notably, there is perineural and angiolymphatic invasion, with the tumor extending into the surrounding soft tissues. Lymph node dissection revealed metastatic involvement: four affected nodes out of thirty-two on the left side, with extranodal extension, most prominently in level 3. On the right side, a large 6 cm lesion extending from level 2 through level 4 involves the adventitia of a large vein and skeletal muscle, which is considered one positive lymph node with extranodal extension. Additional thirty-two right-sided nodes showed no tumor presence, effectively clearing this side. The margins from the surgical resection are tumor-free, though the closest margin is noted at the right aryepiglottic fold/pyriform sinus. The pathologic staging of the tumor is pT4a N2c. In addition, the right thyroid and one central compartment lymph node show no tumor presence, but chronic lymphocytic thyroiditis is noted. Other examined parts including the deep margins of the left and right base of tongue and additional sectional margins are devoid of tumor presence."
371,TCGA-CX-7219-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals a well to moderately differentiated infiltrating squamous cell carcinoma located in the oral cavity, specifically involving the tongue, floor of the mouth, and mandible, with a classification of pT4a. Lymph node analysis from bilateral radical neck dissections shows metastatic squamous cell carcinoma present in multiple lymph nodes across various levels, with notable involvement in right levels I, II, III, and left levels I, II. Extranodal extension is observed in right level III and bilateral submental lymph nodes. Additionally, metastatic thyroid carcinoma (follicular variant of papillary) is identified in a right level III lymph node. There is evidence of venous/lymphatic invasion, but perineural invasion is absent. Importantly, surgical margins, including deep tongue, anterior tongue, left lateral, and right lateral biopsies, are negative for neoplasia and uninvolved by the tumor, although the closest margin is 0.6 mm from the anterior gingival margin."
372,TCGA-CN-A63U-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a diagnosis of invasive squamous cell carcinoma, moderately to poorly differentiated, involving the right supraglottic region with microscopic glottic extension forming a transglottic tumor. The carcinoma involves bilateral epiglottis, false cord, right aryepiglottic fold, and minimal right true cord, extending into the paragottic and pre-epiglottic spaces. Angiolymphatic invasion is present, though no perineural invasion is noted. Resection margins are free of carcinoma. Additionally, a selective dissection of the right neck levels 2-4 showed metastatic squamous cell carcinoma in two out of twenty-five lymph nodes, specifically in levels 2 and 4, with no extranodal spread. The left neck levels 2-4 dissections revealed no tumor presence in twenty lymph nodes. The pathological stage is determined as pT3 N2B. Other sections, including the skin of the stoma site, post-cricoid margin, both lateral pharyngeal margins, and the base of the tongue margins, were found to be free of tumor. The overall findings support a comprehensive assessment crucial for the patient's cancer management plan."
373,TCGA-CN-A63T-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive squamous cell carcinoma, poorly differentiated, occurring in the supraglottic region of the larynx with focal extension to the glottis, specifically involving the aryepiglottic fold. The tumor exhibits angiolymphatic invasion, with significant perineural and intraneural spread, and extends into the pre-epiglottic and paraglottic spaces without cartilage involvement. Metastatic squamous cell carcinoma is detected in two central compartment lymph nodes, both exhibiting extranodal extension. Examination of right neck levels 2 through 5 identifies metastatic carcinoma in three out of forty-two lymph nodes, accompanied by extranodal extension, hyperplasia with focal lymphocyte atypia, and a calcified hyalinized nodule in one lymph node. The left neck levels 2 through 4 present with thirty-six lymph nodes devoid of carcinoma but show hyperplasia with focal lymphocyte atypia. Margins from pharynx and tongue excisions are free of tumor. The thyroid lobe displays nodular hyperplasia with focal fibrosis but no malignancy. The pathological stage is classified as pT3 N2b. Immunohistochemical studies confirm reactive lymph node changes, likely in response to metastatic carcinoma. No fungus was found on Grocott stain in a hyalinized nodule. All surgical margins are tumor-free."
374,TCGA-CV-5979-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the partial glossectomy specimen revealed a diagnosis of moderately differentiated invasive squamous carcinoma. The tumor displayed a gross ulcerating appearance with an infiltrative border composed of thick cords exceeding four cells. Notable pathological features included focal perineural invasion, vascular invasion, and moderate lymphocytic infiltration. Both the mucosal and deep margins were clear of invasive carcinoma. The left neck dissection highlighted metastatic carcinoma in one of thirty-five lymph nodes, specifically in one of eleven nodes at Level II, while no tumor was found in lymph nodes from Levels I, III, or VI. The associated salivary gland and additional skin tag from the left neck were free of tumor. These findings provide important information regarding the extent of the primary tumor and its spread to regional lymph nodes, critical for determining prognosis and guiding therapeutic decisions."
375,TCGA-UF-A7J9-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the laryngeal and neck specimens reveals an invasive moderately differentiated squamous cell carcinoma primarily located in the supraglottic region. The tumor extensively involves adjacent anatomical structures including the glottic and infraglottic regions, right hemithyroidectomy site, cricoid and arytenoid cartilages, as well as the right posterior laryngeal soft tissue. Despite the tumor's extensive local spread, there is no evidence of stromal desmoplasia or invasion into perineural, vascular, or lymphatic structures. Importantly, the surgical margins, left vocal cord, epiglottis, preepiglottic space, and left thyroid gland remain free of neoplastic involvement, with the latter also demonstrating a goiter. All examined lymph nodes from the right and left neck dissections show no metastatic involvement, consolidating a total of 18 lymph nodes free of neoplastic cells (0/18). These findings highlight a locally advanced carcinoma confined to the primary site with no regional lymphatic spread."
376,TCGA-CV-6939-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal the presence of an invasive poorly differentiated squamous carcinoma at the base of the tongue, and a similar carcinoma has been identified in the supraglottic larynx. The analysis of the left functional neck dissection demonstrates one out of ten lymph nodes containing metastatic poorly differentiated squamous carcinoma, with extension into the soft tissue of the subdigastric compartment. Additionally, one out of two lymph nodes in zone 2 (submental-submaxillary compartment) tested positive for metastatic disease. In zone 3 (subdigastric compartment), there is evidence of poorly differentiated squamous carcinoma with lymphatic invasion in the fibroconnective soft tissue. Examination of eight lymph nodes in this zone showed no tumor presence. The tissue overlying the left internal jugular vein, right soft palate excision, right pharyngeal margin, and sublingual and submandibular glands are all tumor-free. The right nasopharyngeal biopsy also did not reveal any malignant cells. Other significant findings include extensive lymphatic permeation by the tumor around the resection margins of the pyriform sinus bilaterally and the anterior soft tissue margins beneath the oral mucosa. Additionally, in situ squamous carcinomas and varying degrees of dysplasia are associated multifocally with the invasive tumor. The tumor involves the vallecula and infiltrates the epiglottis, right lateral glossoepiglottal fold, right palatoglossal arch, and supraglottic space. The anterior segment of the mandibular periosteum shows no gross tumor involvement, and final bone margin evaluation of the mandibulectomy specimen will be confirmed after further processing."
377,TCGA-CQ-7069-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The primary pathological diagnosis is moderately differentiated squamous cell carcinoma of the left mandible, originating in the oral cavity. The tumor exhibits a moderately differentiated histologic appearance with no evidence of lymphovascular or perineural invasion. Comprehensive examination of twenty-eight lymph nodes obtained from levels I-IV of the left neck dissection revealed no metastatic involvement. Additionally, all assessed margins from the floor of the mouth, left cheek, and left buccal areas are devoid of carcinoma, ensuring a tumor-free surgical margin. The closest margin is located 0.7 cm from the tumor. There were no additional pathological changes noted in the examined specimens, including three teeth, which showed no abnormalities upon gross examination. Notably, there was focal chronic sialadenitis in the submandibular gland. The gross examination did not identify any pathological changes in the surgical waste, which comprised a segment of skin. An addendum report on the sections of the mandible is forthcoming to complete the pathological evaluation."
378,TCGA-CV-6948-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of invasive poorly differentiated squamous carcinoma involving the mandibular bone. A partial glossectomy, resection of the floor of the mouth and anterior mandible, and bilateral supraomohyoid neck dissection revealed that the primary tumor extensively replaced the floor of the mouth. The resection margins, including bone margins, are free of tumor, ensuring no residual disease at the surgical edges. The left inferior alveolar nerve and both salivary glands were free of tumor. Examination of the right neck lymph nodes showed no evidence of tumor across all fourteen nodes. Conversely, out of thirty left neck lymph nodes, one level 7 node displayed metastatic squamous carcinoma occupying the majority of the lymph node without extranodal extension. The tumor was noted to be in close proximity to critical margins  from the deep margin and 1 mm from the anterior margin though not at the true margins. Further analysis of the mandibular bone tissue is pending decalcification, with a supplemental report forthcoming."
379,TCGA-BA-A6D8-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of invasive squamous cell carcinoma, moderately differentiated, involving the floor of the mouth, anterior tongue, bilateral neck soft tissues, and bone. The tumor exhibits extensive necrosis and aggressive features such as bone, lymphovascular, large vessel, and perineural invasion. Surgical margins analysis revealed that the en face right mucosal and soft tissue margin and the black-inked inferior margin are positive for invasive carcinoma, while the left mucosal and soft tissue margin and both bone margins are negative. Additionally, P16 immunohistochemistry is negative in the tumor tissue. Lymph node involvement includes metastatic squamous cell carcinoma in multiple nodes, with three of 19 nodes in left neck Level 2 and two of three nodes in another specimen from the same level being positive, both sets showing extracapsular extension. Notably, lymph nodes from levels 2B, 3, and 4 on both sides, as well as additional level 1 nodes, are negative for metastatic carcinoma. Background pathological features include verrucous hyperplasia with superficial infections, chronic sialadenitis with atrophy, oncocytosis, and duct ectasia in the anterior tongue. AJCC pathologic staging is noted as pT4a pN2c pMx, indicating advanced local invasion and regional lymph node involvement, with distant metastasis status not assessed. It is recommended to correlate with clinical and operative findings."
380,TCGA-DQ-7593-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient presents with a ten-month history of a right neck mass and asymmetrical enlargement of the right base of the tongue and vallecula. Biopsies of this area reveal invasive, non-keratinizing, poorly-differentiated squamous cell carcinoma. The specimen obtained during a direct laryngoscopy and esophagoscopy (DLE) procedure consisted of a small tan-pink mucosal fragment from the right base of the tongue. Microscopically, the carcinoma shows poor differentiation, confirming the aggressive nature of the tumor. The pathological findings did not specify the status of surgical margins or lymph node involvement, which are critical for further therapeutic management and prognosis. The diagnosis of poorly-differentiated squamous cell carcinoma at this anatomical location highlights the need for a comprehensive treatment approach, including possible surgical resection, radiation, and/or chemotherapy, tailored to the patient's specific clinical scenario."
381,TCGA-BB-7862-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately to poorly differentiated squamous cell carcinoma of the supraglottis. The excision margins of the tongue were negative for tumor, indicating no residual neoplasm at the excision site. The neck dissection identified metastatic squamous cell carcinoma in one lymph node at left Level 2 out of six examined, and one lymph node at right Level 2 out of seven examined, with no tumor detected in lymph nodes at Levels 3 and 4 on both sides. The total laryngectomy and neck dissection specimen indicated a primary tumor classified as pT3, invading the preepiglottis. Histologically, this squamous cell carcinoma showed venous/lymphatic invasion without perineural invasion and involved two out of 48 lymph nodes on thorough examination. Notably, the surgical resection margins are uninvolved with the nearest margin being 1 mm away from invasive carcinoma. The regional lymph nodes status is pN2, suggesting multiple lymph node involvements, but no nodes exceed 6 cm in size. Extranodal extension was not identified, and distant metastasis could not be assessed (pMx)."
382,TCGA-D6-A6EK-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings confirm the diagnosis of invasive squamous carcinoma of the larynx, specifically a keratinizing verrucous variant (carcinoma planoepitheliale keratodes invasivum verrucosum). The tumor, located in the right glottis region, demonstrated infiltration into both the subglottal and supraglottal areas. The carcinoma is graded as G1, indicating a well-differentiated tumor. On examination of the surgical specimen, all marked margins were free of cancer invasion. Additionally, there were no signs of vascular or nerve invasion. Lymph node analysis, particularly the Delphian lymph node, showed no evidence of metastatic involvement, corresponding to a pN0 classification. Microscopic examination revealed sinus histiocytosis within the lymph node tissue, but neoplastic lesions were absent in intraoperative assessments. Further detailed analysis of paraffin specimens is to be issued for final confirmation."
383,TCGA-CV-7090-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive squamous cell carcinoma, grade 2, identified within the tissue obtained from the partial maxillectomy and hemipalatectomy specimen. The carcinoma demonstrated perineural invasion and a significant thickness. Further analysis is pending on the bone from the posterior wall of the maxilla, as well as bone margins and the hard palate, which were submitted for decalcification. Importantly, no tumor presence was detected in the hard palate, buccal fat biopsy, medial margin line, mucosa from the maxillary sinus, inferior turbinate, or tissue along the nasal cavity, indicating clear margins and no involvement of these areas. The teeth were grossly diagnosed without indication of pathology. Additional supplemental reports will provide further details following decalcification processes."
384,TCGA-CN-6024-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated squamous cell carcinoma of the pharynx with a primary tumor located in the oral cavity. The neoplasm exhibits extensive perineural and venous invasion but fortunately, all examined true soft tissue and bony margins are free of tumor. The tumor has metastasized to multiple regional lymph nodes on both sides of the neck. On the right side, 1 out of 18 lymph nodes shows metastatic involvement without extracapsular spread. In contrast, the left-side dissection reveals metastatic involvement in 5 out of 21 lymph nodes with extracapsular extension and focal microscopic extension into the submandibular gland. The examined submandibular gland on the right side shows no significant pathologic changes, while the left gland exhibits chronic sialadenitis. Additionally, biopsies from various sites including the tongue, pharynx, and floor of mouth do not show evidence of tumor presence. The bone marrow in the left mandible shows only a microscopic focus of carcinoma. The final staging is pT4a N2c MX, indicating a locally advanced primary tumor with significant regional lymph node involvement but no confirmed distant metastasis."
385,TCGA-CV-7440-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the total laryngectomy specimen reveals an invasive poorly differentiated squamous carcinoma, characterized by extensive perineural and vascular lymphatic invasion. The tumor involves the piriform sinus and the left supraglottic region. Marginal analysis indicates that the resection margins, including the left base of the tongue margin, are free of tumor infiltration, confirmed by the absence of tumor in the skeletal muscle at the left base of the tongue. The carcinoma demonstrates aggressive local features but has not extended into the base of the epiglottis or the thyroid cartilage, nor has it involved the glottic or subglottic areas. This comprehensive evaluation underscores the presence of a high-grade malignancy with clear resection margins, though with significant perineural and vascular involvement, which could suggest a potential for future metastasis or recurrence."
386,TCGA-KU-A66T-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive squamous cell carcinoma, moderately differentiated and of the keratinizing type, originating in the gingival soft tissue with invasion into the mandible and surrounding structures. The tumor showed significant infiltration into the sublingual soft tissue and mandible bone but did not exhibit vascular or perineural invasion. Margins were clear with negative radial soft tissue, mucosal edge, and all mandibular transection margins. A total of 24 lymph nodes were examined, all of which were negative for metastatic disease, including the external jugular vein node and those from the modified radical neck dissection. The submandibular gland and skeletal muscle included in the resected specimen were free of malignancy. The presence of ulceration further characterized the tumor. The overall pathological stage was determined as pT4 pN0, corresponding to Stage IVA in the AJCC staging system, aligning with the clinical diagnosis of cT4 cN0 cM0."
387,TCGA-HD-7229-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate an invasive moderate to poorly differentiated squamous cell carcinoma in the left supraglottic region, confirmed through multiple biopsies including an intraoperative consultation. Tumor presence was noted at the cauterized biopsy margins, suggesting potential incomplete resection. Additionally, the pathological examination of the left thyroid cartilage also revealed invasive squamous cell carcinoma. Given the broad foci of the tumor at the margins and the involvement of critical structures such as the thyroid cartilage, the aggressive nature and extent of the carcinoma are evident. These findings warrant further clinical correlation and consideration of comprehensive treatment planning, including possible additional surgical intervention and adjuvant therapies. Notably, the patient's history of heart disease and having undergone coronary artery bypass grafting (CABG) may influence the management approach for this malignancy."
388,TCGA-BA-4076-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the biopsy samples from the false vocal cord and the arytenoid reveals significant findings consistent with squamous cell carcinoma in situ. The biopsy from the right posterior false vocal cord is noted to have focal presence of at least squamous cell carcinoma in situ, with areas suspicious for invasive squamous carcinoma, though definitive invasive carcinoma was not identified under light microscopy. The biopsy from the left arytenoid similarly shows in situ squamous cell carcinoma, accompanied by severe chronic inflammation, but no invasive carcinoma is evident. The margin status and lymph node involvement are not addressed in the provided samples, and no additional pathological abnormalities were noted. These findings collectively suggest a non-invasive but significant presence of squamous cell carcinoma, necessitating further clinical correlation and potentially additional diagnostic or therapeutic interventions."
389,TCGA-QK-A8ZB-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis for the laryngeal specimen reveals a moderately differentiated invasive squamous cell carcinoma primarily involving the left true vocal cord, ventricle, and anterior commissure, with invasion through the thyroid cartilage. Notably, the surgical margins are negative for invasive carcinoma or carcinoma in situ, indicating complete excision of the tumor. No lymph-vascular or perineural invasion is identified. Examination of numerous lymph nodes from various neck levels (1A, 2B, 2A, 3, and 4) shows no evidence of carcinoma, with a total of 81 lymph nodes being negative. The rest of the laryngeal specimen presented an abscess with keratinaceous debris in the subcutaneous tissue. Furthermore, the primary tumor is characterized by its endophytic and ulcerated nature. The pathological staging classifies the primary tumor as pT4a, denoting moderately advanced local disease with extension through the outer cortex of the thyroid cartilage into adjacent structures. The absence of regional lymph node involvement results in a pN0 classification, supporting the favorable prognosis post-surgical intervention."
390,TCGA-MT-A67D-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately differentiated, keratinizing type, invasive squamous cell carcinoma located in the anterior floor of the mouth. The tumor is characterized by a depth of invasion without angiolymphatic or perineural invasion. Importantly, all bone sections, including bone margins, are free of tumor involvement, and the tumor margins are clear, with no malignancy detected in any submitted margins, including left and right lateral and anterior margins, right posterior margin, deep margin, and excised ventral tongue margin. Additionally, benign pathology is noted in the sublingual gland. A thorough lymph node dissection of levels 1, 2A, 2B, 3, and 4 was performed, examining a total of 23 lymph nodes, all of which are negative for metastatic carcinoma. The overall pathological stage of the primary tumor is designated as pT2 with no regional lymph node involvement (N0) or distant metastatic disease (M0)."
391,TCGA-BA-5149-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis revealed a diagnosis of moderately differentiated keratinizing squamous cell carcinoma, involving the ventral surface of the tongue and left floor of the mouth, with extension into the sublingual salivary gland and oral tongue muscle. The tumor exhibited ulceration but no evidence of carcinoma in situ. Comprehensive examination of surgical margins confirmed all to be negative for invasive carcinoma, with the closest margin at 3 mm. Metastatic involvement was identified in multiple lymph nodes: one out of two nodes at right neck level 1, two out of four nodes in the left neck dissection part G, four out of forty-eight nodes in a left neck dissection, and two out of fourteen nodes at left neck level 4, with the largest focus being 1.3 cm. No extranodal extension was noted in any of the positive lymph nodes. Other significant findings included chronic inflammation in the salivary gland and an epidermal inclusion cyst in the left neck skin. Overall, AJCC staging classified the carcinoma as pT3 pN2c, indicating significant nodal involvement but confined nodal metastases."
392,TCGA-CN-6996-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive squamous cell carcinoma, moderately differentiated and keratinizing, from a right hemiglossectomy specimen. The tumor shows a considerable involvement of intrinsic tongue muscles and is characterized by vascular and perineural invasion. While the tumor is absent at the anterior, posterior, and deep tongue margins, it extends to the anterior and posterior floor of mouth margins. Subsequent re-resections of these margins showed no residual tumor. The pathologic staging is noted as pT3 N2b, indicating the primary tumor size and the extent of nodal involvement. Examination of the right neck dissection specimen reveals metastatic squamous cell carcinoma in five out of twenty-four lymph nodes, with evidence of extranodal extension and vascular invasion, specifically involving levels 1A and 2. These findings collectively illustrate an aggressive malignancy with substantive local invasion and significant lymphatic spread."
393,TCGA-F7-8298-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the larynx tissue from the glottis reveals a well-differentiated squamous cell carcinoma involving the vocal cord. The tumor exhibits characteristics typical of this histologic type but does not indicate any extension beyond the vocal cord. No metastatic involvement is observed in any of the fourteen regional lymph nodes examined. The status of surgical margins is not specified. There is no evidence or mention of neoadjuvant treatment in the specimen. Overall, the findings indicate a localized squamous cell carcinoma of the glottis without regional lymph node metastasis."
394,TCGA-HD-8634-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left partial glossectomy revealed a moderately differentiated endophytic squamous cell carcinoma, invasive to a depth of 0.5 cm. All final margins of resection, including anterior, superior, deep, posterior, and inferior, were free of tumor involvement, as confirmed by frozen section analysis. The presence of definite angiolymphatic invasion was not identified. Examination of the sentinel lymph nodes, which were located in the left upper deep cervical region, and additional lymph nodes from left level 3 and left level 1A, showed no evidence of metastatic squamous cell carcinoma with both routine H&E stains and immunoperoxidase stains for pankeratin. Based on the findings, the AJCC pathologic stage is T1, N0. The clinical context pertains to a diagnosis of left tongue cancer."
395,TCGA-F7-A61V-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive keratinizing squamous cell carcinoma located at the base of the left side of the tongue. The tumor presents as a single focus with conventional histologic type and is graded as Grade 1, indicating well-differentiated cells. The resected tumor measures 2.3 cm in its greatest dimension and has a thickness of 1.0 cm. Importantly, the surgical margins are free of invasive or in-situ carcinoma, indicating complete excision of the malignancy. There is no evidence of lymph-vascular or perineural invasion. Pathological staging classifies the tumor as pT2 NO, reflecting a primary tumor with no regional lymph node metastasis. Examination of the submandibular gland and multiple lymph nodes from various levels of the left neck shows no neoplasm, though some nodes exhibit marked follicular hyperplasia. Overall, the findings align with an early-stage localized squamous cell carcinoma, with no regional spread or residual malignant involvement at the margins."
396,TCGA-CV-7253-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate the presence of moderately differentiated squamous carcinoma in multiple regions including the mandible, tongue, soft palate, and hard palate, with focal invasion into the mandible. Margins of the mandibular resection are free of tumor, but there are microscopic foci of carcinoma present at the anterior soft tissue resection margins, posterior resection margins, and soft tissue margin adjacent to the angle of the mandible. The specimen from the left base of the tongue includes necrotic tissue with regions of dysplastic squamous tissue. Four lymph nodes, including subdigastric and maxillary nodes, show no evidence of tumor involvement, and the submandibular gland displays focal atrophic changes and fibrosis, but no tumor presence. Additionally, invasive moderately differentiated squamous carcinoma is identified in tissue from the left pterygoid fossa with microscopic foci present at the resection margin. There is evidence of focal vascular invasion by the tumor, although no definitive lymphatic or perineural invasion is observed."
397,TCGA-D6-A6EO-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination reveals a diagnosis of keratinizing squamous cell carcinoma (Grade 2) of the floor of the mouth, classified as pT4a, pN0, under the ICCD-O-3 or SNOMED codes. The tumor exhibits extensive infiltration, destroying the front part of the mandibular bone and extending into the mucosa of the oral vestibule. The minimum margin of uninvolved tissue is 0.3 cm, with the various marked margins measuring between 0.2 cm and 0.7 cm. The carcinoma infiltrates the skeletal muscles of the floor of the mouth and the mandibular bone, with no evidence of vascular or perineural proliferation. Lymph node involvement is absent, as indicated by the pN0 status. These findings suggest a locally advanced malignancy, emphasizing the critical need for comprehensive surgical and therapeutic management."
398,TCGA-CV-A6JY-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The composite resection of the left mandible, buccal mucosa, and floor of mouth reveals invasive well-differentiated squamous carcinoma. The tumor demonstrates an infiltrative border with thick cords, showing perineural invasion upon further evaluation. Vascular invasion is absent. Bone invasion is confirmed with the lesion involving the mandible but not extending to the anterior mandible margin, which is negative for tumor. Examination of surrounding tissue margins, including lateral deep, masseter, anterior sublingual, anterior alveolar nerve, retromolar trigone, posterior buccal mucosa, and posterior floor of mouth, all reveal no presence of tumor. In the neck dissection, lymph nodes from levels 2A, 2B, 3, and 4 were free of metastatic involvement. The examined teeth are reported grossly only, with no specific abnormalities noted in the provided pathologic details."
399,TCGA-CV-7103-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with deeply invasive, moderately differentiated squamous cell carcinoma following a partial glossectomy of the lateral tongue. Pathological examination revealed focal moderate dysplasia at the medial/anterior surgical margin, though the remaining surgical margins were clear. The anterior medial margin contained minor salivary gland and skeletal muscle, with no tumor present. Lymph node evaluation from the jugular chain showed metastatic squamous carcinoma in one out of three lymph nodes at both levels II and III, while two lymph nodes at level IV were free of tumor. All four lymph nodes examined from the submandibular gland and level I were negative for malignancy, as were additional lymph nodes from level IV. Additionally, a benign oral melanotic macule was identified on the posterior hard palate, and submitted teeth were for gross examination only. These findings are indicative of a moderately advanced malignancy with regional lymph node involvement but clear resection margins, except for the noted dysplasia."
400,TCGA-QK-AA3J-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The right arytenoid biopsy reveals a diagnosis of invasive squamous cell carcinoma with poorly differentiated, basaloid features. The tumor exhibits characteristics that suggest aggressive behavior and poor differentiation. Although the margin status is not explicitly stated, the presence of invasive carcinoma identified in the intraoperative consult indicates the diagnostic significance of the tissue examined. There is no mention of lymph node involvement in the provided findings, making it unclear if any lymph nodes were assessed or resected. The detailed gross description confirms the submission of multiple tissue fragments for both frozen section diagnosis and further pathological evaluation. The patient's clinical history of undergoing panendoscopy aligns with the need for a thorough histopathological examination. Overall, the essential pathological findings highlight the invasive nature of the carcinoma, underscoring the importance of comprehensive treatment planning."
401,TCGA-CN-6997-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals the presence of invasive squamous cell carcinoma predominantly in the left hypopharynx and supraglottis with poorly differentiated histology. There is evidence of metastatic spread to regional lymph nodes, with one out of ten nodes in the right neck showing metastatic squamous cell carcinoma without extracapsular spread, while the left neck displays metastatic involvement with extensive extracapsular spread manifesting in the soft tissue at level II. The tumor exhibits significant angiolymphatic and perineural invasion, but with no involvement of the cartilage or thyroid gland. Additionally, the vallecular margin is positive with a superficially invasive squamous cell carcinoma separate from the primary site. Other notable findings include carcinoma in situ on the lingual surface of the epiglottis, severe dysplasia on the right true vocal cord, and moderate dysplasia on both false cords and the left true cord. The overall pathological stage is classified as pT3 N2c due to the positive regional lymph nodes and extensive extracapsular extension. No tumors were found in biopsies of the left pharyngeal and post-cricoid margins, and there is no significant abnormality seen in the left thyroid gland. The presence of venous and lymphatic invasion, along with perineural invasion, further underscores the invasive nature of this carcinoma."
402,TCGA-P3-A6T4-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately to poorly differentiated keratinizing squamous cell carcinoma involving the left mandible. The tumor, estimated to be at least 8 cm in size, extensively infiltrates the floor of the mouth, tongue, anterolateral skin (ulcerated), parotid gland, and mandible. Margins of resection show carcinoma present at the left inferoposterior and right inferior subcutaneous soft tissue, as well as being within close proximity (0.03 cm) to the right medial and left posterolateral soft tissue margins. Other margins are clear by at least 0.3 cm. Perineural invasion is present with focal suspicion for angiolymphatic invasion. In the left neck dissection at level II, carcinoma is identified in one of eight lymph nodes, while no carcinoma is found in the six lymph nodes from level III. Additionally, chronic sialadenitis is noted. Upon further examination after decalcification, carcinoma is found within the bone, soft tissue, and perineural space at the left posterior-superior mandibular margin, while the right mandibular margin is free of carcinoma. The overall pathologic stage is classified as pT4a, pN1, pMX according to the AJCC TNM Classification (6th ed., 2002)."
403,TCGA-IQ-7630-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected oropharyngeal tissues reveals invasive squamous cell carcinoma (SCC) involving the retromolar trigone with ulceration. The tumor is poorly differentiated and measures 3.5 cm at its greatest extent. Examination of various anatomical sites including the soft tissue tooth socket, tissue medial to the proximal mandible, and additional tissues did not show malignancy, except for the tooth socket #17 and tissue medial to the proximal mandible, which confirmed invasive carcinoma. Importantly, there was no evidence of perineural or lymphovascular invasion. Margins from the resections were negative for tumor presence. Comprehensive lymph node analysis, including a left neck dissection, did not reveal any metastatic involvement in a total of 27 nodes examined, confirming a nodal status of pN0. Additional assessment of bone tissues including the segmental mandible and left maxillary tuberosity revealed no malignancy. Overall, the primary tumor stage is classified as pT2, with no regional lymph node metastasis and no distant metastasis identified."
404,TCGA-BB-7861-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of HPV-related squamous cell carcinoma of the tongue base, confirmed by positive immunohistochemical staining for cytokeratin AE1/3 and P16, as well as positive in situ hybridization for high-risk HPV in biopsied tissue. Additionally, a separate biopsy from the left tongue shows chronic inflammation and lymphoid hyperplasia, with no evidence of tumor present. Lymph node dissection from levels 2 and 3 of the right neck indicates metastatic squamous cell carcinoma involving one of eleven lymph nodes, devoid of extranodal extension. Examination of a lymph node from level 1 reveals a benign lymph node with no malignant involvement. These findings collectively suggest the presence of a primary squamous cell carcinoma of the tongue base, with regional metastatic spread but without extranodal extension or additional primary tumor presence in the left tongue."
405,TCGA-CV-A6JD-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination primarily diagnoses invasive squamous carcinoma, poorly differentiated with sarcomatoid features, in the resected specimen from the right segmental mandibulectomy and floor of mouth resection. The tumor displays an exophytic gross appearance and exhibits infiltrative borders characterized by thick cords of cells. There is moderate lymphocytic infiltration detected within the tumor, but there is no evidence of perineural or vascular invasion. The anterior and posterior bone margins, as well as the floor of the mouth and anterior buccal mucosa margins, show no tumor presence. The posterior buccal mucosa margin reveals focal dysplasia without tumor. On thorough lymph node analysis from the right neck dissection, levels IA, IB, II, and III, no metastasis is identified in any of the examined lymph nodes, totaling zero out of 23 nodes positive for carcinoma. Additionally, the anterior gingiva and sections of the posterior gingiva, apart from exhibiting chronic inflammation, do not contain tumor cells. While the anterior and posterior bone margins are negative for tumor, pathological evaluation confirms that the squamous carcinoma has invaded the bone at the resection site."
406,TCGA-CV-7414-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive moderately differentiated squamous cell carcinoma involving the left hemimandible, left floor of mouth, and left buccal cheek. The tumor infiltrates the medial deep soft tissue margin of excision, whereas all other margins, including anterior mucosal, tongue mucosal, and retromolar trigone, are free from tumor. Evident are vascular/lymphatic and perineural invasion. Metastatic squamous cell carcinoma is detected in 10 of 21 lymph nodes, with one lymph node showing complete replacement by tumor and extranodal extension. The tumor's epicenter lies within the submandibular salivary gland and it extends from the buccal subcutaneous tissue to beneath the oral mucosa, invading the mandible, submandibular gland, and skeletal muscle, but not the epidermis or mucosa. Squamous cell carcinoma in situ is identified in Wharton's duct. Microscopic examination of decalcified sections of the mandible reveals bone invasion with clear bone resection margins. Additional analyses confirm no tumor presence in various soft tissue and skin specimens from left and right chin, perioral skin, and other referenced locations."
407,TCGA-BA-A6DD-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an invasive squamous cell carcinoma of the floor of the mouth and oral tongue, with a histologic grade of moderately differentiated and focally keratinizing features. The tumor is unifocal, bilaterally involving the mandible, subcutis, oral tongue, and floor of the mouth, with extensive invasion noted. Perineural and bone invasion are present, but no vascular invasion is identified. Ancillary studies are negative for p16 by immunohistochemistry and high-risk HPV by in situ hybridization. While carcinoma in situ is not detected, metastatic squamous cell carcinoma is identified in lymph nodes from both the left and right neck dissections, with a significant largest metastasis noted at 2.1 cm in one of the specimens but without extracapsular extension in all nodes examined. Soft tissue margins are focally involved at the left lateral en face mucosal margin, with other margins close but not grossly involved. Bone margins are clear of the tumor. The AJCC pathologic stage is determined to be pT4a pN2c pMx, reflecting an advanced primary tumor with bilateral nodal involvement and no distant metastasis identified at the time of this report. This comprehensive evaluation underscores the critical areas of involvement and margin status, directing subsequent clinical management strategies."
408,TCGA-CV-6934-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals an invasive squamous carcinoma originating in the right oral tongue, characterized by extensive perineural invasion. The tumor was found approximately 1.0 mm from the deep resection margin, while the lateral margin was tumor-free. Examination of eighteen left level I axillary neck lymph nodes showed no evidence of tumor, but metastatic squamous carcinoma was identified in 2 of 4 left level II neck lymph nodes, with the carcinoma significantly replacing the lymph nodes and exhibiting extranodal extension into the adipose tissue. Additionally, metastatic carcinoma was present in 1 of 7 level III lymph nodes, while all five left level IV lymph nodes were negative for tumor. On the right side, the submandibular gland and three lymph nodes from levels III and IV exhibited no tumor presence. Other relevant findings include mild dysplasia in the palatal margin squamous mucosa, with no tumor detected, and the anterior mucosal margin showed squamous mucosa without tumor. Mild to moderate chronic inflammation was noted in the squamous mucosa associated with the teeth. The gross examination highlighted the tumor's approximate proximity to specific margins and its ulceration, with considerable involvement of the tongue and adherence to the medial portion of the mandibular segment, emphasizing the extent and invasive nature of the carcinoma."
409,TCGA-F7-A50I-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the larynx, following a total laryngectomy, reveals a diagnosis of moderately differentiated invasive squamous cell carcinoma. The tumor extensively involves the supraglottic, glottic, and subglottic regions, affecting the true and false vocal cords bilaterally, the right epiglottic fold, piriform sinus, right arytenoid, and extending to the tracheostomy site. The mass also infiltrates the thyroid and cricoid cartilages and demonstrates lymphovascular invasion. Margins are of significant concern, with the radial margin at the left tracheal margin and the anterior margin showing the presence of invasive carcinoma, while all other margins remain free of the tumor. The specimen reveals no additional lesions, and no information is provided regarding lymph node involvement or neoadjuvant treatment. These findings delineate the aggressive nature of the tumor and its extensive local invasion."
410,TCGA-CV-A460-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive poorly differentiated squamous cell carcinoma of the right pyriform sinus. The surgical margins are clear of the tumor, indicating no residual malignancy at the excision borders. Examination of lymph nodes from various levels on both sides of the neck reveals metastatic involvement. Specifically, metastatic squamous cell carcinoma with extracapsular extension is found in three of three lymph nodes at right Level II and one of twenty-two lymph nodes at right Level IV. No tumor is present in lymph nodes at left levels III, IV, V, the submental region, or right levels I and III. Additionally, the thyroid gland and salivary glands are unremarkable. This comprehensive analysis indicates significant metastatic spread in specific right neck lymph nodes, underlining the invasive nature of the carcinoma."
411,TCGA-CV-7254-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of Grade III invasive squamous carcinoma of the right true vocal cord. The right cordectomy specimen also demonstrates Grade III invasive squamous carcinoma with significant lymphatic invasion. Crucially, the tumor is present at the deep margin of resection, extending to the left anterior commissure. Squamous carcinoma is identified within the fibrovacular tissue overlying the arytenoid cartilage, while the false cord and posterior commissure margins are free of tumor involvement, showing only squamous mucosa and muscle, respectively. The left anterior commissure also exhibits invasive squamous carcinoma. Both posterior and anterior subglottic margins, composed of fibrous and fibroconnective tissues, are devoid of tumor. The new arytenoid margin and new anterior commissure margin reveal no carcinoma, though dysplastic epithelium is noted in the latter. The thyroid cartilage is free from carcinoma."
412,TCGA-CV-6933-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive moderately differentiated squamous carcinoma of the tongue, presenting with deep soft tissue involvement. Evidence of angiolymphatic and perineural invasion is identified. Examination of the surgical margins indicates no tumor presence. However, metastatic squamous carcinoma is detected in one out of thirty-two left neck lymph nodes. The distal most facial margin nerve biopsy and the proximal neurovascular bundle V3 biopsy show no tumor presence, comprising only peripheral nerve, skeletal muscle, and vessels respectively. The submandibular gland is unaffected by the tumor. This comprehensive analysis reflects the primary malignancy's local invasiveness, absence in specified resection margins, and limited lymphatic spread."
413,TCGA-BB-4228-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed that excisions from the anterior tongue mucosa, deep anterior, deep lateral pharyngeal, base of tongue mucosa, deep tonsil, and deep biopsy of the vallecula were all negative for tumor presence. However, a resection from the right base of the tongue identified an infiltrating HPV-related squamous cell carcinoma. The carcinoma demonstrates significant invasion, with a noted depth of infiltration. Importantly, the tumor extends to both the deep and lateral margins and closely approaches the medial margin. These findings indicate that the tumor has not been completely excised, suggesting residual disease at the resection margins. No lymph node involvement or additional pathological abnormalities were reported in the specified samples."
414,TCGA-CN-A640-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive, moderately differentiated squamous cell carcinoma originating in the right side of the tongue, exhibiting a highly infiltrative border and involving the skeletal muscle. Notably, there was evidence of perineural invasion. The tumor margins were confirmed to be free of malignancy, and the pathological stage was determined as pT2N2b. Examination of the right floor of the mouth showed no presence of tumor. Between the selective dissections of various cervical lymph node regions, metastatic squamous cell carcinoma was identified in two out of thirty lymph nodes, with significant extranodal extension affecting the internal jugular vein adventitia and skeletal muscle, while other lymph nodes showed no tumor involvement but some exhibited mild chronic sialadenitis. All surgical margins were confirmed to be tumor-free. The overall findings highlight the presence of modestly differentiated invasive carcinoma with both perineural and extranodal extensions, significant lymphovascular invasion, and a regional lymph node involvement."
415,TCGA-UF-A7JF-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a diagnosis of invasive, moderately differentiated squamous cell carcinoma of the larynx. The tumor extensively involved the left glottic, supraglottic, and infraglottic regions, extended to the right infraglottic area, and included adjacent structures such as the left piriform sinus, cricoid, arytenoid and thyroid cartilages, thyroid isthmus, surrounding soft tissues, and trachea. No angiolymphatic or perineural invasion was observed. The neoplasm invaded the left soft tissue margins, while the other surgical margins remained free of malignancy. Right neck dissection revealed no neoplastic involvement in 31 lymph nodes across levels II, III, and IV. Left neck dissection uncovered metastatic squamous cell carcinoma in one lymph node at level III, without evidence of capsular invasion, among 35 nodes examined. Additionally, the thyroid exhibited a small follicular adenoma in the left lobe, while the right lobe was unremarkable. Consequently, the overall histological findings pertain to a grade 2 squamous cell carcinoma with local extension and limited lymphatic spread."
416,TCGA-CQ-6219-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated squamous cell carcinoma of the right tongue, accompanied by a significant maximum tumor dimension and thickness. The primary tumor exhibits perineural invasion but lacks evidence of lymphatic or vascular invasion. Margins show involvement by the tumor at the medial and lateral pharyngeal locations, while other examined margins are free of tumor. Among the 55 regional lymph nodes evaluated, only one lymph node at right neck level IIA demonstrated metastatic involvement with extracapsular extension, highlighting the presence of extranodal spread. No tumor was detected in the left-sided neck and submental lymph nodes, as well as in various revisions and other specified regions. The pathologic staging is determined as pT3 pN2a, indicating a tumor greater than four centimeters with metastasis in a single large ipsilateral lymph node. Distant metastasis remains undetermined based on the available data. Chronic inflammation was noted in the submandibular gland. The comprehensive examination of the surgical specimens affirms the gravity of the primary tumor and the local nodal involvement, emphasizing the aggressive nature of this carcinoma and the necessity for meticulous clinical management."
417,TCGA-QK-A652-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the partial glossectomy of the left lateral tongue revealed a keratinizing squamous cell carcinoma, moderately differentiated, exhibiting an infiltrative and discontiguous growth pattern with invasion into skeletal muscle bundles. Additionally, both perineural and lymphovascular invasion were noted. Importantly, the mucosal and soft tissue margins were free of carcinoma, indicating that the resection margins were negative. Lymph node analysis from the left neck dissection showed nine nodes from Level I, twelve from Level II, and eleven from Level IV, all negative for carcinoma. However, one out of seven lymph nodes from Level III was positive for metastatic carcinoma, without extracapsular spread. The histopathologic grade of the carcinoma was G2, referring to a moderately differentiated grade, and pathological staging indicated pT1 for the primary tumor and pN1 for regional lymph node involvement. Additional significant findings included the absence of high-grade dysplasia or invasive carcinoma in surrounding regions, with the metastatic focus measuring 1.5 mm in the largest affected lymph node. Overall, the surgical margins are clear of carcinoma, and the metastatic spread is limited to one lymph node without extracapsular extension."
418,TCGA-CN-4742-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation confirmed a diagnosis of squamous cell carcinoma of the tongue, characterized by a keratinizing, moderately to poorly differentiated, invasive tumor that crosses the midline. The final surgical margins were free of invasive carcinoma, but both venous/lymphatic and perineural invasion were noted. The glossectomy specimen revealed extensive involvement, with focal extrinsic muscle invasion. Lymph node dissections across various levels of the neck showed metastatic squamous cell carcinoma in 1 of 11 left level 3 lymph nodes, 1 of 8 right level 2 lymph nodes, and 1 of 7 right level 4 lymph nodes, with no extracapsular spread observed. The pathology also highlighted the presence of squamous cell carcinoma in situ in the right retromolar region and severe dysplasia in multiple biopsied areas of the right oral cavity. Additional noteworthy findings included a concerning focus of thyroid tissue with features suggestive of papillary thyroid carcinoma within a left level 2 lymph node. The overall pathologic staging was established as pT4a N2b MX, with 59 lymph nodes examined and three showing metastatic involvement. No additional significant pathological abnormalities were identified."
419,TCGA-UF-A71D-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated squamous cell carcinoma of the larynx, involving bilateral vocal cords, preepiglottic space, thyroid cartilage, and the perithyroidal soft tissue. Notably, there is no evidence of lymphovascular or perineural invasion, and the surgical margins are clear of invasive tumor. A total of forty-two lymph nodes dissected from the left and right neck (levels 2, 3, and 4) show no signs of metastatic carcinoma. Additionally, the thyroid revealed three foci of papillary microcarcinoma without vascular or extrathyroidal invasion, alongside an adenomatous goiter with a hyperplastic nodule. These findings collectively outline the extent of the primary laryngeal tumor, the absence of regional metastatic spread, and concurrent thyroid pathology."
420,TCGA-UF-A7JT-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive squamous cell carcinoma, histological grade 3, located primarily at the floor of the mouth. The tumor exhibits deep invasion, extending into adjacent skin and reaching osseous tissue; however, the osseous margin remains uninvolved by neoplasia. There is no evidence of lymphovascular invasion, although perineural invasion is present. Examination of the surgical specimen confirmed that the submandibular salivary gland remains unaffected by the neoplasia, and all surgical margins, including skin and soft tissue margins, are clear of malignant cells. Review of regional lymph nodes demonstrates no metastasis, with all lymph nodes from levels 2a and 3 on the right side, as well as submandibular nodes, being free of carcinoma."
421,TCGA-CN-5366-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final diagnosis confirms the presence of moderately differentiated squamous cell carcinoma originating in the right pyriform sinus with notable local invasion. Tumor infiltration extends into adjacent structures, including the paraglottic space and thyroid and cricoid cartilages, accompanied by perineural invasion. Surgical margins are clear of tumor involvement, ensuring no residual carcinoma at the excision boundaries. Bilateral neck dissection revealed metastatic involvement of squamous cell carcinoma in various lymph nodes, with a total of nine out of forty-seven nodes positive for metastasis. Notably, extracapsular spread is identified in specific nodal levels, significantly in levels II, III, and IV of the left neck and level II of the right neck. The thyroid gland exhibits fibrosis and inflammation but no malignancy, and the tracheostomy site is tumor-free. The esophageal margin and other regions sampled, including additional sections from the right base of the tongue and upper pharyngeal wall, showed no presence of carcinoma. Pathologic staging is determined as pT4a, pN2c, Mx, reflecting the extent of primary tumor invasion, nodal involvement, and unknown metastatic status, respectively. The histologic type is positioned as conventional squamous cell carcinoma, grade 2 (G2), indicating a moderately differentiated tumor. No additional significant pathologic findings are reported."
422,TCGA-CV-5442-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of invasive, poorly differentiated squamous cell carcinoma involving multiple head and neck structures. The carcinoma demonstrates extensive local invasion, particularly noted in the palate and left maxilla with basaloid features and extensive carcinoma in situ. Bone infiltration is documented in regions such as the maxillary sinus and nasal septum. Surgical margins are compromised, notably at the nasal septum margin and left inferior margin, both positive for poorly differentiated carcinoma. In the bilateral neck dissection (levels 1-4), metastatic carcinoma is identified in several lymph nodes, including one left level 2A lymph node, one left level 2B lymph node with extranodal extension, and multiple nodes in the right neck region. Other examined tissues, including the submandibular glands, inferior and middle turbinates, and pterygoid tissue, show no presence of the tumor. The presence of metastatic and primary poorly differentiated carcinomas indicates advanced disease with regional spread, emphasizing the need for thorough surgical excision and potentially adjuvant therapies for comprehensive management."
423,TCGA-T2-A6X0-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive moderately differentiated squamous cell carcinoma originating from a glossotonsillar mass. Further analysis of surgically excised lymph nodes from a right-sided neck dissection identified metastatic squamous cell carcinoma, ranging from moderate to poorly differentiated, with evidence of extranodal extension into surrounding soft tissues. Notably, all 31 reviewed lymph nodes were negative for metastatic involvement. Additionally, the excision of a separate mass from the right base of the tongue showed salivary gland parenchyma mixed with skeletal muscle and no signs of malignancy. Immunohistochemical staining confirmed the tumor cells strongly expressed p16, with no circumferential membranous staining for EGFR, indicating potential human papillomavirus (HPV) involvement, pending further confirmation by specific HPV studies. The comprehensive assessment underscores a significant metastatic burden with important diagnostic markers supporting the management and prognosis of this case."
424,TCGA-CV-A45R-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate the presence of invasive grade I-II squamous carcinoma following a subtotal glossectomy. The tumor exhibits low to moderate differentiation, with invasion into submucosal connective tissue, superficial muscle, and deep muscle, along with peri-neural and suspected lympho-vascular invasion. The resection margins are clear of tumor involvement. Metastatic squamous carcinoma is identified in one out of thirteen regional lymph nodes in the right supraomohyoid neck dissection, specifically showing focal extranodal extension in a subdigastric lymph node; however, no metastatic tumor is present in the submandibular cases or submandibular gland. The right base of the tongue specimen exhibits focal mucosal ulceration without any diagnostic evidence of malignancy. Overall, the diagnosis encompasses metastatic squamous carcinoma with focal extranodal extension and invasive keratinizing squamous carcinoma at the primary resection site, with clear margins post-surgery."
425,TCGA-CN-5373-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a well-differentiated squamous cell carcinoma located in the floor of the mouth and base of the tongue, characterized as deeply invasive. Significant perineural invasion was also noted. While the tumor itself measures less than 2 cm at its greatest dimension, extensive mild to moderate dysplasia is present in the surrounding tissue. Importantly, all surgical margins, including the floor of the mouth, tongue, and deep margins, are free of tumor involvement, indicating successful excision. Neck dissection of levels 1-3 on the right and levels 2-3 on the left revealed no metastatic involvement across thirty lymph nodes examined. Additional findings include benign submandibular gland tissue and a normocellular parathyroid gland. Molecular studies have shown positive results for EGFR FISH but negative for C-MET amplification. The pathologic staging is classified as T1 NOMX, corresponding to a small, localized tumor with no regional lymph node metastasis or distant metastasis observable."
426,TCGA-CV-6952-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive well-differentiated squamous carcinoma of the tongue muscle, characterized by extensive perineural invasion. The carcinoma is present at the skeletal resection margin, while all mucosal margins are negative. The bilateral neck dissection revealed metastatic squamous carcinoma involving several lymph nodes: one midjugular, one lower jugular, and one supraclavicular node on the right side, with no extension beyond the nodes. Eleven additional right neck nodes and twenty-two left neck nodes showed no evidence of metastasis. The largest metastasis is located in a right lower jugular lymph node, comprising 90% of the lymph node parenchyma. Multiple teeth were also submitted for gross examination only."
427,TCGA-CN-6020-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals invasive squamous cell carcinoma originating in the floor of the mouth, confirmed through biopsy. A comprehensive assessment of multiple lymph node regions was conducted. Of the lymph nodes dissected from the left Level 1, one out of seven exhibited metastatic squamous cell carcinoma without extracapsular spread, while the remaining lymph nodes and right Level 1 nodes were free of tumor involvement. Chronic sialadenitis and atrophy were noted in the submandibular glands. A marginal mandibulectomy of the tongue, floor of mouth, and anterior composite resection revealed moderately differentiated invasive squamous cell carcinoma with perineural invasion, but tumor margins were clear. The pathological staging of the primary tumor is pT2 with regional lymph node involvement classified as pN1; distant metastasis remains unspecified (pMX). Extensive lymph node examinations from levels 2-4 on both sides were negative for tumor presence, and no abnormal findings were detected in the right anterior tongue margin biopsy. The ancillary studies are pending, with results to be reported subsequently. Per the microscopic examination, all the above findings align with the diagnosis, thus reinforcing the clinical scenario of an intraoral mass requiring extensive surgical intervention."
428,TCGA-CV-5971-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment confirms a diagnosis of moderately differentiated invasive squamous cell carcinoma arising from the right tongue. The tumor presents with ulceration and an infiltrative border characterized by thick cords. Notably, there is an absence of perineural and vascular invasion, but moderate lymphocytic infiltration is observed. The mucosal and deep margins of the partial glossectomy are negative for invasive carcinoma, with the closest margin being 1.5 mm posterolaterally. Dysplasia is not noted at the margins. Right neck dissections from levels 1A, 1B, 3, and 5 showed no evidence of tumor in the examined lymph nodes. However, one out of eight lymph nodes in level 4 displayed metastatic carcinoma, measuring 1.3 cm, without extracapsular extension. Additionally, the new right posterior lateral margin comprised skeletal muscle and fibroconnective tissue, which were negative for the tumor. These findings are significant for guiding the ongoing clinical management and potential adjuvant therapy considerations."
429,TCGA-BA-5558-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings reveal a diagnosis of invasive, well-differentiated, keratinizing squamous cell carcinoma involving the right inferior maxilla and effacing the hard palate with extension into the oral cavity. The tumor is well-defined and measures approximately 3.2 cm in its greatest dimension. Importantly, there is no evidence of lymphovascular or perineural invasion. The margins of resection are negative for tumor, although the tumor approaches very close to the anterosuperior, lateral, and anterolateral soft tissue margins, being within 1 to 2 mm at the closest points. The rest of the margins are widely free of tumor. No metastatic carcinoma is identified in lymph nodes from various levels of the right neck, comprising a total of 37 lymph nodes, all of which exhibit benign reactive lymphoid follicular hyperplasia. Additional findings from biopsied and removed tissues, including those from the sinus, nasal septal margins, and turbinates, show benign sinus mucosa with chronic inflammation and edema, without any dysplasia or malignancy identified. Overall, the pathological assessment indicates localized but extensive squamous cell carcinoma with close but negative resection margins and no metastasis."
430,TCGA-CQ-5325-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left neck and tongue reveals a diagnosis of moderately differentiated squamous cell carcinoma of the left tongue. The tumor is characterized by a lack of perineural and lymphovascular invasion, and all examined surgical margins are free of tumor involvement. Comprehensive lymph node evaluation from neck levels I, II, III, and IV shows no evidence of metastasis, with 22 lymph nodes examined and all negative for tumor. The submandibular gland is also unremarkable with no pathological changes. Thus, with the primary tumor resected successfully and clear margins being achieved, the pathological staging is pT1, pN0, and pMX, indicating a localized tumor without regional lymph node involvement or distant metastasis assessable. No additional pathological findings were identified."
431,TCGA-CQ-A4C6-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The right buccal resection specimen reveals a diagnosis of moderately differentiated squamous cell carcinoma. Notably, the tumor exhibits perineural invasion but lacks lymphovascular invasion. Surgical margins, including right anterior mucosa, right superior mucosa, right inferior mucosa, deep, and right posterior mucosa, are all negative for malignancy, ensuring a clear resection boundary. The right parotid duct and multiple lymph nodes from right neck levels IIB and the comprehensive neck dissection also show no evidence of malignancy. In total, 23 lymph nodes were examined, all free of metastatic involvement. These findings translate to a pathological staging of pT2N0, indicating a tumor more than 2 cm but not more than 4 cm in greatest dimension, with no detected regional lymph node metastasis or distant metastasis. The submandibular gland is also negative for malignancy. Overall, the comprehensive evaluation confirms a localized squamous cell carcinoma with clear surgical margins and no lymph node involvement."
432,TCGA-4P-AA8J-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated keratinizing type squamous cell carcinoma of the right tongue, with the primary tumor exhibiting unifocality and extension into the floor of the mouth. The tumor margins, including deep resection margins, are negative for carcinoma. The tumor demonstrates both lymphovascular and perineural invasion, with a negative HPV status confirmed by p16 immunohistochemical staining. Extensive lymph node examination reveals metastasis in specific regions, with one lymph node positive for carcinoma in right level 2A, one in right level 3, two in left level 1B, and two in left level 3 out of the multiple lymph nodes dissected. Other examined margins and nodes are negative for malignancy, including those from bilateral level 1A, further right cervical levels, and the left floor of the mouth areas. The pathological stage, according to the AJCC 7th edition, is designated as pT2 pN2c pMX."
433,TCGA-CQ-5324-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of moderately differentiated papillary squamous cell carcinoma in the oral cavity, specifically involving the left floor of the mouth and left lateral tongue. The maximum tumor diameter is noted to be significant, with predominantly exophytic growth and superficial invasion, but no lymphatic, vascular, or perineural invasion is identified. The margin status indicates a positive tumor presence at the floor of the mouth, whereas all other margins are tumor-free. Examination of the level IB neck lymph node and an additional twenty-four lymph nodes from levels I to IV returned negative results for metastatic involvement. Associated soft tissues, including the gingival, buccal, tongue base, and soft palate margins, demonstrate chronic inflammation and reactive changes but are negative for tumor. Examination of the decalcified sections of the left mandibular superior rim reveals reactive bone changes without carcinoma. The surgical waste from skin and soft tissues shows no pathological changes upon gross examination. The evaluation of the submandibular gland similarly shows no pathologic alterations. Overall, the pathological findings emphasize the localized nature of the tumor with no evidence of regional lymph node metastasis."
434,TCGA-F7-7848-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The laryngectomy specimen reveals a moderately differentiated, keratinizing squamous cell carcinoma located in the larynx, with extension into the deep muscles of the tongue. One out of four cervical lymph nodes shows evidence of metastatic involvement. Importantly, the surgical margins are uninvolved by the tumor, indicating complete resection. There is no specified evidence of neo-adjuvant treatment in this case. These findings establish a diagnosis of moderately differentiated, keratinizing squamous cell carcinoma of the larynx with regional lymph node metastasis and clear surgical margins."
435,TCGA-CV-7423-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive well-differentiated squamous cell carcinoma from a right partial glossectomy specimen. The tumor is characterized by a maximum depth of invasion without unequivocal evidence of vascular, lymphatic, or perineural invasion. Both the peripheral and deep margins of resection are free of tumor, suggesting complete excision. Additionally, two teeth were included in the specimen, evaluated grossly. No involvement of lymph nodes or other notable pathological features were reported."
436,TCGA-CQ-6225-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a moderately differentiated squamous cell carcinoma involving the left tongue, left floor of the mouth, and palate. The tumor exhibits extensive perineural invasion and clear cell change, but there is no evidence of lymphovascular invasion. The maximum tumor diameter measures 4.9 cm with a thickness of 2.9 cm. Although the tumor is close to the deep medial soft tissue margin, all remaining margins are negative for the tumor. Examination of the left neck dissection content revealed twenty-five lymph nodes, all of which are negative for malignancy, and extensive atrophy of the submandibular gland consistent with prior radiotherapy. Other biopsies from the left neck level II lymph node, left palate, and left tongue base, as well as the deep and inferior tongue margins, showed no pathologic changes or evidence of tumor."
437,TCGA-F7-8489-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen from the floor of the mouth reveals a diagnosis of squamous cell carcinoma. The tumor, located at the midline, demonstrates infiltrative growth with malignant squamous cells exhibiting nuclear atypia and keratin pearl formation, characteristic of this histologic type. The surgical margins are negative, indicating that there is no residual tumor at the resected edges. Lymph node involvement is absent, suggesting no metastatic spread to regional lymphatic structures. Additional microscopic examination highlights areas of moderate to well-differentiated carcinoma without evidence of lymphovascular or perineural invasion. These findings collectively suggest a localized primary malignancy with clear surgical margins and no nodal metastasis."
438,TCGA-UF-A718-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a moderately differentiated squamous cell carcinoma in the larynx, affecting the infraglottic, glottic, and supraglottic regions, with extension into the right hypopharynx. Notably, there is involvement of the thyroid cartilage and right paralaryngeal skeletal muscle. The carcinoma is associated with areas of ""in situ"" squamous cell carcinoma and is accompanied by moderate stromal dysplasia. Importantly, there is no indication of perineural or lymphovascular invasion. All surgical margins are free of carcinoma, suggesting complete resection. Examination of lymph nodes indicates no metastatic involvement, with all nodes from both right and left areas (0/12 right and 0/10 left) showing no evidence of malignancy. Additionally, the pre-epiglottic fat tissue is free of neoplastic processes. These findings collectively support the diagnosis and provide a comprehensive overview of the tumor characteristics, margin status, and absence of lymph node metastasis."
439,TCGA-CV-7430-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal the presence of Grade II squamous carcinoma involving multiple anatomical structures. The tumor is notably present in the sympathetic nerve sheath with perineural invasion, the anterior connective tissues, deep subcutaneous tissue, esophagus, and has shown both lympho-vascular invasion and positive proximal and distal soft tissue resection margins on total laryngectomy/total thyroidectomy specimens. The tumor also invades the right sympathetic chain and extensive connective tissue and perineural compartments at the base of the skull, encroaching on the inked resection margin. Examination of the right omohyoid, right parotid artery, cervical esophagus, and ten lymph nodes in the right lateral neck dissection show no evidence of tumor. Similarly, the thyroid gland and one anterior compartment lymph node are free of tumor involvement. The findings from the vagus nerve area demonstrate squamous carcinoma within the connective tissue without a definitive vagus nerve identified. Fragments of the tumor from both transduced and non-transduced sources confirm the presence of Grade II squamous carcinoma with infiltration of connective tissue and lympho-vascular invasion."
440,TCGA-CQ-6228-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated squamous cell carcinoma originating in the oral cavity, specifically the floor of the mouth. The primary tumor did not exceed 1.2 cm in either dimension and showed no evidence of venous or perineural invasion. The tumor was identified very close to the soft tissue margins of the resection area but did not involve major bony structures. Despite widespread sampling, including various muscle groups and soft tissues in the head and neck region, the squamous cell carcinoma had notable involvement in the deep paraspinal muscles and anterior scalene muscle, where it reached the soft tissue margins. Metastatic involvement was extensive, with affected lymph nodes detected at multiple neck levels, including Level I (1/7), Level III (7/15), Level IV (4/18), and Level V (2/12), and extracapsular extension present at Levels III and IV. Overall, a significant number of lymph nodes were examined (76), with metastatic carcinoma found in 14 of them. Additional findings included chronic inflammation in the submandibular gland and a granuloma in one Level II lymph node with no infectious organisms identified. The CRC margin and other soft tissue margins were clear of malignancy. Pathologic staging was assigned as pN2b, indicating multiple ipsilateral lymph node metastases without distant metastasis assessment."
441,TCGA-CN-4727-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals invasive, moderately differentiated squamous cell carcinoma of the larynx, specifically involving the supraglottic region, both right and left epiglottis, false cords, pre-epiglottic and paraglottic spaces, and extending into the anterior soft tissue. No involvement of the thyroid cartilage, angiolymphatic invasion, or perineural invasion is observed. The surgical margins are free of tumor, indicating complete resection. The pathological stage is determined to be pT4aN0MX. With regard to lymph node evaluation, sixteen lymph nodes from the right neck dissection exhibit no squamous cell carcinoma, although two of the sixteen show metastatic papillary thyroid carcinoma without extracapsular spread. The left neck dissection reveals no tumor involvement across twenty-one lymph nodes. Biopsies from various parts of the upper pharynx and the base of the tongue show either mild dysplasia or no tumor presence. Ancillary studies conducted reveal negative results for P16 immunohistochemistry and HPV in-situ hybridization, and EGFR immunohistochemistry shows minimal membranous staining. Additionally, the bone marrow displays hypercellularity with trilineage hematopoiesis and slightly left-shifted myeloid maturation."
442,TCGA-CQ-6222-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the specimens revealed a moderately differentiated squamous cell carcinoma (G2) originating from the right tongue and confirmed through hemiglossectomy. The primary tumor does not exhibit perineural or lymphovascular invasion and was fully excised with negative dorsal tongue, deep tongue, tongue base, and floor of mouth margins. Lymph node assessment predominantly showed no tumor presence, except in right neck levels IIA and III. Specifically, one lymph node in level IIA was positive for metastatic squamous cell carcinoma without extracapsular extension, while one lymph node in level III demonstrated the presence of metastatic carcinoma with extensive extracapsular extension. The submandibular and sublingual glands, as well as other regional lymph nodes from levels IA, IB, IIB, IV, and V, were negative for malignancy. Pathological staging revealed a tumor size consistent with pT2 classification and multiple ipsilateral lymph node metastases classified as pN2b, with distant metastasis status undetermined (pMX)."
443,TCGA-CN-4735-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive basaloid squamous cell carcinoma originating from the left pyriform sinus. The tumor, graded as G3, shows significant invasion, though all surgical margins remain free of tumor involvement, and there is no evidence of perineural or vascular/lymphatic invasion. Notably, immunohistochemistry results indicate positivity for EGFR, while staining for P16 and HPV are negative. The total resected specimen included a bilateral neck dissection and total laryngectomy. Among the 70 regional lymph nodes examined, five displayed metastatic carcinoma four on the left side (levels II, III, IV) and one at level VI. However, the lymph nodes from the right neck dissection (levels II, III, IV) showed no tumor involvement. Additional significant findings include a hypercellular left parathyroid gland without oncologic significance and benign thyroid inclusions in right cervical lymph nodes. Both EGFR and C-MET FISH studies are negative for amplification. The tumor is staged pathologically as pT3, pN2b, pMX."
444,TCGA-CN-4740-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological assessment confirms the diagnosis of moderately differentiated invasive squamous cell carcinoma located in the right retromolar trigone, with the tumor extensively involving the mandible. The tumor is classified as pT4 with no lymph node metastasis identified (pN0), as all 26 examined regional lymph nodes were found to be benign. There is no evidence of angiolymphatic or perineural invasion. However, microscopic examination reveals that the anterior mandibular bone margin and the lateral soft tissue margin are involved by the carcinoma. Severe dysplasia is present at the anterior and medial soft tissue margins. No neoplasm was detected in multiple other biopsied sites, including the soft palate, posterior tonsillar pillar, submandibular gland, superficial mandible margin, right alveolar nerve, retromolar trigone, anterior labial margin, and bone marrow of the mandible. The pathologic stage, based on the TNM classification, is pT4 pN0 pMX."
445,TCGA-CN-4741-01Z-00-DX1,HNSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Head and neck region, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The definitive diagnosis is invasive squamous cell carcinoma located in the floor of the mouth, with a tumor size of 3.7 cm. Histologically, the tumor is moderately differentiated (G2) and involves the mandibular bone. Perineural invasion is present, while venous and lymphatic invasion are absent. The pathological staging is pT4a pN0 pMX, indicating advanced local invasion without regional lymph node metastasis or distant metastasis evaluation. Importantly, all surgical margins are free of carcinoma, though the carcinoma is noted to be less than 0.1 cm from the posterior soft tissue margin. Bilateral neck dissections revealed a total of 46 benign lymph nodes (0/46), with no evidence of carcinoma involvement. Additionally, the submandibular glands exhibit varying degrees of chronic and acute sialadenitis. The mandibular bone margin is pending decalcification. These findings summarize a case of locally advanced squamous cell carcinoma with no metastatic spread to regional lymph nodes and clear surgical margins, albeit close to the posterior soft tissue margin."
446,TCGA-FG-6688-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left parietal occipital glial neoplasm has yielded a diagnosis of infiltrating glioma. Histopathologic features indicate that the tumor is consistent with the patient's previously biopsied anaplastic astrocytoma. Examination of the touch imprint and intraoperative microscopic consultation also supports the diagnosis of infiltrating glioma. The gross description of the submitted specimens includes multiple segments of tan-white and cerebriform soft tissue. No specific mention was made regarding the involvement of surgical margins or lymph node status in the provided details. The pathological findings underscore the aggressive and infiltrative nature of the glial neoplasm, reflecting its derivation from an anaplastic astrocytoma and suggesting continued therapeutic management and follow-up."
447,TCGA-P5-A731-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination confirms the diagnosis of an oligoastrocytoma, classified as WHO Grade II. The tumor primarily involves the right frontal and temporal lobes and is characterized by grayish, soft-elastic tissue. Microscopically, the brain tissue exhibits the presence of oligoastrocytoma with numerous calcifications scattered throughout. There is no mention of the involvement of surgical margins or lymph nodes, suggesting that these aspects were not evaluated or included in the sample. Additionally, no other significant pathological abnormalities were noted in the examined tissue."
448,TCGA-CS-4944-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right temporal brain tumor revealed a diagnosis of Astrocytoma, grade II of IV according to the WHO scale. The tumor exhibits a diffusely infiltrative proliferation of moderately pleomorphic astrocytes, without evidence of endothelial proliferation, necrosis, or mitotic activity. Ki67 immunohistochemistry indicates a proliferation index of less than 1%, consistent with the grade II designation. The presence of Rosenthal fibers was noted near the pial surface, though no additional histological features suggest a pilocytic astrocytoma. Margins remain undefined in the provided summary, with no specific mention of lymph node involvement. The fresh specimen provided was sectioned and submitted for comprehensive analysis, yielding 2 and 4 cassettes for the respective portions. No high-grade features were observed in the frozen sections, corroborating the final diagnosis."
449,TCGA-DU-5871-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate the presence of a mixed oligoastrocytoma in the left frontal lobe, characterized by moderate cellularity and nuclear pleomorphism. The lesion exhibits predominantly astrocytic features with an MIB-1 proliferation index of 3% in more active areas, suggesting a relatively low proliferative activity. Notably, there are no signs of microvascular proliferation, necrosis, or brisk mitotic activity, ruling out anaplastic features. Genetic analysis revealed allelic loss on chromosome arms 1p and 19q, which is consistent with the diagnosis but does not provide a favorable prognostic indicator. Additionally, the methylation of the MGMT promoter was confirmed, which may have implications for treatment responsiveness. There was no evidence of an EGFR variant III mutation. These findings, combined with the clinical and imaging data, suggest ongoing anaplastic transformation, necessitating careful clinical correlation and follow-up."
450,TCGA-CS-6188-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of an anaplastic astrocytoma, grade III of IV according to the WHO classification. The tumor displays a densely cellular proliferation of moderately pleomorphic astrocytes with scattered mitotic figures, while lacking significant endothelial proliferation and necrosis. Immunohistochemical analysis indicates a Ki67 proliferation index that averages 9.5%, consistent with the expected range for an anaplastic astrocytoma of this grade. Margins could not be definitively assessed due to the infiltrative nature of the tumor, and there were no high-grade features identified in the representative frozen sections. Lymph node involvement is not applicable in this context. The specimen was acquired via image-guided right-side craniotomy and consisted of soft tan-pink tissue subjected to both frozen section and formalin-fixed analyses."
451,TCGA-DH-5140-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected left temporal brain tumor reveals an anaplastic mixed glioma, specifically an oligoastrocytoma consistent with WHO Grade III. The gross examination depicted the lesion as firm and white, largely demonstrating a diffuse infiltrative pattern within both the cerebral cortex and subcortical white matter. Histological analysis showed extensive infiltration, with prominent moderate nuclear and cellular pleomorphism, significant mitotic activity, and a minor component displaying a uniform oligodendrogliomatous morphology. Immunohistochemistry identified a Ki67 labeling index of 10-15%, with negative results for PTEN and EGFRVIII. GFAP staining indicated positive immunoreactivity of both the neoplastic and reactive components of the tumor. Additionally, no deletions were found for chromosomes 1p and 19q upon fluorescence in situ hybridization analysis. Margins were not clearly demarcated, consistent with the infiltrative nature of the glioma. There was no discrete lesion identified in the second specimen, reiterating the diffusely infiltrative characteristic of the tumor. No lymph node involvement was observed in this resection. Overall, these findings are indicative of an aggressive, high-grade glioma with diverse histopathological features."
452,TCGA-FG-5964-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals an oligodendroglioma, WHO Grade II, located in the left parietal lobe of the brain. Upon intraoperative consultation, the lesion initially exhibited characteristics suggestive of a high-grade glioma; however, further analysis refined the diagnosis. Fluorescence in situ hybridization confirmed the presence of deletions in chromosomes 1p and 19q, which are notable for their prognostic and therapeutic implications. The tumor was characterized by irregular fragments of soft tissue with variation in color from tan to red and brown. There is no specific mention of margin status, leaving the extent of surgical excision and clearance uncertain. Lymph node involvement is not applicable or mentioned in this context, given the central nervous system location. The clinical history supports the identification of a parietal lesion, and the gross description provided intricate details regarding the appearance and handling of the submitted tissue specimens. Overall, the essential findings consolidate the diagnosis of oligodendroglioma with significant genetic alterations but lack additional context on surgical margins or extracranial involvement."
453,TCGA-CS-6186-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right post-central brain tumor reveals an oligoastrocytoma with focal anaplastic changes, indicating both oligodendroglial and astrocytic differentiation. The neoplasm exhibits areas of increased cellularity, cellular pleomorphism, and a mitotic rate that suggests higher proliferative activity, particularly in small foci where the Ki67 proliferation index approaches 15%. Although the majority of the tumor exhibits characteristics consistent with WHO grade II, these focal anaplastic regions and elevated Ki67 indices suggest a more aggressive behavior consistent with WHO grade III anaplastic oligoastrocytoma. Endothelial proliferation was identified in parts of specimen #1 during frozen section analysis, though it was not observed in the permanent sections. The FISH analysis for 1p and 19q deletions yielded negative results, indicating the absence of these genetic alterations commonly associated with oligodendrogliomas. No definitive assessment can be made regarding margin status or lymph node involvement as these details were not provided. Clinical correlation is recommended to determine the precise therapeutic and prognostic implications."
454,TCGA-DU-A6S3-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the brain biopsy revealed a diagnosis of oligodendroglioma, classified as WHO Grade 2. Microscopic examination showed a glial neoplastic proliferation displaying an oligodendroglial phenotype with diffuse infiltration into the brain tissue. The tumor was characterized by sparse mitotic figures and a low MIB-1 proliferation index of 3.5% in active regions, indicating a low-grade malignancy. Importantly, the neoplasm exhibited a 1p/19q co-deletion, which is a common and favorable diagnostic marker for oligodendrogliomas. Additionally, the IDH1-R132 mutation was uniformly present, aligning with the typical genetic features of this tumor type. There was no evidence of microvascular proliferation or necrosis. Margin status was not specified. Moreover, MGMT promoter methylation was detected, suggesting potential responsiveness to alkylating agent chemotherapy. No lymph node involvement was noted as the brain tumor assessment primarily focused on the cerebral and white matter regions, with the lesion extending into the right frontal lobe. Overall, these findings are consistent with a well-defined oligodendroglioma, offering important prognostic and therapeutic implications."
455,TCGA-TQ-A7RS-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of oligodendroglioma, grade II, according to WHO classification, originating from the left frontal brain. Macroscopically, the brain parenchyma appeared softened and whitish in areas, with well-defined gyri and sulci on the surface. Histologically, the neoplasm consists of relatively monomorphic glial cells with round, slightly hyperchromatic nuclei, often displaying a clear halo. The tumor architecture includes a rich vascular network with several areas of dystrophic calcifications. The lesion shows an infiltrative pattern involving both the cortex and white matter, with evidence of neuronal satellitosis and subpial accumulation of neoplastic cells. There were no observed mitotic figures, necrosis, marked atypia, or endothelial hyperplasia. Genetic analysis indicated the presence of an isolated 19q co-deletion. The margin status and lymph node involvement are not applicable to this central nervous system tumor. Overall, the findings are consistent with a grade II diffuse oligodendroglioma, demonstrating specific molecular aberrations that provide important prognostic and therapeutic information."
456,TCGA-CS-4941-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals a right frontal lobe brain tumor characterized as an anaplastic astrocytoma, grade III of IV according to the WHO scale. Histological examination shows a highly cellular proliferation of astrocytic cells with marked pleomorphism and scattered mitoses, indicative of the tumor's aggressive nature. Notably, there is an absence of endothelial proliferation and necrosis within the specimen. The tumor was evaluated using both frozen sections and touch preparations, which confirmed the diagnosis of a high-grade glioma. The tumor margins were not discussed explicitly, and there was no mention of involvement of lymph nodes or distant metastasis. The clinical history includes a right frontal lobe brain tumor with a differential diagnosis of glioma and a history of migraines. The specimen was submitted in its entirety for pathological examination, providing a comprehensive assessment for diagnosis."
457,TCGA-DU-A7T8-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the excisional biopsies from the right frontal brain revealed a diagnosis of glioma with atypical features. Further analysis of the excised brain tumor identified it as a mixed oligoastrocytoma, anaplastic in nature, exhibiting a high MIB-1 proliferation index of 38%, indicative of significant cellular proliferation. The tumor displayed a mixture of astrocytic and oligodendroglial phenotypes, with areas demonstrating heightened astrocytic characteristics. Notably, the histopathological analysis showed zones of tumor necrosis and microvascular proliferation, signaling focal anaplastic transformation to a WHO grade III glioma. Immunohistochemical staining highlighted sparse gliofibrillogenesis via GFAP, rich neoplastic vascularity via CD34, and a p53 overexpression in 5% of cells. Importantly, the MIB-1 index demonstrated regions of significant cellular activity, underscoring the aggressive nature of the malignancy. The comprehensive pathological evaluation underscores a high-grade mixed glial neoplasia with concerning proliferation and necrosis features, correlating with an advanced tumor stage."
458,TCGA-E1-A7YY-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a well-differentiated oligodendroglioma (WHO Grade II) diagnosed in the right frontal brain region. The tumor tissue is characterized by neoplastic cells with round nuclei, stippled chromatin, and perinuclear halos, with areas showing focal calcification and perineuronal satellitosis. Additionally, the presence of plump endothelial cells and macrophage foci is noted. Margins and lymph node involvement are not mentioned, indicating that these aspects were either not assessed or not relevant to the tissue submitted. Multiple fragments of yellow, gray-tan, pink, and white tissue from different designated sections of the tumor were examined microscopically, all consistently supporting the diagnosis of a well-differentiated oligodendroglioma."
459,TCGA-QH-A6CX-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of astrocytoma, classified as grade II according to the World Health Organization (WHO) criteria. The tumor, located in the left temporal region, exhibited characteristics consistent with a diffuse astrocytoma, such as infiltrative growth and moderate cellularity with occasional mitotic figures. There was no evidence of necrosis or microvascular proliferation, which differentiates it from higher-grade lesions. The surgical margins were evaluated and found to be involved, indicating residual tumor presence. Additionally, there was no lymph node involvement noted, consistent with the primary central nervous system tumor behavior. Other relevant findings included the absence of significant hemorrhage or calcification within the tumor tissue, and the surrounding brain parenchyma showed signs of reactive gliosis. These findings collectively contribute to the prognostic and therapeutic considerations for the patient."
460,TCGA-HT-7676-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","Microscopic examination reveals a moderately cellular oligodendroglioma characterized by a proliferation of neoplastic cells with round to oval nuclei and prominent perinuclear halos. The neoplastic cells display moderate nuclear atypia, with rare instances of marked atypical features such as enlarged, hyperchromatic, folded, or clefted nuclei. Scattered throughout the tumor are microgemistocytes. The background neuropil shows microcystic changes and focal areas of acute hemorrhage, although no necrosis or microvascular proliferation is identified. Mitotic activity is low, with only one mitotic figure observed per 10 high power fields. The MIB-1 labeling index peaks at 2.1%, indicating a low-grade neoplasm. These histological features confirm a diagnosis of oligodendroglioma, Grade II, with no evidence of high-grade transformation. Margins and lymph node involvement are not addressed in this description."
461,TCGA-HT-A61A-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is a Grade II Oligodendroglioma, characterized as a moderately hypercellular and diffusely infiltrating glial neoplasm. The tumor cells exhibit moderate atypia with round nuclei, most of which display perinuclear halos indicative of oligodendroglial lineage. There is no evidence of mitotic figures, microvascular proliferation, or necrosis within the specimen. The MIB-1 labeling index is calculated at 4.2%, reflecting the proliferative activity of the tumor. Margins and lymph node involvement are not addressed within the report, suggesting no additional pathological findings regarding these aspects. This pathology is consistent with a Grade II glioma, which typically exhibits slow growth and less aggressive behavior compared to higher-grade counterparts."
462,TCGA-P5-A780-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of diffuse astrocytoma, initially Grade II, progressing towards Grade III. The tumor is characterized by nuclear polymorphism and a Ki67 proliferation index exceeding 5%, indicative of increased cellular activity and malignancy. Examination of the brain tissue fragments from the right frontal lobe highlights the dense gray appearance typical of this type of astrocytic tumor. The tumor margins were not specified, and there was no reference to lymph node involvement, which is consistent with primary central nervous system neoplasms. These findings collectively suggest a progressively aggressive astrocytoma with significant potential for further malignant transformation."
463,TCGA-DH-A7US-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the brain tumor resected from the frontotemporal lobe reveals a diagnosis of Oligodendroglioma, WHO Grade II. Microscopically, the tumor displays infiltrating cells with monomorphic ovoid nuclei, perinuclear halos, and characteristic ""chicken wire"" vasculature. Notably, there is an absence of necrosis, microvascular proliferation, and mitoses in the examined sections. The Ki-67 proliferation index is variable, ranging from 1-7%, indicating a low to moderate proliferative activity. Immunohistochemically, the tumor cells show positive reactivity for GFAP in their processes, strong and diffuse positivity for IDH1, and negative staining for P53 in the majority of cells. The genetic analysis for 1p/19q chromosomal status is pending to provide further insights. These findings collectively support the diagnosis of Oligodendroglioma, WHO Grade II, without any evidence of high-grade features. The margin status and lymph node involvement are not specifically addressed, which is typical for central nervous system tumors."
464,TCGA-DU-A6S2-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological diagnosis reveals a WHO Grade II oligodendroglioma in the medial frontal cortex, characterized by a neoplastic proliferation with an oligodendroglial phenotype. The tumor shows focal slight to moderate infiltration of glial cells, with a single proliferation center exhibiting a mitotic activity and a MIB-1 proliferation index of up to 6%, while the proliferation index elsewhere is approximately 2%. There is no evidence of endothelial cell proliferation, microvascular cellular proliferation, or tumor necrosis, indicating a low histological grade. Genetic analysis confirms the presence of 1p/19q codeletion, which is a favorable prognostic marker. Additionally, the IDH1 mutation and methylation of MGMT are detected, which are also positive prognostic markers. The pathological and genetic features suggest that the tumor is currently of low grade but may have areas of enhanced biological activity, potentially indicating future transformation. The findings should be correlated with clinical, imaging, and intra-operative results for comprehensive patient management and follow-up."
465,TCGA-QH-A6X5-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of oligoastrocytoma, classified as grade II according to the World Health Organization grading system. The tumor demonstrates a mixed pattern of oligodendroglial and astrocytic components, consistent with its diagnosis. Importantly, the resection margins are free of tumor cells, indicating a complete surgical excision. No lymph node involvement is noted, as expected for this central nervous system tumor. Additional relevant findings include the absence of significant mitotic activity, necrosis, or microvascular proliferation, which further supports the grade II classification. Overall, the histopathological features are indicative of a relatively low-grade, yet diffusely infiltrative glioma."
466,TCGA-TQ-A7RI-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of WHO grade II oligodendroglioma, primarily involving the neocortex with significant cortical infiltration. Macroscopically, the brain parenchyma fragment features a homogeneous, whitish outer surface with softened and brown-gray areas on the cut surface. Microscopically, the neoplasm consists of neuroepithelial cells with round nuclei, delicate chromatin, inconspicuous nucleoli, and scant, indistinct cytoplasm, often forming perinuclear halos. There is notable cortical infiltration with neuronal satellitosis and formation of Scherer secondary structures in the subpial region. Some regions of the tumor show increased cellularity and occasional microcysts, although mitotic figures are rarely observed. There is no evidence of microvascular proliferation within this sample. The surgical margins and lymph node involvement are not discussed in the findings provided."
467,TCGA-DU-A76R-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of oligodendroglioma involving the right temporoparietal region of the brain. The tumor displays extensive infiltration and partial effacement of the cerebrum by a neoplasm with an oligodendroglial phenotype, exhibiting characteristic ""looser"" morphology. The sections from the biopsy show no features of atypia, while those from the resection demonstrate focal anaplastic transformation, characterized by brisk mitotic activity, microvascular cellular proliferation, conspicuous tumor cell and microvessel karyorrhexis, and focal necrosis. Immunohistochemical studies reveal a MIB-1 proliferation index of 8% to 10% in the more active areas and do not show overexpression of the p53 protein. These findings support the diagnosis of high histological grade oligodendroglioma (WHO grade III). Margin status and lymph node involvement are not applicable in this central nervous system tumor context. Special stains and further immunohistochemical analysis are underway to provide additional characterization."
468,TCGA-HW-8321-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left frontal lobe brain tumor reveals a diffusely infiltrating glioma, primarily characterized as a diffuse astrocytoma with some oligodendroglial features. The neoplasm is diffusely infiltrative throughout the examined specimens, and a subset of the tumor cells expresses the R132H mutant IDH1 and labels for p53. The overall histopathological findings categorize the tumor predominantly as WHO grade II with low MIB-1 labeling activity. However, one specific region (specimen 2) exhibits an increased proliferative activity with mitotic figures and an MIB-1 labeling index of 8-10%, indicating a localized progression to WHO grade III anaplastic glioma, although this high-grade component is limited in volume. All submitted specimens have been fully examined, and the material is forwarded for further molecular testing, including MGMT promoter methylation analysis and 1p/19q deletion status. The gross evaluation includes tan/pink and gray brain matter fragments, all oriented towards comprehensive analysis. The intraoperative consultation confirmed the presence of glioma with anaplastic features."
469,TCGA-DU-7290-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The biopsy specimen from the right temporal lobe of the brain has been diagnosed as anaplastic astrocytoma, indicating a high-grade, diffusely infiltrating glioma. Microscopically, the tissue fragments exhibit extensive infiltrative growth by small neoplastic cells, which predominantly lack differentiation but show occasional astrocytic features, confirming the anaplastic nature of the tumor. Perivascular nests of neoplastic cells are observed, although coagulation necrosis and atypical mitosis are not prominent. Immunohistochemical studies show that the neoplastic cells are negative for LCA, EMA, CK-6, and Synaptophysin, solidifying that the cells are not of lymphocytic, neuronal, or epithelial origin. Approximately 20% of neoplastic cells express GFAP, supporting astrocytic lineage. The MIB-1 labeling index reveals a modest proliferation rate, with an average of 10% of cells being positive. Electron microscopy further corroborates the astrocytic characteristics of the neoplastic cells. There is no evidence of tumor-free margins, suggesting incomplete resection and a high likelihood of residual disease. No lymph node involvement is noted, considering the primary brain location. The pathological findings are thus consistent with a highly malignant, infiltrative astrocytic tumor requiring further treatment considerations."
470,TCGA-FG-8186-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate the presence of an infiltrating glioma, confirmed by multiple biopsies from various margins (posterior, lateral superior, and frontal lobe). The primary tumor, located in the right frontal lobe, has been classified as an anaplastic oligoastrocytoma (WHO Grade III). Although over 90% of the tumor presents features consistent with a WHO Grade II oligoastrocytoma, areas of increased cellularity and pleomorphism indicate anaplastic transformation. Notably, one biopsy from the posterior medial tumor did not reveal any evidence of tumor tissue. Margins showed varying degrees of hypercellularity, consistent with infiltrating glioma. There was no mention of lymph node involvement or definitive metastatic spread, which suggests the pathological findings are localized to the brain tissue sampled. Other significant findings include the focally increased cellularity and pleomorphism, hallmarks of anaplastic progression within the tumor, indicating a potentially more aggressive clinical behavior."
471,TCGA-DU-6405-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of multiple brain biopsies from unspecified sites, obtained via craniotomy, reveals the presence of an infiltrating glioma and astrocytomas exhibiting atypical features. Specifically, one excised sample from the left frontal tumor is diagnosed as an anaplastic astrocytoma, classified as WHO Grade III/IV, characterized by a MIB-1 proliferation index of 23%. The neoplasms demonstrate a moderately cellular glial proliferation with moderate nuclear atypia, although mitotic figures are identified only in certain highly cellular areas. Notably, there is a conspicuous absence of necrosis and no definitive microvascular cellular proliferation, despite the presence of prominent reactive astrocytes and occasionally prominent microvessels. Additionally, the tumor infiltrates and effaces both cerebral cortex and white matter significantly. Immunohistochemical staining supports these findings, showing a heavy fibrillary component and highlighting the proliferation index within the more cellular regions. There is no information provided regarding margin status or lymph node involvement. These pathological findings are indicative of an astrocytoma with focal anaplastic transformation, underscoring the tumor's aggressive nature."
472,TCGA-DU-7300-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the resected right frontal brain tumor reveals an anaplastic oligodendroglioma, characterized by focal areas of hypercellularity and moderate nuclear pleomorphism. Increased mitotic figures are noted in some tissue fragments, although there is no evidence of vascular hyperplasia or tumor necrosis, and no astrocytoma component is present. The MIB-1 labeling index is elevated at 25-30%, indicating a higher proliferative rate. The margin status and lymph node involvement are not discussed in the findings. Additionally, molecular analysis shows a methylated MGMT promoter, which could have therapeutic implications. These collective findings confirm the diagnosis and provide insight into the tumor's aggressive features and potential responsiveness to specific treatments."
473,TCGA-QH-A6CY-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of an anaplastic oligoastrocytoma, classified as a grade III tumor according to the World Health Organization (WHO) grading system. The tumor exhibits histological features characteristic of both oligodendroglial and astrocytic components, with marked cellular atypia, increased mitotic activity, and evidence of necrosis. The resection margins are involved, indicating that the tumor extends to the edges of the excised tissue, which may have implications for residual disease and potential recurrence. Examination of regional lymph nodes shows no evidence of metastatic involvement, suggesting that the disease remains localized to the primary site. Additional findings include significant vascular proliferation and areas of microvascular permeability, which are indicative of the high-grade nature of this neoplasm."
474,TCGA-DB-A64Q-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left frontal brain mass reveals a diagnosis of low-grade oligoastrocytoma, oligodendroglial predominant (WHO grade II). Immunohistochemical analysis indicates that GFAP is predominantly positive in background reactive astrocytes and displays focal positivity in neoplastic cells with many gemistocytic features. The presence of IDH1 mutation is confirmed by positive staining for mutant IDH1 (IDH1-R132H). Variable expression of p53 protein is observed in a moderate number of tumor cells. The proliferation marker Ki-67 shows a low to focally moderate labeling index, ranging from 3% to 5%. These findings collectively support the diagnosis of low-grade oligoastrocytoma. Fluorescence in situ hybridization (FISH) studies for 1p19q co-deletion have been ordered to further characterize the genetic profile of the tumor. Notably, the resection margin status and lymph node involvement are not specifically addressed in the provided details."
475,TCGA-FG-A6IZ-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of a WHO Grade II glioma located within the left intracranial region. The biopsies collected from various margins, specifically the anterior lateral, posterior lateral-superior, and posterior lateral sections of the cerebral cortex, did not reveal the presence of any solid tumor, although focal hypercellularity was noted in the cerebral cortex and white matter in some samples. The tumor center biopsy and excision confirmed the presence of a Grade II glioma. Immunohistochemistry identified the tumor cells as reactive with antibody against mutant IDH1 R132H, a marker often associated with certain gliomas. Additionally, fluorescence in situ hybridization (FISH) analysis uncovered losses of chromosomes 1p and 19q, which is characteristic of oligodendrogliomas and often points towards a better prognosis. The intraoperative frozen sections supported these findings, with the submitted specimens revealing no definitive solid tumor in certain sections but identifying areas of infiltrating glioma. No lymph node involvement was described in the examined specimens. The combination of the immunohistochemical profile, genetic analysis, and microscopic findings substantiates the diagnosis of a diffuse glioma with specific molecular alterations."
476,TCGA-S9-A7IX-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of anaplastic astrocytoma, classified as a WHO grade III tumor. Histologically, the tumor shows marked hypercellularity with prominent atypia and mitotic activity, indicative of its high-grade nature. The tumor margins are infiltrative, lacking a well-defined boundary with adjacent brain tissue, which suggests aggressive local behavior. No clear evidence of necrosis or microvascular proliferation is noted, differentiating it from higher-grade gliomas such as glioblastoma. Lymph node involvement is not applicable in this context due to the intracranial location of the tumor. The diagnosis is further supported by the cellular morphology, which is consistent with an anaplastic astrocytic lineage. Overall, these findings are characteristic of an anaplastic astrocytoma, underscoring its potential for significant clinical impact."
477,TCGA-S9-A6U0-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an anaplastic astrocytoma, classified as WHO grade III. Morphologically, the tumor is characterized by pleomorphic astrocytic cells, indicating significant cellular atypia. Mitotic activity is present, suggesting heightened cellular proliferation. Early signs of vascular proliferation are noted, which may indicate an evolving aggressive nature. The proliferation index is measured at 25%, underlining the tumor's high growth potential. Margins are not explicitly detailed in this summary, but the described features suggest an infiltrative behavior typical of higher-grade astrocytomas. No lymph nodes are reported, which is consistent with the primary central nervous system location of astrocytomas. Given the observed pathological features, there is a potential for transition to glioblastoma, warranting close clinical follow-up and consideration for aggressive treatment options."
478,TCGA-FG-7634-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate the presence of a glioma, originating from a neoplasm located in the left frontal region of the brain. Microscopically, the tumor is composed of multiple pink-tan soft tissue fragments, suggestive of a glioma. Tumor margins could not be fully assessed from the intraoperative consultation specimens, and evaluation of permanent sections is pending to provide further detail on margin status. No lymph nodes were included in the specimen submitted, indicating the initial lack of assessment for lymphatic spread. Further examination of permanent sections will be necessary to fully characterize the tumor and provide additional details on its pathologic features, including potential genetic markers and specific histological subtype. Overall, the findings are consistent with a primary brain neoplasm, and comprehensive analysis of the permanent sections will be essential for a complete pathological evaluation."
479,TCGA-DU-5855-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right frontal brain tumor biopsy confirms the diagnosis of an anaplastic oligoastrocytoma, classified as WHO Grade III. The tumor exhibits moderate cellularity with mucin-filled microcystic spaces and consists predominantly of cells with oval to round nuclei, interspersed with irregular and angulated forms. Numerous mini-gemistocytes and astrocytic gemistocytes are present, accompanied by mild to moderate nuclear pleomorphism. Mitotic activity is observed with a count of 2 to 3 per ten high-power fields in densely cellular regions. Frequent apoptotic bodies are present; however, no definitive microvascular proliferation or necrosis is noted. Immunohistochemical analysis reveals moderate p53 positivity in 50% of the tumor cells, with mostly negative epithelial membrane antigen (EMA) staining. The Ki-67 labeling index indicates focal increases up to approximately 15%. Molecular studies show the MGMT promoter is methylated, suggesting potential responsiveness to alkylating agents, and complete loss of heterozygosity (LOH) for chromosome arms 1p and 19q is detected, which is characteristic of oligodendroglial tumors. The operative margins of the excised specimen were not explicitly stated in the report; however, the provided information implies appropriate tumor sampling for diagnostic purposes."
480,TCGA-P5-A72Z-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The findings reveal an anaplastic oligodendroglioma, classified as Grade III. The brain tissue from the right temporal lobe consists of soft gray-whitish pieces, indicative of the tumor. Microscopic examination confirms the diagnosis, showing cellular features consistent with anaplastic oligodendroglioma. The tumor exhibits a high proliferative index, with a Ki-67 labeling index of up to 15%. Margins and lymph node involvement are not mentioned, which may imply they are not applicable or were not assessed in this case. Overall, the pathological findings are consistent with a high-grade malignancy requiring prompt and aggressive treatment."
481,TCGA-WY-A85C-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of diffuse astrocytoma, classified as WHO Grade II, consistent with a low-grade astrocytoma or glioma. The tumor exhibits moderate cellularity and a corresponding degree of cytological atypia, with no mitotic figures identified and a low MIB-1 proliferation index, suggesting a relatively indolent behavior. The absence of mitoses and low proliferative activity are notable features of this grade. Margin status is not explicitly detailed in the findings, and there is no mention of lymph node involvement, which is typical for primary brain tumors. The gross description includes multiple fragments of soft, pink-red and pink-tan tissue, indicative of a brain tumor mass. The clinical and microscopic data cohesively support the diagnosis of a low-grade, infiltrating glioma with no immediate evidence of aggressive behavior."
482,TCGA-FG-A6J1-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of oligodendroglioma, classified as World Health Organization (WHO) Grade II, observed in the left intracranial tissue. Microscopic evaluation of tumor margins discloses focal gliomatous infiltration within the blood-containing fragments of the cerebral cortex. Intraoperative consultation identified a low-grade glioma amid cauterized tissue. Importantly, no mention of lymph node involvement has been made, suggesting the absence of lymph node sampling in this case. The tumor, characterized by its light tan to pink-tan irregular soft tissue fragments, necessitated comprehensive submission of all specimens collected during the surgical procedure for thorough permanent evaluation."
483,TCGA-DU-7298-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left temporal parietal brain tumor reveals a diagnosis of anaplastic astrocytoma. The tumor exhibits nuclear anaplasia, mitotic figures, and moderate glial fibrillogenesis, confirming its high-grade glial nature. Immunohistochemical analysis shows that approximately 25% of the neoplastic cells overexpress the p53 protein, while the MIB-1 proliferation index is about 15%, indicative of a highly proliferative activity. CD34 staining highlights the tumor microvasculature, which lacks significant microvascular proliferation. Notably, there is focal microvascular calcification present but no areas of necrosis were identified. The tumor also demonstrates regions consistent with astrocyte phenotype and a potential minor oligodendroglial component. Importantly, the MGMT promoter is not methylated, which has prognostic and therapeutic implications. The excisional biopsies indicate that the neoplastic cells have infiltrated the surrounding brain tissue, emphasizing the aggressive nature of this anaplastic glioma. The gross description of the specimens reveals grayish-pink and dusky red to gray-tan brain tissue, consistent with the tumor's characteristics. Margin status and lymph node involvement are not applicable to this intracranial tumor."
484,TCGA-CS-5393-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left temporal parietal tumor reveals an anaplastic astrocytoma, grade III according to the WHO classification. The microscopic examination identifies a moderately pleomorphic and highly infiltrative proliferation of astrocytes with rare mitoses, and notably, there is an absence of endothelial proliferation and necrosis. Immunohistochemical staining demonstrates a proliferation index, as measured by the Ki-67 antigen, ranging from 4.4% to 12.5%, with an average of 7.2%, which is consistent with this tumor grade. Gross examination shows a tan-white, soft brain tissue aggregate, partially prepared for frozen section analysis. The provided tissue did not reveal tumor-free margins definitively within the analyzed sections. There is no mention of lymph node involvement, as typically lymph node evaluation is not applicable in central nervous system neoplasms. Overall, the pathological findings are highly indicative of an anaplastic astrocytoma, grade III, which aligns with the clinical presentation of a brain tumor."
485,TCGA-EZ-7264-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The excision of the right frontal brain region reveals an oligodendroglioma, classified as WHO grade II. The tumor exhibits characteristic features under light microscopy, including an infiltrating low-grade glioma pattern with prominent perinuclear halos, focal microcystic changes, and delicate vasculature. The nuclei observed are relatively round with modest nuclear atypia and infrequent mitotic figures, indicating lower aggressiveness. The tumor has infiltrated both gray and white matter. The specimen margins are not explicitly mentioned, implying a focus on the infiltrative capacity of the tumor rather than clear demarcation. Sections of the tumor have been sent for 1p19q co-deletion analysis, with results pending from the Cytogenetics Laboratory. Representative sections were taken from two containers of soft tissue fragments and fleshy brain tissue, which were submitted for detailed histopathological examination. There is no mention of lymph node involvement, which is typically not relevant in the context of primary brain tumors."
486,TCGA-RY-A83Y-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of oligodendroglioma, WHO grade II, in the biopsied and excised samples from the left parietal lobe of the brain. The tumor exhibits typical histological features, including a moderately cellular proliferation of neoplastic oligodendroglia with uniform round nuclei and low mitotic activity, identified as up to 1 mitotic figure per 10 high power fields. There is no evidence of necrosis or microvascular proliferation. Additionally, a macrophage infiltrate is observed within the tumor, with multiple vessels lined by macrophages. Immunohistochemical studies on the tumor cells are positive for IDH1 (R132H mutant) protein and show a MIB1 labeling index of approximately 4%. Fluorescence in-situ hybridization for 1p19q co-deletion is pending. These findings support the diagnosis of oligodendroglioma with a low proliferative index, and there is no mention of the involvement of surgical margins or lymph nodes, as the focus is primarily on the brain tissue."
487,TCGA-HT-8109-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of an oligodendroglioma with focal anaplastic progression (grade III) in the right frontal brain, including the inferior medial frontal lobe. The tumor is characterized by moderate hypercellularity and the presence of mildly to moderately atypical oligodendrocytes. Notably, there is no evidence of microvascular proliferation or necrosis, but the tumor infiltrates both the gray and white matter. Specific areas exhibit nodular foci with increased cellularity and atypia. One region shows a higher mitotic activity with six mitoses observed per 10 high power fields, indicative of early anaplastic progression. Conversely, another region in the inferior medial frontal lobe shows only one mitosis per 30 high power fields. The MIB-1 labeling index is 8.2%, which provides additional information on the proliferative activity of the tumor. This overall pattern suggests an underlying low-grade oligodendroglioma with areas progressing towards a higher grade. The status of surgical margins and lymph node involvement was not reported."
488,TCGA-S9-A6U9-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of an anaplastic astrocytoma, designated as WHO grade III, which is characterized by increased cellularity, marked nuclear atypia, and significant mitotic activity without necrosis. The tumor shows an infiltrative growth pattern with poorly defined margins, making complete surgical resection challenging. No evidence of tumor involvement is noted at the resection margins, suggesting that the excision may have been thorough, but the inherently invasive nature of the astrocytic tumor raises concerns about potential residual disease. Examination of regional lymph nodes, if applicable, shows no metastatic involvement, consistent with the primary brain tumor's tendency to spread locally rather than through lymphatic pathways. Additional studies such as molecular and genetic analyses may provide further insights into tumor behavior and guide therapeutic approaches. Overall, the findings are consistent with a high-grade, aggressive glioma requiring close clinical follow-up and adjunctive treatment."
489,TCGA-HT-7604-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of a well-differentiated Astrocytoma (WHO Grade II). The tumor is characterized by moderate hypercellularity and infiltrative growth into the brain parenchyma, displaying a prominent myxoid and microcystic architecture. The primary neoplastic cells resemble fibrillary astrocytes, with minor populations of small gemistocytes and cells with perinuclear halos. There is mild nuclear atypia observed with occasional moderately atypical nuclei, but mitotic figures are generally absent. Importantly, there is no evidence of microvascular proliferation or necrosis. The MIB-1 labeling index reveals heterogeneous proliferation activity, with the most proliferative regions showing a labeling index of 10.4%, which is notably higher than typical for Grade II astrocytomas. Occasional mitotic figures are identified in these highly proliferative areas. Despite these findings suggesting a potential early anaplastic progression, the overall histologic features do not support reclassification to an anaplastic grade III astrocytoma. Clinical monitoring is recommended due to the elevated proliferation index. Margin status and lymph node involvement are not relevant in this central nervous system neoplasm context."
490,TCGA-E1-A7YJ-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected brain tissue from the right frontal lobe craniotomy confirms the diagnosis of an anaplastic astrocytoma, WHO Grade III. The tumor exhibits marked cytologic pleomorphism and the presence of mitotic figures, but lacks microvascular changes and pseudopalisading necrosis. Noteworthy genetic alterations were identified, including polysomy of chromosome 7, EGFR amplification, and loss of chromosomes 10 and 9p21, along with PTEN allelic loss. Immunohistochemical analysis highlights significant findings: a high proliferation index, partial PTEN loss, and the expression of markers such as LCA, EGFR wild type, S6, AKT, and MAPK. Despite the absence of MGMT promoter methylation, the patient's prognosis could potentially be influenced by the marked amplification of EGFR and the polysomy observed. In conclusion, these findings suggest a high-grade glioma with aggressive characteristics and significant genetic aberrations that may contribute to the patient's clinical course."
491,TCGA-DH-A7UR-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation has led to a diagnosis of anaplastic oligodendroglioma (WHO Grade III), characterized by its highly infiltrative nature. The tumor exhibits oligodendroglioma-like features with classic perinuclear haloes and chicken-wire-like vascular patterns. Notably, there are areas of increased cellularity accompanied by mitoses. The tumor cells extensively infiltrate the cerebral cortex, showing prominent subpial and perineuronal accumulations. Immunohistochemical analysis reveals a Ki-67 labeling index of 15-20%, indicating a significant proliferative activity. Additionally, a few scattered cells exhibit GFAP positivity, while the majority remain negative, which supports the oligodendroglioma diagnosis. The evaluation of tumor margins and lymph node involvement is not described within the provided materials. Molecular analysis for chromosomes 1p and 19q is pending and will be subsequently reported."
492,TCGA-DU-A6S7-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient, a female with a clinical history of brain tumor, underwent a craniotomy procedure targeting the left frontal lobe, which revealed an anaplastic astrocytoma, WHO grade 3. The tumor exhibits diffuse astrocytoma characteristics, with up to 4 mitoses per 10 high power fields, and no definite evidence of microvascular proliferation or tumor necrosis. Molecular analysis showed a positive result for the IDH1-R132S mutation, while no IDH2 mutations nor 1p/19q co-deletions were detected. The Ki-67/MIB1 proliferation index was observed to be approximately 10%. These findings are significant as IDH1 mutations suggest a better prognosis and distinct genetic characteristics compared to wild-type IDH tumors. The gross examination included soft tissue consistent with a diffuse glioma, and further intraoperative cytological smears reinforced the diagnosis of a gliofibrillary neoplasm."
493,TCGA-DH-5141-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of oligodendroglioma with anaplastic foci, identified in all submitted tumor specimens. The excised and biopsied tissues from the right frontal lesion show significant infiltrative characteristics, including effacement of the gray-white junction and extensive pale tan-yellow discoloration indicative of vacuolar degeneration in the white matter. The tumors exhibit regions of increased cellular density and nuclear atypia, with Ki-67 immunostaining labeling up to 20% of nuclei, consistent with areas undergoing anaplastic transformation. Fluorescence in situ hybridization (FISH) analysis demonstrated deletions of both 1p and 19q chromosomes, which is associated with improved prognosis and responsiveness to chemotherapy in oligodendroglial tumors. No specific mention of tumor margins or lymph node involvement is provided in the findings. Additionally, the pathology notes suggest diffuse infiltration of the overlying cortex and extensive involvement of subcortical structures."
494,TCGA-HT-8013-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of oligoastrocytoma, with a predominance of astrocytoma, classified as grade II. The tumor exhibits a moderately cellular proliferation of neoplastic astrocytes, primarily with gemistocytic features, and prominent pleomorphism in certain areas. Additionally, there are focal areas of neoplastic oligodendrocytes present. Notably, there is no evidence of microvascular proliferation and mitotic figures are largely absent, although a rare mitotic figure was identified on MIB-1 staining. The presence of several large foci of necrosis without pseudopalisading is observed. The MIB-1 labeling index is 2.2%, indicating a modestly proliferative tumor. Margin status and lymph node involvement are not described in the provided information, but the tumor's features suggest a mixed glioma with both astrocytic and oligodendroglial components."
495,TCGA-HT-A619-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of anaplastic oligodendroglioma, grade III, characterized by a significant proliferation of cells, as indicated by a MIB-1 labeling index of 9.6%. Microscopic examination shows a glial neoplasm with cells exhibiting prominent perinuclear halos and moderate nuclear atypia, and a notable absence of fibrillary processes. Occasional tumor cells display more pronounced atypia, and up to three mitotic figures are observed per ten high power fields, though necrosis and microvascular proliferation are absent. The tumor infiltrates both white and gray matter, with background hemorrhage and scattered calcifications. Additionally, residual foreign surgical material is noted in the specimen. The invasive nature and cellular characteristics support the classification as an anaplastic oligodendroglioma at grade III."
496,TCGA-TQ-A7RO-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of oligoastrocytoma, WHO grade II, in the left frontal lobe. Microscopic evaluation demonstrated a moderately cellular neuroglial neoplasm composed of both astrocytic and oligodendroglial phenotypes. The tissue exhibited one mitotic figure per 10 high-power fields, with a branched vascular network lacking microvascular proliferation and rare foci of dystrophic microcalcifications. No necrotic areas were identified within the specimen. Immunohistochemical staining showed positive results for GFAP, Bcl-2, and P53, while Galectin-3 was negative. The tumor does not show evidence of necrosis or significant mitotic activity, suggesting a relatively indolent nature. Margins, lymph node involvement, or distant metastases were not addressed in this analysis."
497,TCGA-HT-A617-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of a right insular tumor, characterized as an oligodendroglioma of WHO Grade II, supported by a MIB-1 labeling index of 3.0%, suggestive of low proliferative activity. Microscopically, the tumor infiltrates both gray and white matter and demonstrates mild to moderate hypercellularity. Tumor cells predominantly exhibit round nuclei with mild atypia and prominent perinuclear halos. A minor component of the tumor displays a fibrillary astrocytic or gemistocytic phenotype. Importantly, there is no evidence of mitotic activity, microvascular proliferation, necrosis, neoplastic ganglion cells, or eosinophilic granular bodies. The margin status and lymph node involvement are not addressed in the findings provided, suggesting that these key features were either not applicable or not included in the presented microscopic examination. Overall, the pathological characteristics are consistent with a low-grade oligodendroglioma."
498,TCGA-DU-A7TI-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a glioma with varying degrees of malignancy across different regions of the brain, specifically in the parietal temporal area. Specimen A demonstrates features consistent with a fibrillary astrocytoma, exhibiting diffuse infiltration, moderate nuclear pleomorphism, and a low MIB-1 labelling index of 2%, suggesting a lower-grade tumor (Grade II). In contrast, Specimen B shows characteristics indicative of an anaplastic astrocytoma, with frequent mitotic figures, prominent nuclear pleomorphism, and a high MIB-1 labelling index of 88%, characteristic of a higher-grade tumor (Grade III). Specimen C, taken from the deep margin, also displays infiltration by a fibrillary astrocytoma, signifying the tumor's presence at the resection margin. The fourth specimen (D) presents a glioma with atypical features, including moderate cellularity and nuclear atypia, suggesting a histology that falls between the findings of Specimens A and B, possibly hinting at an oligodendroglial component. Overall, the pathological findings indicate a complex and diffusely infiltrating glial neoplasm with varying histological grades, involving multiple regions and extending to the surgical margins."
499,TCGA-DB-A64P-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an oligodendroglioma with early anaplastic transformation, classified as a WHO grade III tumor, located in the left frontal brain region. Immunohistochemical analysis shows that the neoplastic cells are positive for the IDH1 (R132H) mutation, while scattered cells express the p53 protein. The Ki67 labeling index is variable, ranging from low to moderate, indicating heterogeneous proliferative activity within the tumor. Gross examination of the resected masses includes multiple portions submitted for analysis, confirming the presence of the tumor across several specimens. FISH studies have been ordered to assess 1p19q co-deletion status, which will further characterize the genetic profile of the tumor. There is no mention of margin status or lymph node involvement, suggesting that those details were either not addressed or not relevant to the central nervous system tumor in this context. Overall, the diagnosis of oligodendroglioma with early anaplastic features is confirmed by histological and immunohistochemical findings, with additional molecular diagnostics pending."
500,TCGA-DU-7018-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The right frontal brain tumor has been diagnosed as anaplastic oligodendroglioma, characterized by focal cellular anaplasia, mitotic figures, microvascular proliferation, and areas of necrosis. The neoplasm exhibits karyorrhectic tumor cells dispersed throughout and occasionally within vessels. Additionally, sections revealed focal extensive hyalinization and mineralization. Immunohistochemical studies identified sparse gliofibrillarity indicated by GFAP and focal synaptophysin positivity, suggesting the infiltrative nature of the tumor. The MIB-1 proliferation index was approximately 20% in the more active tumor regions. The neoplastic cells did not overexpress p53, and the Neu N neuronal marker revealed a few positive nuclei. Special molecular testing confirmed methylation of the MGMT promoter. The pathological features and immunophenotype align with a high histological grade of anaplastic oligodendroglioma, possibly containing minor neuronal elements. Margin status and lymph node involvement were not specifically addressed in the provided findings."
501,TCGA-HT-A74J-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of a left temporal brain tumor identified as a grade II oligoastrocytoma with a MIB-1 labeling index of 5.1%. The neoplastic cells are positive for IDH1 and negative for p53, aligning with an oligodendroglial lineage. Microscopically, the tumor is characterized by a moderately hypercellular, diffusely infiltrating glial neoplasm comprising both oligodendroglioma and fibrillary astrocytoma components. Scattered MIB-1 reactive cells are observed throughout, and rare markedly hypercellular regions contain occasional mitotic figures. Importantly, no microvascular proliferation or necrosis is present. Margins and lymph node involvement are not applicable in this intracranial context, therefore not addressed in this pathology evaluation. These findings support the diagnosis and provide essential insights into the tumor's cellular composition and proliferation index."
502,TCGA-HT-7884-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of well-differentiated astrocytoma (WHO Grade II). Microscopically, the tumor is moderately hypercellular and diffusely infiltrates both gray and white matter. The tumor cells exhibit mild atypia with round to oblong nuclei and small caps of eosinophilic cytoplasm, absent of significant atypia, mitotic figures, microvascular proliferation, or necrosis. The cells predominantly show a fibrillary astrocytic appearance with a microgemistocytic phenotype. Immunohistochemical staining reveals numerous p53 immunoreactive cells and scattered MIB-1 reactive cells, with a labeling index of 2.5% in the most proliferative areas, which correlates with the low-grade nature of the tumor. There is no mention of margin status or lymph node involvement, focusing primarily on the identified tumor characteristics, which collectively support the diagnosis of a low-grade astrocytoma."
503,TCGA-TM-A7C3-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the brain tissue reveals a histological diagnosis of anaplastic astrocytoma, WHO Grade III. The tumour is characterized by hypercellularity and diffusely infiltrating, intrinsic glial cells, confirmed by positive GFAP staining. Microscopically, the tumour shows mild to moderate nuclear pleomorphism with a mitotic rate of up to three mitoses per high power field, and a Ki67 proliferation index of approximately 5%. Importantly, there is an absence of endothelial cell swelling and intrinsic necrosis, which are often seen in higher-grade tumours. Notable features include the presence of psammomatous calcifications. The tumour margins are not well-defined, indicative of diffuse infiltration into the cerebral cortex, as evidenced by the presence of normal neurons (NeuN+) and reactive astrocytes in the background tissue. There is no information regarding lymph node involvement. These pathological findings collectively support the diagnosis of anaplastic astrocytoma."
504,TCGA-DU-7294-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings describe an oligodendroglioma localized in the frontal region of the brain. The tumor exhibits a diffuse neoplastic infiltration of both the cerebral cortex and white matter, characterized by glial cells with uniform round nuclei and prominent perineuronal satellitosis, along with occasional perinuclear halos. There is no indication of mitotic activity, microvascular proliferation, or necrosis, and the cells show slight pleomorphism. Immunohistochemical analysis reveals scant gliofibrillogenesis with GFAP, capillary-type microvasculature without microvascular proliferation using CD34, absence of p53 overexpression, and a low proliferation index of about 2% in more active areas as indicated by MIB-1. Special staining with Bielschowsky stain shows no distortion of the normal axonal pattern by the neoplastic cells. The phenotype of the tumor is consistent with one exhibiting loss of heterozygosity. These findings collectively support the diagnosis of oligodendroglioma with no evidence of aggressive or high-grade features."
505,TCGA-FN-7833-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a resected right frontal lobe intracerebral mass has led to a final diagnosis of anaplastic oligoastrocytoma, classified as a World Health Organization (WHO) Grade III tumor. The tumor presents with intact 1p and 19q chromosomal arms, which is a significant molecular finding. Grossly, the tumor tissue appears light gray to pink-gray, serpiginous, and partly hyperemic. Microscopic analysis confirms the anaplastic nature of the tumor without evidence of high-grade glial neoplasms as initially suggested intraoperatively. The surgical margins were not explicitly detailed but the comprehensive submission of all brain tissue for microscopic evaluation ensures thorough pathological assessment. Lymph node involvement was not mentioned in the findings, suggesting no notable lymphatic spread. These collective findings underscore the aggressive nature and complex pathology associated with this anaplastic oligoastrocytoma."
506,TCGA-E1-A7YE-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen consists of a brain tissue resection from the left frontal region, revealing an anaplastic astrocytoma (WHO Grade III). Microscopic examination shows a highly cellular and pleomorphic population of astrocytes, consistent with a high-grade glioma. Initially, intraoperative consultation identified an area of glioblastoma and another area with gliosis and atypical cells. However, permanent sections revealed that the area initially interpreted as necrosis was actually hemorrhage induced by surgical trauma, thus confirming the diagnosis of anaplastic astrocytoma without true necrosis. There is no information on margin status or lymph node involvement, which are not typically relevant for central nervous system tumors of this nature."
507,TCGA-S9-A7IS-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of anaplastic astrocytoma, WHO grade III. However, upon further examination and review, there is a significant suggestion that the lesion may have progressed to glioblastoma, which is characterized by increased cellularity, pleomorphism, marked mitotic activity, and necrosis. The tumor exhibits infiltrative borders, raising concerns about the completeness of surgical resection and the status of surgical margins. No definitive evidence of lymph node involvement was noted, which is consistent with the primary central nervous system origin of the tumor. Additionally, histopathological evaluation revealed regions of necrosis and pseudo-palisading, features supportive of the transition towards glioblastoma. The presented findings emphasize the aggressive nature of the tumor and the potential need for reassessment of therapeutic strategies."
508,TCGA-CS-6667-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left parietal tumor has confirmed the diagnosis of Astrocytoma, WHO Grade II. The tumor is characterized by moderately pleomorphic glial cells that infiltrate the cerebral grey matter, with cortical neurons being surrounded by these tumor cells. Immunohistochemical staining revealed many glial tumor cells expressing GFAP, and positive nuclear staining for p53 was observed in numerous tumor cells. The proliferation index, as indicated by the Ki67 marker, is 1.9%. There is no evidence of a ganglion cell component, as determined by the absence of chromogranin staining. Additionally, NEU-N staining was negative in tumor cells but positive in non-neoplastic cortical neurons within the infiltrated area. The gross examination of the specimen describes an aggregate of tan-red soft tissue. Overall, the pathological findings support the classification of this infiltrating glial neoplasm as an astrocytoma, WHO grade II, without involvement of ganglion cells or significant proliferative activity. Margin status and lymph node involvement are not explicitly detailed in the findings provided."
509,TCGA-DU-A5TU-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","An adult female patient with a history of altered mental status and imaging revealing bifrontal, parasagittal abnormalities underwent a brain tumor biopsy. Pathological analysis identified the tumor as an astrocytoma, WHO grade 2. The tumor exhibited diffuse infiltration of the cerebral cortex with microcystic changes and some endothelial hyperplasia, but no microvascular proliferation, mitotic activity, or necrosis were observed. Immunohistochemistry showed positivity for IDH1-R132H and a low MIB-1 proliferation index of 2%. Additionally, genetic testing indicated no co-deletion of chromosomal arms 1p and 19q (negative LOH). Overall, these findings characterize the tumor as a low-grade astrocytoma with specific molecular markers, lacking significant aggressive features."
510,TCGA-DU-A5TS-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of oligodendroglioma, WHO grade II, based on multiple biopsies of a brain tumor located in the right frontal and temporal lobe regions. Histologically, the tumor exhibits predominantly oligodendroglial features with occasional angulated cells suggesting a minor astrocytic component. Mitotic activity is observed in one of the specimens, although there is no evidence of vascular proliferation or necrosis. The Ki-67 labeling index is up to approximately 8%, with focal mitotic activity potentially indicating an early transition to a grade III lesion, warranting clinical correlation. Molecular testing shows the presence of a methylated MGMT promoter, suggesting a favorable response to therapy with alkylating agents, while Loss of Heterozygosity (LOH) testing indicates no allelic loss on chromosome arms 1p and 19q. The findings offer important insights into the tumor's biological behavior and potential therapeutic responsiveness."
511,TCGA-DU-7008-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the brain biopsy from the temporal lobe reveals a diagnosis of oligodendroglioma, classified as grade B with a labeling index (MIB-1) of approximately 8%. Gross examination noted multiple tannish-white, glistening, semi-firm fragments of brain tissue. Microscopic analysis demonstrates an infiltrating glioma characterized by microcystic changes, frequent microgemistocytic cells, and areas of marked cellularity with nuclear atypia and mitotic activity. However, vascular endothelial hyperplasia and necrosis were absent. The detailed histopathological findings, including the presentation with nuclear atypia and mitotic figures, contribute to the grade B classification of the oligodendroglioma."
512,TCGA-DH-A66F-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology consultation reveals a diagnosis of oligodendroglioma, WHO Grade II, based on biopsy specimens from a brain tumor. The neoplasm displays largely uniform histology with small cells characterized by round nuclei, perinuclear halos, and a distinctive chicken-wire like vasculature. Additional histological features include focal calcification and microcystic changes. The tumor is predominantly diffuse and infiltrating, with occasional nodular foci. A comprehensive search uncovered no definitive mitotic figures in routine sections, though immunohistochemical analysis for phosphohistone H3 identified mitoses within microfoci showing increased Ki-67 immunolabeling. Immunohistochemistry results show strong GFAP reactivity in tumor cell processes, and positive P53 expression in 10-15% of nuclei. IDH-1 is strongly and diffusely reactive across the tumor. These findings are consistent with an infiltrating oligodendroglioma, WHO Grade II. Fluorescence in situ hybridization (FISH) analysis confirmed deletions in chromosomes 1p and 19q, providing further diagnostic support. The implications of the microfoci of increased proliferation remain uncertain. Overall, this detailed pathological assessment emphasizes the tumor's infiltrative nature, specific genetic alterations, and the predominance of low mitotic activity except in isolated areas."
513,TCGA-WY-A858-01Z-00-DX1,LGG,"Please generate a comprehensive and professional pathology report based on the provided slide from Brain, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of anaplastic astrocytoma, WHO Grade III, encompassing features of both grade II and grade III lesions. The tumor exhibits significant cellularity, nuclear atypia, and mitotic activity characteristic of a higher-grade lesion. The MIB-1 proliferation index is around 5%. Although some portions suggest the presence of oligodendroglioma-like features, such as round, uniform nuclei and perivascular halos, the overall features are more consistent with astrocytoma. Molecular studies indicate loss of heterozygosity on chromosome 19q, but not on 1p, which negates the 1p/19q codeletion typically associated with oligodendrogliomas. Margins and the extent of resection are not specifically noted in the provided sections, and no lymph node involvement is mentioned. The gross description of the specimens consists of multiple fragments of mucoid and fibrous soft tissue with varying colors, but no specific sizes or notable additional features are given. The histopathological and molecular characteristics strongly support the diagnosis of an anaplastic astrocytoma over an oligodendroglioma."
514,TCGA-95-7947-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated adenocarcinoma of the left upper lobe of the lung, exhibiting mixed growth patterns, including acinar, papillary, and micropapillary. The tumor shows angiolymphatic invasion, yet no visceral pleural invasion is observed. Surgical parenchymal margins are free of carcinoma, indicating complete excision. Lymph node dissections from stations #6, #7, #9, and #10L yield a total of ten nodes, all of which are negative for metastatic carcinoma, suggesting no regional lymph node involvement. Additionally, some nodes display partial calcification and fibrosis without malignancy. The immunohistochemical profile, with CK7 and TTF1 positivity, supports a lung primary origin for the adenocarcinoma. The left upper lobe also exhibits bullous emphysematous changes but remains free of carcinoma in other submitted sections."
515,TCGA-55-6979-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of lung and lymph node specimens from this patient revealed multiple important findings. In the left lower lobe of the lung, an old calcified granuloma was identified. The left upper lobe lobectomy specimen demonstrated a poorly differentiated adenocarcinoma confined to the lung, with no extension beyond the visceral pleura. One of the regional lymph nodes adjacent to the bronchus within this specimen was positive for metastatic carcinoma, indicating lymphovascular invasion, although venous and arterial invasions were absent. Importantly, surgical margins were uninvolved by invasive carcinoma, suggesting that the tumor was completely excised. Meanwhile, additional lymph nodes, including levels 2, 6, and 9, were benign, with a total of one out of six lymph nodes showing metastatic disease. The pathological staging was determined as pT2, pN1, pMX, reflecting the primary tumor's size, regional lymph node involvement, and the unassessed status of distant metastasis. This concise overview captures the critical diagnostic information and contributes to the overall clinical assessment and staging."
516,TCGA-78-8648-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe and associated chest wall resection revealed a diagnosis of poorly differentiated adenocarcinoma. The tumor presented as a cavitating mass with an ill-defined, lobulated appearance, demonstrating invasion through the visceral pleura and extending into the chest wall's fibrous connective tissue, yet not infiltrating the rib bone. There was evidence of blood vessel invasion, but no lymphatic or perineural permeation was identified. The bronchial resection margin was clear of the tumor. Surrounding the tumor, obstructive pneumonitis and adjacent lung emphysema were noted. Lymph node analysis, including hilar and peri-oesophageal nodes, showed reactive changes without malignancy, indicating no lymph node metastases. Additionally, three small chest wall lymph nodes examined in a supplementary report showed no evidence of malignancy. The overall pathological staging is classified as T3N0MX."
517,TCGA-05-4244-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed the presence of a papillary adenocarcinoma in the right lower lobe of the lung. The tumor exhibits both well-differentiated and focally poorly differentiated areas, with notable signs of pleural infiltration and vascular invasion. Metastatic involvement was identified in the hilar lymph nodes. Based on the tumor classification, it has been classified as M-8140/3 with a high-grade designation of G.3, and it has been staged as pT2, pN2, pMx, indicating a primary tumor with nodal metastasis but no distant metastasis information available at the time. The surgical resection margins are confirmed to be clear of tumor involvement (R0), which is an important consideration for local tumor control. The overall stage of this cancer is determined to be IIIA."
518,TCGA-86-7713-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The lobectomy specimen from the lung reveals a moderately differentiated adenocarcinoma. The tumor exhibits significant malignant characteristics without any gross necrosis or hemorrhage. Pathological assessment indicates that the surgical margins are free of tumor involvement, suggesting complete resection. Lymph node analysis shows no evidence of metastatic involvement, as the single examined regional lymph node is negative for metastasis. The overall pathological findings support a diagnosis of a locally contained, moderately differentiated adenocarcinoma of the lung, with surgical margins clear of tumor and no regional lymph node metastasis."
519,TCGA-05-4395-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of locally advanced, highly mucinous adenocarcinoma of the left upper lobe of the lung, with a mixed large-cell and polymorphocellular solid and small acinar component. The tumor is primarily located peripherally, specifically in the boundary regions of segments 1 and 3, and classified as pT4 pN2 V1 RX, indicating stage IIIB. The neoplasm has focally infiltrated the parietal pleura in the adhesion zone and potentially extends via a perivascular sleeve to the hilum, involving parabronchial lymph nodes. A separate satellite tumor focus exists in segment 3. Central tumor involvement includes infiltration of the pulmonary venous wall and proximity to the hilar resection margin. Due to tangential sectioning, a definitive determination of tumor involvement at the resection margin remains unresolved (RX). Additionally, a lymph node metastasis is identified in one sample, while resection margins of the bronchus and vessels, as well as the pericardial specimen and lymph nodes in other samples, are tumor-free."
520,TCGA-93-7348-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology evaluation reveals a diagnosis of invasive moderately differentiated adenocarcinoma of the right upper lobe of the lung, acinar type, with a tumor size of 1.5 cm. No evidence of lymphovascular or pleural invasion was identified, and the surgical margins are free of tumor involvement. A total of seven lymph nodes from various stations (10, 11, 12, 10R, 4R, and 7) were biopsied, all of which are negative for tumor metastasis. Some lymph nodes demonstrated hyalinized granulomas with one exhibiting necrotic granuloma with calcifications; however, no fungal organisms or mycobacteria were detected. No regional lymph node metastasis was observed, correlating with an assessment of pN0. The tumor's primary classification is pT1a, and distant metastasis could not be assessed (MX). Overall, the pathological stage is pT1a/N0/MX, although this stage might be refined following further clinical evaluation."
521,TCGA-97-8175-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the lung specimen revealed adenocarcinoma predominantly of the solid subtype in the left upper lobe. The tumor exhibited a combination of solid and micropapillary components. Importantly, both the bronchial and vascular margins were free of tumor involvement, indicating complete resection. Examination of the regional lymph nodes, including those at levels 5 and 9, revealed no evidence of metastatic carcinoma, with all nodes being negative. Additionally, there was no evidence of invasion into the visceral pleura or lymphovascular structures. The tumor was staged as pT2a, indicating it is greater than three centimeters but less than five centimeters in greatest dimension and does not involve the main bronchus or cause extensive atelectasis. Molecular and genetic testing for EGFR, KRAS, and ALK mutations were performed and revealed no mutations in EGFR or KRAS and no rearrangement involving the ALK gene. The tumor's poor differentiation (grade G3) was noted, but overall the findings suggest a favorable surgical outcome with no residual disease in the examined margins or nodes."
522,TCGA-55-8089-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate the presence of a poorly differentiated adenocarcinoma in the right upper lobe of the lung, exhibiting a unifocal distribution at a peripheral, subpleural site. The tumor does not show evidence of visceral pleural invasion, lymphovascular invasion, or tumor extension. Immunohistochemical stains confirm the diagnosis of poorly differentiated adenocarcinoma, showing CK7 positivity while being negative for CK5/6, TTF-1, and p63. The adenocarcinoma is pT1a, NO, indicating a localized, small tumor without nodal metastasis. The surgical margins are clear with the tumor located at least 4 cm from the closest parenchymal margin and 8 cm from the bronchial margin. Lymph node analysis reveals no metastatic carcinoma across all examined nodes, with findings limited to anthracosis and reactive changes. These findings collectively represent a new diagnosis of pulmonary adenocarcinoma. Further molecular studies, focusing on the EGFR/KRAS/ALK mutation cascade, have been initiated to guide potential targeted therapies."
523,TCGA-35-4123-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of adeno-squamous carcinoma of the lung. The tumor is of moderate grade (Grade 2) and demonstrates a composition of 74% tumor cell component. The TNM staging indicates a classification of T2 N0 M0, signifying that while the primary tumor has a substantial size, there is no regional lymph node involvement or distant metastasis. The margin status is clear, with no signs of tumor cells at the resection margins, indicating that the surgical excision was complete. Additionally, ancillary tissues including normal blood samples were preserved for further analysis. This comprehensive assessment supports a thorough understanding of the tumor's characteristics and spread, crucial for guiding subsequent therapeutic decisions."
524,TCGA-MP-A4T9-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left upper lobe of the lung reveals an invasive grade 3 adenocarcinoma forming a subpleural mass. The tumor extends to involve the overlying visceral pleura and is present on the pleural surface but is situated at a sufficient distance from the bronchial resection margin, which is free of tumor. Metastatic invasive grade 3 adenocarcinoma is identified in two left subaortic lymph nodes with extranodal extension and in three intraparenchymal peribronchial lymph nodes. However, no tumor involvement is detected in the examined left subcarinal, left pulmonary ligament, left upper lung major fissure, left hilar, and left lower lobe bronchus lymph nodes. The findings indicate regional spread of the adenocarcinoma, primarily involving specific mediastinal and intrapulmonary/hilar lymph nodes, but with clear resection margins and absence of metastasis in other lymphatic stations."
525,TCGA-55-8206-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment revealed a moderately differentiated adenocarcinoma centered in the right upper lobe of the lung, forming a mass. The tumor, which is unifocal, abuts but does not penetrate the visceral pleura and is completely surrounded by histologically normal pulmonary parenchyma. Importantly, all resection margins, including bronchial and vascular, are free of tumor involvement. Four lymph nodes were evaluated, including three variably anthracotic nodes from the lobectomy specimen and one from the hilar region, all of which were benign and devoid of metastatic carcinoma. There was no evidence of tumor invasion into lymphatic or vascular structures. Pathologic staging parameters categorized the tumor as pT1bN0M0, corresponding to Stage IA lung cancer, with no regional or distant metastasis identified. No reflex EGFR and ALK testing were indicated based on current clinical guidelines. Consequently, the patient's sample will be archived for potential future ancillary testing. Overall, the findings delineate a localized early-stage adenocarcinoma with favorable surgical margins and absent lymph node metastatic spread."
526,TCGA-86-A4D0-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of poorly differentiated adenocarcinoma of the lung. The excised tumor involved the visceral pleura, suggesting an invasive nature. Immunohistochemical staining revealed the tumor cells were positive for CK7, CD15, and TTF-1, and negative for CK10 and P63, supporting the diagnosis of adenocarcinoma. The resected margins were not mentioned, implying that the assessment of margin status must be revisited. Importantly, none of the six regional lymph nodes examined showed evidence of metastatic involvement. These findings collectively characterize an aggressive tumor with localized invasion but no regional lymph node metastasis."
527,TCGA-50-6591-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left lower lobe superior segmentectomy revealed a poorly differentiated adenocarcinoma featuring clear cell change and amyloid-like stroma. This tumor displayed significant visceral pleural and angiolymphatic invasion but did not involve any N1 or N2 lymph nodes. The pathological stage was determined as T2N0MX. Microscopically, no metastatic carcinoma was found in the biopsied lymph nodes from various levels, including the carina and right endobronchial locations. The tumor was categorized as G3 due to its poor differentiation, and there was up to 50% tumor necrosis observed. All surgical margins were free of tumor involvement, with the closest margin being 5 mm away. A mild inflammatory response was noted. Histochemical stains, including PAS and mucicarmine, confirmed the presence of mucin, while elastic tissue stains showed pleural invasion, and Congo Red stains were negative. Additionally, there were mild emphysematous changes in the lung parenchyma."
528,TCGA-49-AAR0-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe lobectomy specimen revealed an infiltrating moderately differentiated adenocarcinoma. The tumor did not involve the pleura, and both bronchial and vascular margins were free of tumor involvement. Lymph node assessment showed that two hilar lymph nodes, as well as the R4 and R7 lymph nodes, were negative for tumor infiltration. Additionally, two hyalinized pleural plaques were identified in the non-neoplastic lung tissue. No other significant lesions were noted in the examined lung parenchyma, which showed focal anthracotic pigmentation. The pathological stage of the cancer is classified as T1NoMx."
529,TCGA-05-4390-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The primary diagnosis is peripheral bronchopulmonary adenocarcinoma located in the right upper lobe of the lung, featuring a predominant acinar component and a smaller large-cell solid component, localized specifically in the S2 segment. The TNM classification is pT2, pN0, R0, indicating a stage IB tumor with no regional lymph node involvement and clear resection margins. The pathology reveals that the tumor has extended to the junction with the S1 segment and has infiltrated the retracted visceral pleura, which is notably enlarged with fibrosis. Importantly, the resection margins of the bronchus and vessels are free of tumor, and all dissected lymph nodes (from samples 1 to 7) are negative for malignancy."
530,TCGA-73-4662-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of moderately differentiated invasive adenocarcinoma, involving the left upper lobe of the lung with mixed acinar and bronchioloalveolar patterns. The adenocarcinoma exhibited no angiolymphatic invasion and was localized peripherally within the lung tissue. A wedge biopsy indicated the presence of a well-circumscribed tumor, but subsequent lobectomy did not identify any residual carcinoma. The bronchial margins were free of tumor involvement. Evaluation of lymph nodes, including both biopsy and lobectomy specimens, showed no evidence of carcinoma, encompassing both ipsilateral and contralateral nodes. Additional findings included mild emphysematous changes but no other significant pathological features. The pathological stage is classified as pT1, N0, MX, confirming the absence of regional lymph node metastasis and a small primary tumor without distant metastasis evaluation."
531,TCGA-55-8615-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the right lung reveals a diagnosis of moderately differentiated adenocarcinoma primarily located in the middle lobe. The primary tumor, a lobulated friable mass, shows evidence of visceral pleural invasion without transgression of the pleural elastic layer, signifying a pT3 classification. The tumor extends close to the pleural surface but remains under 1 mm away and is 2.6 cm from the bronchial margin, indicating the surgical margins are clear although close. Lymphovascular invasion is noted. Out of the 22 lymph nodes examined, six are positive for metastatic carcinoma, including lymph nodes from levels 7 and 4R, consistent with N2 staging. Immunohistochemical analysis indicates positivity for TTF1 and CK7, and negativity for CK20, supporting the primary diagnosis of lung adenocarcinoma. The uninvolved lung parenchyma shows congestion and moderate anthracosis. There is no evidence of treatment effect in the tumor."
532,TCGA-55-8097-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was found to have an adenocarcinoma in the right upper lobe of the lung, displaying moderate differentiation. The tumor was unifocal, confined to the lung parenchyma, and measured 2.0 x 1.5 x 1.5 cm. No visceral pleural invasion or lymphovascular space invasion was identifiable. Importantly, the margins were clear, with the tumor situated 4.8 cm from the bronchial margin and less than 1 mm from the pleural surface. Examination of lymph nodes from levels 9, 10, and 11 revealed benign features without evidence of metastatic carcinoma. Additionally, sections showed emphysematous changes and calcified granulomata, while stains for acid-fast and fungal organisms were negative. The overall pathological stage was assessed as pT1a N0. The histologic sections showed features suggestive of bronchoalveolar carcinoma, although no treatment effects were observed. Clinical correlation has been recommended and the case review was concurred by an additional pathologist."
533,TCGA-64-1678-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the lung cancer case revealed a poorly differentiated adenocarcinoma in the right middle lobe. Tumor margins were clear, with no tumor invasion into the bronchial or vascular margins. The evaluation of multiple lymph nodes from various levels (4R, 4L, 7, 2R, 11, and 10R) yielded no evidence of metastatic disease, indicating no lymph node involvement. Specifically, there were no metastatic tumor cells identified in the examined lymph nodes, encompassing a thorough assessment of different nodal regions. Additionally, the tumor demonstrated neither visceral pleural invasion nor lymphovascular space invasion. Overall, the pathological staging is consistent with a primary pulmonary adenocarcinoma, pathologic stage pT2NoMx, given the absence of lymph node metastases and clear surgical margins. The absence of these pathologic features suggests a localized disease without regional spread."
534,TCGA-05-4433-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of peripheral bronchopulmonary mucinous adenocarcinoma with predominant bronchioloalveolar differentiation and spread, along with a minor component demonstrating destructive, infiltrative growth localized in segment S10. The tumor is classified as stage IB according to the TNM system based on the findings, with a designation of pT2 pN0 pMX R0. Importantly, there is no evidence of visceral pleural invasion by the carcinoma. The resection margins, including both the bronchus and vessels, are free of tumor involvement. Additionally, all examined lymph nodes demonstrate no evidence of metastatic disease. These findings collectively suggest a well-defined tumor removal with clear margins and no regional lymph node involvement."
535,TCGA-50-6590-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals an invasive poorly differentiated adenocarcinoma located in the right upper lobe of the lung, accompanied by visceral pleural invasion. The tumor exhibits extensive necrosis and arises within a scarred region of lung parenchyma. Importantly, no angiolymphatic invasion is present. The surgical margins are clear, ensuring complete resection of the tumor. Examination of multiple lymph nodes, including N1 and N2 nodes, confirms they are benign, demonstrating no metastasis. The pathological staging is determined as T2N0Mx. Additionally, the surrounding lung tissue shows emphysematous changes and respiratory bronchiolitis. Ancillary histochemical and immunohistochemical studies corroborate the diagnosis, with tumor cells testing positive for cytokeratin 7 and negative for cytokeratin 20, TTF, mammoglobin, and GCDFP. A biopsy of the left nasopharynx indicates mild chronic inflammation but no significant pathological findings. This accumulation of evidence provides a comprehensive assessment of the patient's lung adenocarcinoma and associated pulmonary conditions."
536,TCGA-78-7147-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The right upper lobe lung specimen reveals a diagnosis of moderately differentiated adenocarcinoma, present as a firm, cream-colored nodule measuring 45 mm in its greatest dimension. This subpleural tumor invades the visceral pleura but does not extend through it, and it is situated well clear of the bronchial and surgical resection margins, which exhibit only mild active chronic inflammation and squamous metaplasia. Notably, there is no invasion into blood vessels, lymphatics, or nerves. A peribronchial lymph node shows metastasis of adenocarcinoma, while the other examined lymph nodes display only reactive changes, with no evidence of malignancy. Adjacent to the carcinoma, a carcinoid tumorlet is identified, while the surrounding lung tissue reveals very mild centriacinar emphysema. The pathological stage is determined to be T2N1MX, reflecting the size and extent of the primary tumor, the involvement of regional lymph nodes, and the absence of distant metastatic assessment."
537,TCGA-44-A47F-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive moderately differentiated adenocarcinoma located within the left upper lobe of the lung. The primary tumor exhibits organ-confined growth with minimal extension into the pleura and is characterized by vessel invasion. The tumor is moderately differentiated and measures significant in dimension. Resection margins indicate that the tumor is approximately 4 mm from the bronchial margin, while the vascular margin is clear. Throughout the specimen, vascular involvement is observed. Out of eight hilar lymph nodes, two are positive for metastatic carcinoma, with one showing probable direct extension and the other confirmed metastatic involvement. Lymph nodes from Level X, VII, and V all test negative for metastatic carcinoma. Overall, the regional lymph nodes indicate a classification of pN1, with distant metastasis status noted as pMX."
538,TCGA-86-7714-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an invasive adenocarcinoma of the right lower lobe of the lung. The tumor is characterized as a poorly differentiated, mixed subtype adenocarcinoma with a glistening white mucoid surface and is noted to be subpleural. The pleura remains intact, as evidenced by the blue inking, and no satellite nodules are present. The tumor is situated 12 mm from the closest stapled margin, indicating that the surgical resection margins are clear. However, angiolymphatic invasion is noted, which signifies a higher possibility of metastatic spread. Notably, there is positive lymph node involvement, with one subcarinal lymph node showing metastatic deposition measuring 0.25 cm. This finding corresponds to a pTNM staging of T2a N2 MX. These pathological details suggest a significant disease burden with definitive signs of metastasis and invasion, necessitating further clinical management."
539,TCGA-93-7347-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive moderately differentiated adenocarcinoma with bronchioloalveolar carcinoma features in the right upper lobe of the lung. The tumor is identified as moderately differentiated and has a size consistent with a T1a classification. Importantly, there is no evidence of lymphovascular invasion or pleural involvement. However, carcinoma is present at the inked staple margin, indicating involvement at this surgical boundary. The lymph node assessment shows no evidence of malignancy across multiple nodes, including those at levels 10, 11, peribronchial areas, and subcarinal regions, with the exception of one lymph node from level 10 which contained rare mucinous cells that are non-diagnostic for carcinoma. The histologic grade of the tumor is G2, and there is no evidence of lymphatic, venous, or arterial invasion. Based on these findings, the pathologic stage includes T1aN0MX, with no regional lymph node metastasis observed and distant metastasis remaining indeterminate."
540,TCGA-97-A4M3-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with adenocarcinoma of the right upper lobe of the lung, displaying mixed histologic subtypes, including lepidic, acinar, papillary, and micropapillary patterns. The tumor margins were clear, with no evidence of invasion into the bronchial or vascular margins. Notably, there was no visceral pleura invasion or lymphovascular invasion identified. Pathological staging revealed a primary tumor classification of pT1b and no regional lymph node metastasis (pN0) with all biopsied lymph nodes from levels 4, 7, and 10 being benign. Molecular studies were conducted, revealing no mutations in the EGFR or KRAS genes and no ALK gene rearrangement. This case also noted an aneuploid population with additional copies of the ALK gene, a finding of uncertain significance. The specimen showed well-differentiated tumor grade and the absence of distant metastasis. The patient's clinical history included a significant smoking history, and the specimen analysis was conducted through multiple tissue sections from various procedural biopsies including the apex, segmentectomy of the upper lobe, and lymph nodes."
541,TCGA-86-6851-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated adenocarcinoma located in the left upper lobe of the lung. The tumor demonstrates a diffuse and invasive growth pattern, extending to the subpleural region. The bronchial margin is free of carcinoma, however, there is involvement of a peribronchial lymph node at the resection margin, which exhibits metastatic disease with extranodal extension into the peribronchial soft tissues. The parenchymal margin shows carcinoma involvement, but the vascular margins are free of tumor. Immunohistochemical staining confirms the diagnosis by showing tumor cells positive for cytokeratin 7, TTF-1, and Napsin-A, while negative for cytokeratin 5/6. The tumor displays rare focal positivity for p63, and an elastin stain fails to show definitive penetration of the visceral pleural elastic layer by the tumor. One of two examined peribronchial lymph nodes is positive for metastatic carcinoma, whereas the remaining lymph nodes are free of metastatic involvement. The largest metastatic deposit identified is 1.3 cm. Based on the provided findings, the tumor staging is categorized as pT1b, pN1, pMX."
542,TCGA-55-8511-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with adenocarcinoma of the right upper lung lobe, confirmed through biopsy and intraoperative consultation. The tumor is histologically characterized as poorly differentiated and unifocal, and it remains confined to the pulmonary parenchyma without evidence of visceral pleural or lymphovascular invasion. Both bronchial and parenchymal surgical margins are in close proximity to the tumor. Examination of four lymph nodes from stations 10, interlobar, right paratracheal, and subcarinal regions revealed no metastatic carcinoma, indicating no lymph node involvement (0/4). The overall pathological staging is determined as pT2a N0, and a lung cancer molecular panel is pending for further characterization. Immunohistochemical staining supports the diagnosis, with the tumor being positive for cytokeratin 7 and thyroid transcription factor-1 (TTF-1), and negative for cytokeratin 20 and p63."
543,TCGA-99-8032-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient, a male with a lung nodule, underwent a right upper lobe lobectomy which revealed a diagnosis of moderately differentiated adenocarcinoma. The tumor is unifocal with the greatest dimension being 2.0 cm and is located in the upper lobe of the right lung. Importantly, there is no evidence of visceral pleural invasion, and all surgical margins including bronchial, vascular, parenchymal, and parietal pleural margins are free of tumor involvement. Multiple peribronchial lymph nodes were excised and demonstrated no signs of malignancy. Additional levels of lymph nodes, including levels II, IV-R, VII, VIII, IX, and XI, were also negative for malignancy. Additionally, no lymph-vascular invasion was identified. Histological examination of the bronchial margin biopsy confirmed the absence of any tumor. These findings collectively indicate a stage pT1a, pN0, suggesting a localized tumor without regional lymph node metastasis, thereby presenting a favorable prognosis upon complete surgical resection."
544,TCGA-MP-A4SY-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of invasive grade 3 adenocarcinoma located in the right lower lobe of the lung, presenting as a centrally located mass. The bronchial margin is negative for tumor involvement, indicating that the surgical resection has clear margins. Among the six intrapulmonary peribronchial lymph nodes examined, one is positive for metastatic adenocarcinoma, suggesting regional lymphatic spread. In contrast, a wedge excision from the right upper lobe displays a necrotizing granuloma, which is non-malignant. Further examination of the lymph nodes collected from the inferior and superior mediastinal regions, including subcarinal and paratracheal areas, reveals necrotizing granulomatous lymphadenitis, with no evidence of tumor in these nodes. Special stains conducted for microorganisms on the subcarinal lymph nodes were negative, ruling out infectious etiologies. Collectively, these findings underscore the presence of a malignant tumor confined to the lung with limited lymph node involvement and a coexisting benign inflammatory condition."
545,TCGA-78-7154-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately to poorly differentiated adenocarcinoma in the left upper lobe of the lung. The tumor, identified within the anterior segment, extends into the overlying parietal pleura but is clear of the soft tissue and bronchial resection margins. Microscopic evaluation also indicates metastasis to one of the peribronchial lymph nodes with transcapsular extension into the adjacent hilar fibrofatty tissue and evidence of perineural and intraneural invasion. Although the bronchial resection margin shows foci of squamous metaplasia and low-grade dysplasia, it is devoid of malignancy. Examination of other lung tissue reveals focal organizing pneumonia, congestion, and emphysema. The lymph node specimen (No. 5) shows partial replacement by metastatic carcinoma, also with transcapsular extension. A supplementary report confirms unequivocal vascular invasion by the tumor. The pathological staging is T3 N2, indicating advanced local tumor invasion with significant lymph node involvement."
546,TCGA-38-4628-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient has been diagnosed with an invasive moderately differentiated adenocarcinoma of the right upper lung lobe. The primary tumor is centrally located near the bronchial margin, which remains uninvolved by the tumor. Histopathological evaluation confirms that the surgical margins, including the bronchial resection margins, are clear of carcinoma. Pleural involvement by the tumor is absent, although there are two small satellite pleural nodules identified near the main tumor mass. Perineural invasion is present, but there is no evidence of angiolymphatic invasion. One of five hilar lymph nodes shows metastatic adenocarcinoma; however, the remaining examined lymph nodes, including those from the right hilar (R10), right mainstem bronchus, R4, R9, and station 7, are negative for carcinoma. Notably, hyalinized granulomata are found in both the involved and non-involved lymph nodes and pulmonary parenchyma, with some areas showing partial calcification. The nontumorous lung parenchyma displays potential post-obstructive changes without evidence of neoplastic involvement."
547,TCGA-69-7980-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right lung specimens reveals a diagnosis of adenocarcinoma exhibiting a lepidic pattern located in the right upper lobe. The tumor did not exhibit vascular or lymphatic invasion. Examination of the bronchial, vascular, parenchymal, and pleura/soft tissue margins confirms they are free of neoplastic involvement. The resected lymph nodes from the right lower lobe wedge, as well as nodes from specific stations (#4, #7, #11, 10R), are all negative for neoplasm, indicating no lymph node metastasis. Consequently, the pathological staging of the tumor is T1b N0 M0, corresponding to Stage IIA. Additionally, detailed gross examinations of the specimens corroborate these findings, highlighting the clear margins and absence of metastatic spread. This comprehensive assessment underscores the localized nature of the adenocarcinoma, with all resected tissues showing no evidence of further neoplastic activity."
548,TCGA-93-A4JN-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of invasive, poorly differentiated adenocarcinoma of the lung, invading the visceral pleura. The primary tumor is staged as T2a and is categorized as Stage IV due to the presence of distant metastasis (M1a). The resection margins are free of tumor, and there is notable arterial invasion with tumor cells colonizing the endothelial walls. Lymphatic and venous invasion are not present. Pathological examination of lymph nodes from levels 7 and 11 shows no evidence of malignancy, confirming pN0 status, although both lymph nodes contain hyalinized granulomas. Granulomatous inflammation is also evident in the non-tumoral lung tissue. Fungal forms and mycobacterial species are absent as indicated by negative GMS, AFB, and FITE stains. Lastly, the pleural deposit demonstrates adenocarcinoma with neuroendocrine differentiation, confirming malignancy through TTF-1 positivity and synaptophysin and chromogranin negativity."
549,TCGA-44-4112-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive poorly differentiated adenocarcinoma in the right upper lobe of the lung. The primary tumor, measuring 5 cm, invades the pleura and is classified as pT2a. The surgical margins are clear of tumor involvement. However, the tumor infiltrates the pleural surface and shows evidence of vascular invasion. Regional lymph node assessment indicates metastatic carcinoma in one of four hilar lymph nodes and in two of ten lymph nodes from level R4, with the largest metastasis demonstrating extracapsular extension. All other sampled lymph nodes, including those from levels 3, 10, middle lobe, and subcarinal regions, are negative for metastatic carcinoma. No distant metastasis is observed. These findings collectively suggest a primary lung carcinoma with significant local invasiveness and regional lymph node involvement."
550,TCGA-44-A47G-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The detailed pathological findings indicate a diagnosis of moderately differentiated adenocarcinoma in the posterior apical segment of the right upper lobe of the lung. The tumor was histologically graded as a grade 2 adenocarcinoma. Importantly, the bronchial and pulmonary resection margins were negative for malignancy, indicating clean surgical margins. Additionally, there was no pleural or vascular invasion. Examination of multiple lymph nodes from levels XI, VII, X, and 2R fat disclosed no evidence of malignancy, affirming the absence of lymph node involvement. Furthermore, three attached peribronchial lymph nodes also showed no signs of malignancy. The non-tumorous lung tissue displayed emphysema, subpleural elastosis, and arteriolar medial hypertrophy. Overall, the pathologic evaluation confirmed the tumor as a T1 stage adenocarcinoma with no lymphatic spread or residual cancer at the surgical margins."
551,TCGA-44-6774-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","A left lower lobe lung resection revealed a moderately to poorly differentiated adenocarcinoma, with a mitotic index of 24 mitoses per 10 high power fields, and a tumor size consistent with a T1 stage. Both the bronchial and pulmonary margins of resection were negative for malignancy, as was the pleura, and there was no evidence of vascular invasion. Examination of associated lymph nodes showed varied findings. Specifically, the level VII lymph node displayed metastatic carcinoma in one of two nodes, without extranodal extension. Conversely, levels V, VIII, IX, and XI lymph nodes exhibited no evidence of malignancy. Additionally, the non-tumorous lung showed focal endogenous lipoid pneumonia. The absence of malignancy in most lymph nodes, coupled with the pathological grading and resection margin status, contributes to a pTNM classification of T1 N2."
552,TCGA-55-8092-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe lobectomy specimen reveals a moderately differentiated adenocarcinoma, infiltrating the visceral pleura but not penetrating it. The tumor, with a greatest dimension of 7.7 cm, is unifocal and primarily located just beneath the pleural surface. The bronchial margins are confirmed to be negative for tumor involvement, ensuring that the resection margins are clear. Lymphovascular invasion is present, raising concerns for potential dissemination. Multiple lymph nodes biopsied (lymph node #10 and lymph node #7) do not show metastatic tumor involvement. Gross examination indicates that while the tumor comes very close to the soft tissue margins at the hilum, there is no actual invasion beyond these margins. The overall pathological diagnosis is stage T3 N0 MX adenocarcinoma of the right upper lobe, characterized by significant local invasion but no current lymph node metastasis detected in the sampled nodes."
553,TCGA-L4-A4E6-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the patient's right upper lobe wedge excision and subsequent right upper lobectomy revealed a diagnosis of poorly differentiated (G3 of 4) adenocarcinoma, located subpleurally in the right upper lobe. The tumor was unifocal and did not invade the visceral pleura or adjacent structures, with no associated atelectasis or obstructive pneumonitis observed. However, there was evidence of venous invasion. The surgical margins were all negative for carcinoma, including the bronchial margin, with a comfortable clearance margin to the nearest edge. All six sampled lymph nodes were benign, indicating no lymph node involvement. Consequently, the tumor was staged as pT1pN0 according to the AJCC criteria. The gross examination further described the pleural surface with minimal anthracotic stippling and a firm, gray, ill-circumscribed mass beneath the pleura without additional masses in the remaining parenchyma. Immunohistochemistry on the formalin-fixed, paraffin-embedded tissue indicated positive staining for p63, reinforcing the adenocarcinoma diagnosis."
554,TCGA-73-7499-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation confirmed a diagnosis of moderately differentiated adenocarcinoma located in the right upper lobe, characterized by a mixed subtype with a dominant acinar pattern. The bronchial margin is not involved by the tumor, and there is no evidence of angiolymphatic or visceral pleural invasion. The primary lesion is moderately differentiated and does not display satellite tumors. Examination of lymph nodes included multiple levels, specifically levels 2R, 2L, 4R, 4L, and 7, with all nodes found to be benign, indicating no lymph node involvement (0/19 N2 nodes and 0/1 N1 node). Additional findings noted emphysematous changes and atelectasis in non-neoplastic lung tissue. The pathological staging is pT2a, Mx according to the AJCC Cancer Staging Manual, 7th Edition."
555,TCGA-MP-A4TH-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left lung reveals an invasive adenocarcinoma in the left lower lobe, characterized by a lepidic growth pattern and forming an ill-defined mass. Notably, the tumor does not invade the visceral pleura or angiolymphatic structures. The surgical margins are clear of tumor. Additionally, the left upper lobe contains a necrotizing granuloma, with further microbial staining identifying the presence of fungal organisms consistent with Histoplasma species, and no acid-fast bacilli observed. The non-neoplastic lung parenchyma appears unremarkable. Regarding lymph node status, biopsies from multiple stations, including the interlobar, subcarinal, and subaortic nodes, show no evidence of malignancy. The subaortic lymph node also contains benign tissue with adjacent calcified granulomas. There is no residual malignancy in the supplementary wedge resection of the left lower lobe, and the bronchial margin is free of tumor. Intrapulmonary and peribronchial lymph nodes are also negative for malignancy."
556,TCGA-64-1681-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology evaluation of the right lung cancer reveals a well-differentiated adenocarcinoma confined to a 2.5 cm mass within the resected lobe. The tumor is situated 0.6 cm from the bronchial margin, which, along with the vascular margins, is free of tumor involvement. There is no evidence of tumor invasion into the visceral pleura, and angiolymphatic invasion is not identified. Comprehensive examination of multiple lymph node groups, including 10R, 8R, 11R, 4R, 2R, and level 7 nodes, shows no metastatic involvement, with all nodes being free of tumor (0/46 examined). Based on these findings, the pathological staging is pT1 N0 Mx, indicating a primary tumor of limited size without regional lymph node metastasis, with the metastatic status remaining undetermined."
557,TCGA-64-1680-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination confirmed the diagnosis of right lung adenocarcinoma, WHO mixed subtype, featuring acinar, papillary, and lepidic growth patterns. The primary tumor in the middle lobe, measuring 8.0 cm, shows moderate differentiation and invasion into the visceral pleura, with subcentimeter satellite lesions present in the lower lobe. Despite identified lymphovascular invasion, the surgical resection margins are negative for carcinoma, ensuring no residual tumor at the edges of the resected tissue. However, the carcinoma has metastasized to lymph nodes, showing involvement in five of fifteen at level 7, two of three at level 10R, one of eight at level 11, and one of nine at level 4R, while the level 9 lymph node and rib specimen reveal no tumor presence. These findings correspond to a pathological staging of pT2 N2 M1, indicating a primary tumor with significant nodal involvement and distant metastasis."
558,TCGA-62-A46O-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right lower lobe of the lung reveals a diagnosis of adenocarcinoma (not otherwise specified). The tumor displays high-grade features (G3) and involves the pleura visceralis. Immunohistochemical staining shows the tumor cells are positive for CK7 and CEA, with partial positivity for TTF1 and Vimentin, and negative for Chromogranin A, Synaptophysin, NSE, CK13, CK14, and CD56. The Ki-67 proliferation index is notably high at 40-50%, indicating a high level of cellular proliferation. Margins of resection are clear, and no lymph node involvement is identified (0 out of 22 lymph nodes examined). The tumor is classified as pT2, pN0, pMx, confirming its current primary stage without regional or distant metastasis."
559,TCGA-NJ-A55O-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the specimens from the right upper lobe lobectomy reveals an invasive adenocarcinoma with mucinous features, classified as grade 1, and staged pT1bN1 (PLO). The tumor, unifocal and measuring 2.6 cm, is located within the right upper lobe. Immunohistochemical testing confirmed lung primary, with tumor cells positive for CK7 and TTF-1, and negative for CK20 and CDX-2. Notably, bronchial, vascular, parenchymal, and visceral pleural margins are all free of malignancy. One out of five peribronchial lymph nodes showed metastatic adenocarcinoma involvement with no extracapsular extension, while the right paratracheal tissue and subcarinal lymph nodes tested negative for malignancy, albeit showing anthracotic changes. No lymphatic vascular invasion or extension into other structures was observed. The examination of the remainder of the lung revealed benign meningothelial-like rest, and additional lung tissue displayed anthracosis and mild congestion."
560,TCGA-38-4629-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The right upper lobe lobectomy and contiguous chest wall resection revealed a diagnosis of poorly differentiated adenocarcinoma extending through the pleura and involving adjacent chest wall structures. The primary tumor did not involve the bronchial or chest wall surgical margins. Examination of the peribronchial, station 7, right middle lobe, and R4 lymph nodes showed no metastatic carcinoma. The adenocarcinoma exhibited significant pleural involvement at the site of pleural adhesions, but no angiolymphatic or perineural invasion was identified. The uninvolved lung tissue showed areas of patchy acute bronchopneumonia and a subpleural fibrous plaque. Importantly, all lymph nodes sampled were negative for metastatic spread, with no evidence of carcinoma in any resection margins, supporting a localized disease process."
561,TCGA-73-4658-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive poorly differentiated adenocarcinoma in the left lower lobe of the lung, characterized by a large primary tumor in a background of multifocal bronchioloalveolar carcinoma. The tumor demonstrates angiolymphatic invasion and extends to the visceral pleural margin, which is positive for tumor involvement. Notably, the bronchial margin is negative for tumor, although dissociated tumor clusters are present within the bronchial lumen and adjacent alveoli. Examination of the relevant lymph nodes, including peribronchial, hilar, and 10L nodes, confirms no metastatic involvement (0/3). Additionally, the resection of the 6th rib shows unremarkable bone and bone marrow with no signs of malignancy. Non-neoplastic lung tissue exhibits changes indicative of atelectasis, interstitial fibrosis, and chronic inflammation. The overall findings align with a pathologic stage of pT2N0Mx, reflecting the absence of lymph node metastasis and the local extension of the primary tumor."
562,TCGA-05-4398-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a locally advanced, peripheral bronchopulmonary adenocarcinoma of the right upper lobe of the lung, characterized by a histologically mixed tumor with a predominant large-cell, polymorphocellular, and partly clear-cell solid component. The tumor also exhibits a bronchioloalveolar growth pattern at its periphery and a very small acinar part, mainly located in segment S1 with a satellite focus in S3. The TNM classification of pT4 pN3 L1 V1 R0 indicates the presence of an advanced tumor with lymphatic invasion, vascular invasion, and metastasis to regional lymph nodes, but with no residual tumor at the resection margins. The main tumor demonstrates a significant cicatricial area and invasion into small blood vessels and lymph nodes. Lymph node metastases were identified in samples 1 to 4, 6 to 8, and 10, whereas the visceral pleura and resection margins of the bronchus and vessels, as well as lymph nodes in samples 5 to 9, were free of tumor involvement, confirming complete surgical resection. The stage of the cancer is determined to be IIIB, with the corresponding ICD-O-3 code C34.1 M8255/3."
563,TCGA-97-8179-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings pertain to a resected tumor from the right upper lobe of the lung, specifically an adenocarcinoma with acinar predominance. The tumor, moderately differentiated and unifocal, consists of a mix of acinar (60%) and lepidic (40%) components, and measures 1.2 cm. The resected margins, including bronchial and vascular, are free of tumor involvement, and no visceral pleura invasion was identified. There was no lymph-vascular invasion or extranodal extension observed. Nine regional lymph nodes were examined, all of which tested negative for carcinoma (0/9). The cancer is staged as pT1a pN0. Molecular testing showed no rearrangements involving the ALK gene, and both KRAS and EGFR mutation analyses returned negative results. Additional pathological findings include the presence of emphysema in the lung tissue. The patient's history includes significant smoking and multiple ground-glass nodules bilaterally. The specimen was subjected to various diagnostic techniques, including FISH and PCR, which confirmed the absence of significant mutations or genetic rearrangements associated with poor prognosis or therapy resistance."
564,TCGA-78-7539-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of a moderately differentiated adenocarcinoma in the right upper lobe of the lung. The tumor exhibits a mix of lepidic, acinar, papillary, and micropapillary growth patterns, and is partially composed of elastotic scarring. There is evidence of subpleural and focal visceral pleural invasion, as well as blood vessel and probable lymphatic permeation. No perineural invasion is present, and the tumor is well clear of the bronchial resection margin. Examination of the hilar lymph nodes and additional lymph nodes from levels 10 and 11 shows no metastases, featuring only reactive changes with prominent sinus histiocytosis. Non-neoplastic lung tissue exhibits mild emphysema, patchy mild inflammation, small non-necrotizing granulomas, and rare organizing pneumonia, with the inflammation more prominent near the tumor. The tumor staging is T2bN0Mx, given the absence of lymph node involvement and other clear metastatic indicators. Special stains confirm pleural invasion through the elastin layers, although no tumor is present on the pleural surface."
565,TCGA-55-1594-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated adenocarcinoma confined to the right lower lobe of the lung, following a lobectomy. The tumor, located subpleurally, does not extend to the pleural surface and the resection margins are free of invasive carcinoma. Notably, there is an absence of lymphovascular, venous, and arterial invasion. The examination of regional lymph nodes from the right lower lobe reveals no evidence of involvement by the carcinoma, with all 13 nodes tested returning benign results. However, metastatic poorly differentiated carcinoma is identified in one of nine lymph nodes from the level 7 subcarinal region, although there is no extranodal extension. The level 4 paratracheal lymph nodes contain three benign nodes. Overall, the pathological stage is determined to be pT2 pN2 pMX, with efforts to assess distant metastasis remaining inconclusive. Intraoperative consultation confirmed the bronchial margin as negative for carcinoma on a frozen section."
566,TCGA-55-1592-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated adenocarcinoma in the left upper lobe of the lung, confirmed by a wedge resection biopsy. The tumor, noted to be 2.0 cm in greatest diameter, is well-circumscribed and exhibits characteristics typical of adenocarcinoma, including growth along alveolar spaces. However, the presence of dense fibrosis excludes bronchoalveolar carcinoma from consideration. The carcinoma extends up to but not through the pleural surface and lies 1 cm from the resection margin. Importantly, the surgical resection margins are clear, indicating no tumor infiltration at the edges of the excised tissue. Additionally, although the tumor is identified within endothelial-lined lymphovascular spaces, no lymph nodes were resected or examined, leaving the nodal status undetermined. The findings highlight a localized invasion without clear evidence of further metastatic spread within the sampled tissue."
567,TCGA-78-7540-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen from the left lower lobe demonstrates an invasive well-differentiated adenocarcinoma characterized predominantly by a mucinous bronchiolo-alveolar carcinoma component. The tumor exhibits diffuse infiltration with a rubbery tan appearance, involving multiple lung segments and surrounding a major segmental bronchus, extending near the bronchial resection margin but sparing the medial margin. Microscopically, the tumor shows focal invasive characteristics and is closely positioned to the pleural surface, which shows organizing fibrinous pleurisy; however, confirmatory stains have ruled out pleural invasion. Importantly, no vascular or perineural invasion is identified, and small satellite tumor deposits are noted in adjacent parenchyma. Both the bronchial resection margin and the adjacent bronchus section are free of malignancy. Examination of hilar lymph nodes reveals carbon deposition and sinus histiocytosis without metastases. Additional examination of lung tissue away from the mass reveals no specific abnormalities. The final pathological staging is T2N0Mx, indicating the lack of lymph node involvement and no distant metastasis on current assessment. Additionally, a separate specimen identified as a back lipoma consists of lobulated mature adipose tissue with no evidence of malignancy, consistent with a benign lipoma diagnosis."
568,TCGA-05-4410-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the pulmonary wedge resection reveals a diagnosis of adenocarcinoma with focal mucin production, primarily displaying tubular/acinar structures, along with a bronchioloalveolar growth pattern, and minor solid and papillary components. This peripheral mixed bronchopulmonary adenocarcinoma corresponds to stage IB under the TNM classification (pT2 pN0 pMX). Notable findings include foci of visceral pleural infiltration and tumor extension to the basal resection margin, leading to an RX margin status. Lymphovascular invasion is present, as indicated by L1 and V1 classifications. Immunohistochemical staining highlights the tumor's bronchopulmonary origin, with positivity for cytokeratin 7 and TTF-1, and negativity for cytokeratin 20 and CDX-2."
569,TCGA-49-AAQV-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation confirms a diagnosis of poorly differentiated adenocarcinoma with a histologic composition of 70% acinar and 30% solid patterns, located in the left lower lobe of the lung. The resected tumor did not involve the surgical margins, indicating complete excision. One out of eleven examined regional lymph nodes demonstrated metastatic involvement, consistent with pN1 staging, while the remaining sampled lymph nodes, including those from stations 6, 7, 8, and 10, were negative for tumor involvement. There was no evidence of venous or arterial invasion, although lymphatic invasion remained indeterminate. Notably, molecular analysis revealed a positive EGFR mutation (E746-A750 deletion in exon 19), which suggests a potential responsiveness to EGFR tyrosine kinase inhibitors; however, ALK rearrangement was not detected. The tumor staging aligns with pT1b, indicating a primary tumor size greater than 2 cm but less than or equal to 3 cm, and the distant metastasis could not be assessed (pMx). No grossly identifiable hilar lymph nodes were noted in the specimen, and the remaining lung parenchyma was grossly unremarkable."
570,TCGA-62-A471-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of adenocarcinoma, not otherwise specified (NOS), located in the upper lobe of the left lung. The tumor is characterized by significant proliferation, indicated by a high Ki-67 index of 40%, and is graded as G3, suggesting a high grade of malignancy. Immunohistochemical (IHC) staining shows the tumor cells are positive for CK7 but negative for CK5/6, CK14, SP-A, TTF1, CD56, Chromogranin A, and Synaptophysin, providing further confirmation of the adenocarcinoma diagnosis. The tumor measures significantly in size but does not infiltrate the pleura visceralis. Lymph node involvement is evident, with six out of twenty-eight lymph nodes tested positive, classifying the nodal stage as pN1. The pathological stage is pT2b, indicating tumor extension within the lung. Margins of resection are not specified, and distant metastasis remains indeterminate (pMx)."
571,TCGA-05-4402-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of mixed adenocarcinoma primarily situated in the lower lobe of the lung, displaying a predominant acinar component. Additionally, a smaller large-cell solid component with a bronchioloalveolar growth pattern is noted at the tumor periphery, accompanied by slight mucin formation and significant lymph vessel involvement within the lung tissue and visceral pleura. The tumor has infiltrated the visceral pleura, with focal penetration of its surface, and extends to the basal margin following the removal of the metal clamps. The tumor is classified as pT2, indicative of its size and extent of invasion, with indeterminate lymph node involvement (pNX) and unknown metastatic status (pMX). The marked lymph vessel propagation further signifies advanced local spread. Lastly, the margin status remains undetermined (RX), necessitating further evaluation through immunohistological analysis for confirmation."
572,TCGA-44-A47A-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated adenocarcinoma in the right upper lobe of the lung. The tumor exhibits a histologic grade of 2 out of 3 and has a mitotic index of 4 mitoses per 10 high-power fields. Importantly, both the bronchial and pulmonary resection margins are negative for malignancy, indicating successful surgical excision without residual tumor at the resection borders. No evidence of malignancy is found in the examined lymph nodes from levels R4, X, and VII, suggesting no lymphatic spread, and resulting in an N0 classification. There is an absence of vascular invasion, and the pleura also shows no malignancy. The tumor displays a portion with a more solid appearance but remains consistent with adenocarcinoma upon immunohistochemical analysis, showing TTF-1 positivity and CK5/6 negativity, with weak p63 positivity. The pTNM stage is determined to be T2a N0, correlating with the observed tumor characteristics and lack of nodal involvement. Non-tumorous lung tissue reveals emphysema. Overall, these findings collectively indicate a localized adenocarcinoma of the lung without metastatic spread, successfully resected with clear surgical margins."
573,TCGA-44-6148-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of well-differentiated mucinous adenocarcinoma in the left lower lobe of the lung, with the primary tumor measuring 3 cm in its greatest dimension (pT1b). The tumor is well-circumscribed and does not involve the pleura or the large stem bronchus. There is no evidence of venous, arterial, or lymphatic invasion, and the vascular and bronchial margins of resection are free of tumor. Assessment of regional lymph nodes, including those from the left lower lobe, level 10, left upper lobe, and subcarinal regions, shows no metastatic involvement (pN0). The background pulmonary parenchyma appears relatively unremarkable, aside from some anthracosis and histiocytes within the lymph nodes. The status of distant metastasis cannot be evaluated from this specimen (pMx)."
574,TCGA-62-A46V-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of adenocarcinoma of the left lower lobe of the lung, exhibiting a mixed subtype with papillary, micropapillary, acinar, and solid components. The tumor infiltrates the pleural visceral surface, highlighting its invasive nature. Pathological staging reveals a primary tumor classification of pT2 with no regional lymph node involvement, confirmed by the absence of metastatic cells in all 11 examined lymph nodes (pN0). The metastatic status is unspecified (pMx), and the tumor is graded as G3, indicating a high-grade malignancy. The margin status and further detailed histopathological evaluation reinforce the aggressive characteristics of this adenocarcinoma subtype."
575,TCGA-MP-A4TE-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis revealed an invasive adenocarcinoma of the left lower lobe of the lung, graded as 3 out of 4, forming a peripheral mass. The tumor demonstrated visceral pleural invasion but no angiolymphatic invasion. Importantly, the bronchial margin was clear of the tumor. Comprehensive biopsy of lymph nodes from various stations, including 7, 4L, 4R, 9L, 11L, 10L, and 5, showed no evidence of metastasis, with all lymph nodes being negative for tumor cells. This aligns with the AJCC staging designation of T2bN0MX. K-ras mutation analysis is pending and will be conducted on paraffin-embedded lung tissue. The findings underline the localized nature of the disease, with no lymphatic spread, which is crucial for the prognosis and future management of the patient."
576,TCGA-55-6981-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of adenocarcinoma in the left upper lobe of the lung. The tumor is noted to be moderately to poorly differentiated (histologic grade G2-3), with a maximum size consistent with a pT1 classification. Examination of the regional lymph nodes indicates significant metastatic involvement, with ten out of twelve nodes, including those in the subcarinal region, harboring metastatic disease (pN2). The aortopulmonary and anterior pulmonary ligament lymph nodes were found to be free of tumor. Margins of the resected specimen, including bronchial, vascular, and pleural margins, were clear of carcinoma, although the tumor was noted to approach within less than 1mm of the inked hilar pleural surface. There was no evidence of direct tumor extension into adjacent structures, and no venous invasion was identified. However, extensive lymphatic invasion was present, particularly in the lung and subpleural lymphatics. There were no additional significant pathological findings noted."
577,TCGA-55-6642-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an adenocarcinoma in the right lower lobe of the lung, confirmed by histological examination of a wedge biopsy and a subsequent lobectomy. The tumor exhibits complex anastomosing glands and papillae with marked nuclear atypia and mitoses, extending into the visceral pleura but without venous or arterial invasion. The primary tumor is categorized as pT2, with no regional lymph node metastasis (pN0) and distant metastasis status undetermined (pMX). Margins are clear, with the tumor at a minimal distance from the staple line. Examination of the subcarinal lymph node shows moderate sinus histiocytosis and anthracosis, but no evidence of metastatic disease. The lobectomy specimen also contained a small spindle cell carcinoid tumor and associated obstructive/lipoid pneumonia, but all examined lymph nodes, including peribronchial and hilar nodes, were negative for tumor involvement. Additionally, benign lung parenchyma with fibrofatty tissue was identified in the inferior pulmonary ligament, and clotted blood with reactive mesothelial cells was found in the hilar lymph node without any tumor presence. Special stains identified tumor cells positive for TTF-1, consistent with a lung primary site, and spindle cell tumor cells positive for synaptophysin and chromogranin, confirming a diagnosis of carcinoid tumor."
578,TCGA-L9-A7SV-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of adenocarcinoma located in the left lower lobe of the lung, specifically classified as histologic grade 2. The tumor was unifocal with extensions noted neither beyond the primary site nor into the visceral pleura. Adequate surgical margins were achieved, with the closest margin being 3 mm away from the invasive carcinoma. Among the 15 lymph nodes examined, only one peribronchial lymph node showed evidence of tumor involvement, indicating a pathologic staging of pN1. Additionally, lymphovascular invasion was identified. The surrounding lung parenchyma exhibited emphysematous changes, and most of the lymph nodes outside the peribronchial area showed reactive changes rather than malignancy, except for one non-neoplastic lung tissue sample in which a lymph node was not identified. There was no evidence of distant metastasis, conforming to the staging criteria for non-small-cell lung carcinoma. The tumor measured 3.7 cm in its greatest diameter and was thoroughly examined following established protocols, confirming the integrity and proper handling of the specimen."
579,TCGA-55-6982-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination reveals a diagnosis of non-small cell lung carcinoma, specifically adenocarcinoma, located in the right lower lobe of the lung. The tumor is poorly differentiated and measures 3.5 cm in its greatest dimension. Importantly, the bronchial margins are free of tumor involvement, indicating clear surgical margins. Examination of lymph nodes from various stations, including the lower paratracheal, pulmonary ligament, right hilar, and paraesophageal regions, showed no evidence of malignancy, except for the identified metastases in the ipsilateral peribronchial and hilar lymph nodes (N1). Additionally, the tumor exhibits direct extension into the visceral pleura and demonstrates venous, arterial, and lymphatic invasion. The presence of a calcified granuloma in the right lower lobe is noted as a significant finding. These findings collectively provide a comprehensive assessment of the tumor's local and regional spread, alongside other relevant pathological observations."
580,TCGA-05-4420-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is a histologically mixed adenocarcinoma of the right lower lobe of the lung, predominantly featuring papillary and small acinar components with slight mucin formation, and primarily localized in segments 7 to 9. The tumor has extended to segment 4 of the middle lobe. The TNM classification for this case is pT2 pN0 pMX, corresponding to stage IB. Importantly, the resection margins of the bronchus and vessels are free of tumor involvement, and all dissected and identified lymph nodes are also devoid of tumor. These findings indicate a localized disease with no lymph node metastasis and complete resection."
581,TCGA-53-7813-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a right upper lobe wedge resection reveals a moderately differentiated adenocarcinoma. This primary tumor is accompanied by multiple microscopic foci of bronchioalveolar carcinoma, including involvement at the stapled resection margins. Notably, no evidence of tumor involvement is detected at the right upper lobe bronchial margin. Examination of the regional lymph nodes, specifically from hilar, lower paratracheal, subcarinal, inferior pulmonary ligament, and parabronchial regions, shows no metastasis, as no tissue was present in these nodes. Additionally, the right upper lobe exhibits atypical pneumocyte hyperplasia. No evidence of visceral pleural involvement, large vessel invasion (both venous and arterial), or lymphatic invasion is identified. Consequently, the pathological staging is determined to be pT1 pN0 pMX. The absence of metastasis in the regional lymph nodes further emphasizes the localized nature of the malignancy. 

This summary provides a concise representation of the essential pathological findings, highlighting the diagnosis, tumor characteristics, margin status, and the absence of lymph node involvement, which are critical for informing clinical decisions and management plans."
582,TCGA-49-AAR3-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation has culminated in a diagnosis of adenocarcinoma, not otherwise specified (NOS), in the right upper lobe of the lung following a lobectomy. The tumor is characterized as poorly differentiated (G3) with a maximum dimension of three centimeters. Immunohistochemical staining revealed positivity for TTF-1 and CK7, supporting the adenocarcinoma diagnosis and ruling out malignant mesothelioma and melanoma. The examination of lymph nodes revealed metastatic carcinoma presence in one of the thirteen lymph nodes excised, specifically in the right station 10 node, corresponding to a pN1 regional lymph node stage, indicating metastasis in ipsilateral peribronchial, hilar, or intrapulmonary nodes. The surgical margins are free of invasive carcinoma, indicating no residual tumor at the excision sites. Both venous and lymphatic invasions have been observed, signifying a more aggressive and potentially disseminative disease. Additionally, a pleural plaque was identified as dense fibrous tissue with no tumorous involvement. Other excised lymph nodes from various stations, including R-4, R-11, and lower R-4, were all negative for tumor involvement, indicating no metastatic spread to these regions."
583,TCGA-97-8172-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathology diagnosis reveals the presence of a moderately differentiated adenocarcinoma, predominantly acinar in type with a minor lepidic component, located in the right upper lobe of the lung. The tumor exhibits prominent extracellular mucin and measures 3.5 cm in greatest dimension. Importantly, the bronchial and vascular margins are free of invasive carcinoma. Histological examination of seven lymph nodes from this lobe showed no evidence of carcinoma (0/7). Additional lymph node biopsies from stations 10, 11, 2, 4, and 7 collectively assessed 25 nodes, all of which were negative for carcinoma (0/25). There is no visceral pleural invasion, and lymphovascular invasion is also absent. The tumor is staged as pT2a with no regional lymph node metastasis (pN0). The specimen submitted for molecular analysis revealed a KRAS mutation (p.G12V), which is associated with a poor prognosis and resistance to tyrosine kinase inhibitor therapies common in non-small-cell lung cancer. No mutations were detected in the EGFR gene. The clinical history notes a past diagnosis of breast cancer, now presenting with right upper lobe adenocarcinoma."
584,TCGA-50-6593-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings on the right upper lobectomy reveal a poorly differentiated adenocarcinoma of the lung, classified as mixed solid and acinar type. The tumor exhibited angiolymphatic invasion but did not show extension into the visceral pleura. The excised tumor was free of all margins, although carcinoma was noted within 1-2 mm of the bronchial resection margin. Additionally, significant involvement of both N1 and N2 lymph nodes was observed, with six out of thirteen N1 nodes and two out of fourteen N2 nodes testing positive for metastatic adenocarcinoma. The final pathologic staging for this tumor is T1 N2 Mx, given the absence of extrapulmonary parenchymal invasion. Ancillary studies, including histochemical stains, PAS-D, mucicarmine, and elastic tissue stains, confirmed vascular invasion. Molecular analysis identified EGFR amplification without mutations in KRAS codons 12/13 or EGFR exons 19 and 21, and there was no evidence of EML4/ALK rearrangement. The background lung parenchyma showed marked emphysematous changes with respiratory bronchiolitis."
585,TCGA-64-5779-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left lung reveals a diagnosis of adenocarcinoma, WHO acinar subtype, characterized by poor differentiation. The tumor measure indicates its largest dimension without involving the visceral pleura. Notable pathological features include the presence of angiolymphatic invasion; however, large vessel invasion is absent. Surgical margins are clear of carcinoma. Lymph node evaluation identifies metastatic carcinoma in multiple examined lymph nodes, specifically involving four out of twelve peribronchial nodes and varying numbers across levels 5, 7, and 11L nodes, indicative of regional spread (N2). Particularly, metastatic involvement is marked in two out of fifteen level 5 lymph nodes, three out of six in 11L lymph nodes, and two out of three in level 7 lymph nodes without metastasis in other sampled levels, including level 9, 8, 12L, and new bronchial margin nodes. Additional findings show fibrous adhesion in the diaphragmatic sample and no tumor in the examined portion of the 6th rib. Overall, there is extensive lymph node involvement, reflecting significant nodal metastasis while primary tumor margins remain uninvolved."
586,TCGA-44-6144-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately differentiated adenocarcinoma of the right upper lobe of the lung. The primary tumor, measuring 2 cm in greatest dimension, is categorized as pT1a with no extension to the pleura or main stem bronchi. Importantly, the resection margins, including the bronchial stump and vascular margins, are negative for tumor involvement. Venous invasion is present, while arterial invasion is absent; lymphatic invasion is also noted. Examination of regional lymph nodes reveals no metastasis, with two lymph nodes from the lobectomy specimen, one from R4, and four from level 7 being negative for metastatic disease (pN0). Additionally, there is an area of intraparenchymal pulmonary hemorrhage, which may be secondary to a prior pulmonary embolus, but no organized thromboembolus is detected. There is no evidence of distant metastasis (pMx), and no intraparenchymal metastasis is identified."
587,TCGA-55-A492-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe lung specimen and associated lymph nodes revealed an invasive adenocarcinoma, classified as moderately differentiated. The tumor is confined to the lung without evidence of visceral pleural invasion or involvement of extra-pulmonary structures. Importantly, all resection margins are negative, indicating a complete excision (R0 status). Additionally, a total of nineteen lymph nodes were evaluated, and none showed evidence of metastatic carcinoma (pN0). The microscopic evaluation of the lymph nodes also identified hyalinized nodules, indicative of old granulomas, but no active malignancy. There is no presence of lymphovascular or perineural invasion, reinforcing the localized nature of the tumor. The pathological stage is determined as IA, corresponding to a small primary tumor without regional lymph node metastasis or distant spread. The detailed findings support a favorable prognosis post-surgical resection."
588,TCGA-38-A44F-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe wedge resection of the lung revealed an invasive lung adenocarcinoma, primarily acinar-predominant with a mixed acinar and micropapillary subtype. The tumor was classified as moderate to poorly differentiated. It was a unifocal lesion, without involvement of adjacent structures, in situ carcinoma, or vascular, lymphatic, perineural, or pleural invasion. The surgical margins of the resection were negative for tumor involvement. Notably, no tumor was seen in the single lymph node examined within this specimen, confirming its status as (0/1) lymph node involvement. Additionally, the non-tumorous lung tissue exhibited emphysematous changes, multifocal bronchiolar metaplasia, and focal fibrous remodeling. The pathological TNM staging was determined to be pT2a pN0. Furthermore, the lymph node from Station 4 was found to contain benign fibroadipose tissue with no identifiable lymph nodes or tumor involvement. Molecular studies are underway and will be reported separately."
589,TCGA-44-2656-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of moderately differentiated adenocarcinoma of the right upper lobe of the lung. The primary tumor measures 2.0 cm and invades the visceral pleura. Notably, the surgical margins are uninvolved, and there is no direct extension of the tumor. However, both venous and arterial large vessel invasion are present, while lymphatic invasion is not identified. A second smaller lesion along the pleural aspect suggests biopsy site changes but lacks malignancy. No lymph node metastasis is detected, with nine nodes from the main specimen, as well as additional nodes from the 2R, 4R, and Stations 7 and 9, all being negative for metastatic involvement. The microscopic examination also identifies granulomatous inflammation in an intraparenchymal lymph node and Station 7 lymph nodes, with negative stains for acid-fast bacilli (AFB) and fungal organisms. There is no evidence of distant metastasis as this cannot be evaluated by the current specimen."
590,TCGA-55-1595-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of moderately to poorly differentiated adenocarcinoma in the left lower lobe of the lung, which includes a clear cell carcinoma component. The tumor demonstrated a moderate degree of differentiation and extended to a maximum dimension of 2.0 cm without involvement of the pleura. Importantly, the bronchial and vascular margins were free of tumor invasion, and there was no evidence of blood or lymphatic vessel invasion. The examination of lymph nodes from multiple regions, including subcarinal, inferior pulmonary ligament, proximal bronchial, and AP window areas, showed no metastatic carcinoma, with all nodes being benign. Additionally, special stains confirmed the nuclear positivity of TTF-1 in the neoplastic cells, supporting the diagnosis of primary lung carcinoma. Thus, the overall pathological findings indicate a localized adenocarcinoma with no evidence of lymph node metastasis or distant spread."
591,TCGA-86-7701-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnostic analysis reveals a poorly differentiated adenocarcinoma located in the patient's right upper lung. The tumor extends to the visceral pleura and possesses additional nodules. Immunohistochemical staining was positive for CD15, CK7, and TTF1, and negative for CK20 and CDX2. Margin status, lymph node involvement, and the presence of lymphatic or venous invasion were not specified. There is no information regarding evidence of neo-adjuvant treatment or additional pathological findings specified."
592,TCGA-69-7979-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals the presence of invasive adenocarcinoma, acinar type, localized to the right upper lobe of the lung. The submitted lung tissue showed severe emphysematous changes, but the bronchial, vascular, parenchymal, and pleural margins were all negative for neoplasm. Additionally, no vascular or lymphatic invasion was identified. Lymph node analysis across various levels, including L4, 2R, 2L, 3, 4R, 7, 10, and 11, confirmed the absence of malignancy in all harvested nodes. Furthermore, a chest wall mass was excised and found to be composed of unremarkable fibroadipose tissue, with no malignant cells present. Considering these findings, the pathological staging is pT2a pN0 pMX, corresponding to Stage 1b lung cancer, which indicates a localized disease without regional lymph node involvement. The overall clinical impression is consistent with primary lung adenocarcinoma, and the comprehensive pathological examination supports the conclusion that the tumor has been completely resected with clear surgical margins."
593,TCGA-97-7554-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately differentiated adenocarcinoma of the left lower lobe. The tumor displays mixed histologic features and does not show visceral pleura or other extensions. The bronchial, vascular, and parenchymal margins are free of invasive carcinoma. However, there is evidence of lymph-vascular invasion. Examination of the level 7 lymph node reveals metastatic carcinoma in two of three nodes, substantiated by positive immunostains for cytokeratins AE1/AE3 and CK7, while all other lymph nodes, including levels 9, 11, and 5, show no carcinoma. Notably, 15 lymph nodes from the lobectomy specimen are also negative for carcinoma. The pathological stage is pT2a based on tumor size, and pN2 due to metastasis in ipsilateral mediastinal nodes. Additional findings include benign mesothelial hyperplasia in the pleural biopsy and focal non-necrotizing granulomatous inflammation in a level 5 lymph node. Special studies, including immunohistochemical analysis, confirm the lung origin of the tumor, with positive reactivity for TTF-1 and CK7. There is no evidence of distant metastasis, and no additional non-tumor findings were identified."
594,TCGA-55-8620-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment reveals the presence of a primary adenocarcinoma located in the left upper lobe of the lung, characterized as moderately to poorly differentiated (Grade II-III). The tumor is unifocal, and its distance from the parenchymal margin is sufficient, with no evidence of visceral pleural or lymphovascular space invasion. One lymph node in Level VII is positive for metastatic adenocarcinoma, while four lymph nodes in Levels V and VI show no metastatic involvement. The pathological staging is determined as pT1a N1, indicating a small primary tumor with limited nodal involvement. These findings provide critical insights into the disease's extent and assist in guiding subsequent therapeutic decisions."
595,TCGA-73-4675-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings revealed a well-differentiated adenocarcinoma located in the peripheral lower lobe of the left lung. Notably, the tumor was observed to be well-differentiated with clear margins at the bronchial sites, ensuring no involvement of the bronchial margins by the carcinoma. While 24 lymph nodes were examined, tumor involvement was detected in three peribronchial lymph nodes, categorizing the nodal involvement as N1. There was no evidence of angiolymphatic invasion or satellite tumors, and the visceral pleural involvement was confirmed, with non-neoplastic lung tissue showing emphysematous changes. Additionally, rib fragments examined were devoid of any pathological abnormalities. Pathological staging, following the AJCC 7th Edition, designates the stage as pT3, N1, MX."
596,TCGA-05-4418-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of locally advanced peripheral bronchopulmonary adenocarcinoma of the left lower lobe of the lung, exhibiting histologically mixed characteristics including large-cell and clear-cell, solid and acinar components, along with mucin formation and localization in segment 8 (S8). TNM classification indicates pT3 pN2 pMX V1 R0, placing the cancer at stage IIIA. The carcinoma has infiltrated the pericardial fatty tissue, and lymph node metastases are present in the hilar region. Importantly, the resection margins of the bronchus and vessels, as well as the pericardial resection material, adhered part of the parietal pleura, and lymph nodes from designated samples, are free of tumor involvement, indicating successful surgical excision with negative margins."
597,TCGA-75-6212-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of adenocarcinoma, micropapillary type. The tumor exhibits features consistent with its classification, demonstrating notable malignant characteristics. The surgical margins are clear of tumor involvement, indicating a successful excision with no residual disease at the margins. The specimen contains lymph nodes that exhibit metastatic involvement, classified as N1, indicating the spread of cancer cells to nearby lymph nodes. There is no evidence of distant metastasis, as denoted by the clinical M0 designation. This tumor is staged as T2, according to the pathological staging criteria, reflecting its local extent. Histological analysis has identified a moderate differentiation grade, which has implications for prognosis and potential treatment strategies. Overall, the findings are consistent with a diagnosis of stage II adenocarcinoma, micropapillary type, taking into account the tumor size, nodal involvement, and absence of distant metastasis."
598,TCGA-86-A4P8-01Z-00-DX1,LUAD,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The submitted specimen from the right lower lobe of the lung has been diagnosed as adenocarcinoma, histologic grade G3. The primary tumor measures 2.1 cm and is located very close to the visceral pleura but does not involve the pleura or the bronchial and vascular margins, indicating uninvolved surgical margins. Lymphovascular invasion is present, signaling an aggressive tumor behavior. Lymph node evaluation reveals metastatic involvement in multiple stations: 1 of 2 nodes in Station 8, 2 of 3 nodes in the subcarinal region, 1 of 3 nodes in Station 11, 1 of 1 node in Station 4, and 5 of 6 nodes in the peribronchial region, while nodes from Station 9 and Station 7 are uninvolved. These findings classify the pathologic stage of the tumor as pT1b pN2 pMx. Notably, there is a discordance with a prior fine needle aspiration (FNA) biopsy that did not show tumor cells in some of the lymph nodes where metastases are now identified, suggesting incomplete sampling in the FNA specimens. Testing for EGFR with ALK reflex is pending."
599,TCGA-18-3406-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The submitted specimens include tissue from various anatomical sites related to lung and lymph nodes. Tissue near the aorta exhibits fibrous connective tissue without neoplastic changes. A biopsy from the left upper lobe bronchus shows fragments of squamous cell carcinoma, precluding invasion assessment due to the absence of stroma. The AP window lymph node is negative for malignancy, as is a lymph node within connective tissue from a nodule on the pleura near the aorta. The completion left pneumonectomy specimen reveals a peripheral, well-differentiated squamous cell carcinoma, with no pleural invasion. The bronchial margin of resection is free of malignancy, and two interlobar and one segmental lymph node are also negative for malignancy. These findings suggest a complete resection of a T1N0 squamous cell carcinoma, which appears metachronous to a previously noted tumor. The overall pathological assessment indicates a favorable margin status with no lymphatic involvement."
600,TCGA-22-4609-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe of the lung reveals an invasive grade 3 squamous cell carcinoma with central necrosis, forming an ill-defined intrapulmonary nodule. The carcinoma does not involve the overlying pleura. The bronchial margin is clear of tumor involvement, and an intrapulmonary peribronchial lymph node is also negative for tumor presence. Notably, organizing pneumonia is present focally, forming two separate nodules. The excision of the superior and inferior mediastinal, as well as the N1 lymph nodes, demonstrates that multiple lymph nodes, including those in the right lower paratracheal, subcarinal, and right hilar regions, are negative for tumor involvement, indicating an absence of lymphatic spread."
601,TCGA-66-2757-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the resected left upper lobe of the lung revealed a poorly differentiated, non-keratinizing squamous cell carcinoma located in the peripheral section of segment 1, with no evidence of pleural infiltration or vascular invasion. The tumor exhibited subepithelial intramural propagation within a subsegmental bronchus but demonstrated clean resection margins with unremarkable architectural changes in the surrounding lung parenchyma. Extensive histological examination of the hilar and other regional lymph nodes showed no evidence of metastatic involvement, although these nodes did exhibit significant anthracosis and mild histiocytosis. The overall classification of the tumor is M-8070/3, G3, staged as pT1, pN0, pMX, indicating stage IA with clear margins (RO). Based on these findings, the patient has a localized primary tumor without lymph node metastasis or distant spread."
602,TCGA-85-A4QR-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately differentiated squamous cell carcinoma (Grade 2) in the lung. The tumor, described as a dense-elastic gray-pink mass, is confined to the lung tissue and shows no evidence of venous invasion. Margins are uninvolved, indicating that the resected tissue is free of cancerous cells at the edges. Additionally, all examined lymph nodes, including one bronchopulmonary, three subcarinal, and one mediastinal, show no metastatic involvement but demonstrate anthracosis. An abscess was also identified separately within the lung tissue. The specimen type was derived from a pneumonectomy, and there is no indication of the tumor extending beyond the localized site. Overall, the findings suggest localized squamous cell carcinoma of the lung without lymph node metastasis and clear surgical margins."
603,TCGA-77-A5GF-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated squamous cell carcinoma located in the left lower lobe of the lung. The tumor is primarily subpleural, with a maximal dimension of 27 mm and exhibits pleural invasion. Importantly, the carcinoma is well clear of the bronchial resection margin, indicating that surgical removal appears to have achieved clear margins. There is evidence of metastatic involvement in the hilar lymph nodes, with some nodes showing transected tumor deposits at the margins. However, the pathological assessment of the lymph node labeled as No. 10 indicates no presence of metastatic carcinoma, only showing carbon pigment and silica material. Additional findings include emphysema and significant fibrosis in the non-neoplastic lung tissue, with a usual interstitial pneumonia (UIP)-like pattern most pronounced at the base of the lobe. These findings support a staging of T2a N1 according to the AJCC 7th edition."
604,TCGA-77-8008-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of moderately differentiated keratinising squamous cell carcinoma located in the right lower lobe of the lung. The tumor exhibits extensive central necrosis and cavitation and is surrounded by a fibrous capsule. Notably, it invades into the thickened fibrous pleura but does not extend to the pleural surface. There is no evidence of lymphatic or vascular invasion in the tumor. Additionally, the bronchial and vascular resection margins are clear of malignancy. Peribronchial lymph nodes and sampled lymph nodes (right upper lobe sump node, No. 11, and No. 7) show reactive hyperplasia but no metastases. There is also obstructive pneumonitis in the surrounding lung tissue and centriacinar emphysema in more distant lung areas. The pathological stage is determined to be T2 N0, with no evidence of lymph node metastases."
605,TCGA-98-A538-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of moderately differentiated squamous cell carcinoma in the left upper lobe of the lung. The tumor is unifocal and measures 7.0 cm in its greatest dimension. Importantly, the surgical bronchial and vascular margins are negative for malignancy, indicating no invasive carcinoma at these resection borders. No lymphovascular invasion is detected. The pathological staging of the tumor is pT2bN0Mx, reflecting a tumor size greater than 5 cm but less than or equal to 7 cm, without regional lymph node metastasis. Examination of multiple lymph nodes from various levels shows no evidence of tumor involvement. Additionally, the lung parenchyma adjacent to the tumor exhibits changes consistent with organizing pneumonia with BOOP-like features, but no definitive tumor is observed in those areas. These findings are significant for treatment planning and prognosis."
606,TCGA-51-4080-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of squamous cell carcinoma with both usual and basaloid variant subtypes, moderately to poorly differentiated, primarily involving the right lung. The main tumor is limited to an in situ carcinoma in the trachea, without evidence of invasive carcinoma. A pneumonectomy specimen revealed no pleural involvement and no evidence of invasion into vascular or perineural spaces. Significant findings include two satellite nodules within the same lobe alongside numerous lymph node examinations. Metastatic squamous carcinoma was identified in three out of fifteen lymph nodes, although there was no extracapsular extension. Surgical margins were free of tumor. In other regions, including lymph nodes from various stations and levels, no metastatic carcinoma was observed. Other notable findings in the nontumorous lung included anthracosis. According to the AJCC staging, the pathological findings classify this as pT4 pN1 pMx, with the overall staging requiring further clinical correlation."
607,TCGA-66-2727-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of poorly or largely undifferentiated large cell squamous cell epithelial carcinoma with keratinization, located in the left lower pulmonary lobe and extending from the center to the periphery. The tumor exhibits significant characteristics including an irregularly circumscribed mass with areas of necrosis and disruption to large pulmonary veins and the pulmonary artery branch, causing infarction and accumulation of siderophages, accompanied by fibrinous pleurisy. The carcinoma extends peripherally into the pleura of the inter-lobar cleft with minimal progression into the jointly resected flap of pulmonary tissue, though the resection area is free of tumor. Margins at the bronchus and vascular displacement borders are also free of tumor. Lymph node analysis indicates reactive changes without malignancy, although some nodes show anthracotic pigment deposition. Additional findings include chronic inflammation in pleural and mediastinal tissue and interstitial fibrosis with smooth muscle development in a small fragment of pulmonary tissue. A larger parenchymal scar with atypical cell proliferation is noted, but without bronchiolo-alveolar carcinoma. The staging of the tumor is pT2 pN0 V1 R0, corresponding to stage IB, with a morphology code 8070/3 and topography code C34.3, indicating high-grade malignancy."
608,TCGA-77-8156-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings from the left upper lobectomy reveal a diagnosis of poorly differentiated squamous cell carcinoma with a notable absence of lymphatic, vascular, or perineural invasion. The tumor exhibits irregular geographic zones of necrosis and abuts the visceral pleura without evidence of pleural invasion. It is clear of the bronchial resection margin, although mild to moderate squamous dysplasia is noted at the margins. Examination of both peribronchial and separately submitted left hilar and mediastinal lymph nodes shows reactive changes, but no tumor involvement is identified. The adjacent lung parenchyma demonstrates obstructive pneumonitis characterized by endogenous lipoid pneumonia, while the distant lung parenchyma displays emphysematous changes with subpleural bulla formation and features consistent with a usual interstitial pneumonia type reaction pattern, including patchy interstitial fibrosis, fibroblastic foci, and early honeycomb change. The pathological stage is designated as pT2a NO, indicating a localized tumor without nodal involvement."
609,TCGA-96-8169-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of poorly differentiated squamous cell carcinoma in the right lower lobe of the lung, confirmed via immunohistochemical stains showing positivity for p63 and negativity for TTF-1, with a negative mucin stain. The tumor was unifocal and measured 1.6 cm, without evidence of visceral pleura invasion. The resection margins, including the staple line, were free of tumor. Examination of lymph nodes at stations 4, 7, and 9 all yielded negative results for carcinoma, indicating no regional lymph node metastasis (0 out of 4 nodes examined showed involvement). Accessory findings showed no lymph-vascular invasion or extranodal extension. The pathological staging for the primary tumor is pT1a and pN0. Additionally, non-tumorous findings included emphysematous changes in the lung parenchyma. The clinical background includes a history of ex-smoking with a preoperative diagnosis of right lower lobe non-small cell lung cancer."
610,TCGA-85-8666-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the lung specimen reveals a moderately differentiated squamous cell carcinoma located in the upper lobe of the lung. The tumor presents as a grey-pinkish mass and is confined to the site of origin without evidence of local or distant spread. Examination of the surgical margins shows no tumor involvement, indicating clean and uninvolved margins. Additionally, 11 lymph nodes, including those from the aortic window, bifurcational, and bronchopulmonary regions, were assessed and all tested negative for metastasis. There is no evidence of venous invasion. The absence of tumor spread beyond the localized region and uninvolved margins are favorable indicators for the patient's prognosis. The presence of bronchopulmonary anthracosis is noted but unrelated to the malignancy. The lung tissue was obtained through a pneumonectomy procedure for thorough analysis."
611,TCGA-18-3417-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of poorly differentiated squamous cell carcinoma in the right lung, predominantly located in the right lower lobe with metastatic involvement in the right upper lobe. The primary tumor exhibits extensive vascular and visceral pleural invasion, and is associated with perineural invasion. Importantly, the bronchial resection margin is clear of malignancy. Lymph node assessment reveals six out of thirty-one peribronchial lymph nodes positive for metastatic carcinoma, including the interlobar lymph nodes. However, biopsies from various other locations, such as the subcarinal and inferior pulmonary ligament nodes, are negative for malignancy. Additional findings include multifocal infarcts and patchy chronic inflammation with focal interstitial fibrosis. The pathological staging corresponds to pT2N1M1, indicating tumor extension into the visceral pleura, involvement of ipsilateral lymph nodes, and the presence of distant metastasis within the ipsilateral lung."
612,TCGA-98-A53C-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the patient's right lower lobe lobectomy revealed a moderately differentiated squamous cell carcinoma without any evidence of lymphovascular invasion. The carcinoma was unifocal and measured within the size parameter specified for a pT1a tumor, suggesting that it is confined to the lung or visceral pleura without involvement of the main bronchus. Importantly, the bronchial, vascular, parenchymal, pleural, and chest wall margins were clear of invasive carcinoma, indicating no residual disease at the surgical resection margins. Additionally, numerous regional lymph nodes from various levels (II, IV, VII, VIII, IX, XI) were excised, and no tumor was identified in any of the lymph nodes examined, consistent with a pN0 status, meaning no regional lymph node metastasis was found. An incidental benign chondroid hamartoma was also noted. Overall, these findings indicate a localized lung carcinoma with no evidence of metastasis, which is critical for prognosis and subsequent management."
613,TCGA-39-5022-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the right upper lung lobe reveals a moderately to poorly differentiated squamous cell carcinoma with no evidence of vascular invasion. The tumor is confined to the pleura but does not cross the elastica, and the bronchial and parenchymal margins are free of tumor involvement. The mainstem bronchus is not involved. Examination of the surrounding non-neoplastic lung tissue exhibits emphysematous changes, focal atypical adenomatous hyperplasia, organizing pneumonia, and respiratory bronchiolitis. Additionally, no tumor presence is detected in the two peribronchial and seven intraparenchymal lymph nodes sampled. The right level ten, eleven (both mediastinal and interlobar), and level four mediastinal lymph nodes all show no evidence of tumor, with some nodes showing old calcified granulomas but no active malignancy. Special stains (AFB, FITE, GMS, EVG) conducted on the tissue did not reveal any mycobacteria or fungi. The intraoperative frozen section evaluations were consistently benign and were confirmed by permanent diagnoses."
614,TCGA-22-5477-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the right inferior segment lower lobe post-lobectomy reveals a diagnosis of invasive grade 3 squamous cell carcinoma. The carcinoma presents as a nodular mass, which distorts but does not invade the pleural surface. The surgical resection margins are free of tumor, indicating a negative margin status. The examination of a single intrapulmonary lymph node indicates no presence of tumor. Additionally, the nearby lung parenchyma demonstrates signs of emphysematous changes. Further lymph node analysis, including bronchus intermedius, superior mediastinal (right lower paratracheal), and inferior mediastinal (subcarinal and pulmonary ligament) lymph nodes, shows no evidence of metastatic involvement. Overall, the findings suggest a localized high-grade squamous cell carcinoma with no lymphatic spread and clear resection margins."
615,TCGA-56-7223-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right middle and lower lobes of the lung following bilobectomy revealed a primary diagnosis of poorly differentiated squamous cell carcinoma. The tumor was extensive, measuring 14 cm at its greatest dimension. Importantly, there was no invasion into the visceral pleura, and the surgical margins were negative, with the tumor located 0.5 cm away from the bronchial margin. No lymphovascular invasion was identified. However, metastatic carcinoma was detected in one out of twenty-nine regional lymph nodes examined, specifically in one peribronchial lymph node (N10R). The pericardial tissue was found to be free of tumor involvement. Based on these findings, the tumor is staged at pT3, with regional lymph node involvement classified as pN1, and no distant metastasis confirmed (pMX), resulting in an overall pathologic stage of IIIA. The absence of visceral pleural invasion was further confirmed by elastic staining."
616,TCGA-22-5480-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of Grade 4 squamous cell carcinoma in the left upper lobe of the lung. The tumor forms a mass and is located away from the bronchial margin, which is negative for tumor invasion. Histopathological examination of multiple intrapulmonary peribronchial lymph nodes and the visceral pleura reveals no evidence of metastatic disease. Additionally, a soft tissue excision from the left hilar region confirms the presence of Grade 4 non-small cell carcinoma with squamous features. An intraparenchymal lymph node from the left lower lobe shows no signs of neoplasm but does exhibit non-necrotizing granulomatous inflammation. Special staining results for potential microorganisms in this lymph node are pending. Furthermore, extensive sampling of lymph nodes from the superior mediastinal, aortic, inferior mediastinal, and left lower lobe bronchus regions reveal no metastatic involvement."
617,TCGA-21-1077-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of high-grade bronchiogenic squamous cell carcinoma involving the left upper lobe of the lung. The tumor is notably invasive, penetrating the visceral pleura and affecting the bronchial margin. Metastatic squamous cell carcinoma is identified in three out of fifteen peribronchial lymph nodes. Examination of additional lymph nodes from various levels, including levels 5, 6, 7, and 11, shows no tumor involvement. The rib specimen and multiple mediastinal margins, including the anterior, posterior, superior, and medial margins, as well as two bronchial margins, are free of neoplastic involvement. The pathological staging is pT2N1Mx, indicating a primary tumor with invasion, regional lymph node metastasis, and an indeterminate distant metastasis status. This comprehensive analysis underscores the aggressive nature of the carcinoma and meticulous evaluation ensures accurate staging and margin assessment."
618,TCGA-21-5784-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a resected right upper lobe of the lung with associated lymph nodes reveals a diagnosis of high-grade squamous cell carcinoma. The tumor measures 4.0 cm in its greatest dimension and is localized without involvement of the visceral pleura or evidence of angiolymphatic, venous, or arterial invasion. Importantly, surgical margins, including visceral pleura, vascular, and bronchial margins, are free of tumor involvement. Thorough lymph node assessment, including 32 regional lymph nodes from multiple levels (11R, 3A, 10R, 7, 10, 4R), reveals no metastatic involvement (0/32). The pathological staging is reported as T2 N0 Mx, indicating a primary tumor of substantial size without regional lymph node metastasis or distant spread at the time of evaluation. These findings suggest a localized, high-grade malignancy appropriately managed through surgical resection without immediately evident metastatic disease."
619,TCGA-NK-A5CX-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with moderately-differentiated squamous cell carcinoma (grade 2) of the right lower lobe of the lung. The tumor, characterized by areas of necrosis, was excised via lobectomy and measured 4.5 cm in its greatest dimension. Importantly, the bronchial, vascular, and visceral pleural margins were all free of malignancy. Additionally, there was no evidence of lymphatic vascular invasion or extension into other structures. The histologic examination of five peri-bronchial lymph nodes, along with lymph nodes from levels 7 and 11, revealed no metastatic involvement. The remaining lung tissue showed no significant pathological changes. The final pathological staging was determined to be pT2bN0, indicating a tumor confined to the lung without nodal metastasis."
620,TCGA-77-8145-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated squamous cell carcinoma (SCC) originating from the left upper lobe bronchus. The tumor predominantly occupies the left upper lobe, with some extension into the upper portion of the lower lobe, and includes a notable area of cavitation. Tumor invasion is evident on both medial and lateral pleural surfaces and involves the pulmonary vein, where the cancer cells have infiltrated through the vein wall, though the venous resection margin remains clear. The bronchial resection margin is also free of malignancy, with no evidence of squamous metaplasia or dysplasia observed. Lymphatic invasion is not definitively identified, but one hilar lymph node (number 10) shows metastatic disease, while the other peribronchial and sampled lymph nodes are free of malignancy. The lung parenchyma distal to the tumor exhibits severe emphysema and multiple foci of ossification. The initial pathological staging was T3 N1 due to the primary tumor's size and thoracic invasion, but was later upgraded to T4 N1 upon identifying atrial muscle invasion. The pulmonary vein stump shows no malignancy, consisting primarily of a small portion of atrial wall. Overall, the findings align with a diagnosis of aggressively invasive SCC with single lymph node metastasis."
621,TCGA-63-A5MU-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings of the examined sample indicate a diagnosis of Squamous Cell Carcinoma, Not Otherwise Specified (NOS), located in the right lower lobe. Histologically, the tumor is identified as squamous carcinoma and exhibits moderate differentiation, corresponding to Grade II. Pathological staging reveals a T2b classification, signifying a tumor of moderate extent. Notably, there is lymph node involvement, classified as N1, indicating the presence of regional lymph node metastasis. No distant metastasis is observed, aligning with a clinical M0 status. These findings collectively provide important insights into the nature and extent of the malignancy, informing potential treatment options and prognosis."
622,TCGA-63-7021-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of a malignant tumor in the lung. Histological examination reveals a moderately differentiated tumor located in the left lower lobe. The tumor margins are clear, suggesting complete surgical excision without residual tumor at the resection edges. Lymph node assessment shows no evidence of metastatic involvement, as all sampled nodes are free of malignant cells. The tumor is staged as T2, without regional lymph node metastasis (N0), and no distant metastasis is identified (M0), corresponding to an overall stage II classification. The outcome reflects a localized disease with potential for a favorable prognosis following the surgical intervention. No additional significant pathological features or anomalies were noted in the specimen."
623,TCGA-77-7465-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobectomy reveals a diagnosis of moderately to poorly differentiated squamous cell carcinoma (SCC). The central lobulated tumor displays areas of necrosis and carbon pigment, indicating its aggressive nature. Notably, the tumor involves peribronchial fat at the hilum but is clear of the bronchial resection margin, with no evidence of squamous metaplasia or dysplasia at the margin. The tumor invades one peribronchial lymph node directly and exhibits several foci of vascular invasion, including a major branch of the pulmonary artery, though there is no lymphatic or perineural invasion. The surrounding lung parenchyma shows features such as emphysema, bronchiectasis, and iatrogenic parenchymal hemorrhage, with additional non-tumorous nodules and granulomas present. Examination of the number 4 and number 5 lymph nodes reveals anthracotic changes and small silicotic nodules but no metastatic carcinoma. These findings collectively stage the disease at T2a N1, indicating a tumor size under or equal to the threshold for T2a classification and involvement of ipsilateral peribronchial or hilar lymph nodes."
624,TCGA-21-5782-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left lower lobe of the lung reveals an invasive, poorly differentiated squamous cell carcinoma. The tumor exhibits a firm, tan, and slightly nodular appearance with hyperemic areas. Importantly, the pleural margins and the inked resection margins are negative for the presence of carcinoma, indicating that the tumor has been completely excised with no residual disease at the edges of the biopsy specimen. The surrounding pulmonary parenchyma shows signs of emphysematous changes. Additionally, examination of the level 9L lymph node, which presents with anthracotic staining, reveals no evidence of metastatic carcinoma, confirming a lack of lymphatic spread in the examined node."
625,TCGA-34-A5IX-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of invasive moderately differentiated squamous cell carcinoma located in the right lower lobe of the lung, with associated organizing pneumonia and an organizing thrombus within the pulmonary artery. The tumor exhibited lymphovascular invasion and extended through the visceral pleura into the diaphragm. Margins, including bronchovascular and diaphragm soft tissue, were clear of malignancy. Multiple lymph nodes from different anatomical levels, including peribronchial and other sites (Levels 4, 7, 10, and 11), showed anthracosilicotic changes but were negative for malignancy, indicating no lymph node involvement (0/21). Immunohistochemical staining supported the diagnosis, with tumor cells positive for CK5/6 and p63 and negative for CK7, TTF-1, PAS-D, and mucicarmine. The pathologic staging was determined as pT3N0, corresponding to a tumor size of 6.7 cm at its largest dimension and moderate differentiation grading (G2). This comprehensive diagnostic profile underscores the locally advanced nature of the tumor without distant metastasis or nodal involvement."
626,TCGA-85-8070-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the lobectomy specimen from the left upper lung lobe revealed a diagnosis of squamous cell carcinoma, classified as moderately differentiated. The tumor did not show involvement of the surgical margins, indicating that it was completely excised. Examination of the regional lymph nodes revealed no evidence of metastatic disease, with all sampled nodes being free of tumor involvement. The absence of lymph node metastasis and the clear surgical margins are favorable prognostic factors. Overall, the pathological findings provide an essential basis for further clinical management and prognostication for the patient."
627,TCGA-22-4594-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of Grade 4 squamous cell carcinoma in the left upper lobe of the lung. The tumor presents as a peripheral mass with significant invasiveness, penetrating through the pleura into the chest wall soft tissue. Importantly, the resection margins from both the bronchial and chest wall specimens are free from malignancy, indicating that no residual cancer is detectable at these edges. However, there is concerning lymphatic involvement as 2 out of 4 intrapulmonary peribronchial lymph nodes and 2 out of 4 superior mediastinal (paratracheal) lymph nodes are positive for metastatic squamous cell carcinoma. In contrast, all examined lymph nodes from the inferior mediastinal (subcarinal), left pulmonary artery, and left lower lobe lung regions show no evidence of tumor metastasis. These findings underscore the aggressive nature of the primary tumor and its partial spread to regional lymphatic structures."
628,TCGA-85-6175-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pneumonectomy specimen reveals a well-differentiated squamous cell carcinoma located in the lung. The tumor exhibits characteristic histologic features of this type of carcinoma. Essential details such as tumor extent, additional tumor nodules, lymph node involvement, lymphatic and venous invasion, surgical margin status, and evidence of neo-adjuvant treatment are not specified. No additional pathological findings are noted. The provided information focuses on the diagnosis and histologic grade but lacks comprehensive details about tumor spread and other critical aspects that are necessary for a complete pathological assessment."
629,TCGA-NK-A7XE-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of invasive squamous cell carcinoma, grade 2, in the left lung, specifically located in the upper lobe. The tumor extends into the perihilar mediastinal fibroadipose tissue and shows both lymphatic and perineural invasion. Notably, three out of eight perihilar lymph nodes and three out of fourteen level 7 subcarinal lymph nodes contain metastatic squamous cell carcinoma, with evidence of extracapsular extension in the latter group. The margins of resection, including bronchial, vascular, and parenchymal, are free of tumor involvement. However, there is involvement of the mediastinal pleura. All lymph nodes from the pulmonary ligament and level 9 were negative for metastatic tumor. The specimen retained its integrity throughout the process, and the final staging is determined as T4N2PL3, indicating an advanced stage of disease with significant local and nodal involvement. These findings underscore a complex and aggressive tumor pathology."
630,TCGA-37-A5EL-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","A Caucasian male was diagnosed with primary squamous cell carcinoma of the left lung. The histological examination revealed characteristic features of squamous cell carcinoma. Pathologically, the tumor was analyzed to determine the grade and TNM stage. The margins following the surgical excision were evaluated, and it was noted that the tumor was entirely removed with clear surgical margins. Lymph node involvement was assessed, revealing no metastasis to the regional lymph nodes. Additionally, blood specimens were examined, confirming no abnormal findings. The pathological findings emphasize the localized nature of the carcinoma, offering a complete view for appropriate therapeutic planning."
631,TCGA-66-2753-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals the presence of a poorly differentiated squamous cell carcinoma in the resected left inferior pulmonary lobe, characterized by a grayish-white, well-demarcated tumor with central necrosis and pseudocystic changes, extending up to the pleura. The tumor demonstrates significant hemangioinvasion and nearby peritumorous pneumonia, but the bronchial resection margin is free of tumor involvement. The lymph nodes examined (designated as L 3, L 4, L 7, L 9, L 11, and L 12) exhibit lymphofollicular hyperplasia and anthracosis, without any evidence of malignancy. Additionally, the parietal pleura sample displays hyaline plaque formation along with sclerohyalinosis and lymphoid infiltration. The tumor is classified as M-8071/3, G3, staging as pT2, pV1, pN0, pMX, indicative of stage IB with clear margins (R0 resection). The overall findings support a diagnosis of stage IB squamous cell carcinoma with no lymph node metastasis and complete surgical resection."
632,TCGA-39-5031-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis confirms a diagnosis of moderately differentiated squamous cell carcinoma in the left upper lobe of the lung. The tumor is characterized by ill-defined, stellate borders and shows evidence of lymphovascular invasion, but no perineural invasion is identified. Importantly, the bronchial and pleural margins are free of tumor, indicating no direct tumor extension to these areas. There is an additional finding of a separate focus of bronchioloalveolar carcinoma, as well as multiple foci of atypical adenomatous hyperplasia within the lung parenchyma. The non-neoplastic lung tissue exhibits signs of emphysema, focal organizing pneumonia, and the presence of carcinoid tumorlets. Examination of lymph nodes from levels 9, 11, 5, and 12, along with peribronchial nodes, reveals no metastatic involvement, with all nodes tested being benign. Furthermore, a resected segment of the sixth rib shows no signs of malignancy, exhibiting normal bone and bone marrow histology."
633,TCGA-60-2710-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The examination of multiple specimens from the left lung and associated lymph nodes revealed key pathological findings. The primary diagnosis is a moderately differentiated squamous cell carcinoma located in the peripheral left upper lobe, identified in a lobectomy specimen. The tumor showed a dimension of 2.0 x 1.7 cm, with negative margins for both the pleural surface and bronchial regions, indicating no residual tumor at the resection margins. Importantly, metastatic carcinoma was identified in one peribronchial lymph node, denoted as N1 involvement, while lymph nodes in levels 5, 6, 7, and 9 were negative for tumor involvement, consistent with N2 lymph nodes receiving no pathological evidence of carcinoma. Angiolymphatic invasion was present, further confirming the invasive nature of the carcinoma. The non-neoplastic lung tissue exhibited moderate emphysematous changes but was otherwise unremarkable. The pathological stage has been classified as pT1 N1 MX, indicating a primary tumor with limited nodal involvement and an indeterminate metastatic status."
634,TCGA-43-6647-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated squamous cell carcinoma in the right lower lobe of the lung, characterized by a centrally cavitating tumor with arterial invasion. The tumor was found to infiltrate the full thickness of the bronchus, though the pleura and vascular margins, as well as the bronchial stump, were negative for tumor. One out of five peribronchial lymph nodes showed involvement by direct extension of the carcinoma, suggesting regional lymph node involvement (pN1). Additional findings include rare acute bronchopneumonia and obstructive type pneumonia. Several levels of lymph nodes, including those from levels 1, 2L, 4, 4L, 7, 8, 9, 11, and the 2R fat pad, were examined and found to be negative for metastatic disease. The middle lobe showed no significant pathology, and its bronchial margin was negative. The proximal margin of the bronchus intermedius, which contained marked calcification, was also negative for tumor. No distant metastasis could be assessed from this examination."
635,TCGA-O2-A52S-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left lower lobectomy specimen revealed a poorly-differentiated squamous cell carcinoma of the lung with the main tumor located near but not penetrating the pleural surface. Microscopic evaluation confirmed vascular invasion and the presence of metastatic squamous cell carcinoma in one of three peribronchial lymph nodes. Margins analysis showed a positive bronchial margin, while visceral pleura was also involved, indicative of tumor invasion. Other aspects including the mainstem bronchus, chest wall, and mediastinum were negative for tumor involvement. Additionally, the patient exhibited post-obstructive organizing pneumonia and bronchiectasis. Lymph node biopsies identified metastatic carcinoma in lymph nodes at levels 7 and 11. The final bronchial margin was clear of malignancy. Pathologic staging according to the AJCC 5th Edition is pT4 pN2 pMx, suggesting an advanced local invasion with regional lymph node involvement and unassessed distant metastasis."
636,TCGA-22-A5C4-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals an invasive grade 4 squamous cell carcinoma located centrally in the right lung, forming a well-circumscribed and partially necrotic mass. Importantly, the tumor does not exhibit visceral pleural invasion. Examination of the bronchial margin shows it to be clear of tumor, with a significant negative margin. Additionally, there is no evidence of tumor involvement in multiple (17) intrapulmonary peribronchial lymph nodes, and lymph nodes from the right lower paratracheal, subcarinal, and right pulmonary ligament regions also test negative for tumor presence. The adjacent non-neoplastic lung parenchyma shows respiratory bronchiolitis. The overall staging of the tumor is classified as pT2bN0 according to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system. The diagnosis is confirmed through detailed histological evaluation with Hematoxylin and Eosin (H&E) staining."
637,TCGA-22-5473-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left lower lobe of the lung revealed an invasive, high-grade (grade 3 of 4) squamous cell carcinoma characterized by a mass that infiltrates the visceral pleura but does not extend to the pleural surface. The tumor, located 3.5 cm from the bronchial margin, was resected with all surgical margins, including the bronchial margin, free of tumor involvement. Comprehensive lymph node assessment showed no evidence of metastatic disease, with all examined intrapulmonary peribronchial lymph nodes and mediastinal lymph nodes (encompassing right upper and lower paratracheal, left lower paratracheal, subaortic, subcarinal, and right pulmonary ligament stations) being negative for tumor. Additionally, the single interlobar lymph node assessed was also negative for tumor. These findings suggest a localized disease with no detectable lymph node metastasis."
638,TCGA-56-7221-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated large cell carcinoma with squamous differentiation in the right lower lobe of the lung. The primary tumor measures 3.5 x 3.3 x 2.6 cm and is located less than 1 mm from the pleural surface but does not invade it. There is evidence of lymphovascular space invasion, though there is no involvement of the pleura. The surgical resection margins are clear, with the tumor being 4.3 cm away from the bronchial margin. Examination of the lymph nodes from different levels, including levels 4, 7, 8, 9, and 10, shows no metastatic carcinoma; these lymph nodes demonstrate varying degrees of anthrasilicosis, reactive sinus histiocytosis, and granulomas. The bronchial lymph nodes also do not contain metastatic carcinoma. Additionally, subpleural fibrosis and emphysematous changes are observed in the lung parenchyma. The pathological stage of the tumor is determined to be pT2NO."
639,TCGA-63-A5MJ-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of squamous cell carcinoma, not otherwise specified, located in the left lung. The tumor demonstrates features of a grade III squamous carcinoma, indicating poorly differentiated cancer cells. It is situated primarily at the hilum and predominantly involves the upper lobe, with no evidence of extension to the lower lobe. The tumor is classified as pathological stage T2 and shows involvement of regional lymph nodes, staged as N1. There is no clinical evidence of distant metastasis (M0). The surgical margins have not been specified, but the detailed findings highlight significant local invasion without distant spread, emphasizing the importance of the tumor's aggressive nature and the need for thorough clinical management."
640,TCGA-85-6561-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the lobectomy specimen from the lung revealed a moderately differentiated squamous cell carcinoma. The tumor exhibited characteristic features of squamous differentiation, including keratinization and intercellular bridges. It was confirmed that the neoplasm did not extend to the resection margins, indicating clear surgical margins. Additionally, the analysis of lymph nodes showed no evidence of metastatic involvement. Other pertinent findings included areas of necrosis within the tumor, which is consistent with its aggressive nature, but there was no evidence of vascular or lymphatic invasion. These findings collectively suggest a primary squamous cell carcinoma of the lung with no residual disease at the resection margins and no lymph node metastasis."
641,TCGA-43-5670-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of poorly differentiated squamous cell carcinoma of the lung. The primary tumor, located in the left lower lobe, exhibits a focal area of necrosis and measures 5.5 cm at its greatest dimension, extending into the pleura but not reaching the outer surface of the specimen. There is no evidence of vessel invasion, and the surgical margins are free of tumor. A thorough examination of the regional lymph nodes, including those from levels R4, L4, 5, 7, 9, and 10, shows no metastatic involvement. Additionally, the remaining lung tissue displays features of chronic emphysematous disease, marked by dilated air spaces, fibrosis, and mild inflammation with reactive changes. The findings are consistent with a stage designation of pT2b, pN0, with the distant metastasis status being unknown (pMx)."
642,TCGA-52-7622-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a primary diagnosis of moderately differentiated squamous cell carcinoma in the superior segment of the right lower lobe. The tumor is unifocal and measures 2.0 cm in its largest dimension. The overlying pleura shows no evidence of tumor invasion, and there is no vascular or lymphatic invasion observed. The surgical margins, including the bronchial and vascular margins, are free of invasive carcinoma. Pathologic staging indicates pT1a, NO, MX, suggesting a tumor confined to the lung with no regional lymph node involvement or distant metastasis. Multiple lymph nodes, from stations 7, 8, 9, and 11, were evaluated and found to be free of malignancy. The specimen from the 6th rib showed no evidence of carcinoma, and the right lower lobe superior segment bronchial mucosa is also free of malignancy. Additionally, the intrabronchial lesion consists of detached nests of carcinoma cells mixed with blood, with diagnostic information being limited from the frozen section slide due to a few distorted atypical cells. Overall, the findings indicate a well-defined localized squamous cell carcinoma without metastasis or direct extension beyond the lung tissue."
643,TCGA-66-2771-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination confirms a diagnosis of a poorly differentiated large-cell squamous cell carcinoma of the right upper lobe of the lung. The tumor exhibits a peripheral bronchopulmonary origin and has been classified as pT2, pN1, V1, R0, stage IIB. Microscopic analysis reveals small areas of tumor necrosis and tumor-related inflammation with microabscess formations. Additionally, local chronic concomitant pleuritis and pronounced emphysematous stromal remodeling of the lung parenchyma were observed, along with the formation of subpleural cysts and clusters of alveolar pigment-laden macrophages. Lymph nodes show slight to moderate anthracotic pigment deposits, reactive macrophages, and occasional foci of epithelioid cell reactions. Notably, there is focal invasion of the visceral pleura by the carcinoma, particularly enlarged with connective tissue in the retracted area. A micrometastasis is present in the hilar lymph node, and a larger lymph node metastasis is found in an examined sample. Importantly, the carcinoma extends to the staple suture line in the wedge resection, but the subsequent residual upper lobe is free of the tumor."
644,TCGA-22-5492-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left upper lobectomy revealed an invasive grade 3 squamous cell carcinoma forming an intrabronchial and parenchymal hilar mass. The invasive carcinoma extends to within a few millimeters of the bronchial margin, which is involved by extensive in-situ carcinoma; however, the tumor does not invade the overlying pleura, although the pleura is retracted. Obstructive pneumonia was observed in the adjacent pulmonary parenchyma. Multiple intrapulmonary peribronchial lymph nodes exhibited metastatic involvement, with 6 out of 14 nodes affected. Additionally, metastatic squamous cell carcinoma was identified in aortopulmonary and anterior mediastinal lymph nodes. Notably, lymph nodes in the superior and inferior mediastinal regions, as well as within the fissure, showed no evidence of tumor involvement."
645,TCGA-43-A56V-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of moderately differentiated squamous cell carcinoma in the right middle lobe of the lung, with a primary tumor size of 4.5 cm and involvement of the visceral pleura, classified as pT2a. The bronchial margin was clear of malignancy, but the tumor was found in the pulmonary parenchyma near the vascular resection margins. Lymph node biopsies from level 11 were negative for malignancy. However, metastatic squamous cell carcinoma was identified in multiple lymph nodes from level R4, with the presence of extranodal extension, categorizing the nodal involvement as pN2. No evidence of large vessel invasion was detected, though lymphatic invasion adjacent to the venous resection margins was noted. The findings indicate regional spread but do not suggest distant metastasis at this stage. An elastic stain was evaluated to further assess the tissue characteristics. The gross examination of the lung specimen showed a central ulcerated hemorrhagic area surrounded by the tumor, without other distinct lesions in the remaining lung parenchyma."
646,TCGA-66-2792-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left lung reveals a bifocal bronchopulmonary carcinoma, predominantly located in the left lower lobe. Histologically, it is a poorly differentiated, nonkeratinizing squamous cell carcinoma. The tumor extends into the main bronchus with irregular mucosal protrusion and involves lymph nodes at the hilum. Crucially, the resection margins of the bronchus, vessels, and hilar surface are tumor-free, indicating an R0 status. The TNM classification has been revised to pT2(2) pN1 pMX, corresponding to stage IIB. Secondary findings include active chronic and focal organizing pneumonia at the tumor margin, chronic atelectasis with pleural adhesion in segment 6, and subpleural bullous emphysema in the upper lobe. The presence of brown and anthracotic pigment-laden macrophages suggests significant environmental exposures or smoking history. Additionally, lymph nodes exhibit reactive changes with anthracotic deposits. Overall, these findings underscore a locally advanced disease requiring comprehensive clinical management."
647,TCGA-56-8201-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with poorly differentiated squamous cell carcinoma of the right upper lobe of the lung, which exhibited significant invasion through the visceral and parietal pleura into the chest wall skeletal muscle and rib bone. The tumor did not demonstrate lymphovascular space invasion, and proximal bronchial resection margins were clear of carcinoma. However, the carcinoma extended to less than 0.1 cm from the superior chest wall soft tissue margin. All examined lymph nodes, including R4, level 7, L4, R2, R4 #2, level 10, and level 11, were negative for malignancy, reflecting no lymph node involvement (pN0). Additional specimens, including the 5th posterior rib and various soft tissue margins, were also negative for malignancy, and a right lower lobe nodule was identified as a benign fibrotic nodule. The final pathologic stage of the tumor was classified as pT3 pN0 PL3."
648,TCGA-60-2720-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of moderately differentiated squamous cell carcinoma of the lung, specifically located in the lower lobe of the right lung. The carcinoma, measuring up to 4.5 cm in its greatest dimension, exhibits extensive necrosis and centrally involves the bronchus but does not invade the visceral pleura. The analysis of both proximal and distal bronchial margins reveals that while the carcinoma is close, it does not involve these margins. Notably, a detached fragment of dysplastic squamous epithelium with at least moderate dysplasia is identified at the medial margin. Lymphovascular invasion is not present, as confirmed by a CD34 immunostain. Examination of the resected lymph nodes shows no evidence of carcinoma across multiple sampled nodes, including those from the right distal paratracheal (4R), left distal paratracheal (4L), subcarinal (Level 7), right proximal paratracheal (2R), and additional nodes from Levels 7, 9R, and 11R. The findings include chronic inflammation and squamous metaplasia but no satellite tumors. Overall, the pathological staging is designated as pT2, with no regional or distant metastatic disease identified."
649,TCGA-MF-A522-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an invasive squamous cell carcinoma, keratinizing type, in the right upper lobe of the lung, characterized as poorly differentiated. The tumor was identified to be free from significant angiolymphatic and visceral pleura involvement, with no extension to the parietal pleura. Margin analysis showed that both bronchial and vascular/parenchymal margins are clear, with the tumor being closest to the bronchial margin. The lobar bronchus was involved, but the tumor did not infiltrate beyond this. A total of 12 lymph nodes were evaluated, with none displaying metastatic involvement. In addition to the malignancy, other findings in the uninvolved lung included obstructive pneumonia and emphysema. The tumor is staged as pT2a, N0. The remaining submitted lymph nodes across various stations all demonstrated no evidence of malignancy. Microscopic examination of a wedge biopsy from the right middle/lower lobe corroborated obstructive pneumonia and lymphocytic inflammatory infiltrate without malignancy."
650,TCGA-66-2781-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The examination of the left upper lobe reveals a diagnosis of moderately differentiated, slightly keratinizing squamous cell carcinoma with focal gigantocellular features. The primary tumor, mainly located in segment S2, displays regions of blackish pigmentation and pale yellow patches with a firm, whitish appearance and unclear demarcation. The carcinoma extends peripherally to within close proximity of the medial visceral pleura and has polypous spread to the central section of B3. Margin status indicates the absence of tumor involvement in the resection margins of bronchus and vessels, as well as the visceral pleura. The examined lymph nodes, including hilar, paraaortic, subaortic, subcarinal, and lobar nodes, are free of tumor metastasis, showing mainly uncharacteristic anthracotic pigment deposits. Additionally, histological findings include moderate centrocinar pulmonary emphysema, focal intraalveolar pigmented macrophage accumulation, and subpleural scarring with fibrous enlargement of the visceral pleura at the apex of the upper lobe. No asbestos bodies are identified, but further investigations are recommended to assess asbestos exposure. The TNM classification is pT2 pN0 Mx V1 R0, corresponding to stage IIB (C34.1, M8070/3)."
651,TCGA-60-2713-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive poorly differentiated non-small cell carcinoma, consistent with squamous cell carcinoma, located in the right lower lobe of the lung. The tumor was noted to be free from the bronchial margin and visceral pleura, suggesting no direct extension to these areas. Importantly, the carcinoma did not exhibit angiolymphatic invasion. The examination of lymph nodes from various levels, including 4R, 4L, 7, 10, 11, and 12, revealed no evidence of metastatic spread. Additional pathological findings in the lung tissue included adjacent interstitial fibrosis and focal organizing pneumonia, but no tumor involvement. Immunohistochemical staining confirmed the carcinoma subtype as squamous cell carcinoma, negative for synaptophysin, chromogranin A, and CD56. Collectively, these findings culminate in a pathologic stage of pT2 NO Mx, indicating a localized tumor without regional lymph node or distant involvement."
652,TCGA-22-1017-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination confirms a diagnosis of invasive glandular carcinoma (IGC). The tumor is characterized by its glandular differentiation, which is a hallmark of this malignancy. Margin analysis reveals clear surgical margins, indicating that no residual tumor cells are present at the resection boundaries. Lymph node evaluation shows no evidence of metastatic involvement, suggesting that the cancer has not spread beyond the primary site. Additional pathological findings include the presence of tumor-infiltrating lymphocytes, which may have prognostic significance. Overall, the findings suggest a localized invasive glandular carcinoma with no regional lymph node metastasis and clear surgical margins, which are crucial parameters for determining prognosis and subsequent therapeutic strategies."
653,TCGA-66-2789-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a primary diagnosis of a poorly differentiated, large-cell, non-keratinizing squamous cell carcinoma of the left lower lobe of the lung, specifically localized in segment S9. The tumor, involving a 1.9 cm whitish mass with unclear margins, was positioned 0.1 cm from the staple suture line of the resection tissue. There was evidence of lymphangioinvasion at the tumor margin and metastases observed in the hilar lymph nodes, as well as in additional nodal stations. The resection margins, including bronchus and vessel margins, were free of tumor involvement (R0). The TNM classification was determined to be pT1 pN3 pMX L1, denoting stage III. Additionally, secondary findings included numerous non-necrotizing epithelioid granulomas largely in paravasal interstitial locations, slight centroacinar pulmonary emphysema, and hypocellular fibrosis of the parietal pleura. The lymph nodes exhibited epithelioid cell reactions with nodular centers and areas of necrotic sclerosis, as well as anthracotic pigment deposits. The skin sample from the thorax showed seborrheic keratosis of the acanthotic type. No asbestos bodies were detected, though further investigation into asbestos exposure was recommended. The distribution pattern of epithelioid cell granulomas primarily suggests sarcoidosis."
654,TCGA-85-8287-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a pulmonectomy specimen from the left upper lung lobe reveals a poorly differentiated squamous cell carcinoma. The tumor exhibits aggressive histologic features and is notable for its significant lack of differentiation. Importantly, the surgical margins are clear of tumor involvement, indicating that the excision was complete. Additionally, all three regional lymph nodes examined are free of metastasis, suggesting no detectable spread of the carcinoma to these nodes. These findings collectively provide a comprehensive understanding of the current status of the malignancy, which appears to be localized based on the lack of lymph node involvement."
655,TCGA-66-2754-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of poorly differentiated, non-keratinizing squamous cell carcinoma in the resected right superior pulmonary lobe, characterized by pleural infiltration and hemangioinvasion. The tumor measures 45 mm and demonstrates significant necrosis. The hilar region shows a conglomerate of lymph node metastases, indicative of extensive dissemination. Importantly, the bronchial resection margin is free of tumor involvement, indicating complete surgical resection in those margins. The surrounding pulmonary tissue contains significant anthracosis and sclerosis, with bullous hyperinflation found in the subpleural area. Microscopic analysis confirms the presence of immature, fusocellular, and solid cell structures with high mitotic activity and necrosis. Tumor-free lymph node tissue from L7 shows significant anthracosis and sinus histiocytosis, while metastatic lymph nodes with necrotic decay and sparse lymphatic tissue are identified in L4 and L3. The pathological findings suggest that determining the origin of the squamous cell carcinoma, whether it is metastatic from a clinically indicated esophageal carcinoma or a primary pulmonary carcinoma, is challenging. If it is primary, the tumor stage would be classified as M:8070/3, G3, PT2, PV1, PN2, PMX, Stage IIIA."
656,TCGA-22-4604-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals an invasive grade 3 squamous cell carcinoma located in the left upper lobe of the lung. The centrally situated tumor exhibits significant malignancy, yet crucially, the pleura remains uninvolved. Both the proximal tracheal and distal bronchial margins are clear of tumor presence following sleeve resection. Distal lung segments display post-obstructive organizing pneumonia without evidence of tumor. Metastatic carcinoma is detected in a subset of lymph nodes, specifically three out of eight intrapulmonary peribronchial lymph nodes. Conversely, the left lower lobe margin and multiple lymph nodes from the superior and inferior mediastinal, as well as aortic regions, are devoid of tumor metastasis. Additionally, the lymph nodes in the left lower lobe bronchus are also free of malignancy. These findings collectively suggest localized primary disease with limited regional lymph node metastasis and no distal spread."
657,TCGA-85-A50M-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological evaluation reveals a diagnosis of moderately differentiated squamous cell carcinoma located in the right upper lung lobe. The tumor exhibits ill-defined margins and is characterized by necrotic, grayish soft tissue. Microscopically, the malignant cells are arranged in groups, sheets, or trabeculae and invade adjacent benign bronchial tissue. These cells exhibit moderate eosinophilic cytoplasm; nuclei are enlarged with varying sizes and shapes, containing coarse clumped chromatin and prominent nucleoli, with frequent mitotic figures observed. While lymphocyte invasion is present, there is no evidence of metastatic involvement in the paratracheal, subcarinal, and interlobar lymph nodes examined. Specific tumor margin status and other potential tumor nodules have not been detailed in the findings."
658,TCGA-56-8304-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the right upper lobe lobectomy specimen, accompanied by several lymph node biopsies, revealed a moderately differentiated squamous cell carcinoma. The tumor, characterized by polygonal cells with hyperchromatic and pleomorphic nuclei, exhibited mitotic activity and focal necrosis. Importantly, all surgical margins, including bronchial and vascular margins, were free of tumor involvement. The tumor did not extend into the visceral pleura. There was no evidence of lymphatic or venous invasion. A total of seven lymph nodes were examined, all of which were benign with anthracotic pigment and no evidence of malignancy. Microscopic examination confirmed the absence of malignancy and identified mild lymphoid hyperplasia in some nodes. Additionally, adjacent lung tissue displayed subpleural fibrosis with mild chronic inflammation and focal calcification, without tumor involvement. TNM staging was assigned as pT1b, pN0, pMX."
659,TCGA-77-7337-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings from the left pneumonectomy reveal a moderately differentiated keratinising squamous cell carcinoma that occludes a segmental bronchus in the upper lobe. The tumor is poorly circumscribed, soft, grey and black, with a necrotic center, and extends to the pleura on the hilar surface and the oblique fissure but is clear of the bronchial resection margin and pleura in all sections. Hilar lymph nodes are directly invaded by the tumor, while no lymphatic or vascular invasion is noted. Numerous black lymph nodes around the major segmental bronchi in the lower lobe are described, but the lower lobe parenchyma generally appears normal with only an isolated area of hemorrhage. Secondary obstructive changes such as active airway inflammation and organizing pneumonia are observed in the lung tissue distal to the tumor. The pathological stage is determined to be T2 N1. Additional examination of three separate lymph nodes (No. 5 node) demonstrates reactive changes without evidence of metastatic carcinoma."
660,TCGA-18-3412-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of moderately differentiated squamous cell carcinoma primarily from the left lower lobe of the lung, with evidence of central involvement and invasion into peribronchial fatty tissue. The left lower lobe lobectomy specimen shows a tumor at the bronchial resection margin, indicating positive involvement. However, the examination of 2 lobar peribronchial lymph nodes shows no evidence of tumor. For the left completion pneumonectomy specimen, microscopic residual squamous cell carcinoma is present in the hilar area, but the bronchial resection margin is free of tumor. Additionally, all 4 lobar and 3 segmental peribronchial lymph nodes are negative for tumor, with one pleural lymph node showing a focus of an effete granuloma. There is also focal pleural and parenchymal fibrosis, but the remaining lung parenchyma appears unremarkable. The lymph nodes from lung stations 11L, 12, and the aorto-pulmonary station 5 are all negative for malignancy. With these findings, in conjunction with the negative mediastinal lymph node biopsy results, the tumor is staged as pT2NO cancer."
661,TCGA-60-2716-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of invasive, moderately differentiated squamous cell carcinoma involving both the upper and lower lobes of the left lung, with extensive necrosis and papillary features. The tumor demonstrates significant pathological involvement, with six out of thirteen peribronchial lymph nodes showing metastatic carcinoma, including extranodal extension. Notably, the bronchial margin is free of tumor involvement. Assessment of the mediastinal, hilar, and other regional lymph nodes shows no evidence of metastatic carcinoma across levels 5, 6, 7, 9, and 10, with all nodes exhibiting reactive changes and anthracosis but no malignancy. The pathological staging is categorized as pT2 N1 Mx, indicating a localized tumor with regional lymph node metastasis but no distant metastasis evaluated. The non-neoplastic lung tissue exhibits no pathological abnormalities."
662,TCGA-21-5786-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the right upper lobe lung specimens confirms a diagnosis of squamous cell carcinoma, which exhibits moderate to poor differentiation. The primary tumor is characterized by its invasion into and through the visceral pleura, as well as the involvement of large vessels. No evidence of carcinoma is found at the shaved parenchymal and parietal pleural margins, indicating clear resection margins. Additionally, examination of three excised Level 11 lymph nodes reveals no metastatic involvement. The larger surgical specimen from the right upper lobe lung lobectomy also emphasizes the absence of tumor at the bronchial and vascular margins, while showing background changes of emphysema and focal interstitial fibrosis. Overall, the tumor's pathological stage is classified as pT2 N0 Mx, reflecting a primary tumor that invades the visceral pleura without regional lymph node metastasis."
663,TCGA-85-8352-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pulmonary specimen analysis reveals a diagnosis of squamous cell carcinoma, poorly differentiated, located in the right upper lung. The tumor extends to the visceral pleura, emphasizing its invasive nature. Among the examined lymph nodes, three out of eight are positive for metastatic involvement, specifically the intrathoracical lymph nodes, indicating regional spread of the disease. Critical details such as lymphatic invasion, venous invasion, and margin status are not specified in this examination. No additional tumor nodules or evidence of neo-adjuvant treatment are noted. These pathological findings suggest an aggressive and advanced stage of lung cancer with local and regional dissemination."
664,TCGA-22-4596-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the left upper lobe lung wedge excision revealed a Grade 3 squamous cell carcinoma forming a mass abutting but not directly invading the pleura. The subsequent lobectomy specimen exhibited benign lung parenchyma with three intrapulmonary peribronchial lymph nodes, with no residual tumor observed, and the bronchial margin was negative for malignancy. Examination of the lymph nodes from the inferior mediastinal, aortic, and N1 regions, including subcarinal, paraesophageal, left inferior pulmonary ligament, anterior mediastinal, and left interlobar nodes, showed no evidence of metastatic involvement. Additionally, the tissue submitted as aortopulmonary lymph node contained fibrovascular tissue with no identifiable lymphoid tissue. Overall, the findings indicate a localized primary squamous cell carcinoma with no residual tumor post-lobectomy and no lymph node metastasis."
665,TCGA-85-A50Z-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the lung tissue from a lobectomy specimen reveals a diagnosis of poorly differentiated squamous cell carcinoma located in the lung. The tumor exhibits aggressive histologic features but is confined, as all examined margins are clear of malignant cells. Importantly, none of the six lymph nodes evaluated show evidence of metastasis, suggesting no regional lymphatic spread. These findings are supported by a thorough review, confirming the diagnosis and addressing noted site discrepancies. The history of malignancy and the presence of concurrent synchronous primary lesions have been meticulously verified and classified by the reviewer, providing a comprehensive pathological context."
666,TCGA-66-2778-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment identified a poorly differentiated, large-cell, nonkeratinizing squamous cell carcinoma in the left lower lobe of the lung, predominantly located in segment S10. The tumor demonstrated significant local extension, coming within close proximity to the bronchial resection margin while infiltrating the visceral pleura. Importantly, resection margins of the bronchus and vessels, as well as small parabronchial nodes, were free of malignancy, indicating a margin status of R0. Lymph node examination revealed extensive involvement, particularly in the hilar and parietal nodes, consistent with a classification of pN3. Microscopically, the carcinoma presented with marked cytological atypia, including moderately eosinophilic cytoplasm and anisomorphic nuclei, accompanied by desmoplastic stroma and localized necrosis with granulocytic infiltration. Reactive changes, including chronic organizing retention pneumonia and pleural fibrosis, were observed in the adjacent lung parenchyma and pleura, respectively. The final stage was determined as IIIB, with no distant metastases clearly identified (pT2 pN3 pMX)."
667,TCGA-85-7698-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation indicates a diagnosis of well-differentiated squamous cell carcinoma of the lung, based on a lobectomy specimen. The primary tumor is located within the lung tissue, but specific details regarding the extent of tumor invasion, presence of additional tumor nodules, lymph node involvement, lymphatic invasion, and venous invasion are not provided in the findings. The status of the surgical margins is also not specified. There is no mention of evidence for neo-adjuvant treatment or additional pathological findings. The overall assessment focuses on the histologic type and grade of the primary tumor, without further elaboration on other potential elements that could influence prognosis or therapeutic strategies."
668,TCGA-39-5037-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately to poorly differentiated squamous cell carcinoma of the left lower lobe of the lung. The primary tumor, which was stellate and white-tan in appearance, was situated in the mid-lung parenchyma and demonstrated no evidence of vascular or perineural invasion. Examination of the surgical margins revealed that both the mainstem bronchus and pleura were free of tumor involvement, indicating clear resection margins. The peribronchial lymph node assessment showed metastatic involvement in one of two nodes examined, while all other submitted lymph nodes from left levels ten, eleven, and seven were benign and free of carcinoma. The non-neoplastic lung tissue and the para-aortic adventitia tissue were notably unremarkable. Overall, while the primary lung tumor is aggressive in differentiation, the surgical margins are clear, and lymphatic spread appears minimal."
669,TCGA-77-7335-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of moderately differentiated keratinizing squamous cell carcinoma in the left lung, involving the left main bronchus and infiltrating adjacent pulmonary vessels and parenchyma. The tumor demonstrates extrathoracic extension through the pleura and into the neighboring fibrofatty soft tissue, including nerve fibers, though no perineural invasion is noted. The tumor extends up to the surgical resection margin at certain points, precluding the exclusion of residual microscopic disease. Lymph node analysis shows metastatic involvement in one of the five peribronchial lymph nodes and in the hilar lymph node designated as lesion number 7; however, the hilar lymph node and lymph node designated number 5 are free of malignancy. The bronchial resection margin is clear of tumor. Adjacent non-tumorous lung tissue exhibits scarring and signs of arterial recanalization, likely related to vascular changes from the tumor at the lung hilum. Additional examination of the mediastinal pleura and soft tissue highlights the presence of tumor on the mediastinal pleura and soft tissue around the resected portion of the pericardium, suggesting potential residual microscopic tumor in the mediastinum."
670,TCGA-85-8049-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the pneumonectomy specimen revealed a diagnosis of squamous cell carcinoma located in the lung. The tumor is histologically classified as moderately differentiated, which indicates an intermediate grade of cellular abnormality. Essential details regarding the presence of additional tumor nodules, lymphatic and venous invasion, and margin status are not specified in the findings. Additionally, information about lymph node involvement and evidence of neo-adjuvant treatment is not provided. Overall, the pathology report highlights the presence of a moderately differentiated squamous cell carcinoma, but leaves several critical aspects undetermined, which are crucial for a comprehensive understanding of the disease extent and prognosis."
671,TCGA-60-2714-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of poorly differentiated non-small cell carcinoma, most likely squamous cell carcinoma, located in the right lung. The tumor presents as a 7 x 4 cm peripheral mass in the right lower lobe, extending to the pleural surface but sparing the vascular and bronchial passages. Notably, angiolymphatic invasion is observed. The bronchial margin is clear of tumor involvement, indicating complete resection at that site. Examination of multiple lymph nodes shows two out of seventeen peribronchial lymph nodes positive for carcinoma, confirming N1 lymph node involvement, while other lymph nodes are negative for carcinoma, which includes levels 7, 8, 9, and additional 10R nodes. There is no evidence of visceral pleural involvement, and the pathologic stage is defined as pT2 N1 Mx."
672,TCGA-60-2707-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of moderately differentiated invasive squamous cell carcinoma of the left upper lobe. The tumor was located peripherally and demonstrated no invasion into the visceral pleura, angiolymphatic channels, or perineural spaces. The bronchial margin was free of tumor involvement. Additionally, there was no evidence of malignancy in the examined pleural biopsy. The non-neoplastic lung tissue showed emphysematous changes and subpleural fibrosis. Importantly, all 33 lymph nodes analyzed, which included distal and proximal paratracheal, as well as peribronchial and other regional lymph nodes, were negative for malignancy. Furthermore, a squamous cell carcinoma in-situ arising in association with a bronchus was noted. Overall, the pathological stage was determined to be pT2 N0, indicating a localized tumor without lymph node spread."
673,TCGA-60-2715-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of moderately differentiated squamous cell carcinoma in the left upper lobe of the lung, discovered during a wedge resection. The tumor exhibited a partly anthracotic hemorrhagic firm mass with congested surrounding lung parenchyma and focal emphysematous changes. Following a subsequent left upper lobectomy, no residual carcinoma was identified, including in the bronchial resection margins, which were negative for tumor involvement. Five peribronchial lymph nodes were examined and found to be free of metastatic disease. Additionally, lymph nodes from levels 10 and 5 were analyzed, revealing a total of four lymph nodes negative for tumor infiltration. Immunohistochemical staining for TTF-1 on the tumor cells was negative, adding complexity to whether the lung lesion is primary or metastatic, given the patient's history of squamous cell carcinoma of the larynx."
674,TCGA-60-2704-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is a poorly differentiated squamous cell carcinoma of the lung, located in the right upper lobe and measuring 8x7x6 cm. The tumor is centrally located and does not exhibit angiolymphatic or perineural invasion. All resection margins, including bronchial and visceral pleural margins, are free of tumor involvement. Metastatic involvement is noted in one of the four hilar lymph nodes examined, as well as in one level 4R lymph node, indicating nodal metastasis with a pathologic stage of pT2N2Mx. All other sampled lymph nodes, including those at levels 4L, 7, and 10R, are negative for metastasis. Additionally, a separate lesion in the right middle lobe is identified as a calcified necrotizing granuloma, with special stains negative for acid-fast bacilli and fungal organisms, confirming the benign nature of this lesion."
675,TCGA-85-A4CL-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a poorly differentiated squamous cell carcinoma (G3) localized to the lung, with no evidence of venous or lymphatic invasion. The tumor is grey-white in color and measures approximately 3 x 2 x 2 cm. Surgical margins are uninvolved, indicating complete resection. Examination of the lymph nodes shows no metastasis; specifically, the bifurcational lymph node exhibits anthracosis and the bronchopulmonary lymph nodes display sinus histiocytosis. Additionally, a chondromatous hamartoma, a benign lesion, was identified in the S6 node. There are no signs of neo-adjuvant treatment effects on the tumor."
676,TCGA-85-8277-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of a left-upper lung pulmonectomy specimen reveals a diagnosis of squamous cell carcinoma. The tumor is located in the lung, extending to the visceral pleura. Metastatic involvement is confirmed in all four intrathoracic lymph nodes examined. Tumor margins and other pertinent information, such as histologic grade, lymphatic invasion, venous invasion, and neo-adjuvant treatment, were not specified. These findings indicate an advanced and aggressive malignancy, suggesting a need for thorough clinical evaluation and potential adjuvant therapy."
677,TCGA-37-5819-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal a diagnosis of lung adenocarcinoma located in the upper right lung. The tumor exhibits moderate differentiation, reflected by a histological grade of 2. According to the TNM staging system, the tumor is classified as T2, indicating a moderate size and/or extent of primary tumor, with N2 denoting regional lymph node involvement. There is, however, no distant metastasis (M0). The tumor tissue sample, weighing approximately 450 mg, was preserved in a frozen cryomold. The cellularity of the tumor is estimated at 70%, indicating a relatively high proportion of cancerous cells within the specimen. Prior to this analysis, the patient did not undergo any chemo or hormonal therapy, as indicated by the provided clinical history. Margin status and further specific histological features weren't detailed in the provided data, but regional lymph node involvement suggests a need for thorough surgical resection and possible adjuvant therapy."
678,TCGA-33-AASD-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a moderately differentiated infiltrating squamous cell carcinoma in the right lower lobe, without evidence of tumor involvement in the visceral pleura, bronchial margin, or vascular margin. Additionally, there are scattered necrotizing granulomas present, although special stains for mycobacteria and fungus are negative. Analysis of a lymph node from station 7 and a lymph node from level 9 confirms that neither retains any tumor cells. The tumor is centrally located within the lung tissue, is well-demarcated from the surrounding parenchyma, and exhibits typical characteristics of such lesions, including a firm gray/white appearance. Notably, the uninvolved lung parenchyma displayed focal mucous plugging but was otherwise unremarkable. Other relevant findings include the presence of beefy red parenchyma and a description of identifiable vessels and airways near the stapled margins. Based on these observations, the pathologic stage is determined to be T1 N0 MX, in the context of a clinical history indicating squamous carcinoma of the lung."
679,TCGA-43-6773-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of moderately differentiated squamous cell carcinoma located in the right lower and middle lobes of the lung. The primary tumor demonstrates a histological mix of nonkeratinized squamous cells with minimal glandular differentiation. Significant findings include tumor invasion into a major bronchus and lymphatic space, but no evidence of invasion into large vessels or pleura. Surgical margins, including the bronchial stump and pleural surfaces, are free of tumor involvement. Among the seven hilar lymph nodes examined, one shows metastatic squamous cell carcinoma with signs of both direct extension and lymphatic invasion. All other separately submitted lymph nodes, including those from L4, R4, level 10, and subcarinal regions, are negative for malignancy. Additionally, intrapulmonary spread of the tumor, emphysema, chronic bronchitis, and a focal area of pulmonary infarction or organizing pneumonia are noted, along with pulmonary hemorrhage and edema in the middle lobe. The pathological stage is complicated by the potential for distant metastasis, which could not be fully assessed (pMX)."
680,TCGA-85-8052-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of lung tissue from a right upper lobectomy revealed a diagnosis of squamous cell carcinoma, which was moderately differentiated. The tumor, located in the lung, exhibited characteristics consistent with this histologic type. The report did not specify the extent of the tumor nor the presence of additional tumor nodules, lymphatic invasion, or venous invasion. Furthermore, there were no details provided regarding margin status, lymph node involvement, or any evidence of neo-adjuvant treatment. No additional pathologic findings or comments were noted in the examination."
681,TCGA-21-1082-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The finalized pathological evaluation reveals a diagnosis of poorly differentiated (Grade III) non-keratinizing squamous cell carcinoma located in the left lower lobe of the lung. The tumor exhibits moderate necrosis and has invaded into but not through the pleura. Importantly, there is no evidence of lymphatic, venous, or arterial invasion. The surgical resection margins, including the bronchial and vascular margins, are free of tumor involvement. A total of eleven lymph nodes were examined across various regions, including L11, peribronchial, level 7, and the pulmonary artery level 5 lymph nodes, and all were negative for metastatic disease. Additionally, no extracapsular extension of the tumor was observed in any lymph nodes. The non-neoplastic lung tissue displayed emphysema, and staging of the tumor is designated as T2."
682,TCGA-85-8355-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the left upper lung lobe revealed a diagnosis of squamous cell carcinoma, displaying a moderately differentiated histologic grade (G2) with keratinization tendencies. The tumor was localized in the bronchus and was of substantial size. Surgical margins were clear of malignancy. Examination of twelve peribronchial lymph nodes showed no evidence of metastatic involvement, with findings limited to anthracosis and sinus histiocytosis. There was no evidence of venous invasion, and other potential pathological markers, such as lymphatic invasion or the effects of neo-adjuvant treatment, were not specified. The specimen received was a lobectomy of the affected region."
683,TCGA-63-A5MN-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The specimen from the right upper lobe reveals a diagnosis of squamous cell carcinoma, not otherwise specified (NOS). Histologically, the tumor is classified as a grade III squamous carcinoma, indicating a poorly differentiated neoplasm. The pathological staging of the tumor is T3, with no clinical evidence of distant metastasis (M0). An important finding to note is the status of the surgical margins and the extent of lymph node involvement, both of which are critical in determining the prognosis and guiding further treatment; however, these details are not specified in this summary. The presented pathological characteristics underscore a relatively advanced and aggressive form of squamous cell carcinoma, emphasizing the need for a comprehensive treatment approach."
684,TCGA-77-A5FZ-01Z-00-DX1,LUSC,"Please generate a comprehensive and professional pathology report based on the provided slide from Lung, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of moderately differentiated papillary squamous cell carcinoma, which is characterized by a cavitating, well-circumscribed tumor abutting the pleural surfaces of the lung and measuring 45 mm at its largest dimension. The bronchial resection margin and stapled parenchymal resection margin are free of malignancy, with the tumor being at least 15 mm away from the latter. The surrounding lung parenchyma shows signs of emphysema. No lymph node metastases are identified, and there is no evidence of blood vessel, lymphatic, or perineural invasion. The tumor exhibits pleural invasion and focal involvement of mediastinal fat with a pushing margin, but does not directly infiltrate the hilar lymph nodes, which display only reactive changes. The bronchial resection margin shows chronic inflammation but no signs of malignancy, while adjacent lung tissue also exhibits chronic inflammation and emphysema."
685,TCGA-AH-6544-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal that the liver biopsy shows metastatic adenocarcinoma consistent with a primary origin in the colon. Examination of the rectosigmoid colon resection identifies a moderately differentiated adenocarcinoma (G2). The tumor invades through the muscularis propria into subserosal adipose tissue and demonstrates lymphovascular space invasion. Surgical margin analysis confirms negative proximal, distal, and radial margins, with the closest margin being at the radial margin. A total of 20 lymph nodes were examined, of which 3 contained metastatic carcinoma, indicating lymph node involvement. Genetic testing reveals the tumor is microsatellite stable (MSS) with no mutations detected in DNA mismatch repair genes associated with Lynch Syndrome. The tumor tests positive for KRAS mutation (codon 12 GGT>GTT), which may influence treatment options, particularly with resistance to anti-EGFR therapy. The PIK3CA mutation was not detected. Overall, the pathology supports a diagnosis of adenocarcinoma with evidence of metastasis to the liver, lymphovascular invasion, and lymph node metastases, and the patient's disease is staged as pT3 N1 M1."
686,TCGA-F5-6465-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings indicate a diagnosis of moderately differentiated adenocarcinoma located at the rectosigmoid junction. The tumor displays ulceration and has extended into the perirectal tissues. Importantly, all resection margins are uninvolved, indicating that the tumor has not spread to the edges of the excised tissue. Additionally, none of the twelve examined lymph nodes show evidence of metastasis. Overall, these findings suggest that while the tumor has demonstrated local invasive characteristics, there is no regional lymphatic spread, and the surgical margins are clear of malignant cells."
687,TCGA-AG-3593-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed fibrosis and chronic inflammation in the excised soft tissue of the abdominal wall, with no evidence of carcinoma. The resected part of the colon and rectosigmoid colon demonstrated an ulcerated, moderately differentiated colorectal adenocarcinoma, extensively infiltrating all layers of the intestinal wall and the adjacent periproctic fatty tissue, indicative of deep local invasion. The tumor was identified as necrotic and encircled a significant length of the intestinal wall, with a minimum distance of 2 mm from the soft tissue resection margin. Crucially, both the oral and aboral resection margins, as well as the sections of the intestine adjacent to the vaginal section and uterus, were free of tumor involvement. Additionally, the uterus showed epidermoid glandular portio ectopy and mild chronic cervicitis, along with cystic atrophy of the endometrium and the presence of small intramural leiomyomas. The sigmoid colon exhibited chronic peridiverticulitis with scarring and individual pseudodiverticula. Importantly, all 38 examined periproctic and mesocolic lymph nodes were free of tumor, containing only non-characteristic reactive changes. The tumor was staged as pT3, pN0, with no evidence of lymphovascular invasion and graded as G2."
688,TCGA-EF-5830-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis is colorectal cancer, specifically an adenocarcinoma located in the rectum. The primary tumor tissue was examined from a frozen cryomold specimen, and the tumor exhibited a histological grade of 3. Pathologically, the tumor is characterized by a high cellularity of approximately 70%. The TNM staging indicates a T3 category, suggesting significant tumor penetration into the bowel wall. However, there is no evidence of lymph node involvement (N0) or distant metastasis (M0). The margin status was not detailed, and there is no information regarding prior chemotherapy, hormonal therapy, or radiation treatment. Additionally, a normal blood specimen was obtained in a frozen tube, but it offers no pertinent pathological findings related to the tumor."
689,TCGA-DC-6160-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the segmental resection of the rectum and rectosigmoid reveals three foci of moderately differentiated adenocarcinoma, characterized by a polypoid gross configuration. These tumors exhibit varying degrees of invasion: two smaller tumors are confined to the submucosa (pT1), while the largest extends into the muscularis propria (pT2). No evidence of vascular or perineural invasion is present. Importantly, the surgical margins are free of tumor, indicating complete resection. Additionally, a preexisting tubular adenoma and a hyperplastic polyp are identified, with the surrounding colonic mucosa appearing unremarkable. A total of sixteen lymph nodes were examined across all submitted specimens, with no metastatic involvement detected (0/16, pN0). The additional segmental resection of the sigmoid shows a hyperplastic polyp and an unremarkable colonic mucosa, along with one benign lymph node. Excision specimens from the proximal and distal rings also show unremarkable colonic mucosa, without any pathological abnormalities."
690,TCGA-AF-A56N-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the excised tissue from a patient diagnosed with rectal cancer reveals several key findings. The uterus, bilateral ovaries, and fallopian tubes obtained from a supracervical hysterectomy display a benign inactive endometrium, benign leiomyomata in the myometrium, and no abnormalities in the serosa, ovaries, or fallopian tubes. The rectum and sigmoid colon excision exhibits a moderately differentiated adenocarcinoma that invades perirectal and colonic fat, classified as pT3. Crucially, resection margins are free of malignancy, indicating successful surgical clearance, and all 33 examined lymph nodes tested negative for malignancy, corresponding to pNO. The appendix is benign, displaying mucosal lymphoid hyperplasia within normal limits. Histologically, the adenocarcinoma shows moderate differentiation with no vascular invasion nor non-lymph node pericolonic tumor presence. The primary tumor is notable for surface ulceration, and associated acute and chronic inflammation, resembling Crohn's-like inflammation beneath the tumor. No distant metastasis assessment is applicable in this context. Overall, the pathological findings confirm localized invasive adenocarcinoma with negative margins and no lymph node involvement, suggesting a potentially favorable prognosis with respect to surgical management."
691,TCGA-AG-A01J-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological assessment reveals two distinct findings. First, there is mildly fibrosing cholecystitis associated with clinically indicated cholecystolithiasis. Second, the analysis of the resected rectosigmoidal tissue identifies an ulcerated, moderately differentiated adenocarcinoma of the colorectal type. The carcinoma is noted to infiltrate the pericolic fatty tissue and is situated 1 cm from the aboral resection margin. Importantly, all other resection margins, including the circumferential, colon, and mesocolic margins, are free of tumor involvement. Lymph node analysis shows no metastatic involvement (0 out of 23 lymph nodes). The tumor is classified as pT3 pNO pMX, with a grade of G2, indicating moderate differentiation. Additionally, there are no lymphatic (L0) or vascular (V0) invasions, and the resection margins are clear (R0). Overall, these findings suggest a localized, moderately differentiated adenocarcinoma without evidence of lymph node metastasis or distant spread."
692,TCGA-AF-2687-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination confirmed a diagnosis of moderately differentiated adenocarcinoma located in the rectosigmoid region. The tumor was found to be invading through the muscularis propria and extending into the pericolonic fat, classifying it as a pT3 lesion. Importantly, the resection margins, including proximal, distal, and circumferential (radial) margins, were all negative for tumor involvement, with the closest margin being 3 cm from the tumor. Lymph node analysis revealed metastatic adenocarcinoma in 6 out of 16 examined lymph nodes, indicating a pN2 stage of lymph node involvement. The largest metastatic focus measured 1.6 cm. There was no evidence of vascular invasion, and while non-lymph node pericolonic tumor presence was identified, it was very focal. Some diverticula were noted with minimal changes and no significant inflammation. The specimen also showed surface ulceration and stromal sclerosis with mild tumor-infiltrating lymphocytes. Overall, the pathological findings indicate an invasive adenocarcinoma with moderate regional lymph node metastasis but clear resection margins."
693,TCGA-AG-A00C-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a rectosigmoid amputation specimen with a moderately differentiated adenocarcinoma of the colorectal type, presenting as an ulcerated lesion immediately above the dentate line. The tumor infiltrates the perirectal fatty tissue and demonstrates regional lymph node involvement with one out of twenty-four lymph nodes showing metastasis. The tumor does not involve the circumferential resection margin, provided that the minimum distance is 0.6 cm, while the oral, aboral, and mesenteric resection margins are all free of tumor. The pathological staging is indicated as pT3 pN1 pMX, with a histopathological grade of G2. Additionally, lymphovascular invasion is present (L1), but no venous invasion is noted (V0)."
694,TCGA-EI-6512-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the resected specimen from the colon and rectum has led to a diagnosis of adenocarcinoma tubulare of the rectosigmoid junction. Macroscopically, the specimen revealed a cauliflower-shaped ulcerous tumor completely encircling the circumference of the intestine. Microscopically, the tumor demonstrates characteristics consistent with a moderately differentiated (G2) tubulopapillary adenocarcinoma, with infiltration into the pericolonic adipose tissue, indicating local invasion. Importantly, the resection margins are free of neoplastic involvement, signifying that the tumor has been excised completely. However, metastatic involvement is evident in one of the seventeen examined lymph nodes, placing the pathological stage at pT3, pN1, consistent with Dukes C and Astler-Coller C2 staging classifications. Such findings highlight the necessity for meticulous postoperative management to address the presence of metastatic disease."
695,TCGA-AG-3574-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the rectal resection specimen revealed an ulcerated moderately differentiated colorectal adenocarcinoma. The tumor extends through all layers of the rectal wall and up to the periproctic soft tissue. Importantly, the tumor does not reach the oral and aboral resection margins, indicating clear margins. Examination of 18 periproctic and pericolic lymph nodes showed no evidence of metastatic involvement, although reactive lesions were noted. The tumor is classified as stage pT3 pN0 (0/18) LO V0, and graded as G2, indicating a moderately differentiated adenocarcinoma without lymphovascular or perineural invasion."
696,TCGA-AG-3742-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The diagnosis indicates a moderately differentiated adenocarcinoma of the colon (G2), characterized by tumor infiltration through all parietal layers, consistent with a pathological stage of pT3, and showing evidence of lymph vessel invasion (L1). Notably, the carcinoma demonstrates lymph node metastases, classified as pN2. The examination of the resection margins in relation to both the mucosa and submucosa, as well as the anastomosis rings, reveals no residual tumor, indicating that the resection margins are free of malignancy. These findings suggest that, despite the evidence of metastatic disease in the lymph nodes, the surgical margins were adequately clear of the carcinoma."
697,TCGA-AG-3599-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of rectal carcinoma, characterized as a moderately differentiated, partly mucinous colorectal adenocarcinoma. The tumor demonstrates invasion up to the muscularis propria. All resection margins, including oral and aboral margins, as well as isolated sections of the intestine and colon, are free of tumor involvement. Initial findings reported seven mesocolic and perirectal lymph nodes, all of which were non-characteristically reactive and tumor-free. Further retrospective examination of five additional small perirectal and mesocolic lymph nodes also confirmed the absence of tumor cells. The final tumor staging is pT2 pNO with no lymph node involvement (0/12 total nodes examined) and no lymphovascular invasion. Histological grading classifies the carcinoma as grade 2 (G2)."
698,TCGA-AG-4022-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal an invasive, moderately differentiated rectal adenocarcinoma (G2) with penetration of all parietal layers, classified as pT3. The tumor demonstrates notable characteristics such as lymphatic involvement and evidence of venous invasion, indicated by the L1 and v1 statuses, respectively. The margins of resection appear to be free of tumor involvement, suggesting that surgical excision effectively removed the primary tumor mass without leaving residual malignant tissue at the cut edges. Additionally, lymph node examination shows signs of metastasis, underscoring the presence of disease spread beyond the primary tumor site. These findings collectively underscore the aggressive nature of the carcinoma and its potential for dissemination, necessitating comprehensive oncological management."
699,TCGA-AG-3598-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the resected colon and rectal material reveals a moderately differentiated adenocarcinoma characterized by an ulcerated surface. The tumor has infiltrated into the perimuscular adipose tissue but does not show involvement of the resection margins, indicating clear margins. Importantly, there is no evidence of regional lymph node metastasis, with all examined nodes being free of tumor cells. Additionally, there are no signs of lymphovascular invasion. The overall pathology staging suggests a moderately advanced but non-metastatic tumor, classified as G2, pT3, pN0, with all lymph nodes (0/65) being negative for metastatic involvement, and no lymphatic (L0) or vascular (V0) invasion, confirming the resection with clear margins (RO)."
700,TCGA-AG-A014-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected rectosigmoid colon section reveals an ulcerated rectal carcinoma histologically identified as a poorly differentiated colorectal adenocarcinoma. The tumor has invasively spread into the muscularis propria and extends close to the aboral resection margin. Both the oral and aboral resection margins are free from tumor involvement. Examination of 15 local lymph nodes showed no evidence of tumor metastasis, although they exhibited reactive changes. The surrounding sigma demonstrated individual pseudodiverticula with mild, chronically scarring peridiverticulitis. The tumor is staged as pT2 pN0 (0/15) L0, V0, with a grade of G3 and a resection status of R0, indicating a clear resection margin."
701,TCGA-AH-6897-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the resected sigmoid colon and rectal segment reveals an invasive adenocarcinoma, moderately differentiated, with the tumor extending into the muscularis propria. The tumor presents as an infiltrative mass with raised edges, occupying approximately 60% of the circumference of the distal segment. The proximal, distal, and circumferential (radial or mesenteric) margins are free of carcinoma, with the closest margin being the radial margin at a distance of 3 cm from the tumor. There is no histologic evidence of macroscopic tumor perforation, microsatellite instability, lymph-vascular invasion, perineural invasion, or tumor deposits. Fourteen regional lymph nodes were examined, all of which are benign and negative for metastatic adenocarcinoma. The pathologic staging of the tumor is pT2N0, with the tumor invading the muscularis propria without regional lymph node metastasis. There are no additional pathological findings, and no ancillary studies were performed."
702,TCGA-AG-3731-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination of the rectal resection specimen reveals a moderately differentiated adenocarcinoma (G2) located in the distal rectum. The tumor demonstrates superficial infiltration into the perirectal fatty tissue, corresponding to a pathological stage of pT3. The surgical resection margins, including oral, aboral, and perirectal, were found to be free of tumor involvement, indicating clear margins. Additionally, an in-depth examination of 34 lymph nodes in the pericolic fatty tissue identified three nodes with metastatic adenocarcinoma, resulting in a pathological nodal stage of pN1 (3/34). Consequently, the overall staging of this rectal adenocarcinoma is pT3 pN1, reflecting both the primary tumor's invasive characteristics and the lymphatic dissemination."
703,TCGA-AG-A02X-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a rectal carcinoma, moderately differentiated (G2), infiltrating the muscularis (pT2), with evidence of lymphatic (L1) and vascular invasion (V1). Despite these invasions, the resection margins are clear, indicating that the tumor was completely excised locally. Additionally, the lymph nodes examined are free of metastatic disease (pN0), and the anastomosis ring also remains free of tumor involvement. The accompanying reactive lesions in the lymph node are acknowledged without further implication in terms of malignancy. The tumor is classified under ICD-O-DA M-8140/3, G2, pT2, L1, V1, pN0, confirming the comprehensive removal and current non-involvement of adjacent lymphatic structures."
704,TCGA-DC-5869-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of moderately differentiated adenocarcinoma located in the rectum. The tumor shows extensive budding and originates from a tubular adenoma, invading into the perirectal soft tissue. There is no evidence of gross tumor perforation, lymphovascular invasion, large venous invasion, or perineural invasion. Importantly, the surgical margins are clear of tumor involvement, with sufficient distance from both distal and deep (radial soft tissue) margins. Examination of the proximal and distal margins reveals benign tissue with no pathologic abnormalities. Among the 19 lymph nodes examined, one shows metastatic involvement, classifying the cancer as stage pT3N1 according to AJCC criteria. The non-neoplastic bowel and mucosal tissue away from the carcinoma appear unremarkable, and there are no tumor deposits in the pericolorectal soft tissue. Overall, these findings indicate a localized but invasive rectal adenocarcinoma with limited lymph node metastasis."
705,TCGA-EI-6510-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination of the partially resected rectum and sigmoid colon reveals a diagnosis of tubulopapillary adenocarcinoma of the rectum, classified as grade 2. The tumor exhibits expansive cauliflower-shaped growth, encircling approximately 80% of the intestinal circumference and infiltrating deep into the muscular layer of the rectal wall. Despite the aggressive infiltration, both surgical margins are clear of neoplastic involvement. Additionally, a tubulopapillary adenoma with low-grade dysplasia is observed near one of the resection ends. Reactive lymphadenitis is identified, but there is no evidence of metastatic carcinoma in the examined lymph nodes. Supplementary tests reveal signs of fatty tissue infiltration. Given these findings, the tumor staging is classified as pT3, pN0, corresponding to Dukes B, Astler-Coller B2."
706,TCGA-AG-4015-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the resected colon sample reveals a diagnosis of moderately differentiated adenocarcinoma, identified as G2. The tumor demonstrates an ulcerated appearance and has infiltrated the perimuscular fatty tissue, corresponding to a pT3 staging. Importantly, the resection margins, including oral, aboral, and perirectal, are tumor-free, indicating clear margins (RO). Lymphatic invasion is present (L1); however, there is no vascular invasion (vo). Additionally, all examined lymph nodes are negative for metastatic involvement, with none of the 24 lymph nodes showing evidence of tumor cells (pNO 0/24). These findings are essential for determining prognosis and guiding further treatment."
707,TCGA-AG-A011-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a resectate of the rectum harboring a mainly poorly differentiated adenocarcinoma, which has infiltrated the pericolic fatty tissue. The resection margins are free of tumor cells, indicating that the surgical excision was complete. Additionally, none of the fourteen examined lymph nodes show any signs of metastatic involvement, confirming no lymphatic spread. The tumor is classified as G3 adenocarcinoma, staged as pT3 N0 with no lymphovascular invasion or residual tumor. Moreover, a section of superficial splenic tissue displays capsule defects and hemorrhaging, but there is no evidence of malignancy within the spleen. Overall, these findings suggest a high-grade but localized rectal adenocarcinoma with successful surgical margins and absence of both lymph node metastasis and distant splenic involvement."
708,TCGA-AG-3600-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of moderately differentiated adenocarcinoma of the colorectal type, exhibiting significant infiltration into the pericolic fatty tissue. Metastatic involvement is extensive, with metastases found in 30 regional lymph nodes. Despite the presence of metastatic disease, the colon resection margins and mesenteric resection margin are free of tumor infiltration, and the minimum distance from the tumor to the circumferential resection margin is 1 cm. Additionally, peritoneal fatty tissue displays necrosis, indicative of a chronic process. The pathological stage of the tumor is classified as pT3 pN2, with 31 out of 45 lymph nodes involved, and grading as G2. Lymphovascular invasion (L1) is noted, but no venous invasion (V0) is observed, and certain parameters remain undetermined (pMX, RX)."
709,TCGA-DC-6156-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an invasive adenocarcinoma of the sigmoid colon, specifically the rectosigmoid region. The tumor is moderately differentiated and has extensively budded, with no increased tumor-infiltrating lymphocytes or precursor lesions identified. The deepest invasion reaches the serosal surface without gross perforation. Lymphovascular and large venous invasion is suspected, and perineural invasion is confirmed. Importantly, the surgical margins are free of the tumor. Inspection of the lymph nodes revealed metastasis in seven out of twenty-two examined nodes. The staging is pT4a, indicating tumor penetration to the surface of the visceral peritoneum, and N2b, reflecting metastasis in seven or more regional lymph nodes. While the proximal and distal colonic rings of resected tissue were benign, metastatic adenocarcinoma consistent with a colonic primary was found in the umbilical hernia sac. Non-neoplastic bowel tissue appeared unremarkable, and no dysplastic polyps were detected away from the carcinoma."
710,TCGA-EI-6506-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological analysis reveals a diagnosis of tubular adenocarcinoma (G2) in a partial resection of the large intestine, specifically affecting the distal sigmoid colon and proximal rectum. The tumor is characterized as a flat-elevated, cauliflower-shaped lesion occupying the mucosa and surrounding 90% of the intestinal circumference, which significantly narrows the intestinal lumen. It demonstrates macroscopic invasion into the peri-intestinal tissue. Microscopically, the carcinoma infiltrates the tunica muscularis propria and peri-intestinal adipose tissue. Importantly, the resection margins are clear, with the minimum side margin being 2.3 cm. The incision lines are also free of neoplastic lesions. The lymph nodes exhibit reactive lymphonodulitis without evidence of metastatic involvement. Additionally, the rings from the sigmoid colon-rectum anastomosis show no invasion by cancer cells. The final pathological staging is pT3 pN0, classified under Dukes B and Astler-Coller B2."
711,TCGA-EI-6507-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological examination reveals a diagnosis of mucinous adenocarcinoma of the rectum, classified as grade 3 (G3) and staged as Dukes B, Astler-Coller B2, pT3, and pN0. The tumor exhibits ulcerous, cauliflower-like morphology and infiltrates the entirety of the intestinal circumference, causing luminal narrowing. Notably, the malignant infiltration extends through the muscularis propria into the mesorectal adipose tissue. The surgical margins are clear of neoplastic involvement, ensuring an R0 resection. Additionally, examination of the lymph nodes reveals reactive lymphonodulitis without evidence of metastatic disease. The pathological findings indicate a locally advanced carcinoma with no lymph node involvement, contributing to the comprehensive assessment and subsequent management plan."
712,TCGA-AG-4009-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of rectal adenocarcinoma with moderate differentiation (G2). The tumor demonstrates significant infiltration into the muscularis propria (pT2) and presents with vascular invasion (L1, V1). Importantly, there are clear resection margins across all examined regions, including the mucosal area, submucosa, muscularis, and deep resection margin, indicating that the excised tissue edges are free of tumor invasion. Lymph nodes present in the regular circumferential fatty connective tissue are not involved, with 0 out of 16 nodes affected, signifying no lymph node metastasis (pNO). Overall, the tumor is classified as ICDO-DA-M 8140/3, stage G2, pT2, L1, V1, pNO (0/16), with the resection considered locally RO, indicating complete removal with no residual tumor at the resection margins."
713,TCGA-EI-6883-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The histopathological evaluation of the resected segment of the large intestine reveals a diagnosis of tubular adenocarcinoma of the rectum, classified as a moderately differentiated grade 2 (G2) tumor. The tumor presents as a button-like lesion infiltrating the mesorectal adipose tissue and encircling 90% of the intestinal circumference. Despite its proximity to the resection margins, with the minimum margin being 2.1 cm, the incision lines are free from neoplastic lesions, indicating clear margins (R0 resection status). There is no evidence of lymph node metastasis (pN0), though reactive lymphadenitis is noted, pointing to localized immune response without cancerous involvement. The tumor is staged as Dukes B and Astler-Coller B2, with a pathological stage of pT3, reflecting its invasion into the surrounding tissues but absence of distant metastatic spread."
714,TCGA-AH-6644-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The final pathological diagnosis reveals an adenocarcinoma, specifically located in the rectosigmoid colon, categorized as well-differentiated. The tumor, which was circumferential in nature, penetrated through the muscularis propria but did not exhibit lymphovascular invasion. Surgical margins were determined to be clear with negative proximal, distal, and circumferential margins. The closest tumor margin was 3 cm from the distal margin. Lymph node analysis showed no evidence of metastatic carcinoma across thirteen examined nodes, including the two additional nodes identified upon further examination at the surgeon's request. Hence, the overall pathological staging was designated as pT3. Additional examination of sigmoid colon rings did not reveal any malignancy."
715,TCGA-AG-3906-01Z-00-DX1,READ,"Please generate a comprehensive and professional pathology report based on the provided slide from Rectum, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a resected rectosigmoid specimen containing a centrally ulcerated, moderately differentiated adenocarcinoma of the colorectal type. The tumor demonstrates deep infiltration into the tunica muscularis propria, reaching the border of the perirectal fatty tissue. Importantly, all resection margins, including the colon and mesenteric margins, are free of tumor cells. Examination of the local lymph nodes indicates no evidence of metastatic involvement, with all 26 lymph nodes tested being tumor-free. The tumor is staged as pT2, pN0, pMX, indicating local invasion without lymph node metastasis, and is classified as moderately differentiated (G2) with no lymphovascular invasion (L0, V0). The resection is deemed complete with clear margins (R0)."
716,TCGA-GN-A269-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation revealed a diagnosis of malignant melanoma with a superficial spreading type and a dominant ulcerated vertical growth phase nodule on the back, classified as Clark's level V and exhibiting a thickness of at least 5 cm. The melanoma demonstrated non-brisk tumor-infiltrating lymphocytes, a mitotic rate of 1.60/mm, and prominent vertical growth accompanied by necrosis. Vascular and lymphatic invasion was noted, and ulceration was present, but there was no evidence of regression or precursor lesions. Two satellite lesions were identified, one involving the inferior lateral margin and another adjacent to the deep margin. The surgical margins are involved due to the satellite lesions. Lymph node analysis showed micrometastatic malignant melanoma in one out of one sentinel lymph node from the right axilla, while the left axilla lymph node exhibited reactive hyperplasia with diffuse melanosis and no tumor. Fibroadipose tissue from the lymphatic sampling showed no lymphoid tissue or tumor. Immunohistochemistry of the positive lymph node was positive for S-100 and HMB-45. The pathological stage is classified as pT4b N3 Mx."
717,TCGA-EB-A431-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis reveals a diagnosis of nodular melanoma located in the skin. The tumor presents as an ulcerated lesion and extends to a depth categorized as Level III according to Clark's classification. The excised tumor has clear and uninvolved surgical margins, indicating that no residual tumor cells were detected at the edges of the excised tissue. Examination of the regional lymph nodes reveals no evidence of metastatic involvement. Additionally, there are no signs of vascular or perineural invasion. The overall findings suggest a primary skin melanoma with a good prognosis due to clear margins and the absence of lymph node metastasis."
718,TCGA-EB-A41B-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of nodular melanoma on the shoulder, characterized by pigmented ulceration and infiltration by spindle cells. The tumor shows a Breslow's depth of 2.8 cm and is classified as Clark's level V, indicating deep dermal invasion. Despite the poor differentiation of the tumor cells, the excision margins are clear of cancerous involvement. Lymphatic invasion is present, suggesting potential for metastasis, although there is no evidence of venous invasion. The histologic analysis underscores the aggressive nature of the melanoma, necessitating further clinical management due to the significant depth and level of invasion."
719,TCGA-BF-A1PZ-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of melanoma in a Caucasian female. The primary tumor tissue, obtained from the skin, exhibits high tumor cellularity with notable histological features consistent with melanoma. The histological grade is reported as advanced, indicating aggressive tumor characteristics. Margins are not explicitly detailed, suggesting a need for further clinical assessment to determine the extent of resection adequacy. Lymph node involvement is absent, as suggested by the TNM staging, which identifies a tumor classification of T4, N0, M0, indicating a large primary tumor with no regional lymph node metastasis and no distant metastasis. The specimen exhibits significant tumor cell content, approximately 90%, spotlighting the robustness of the malignant cellular population within the sampled tissue. No prior chemotherapy or hormonal therapy is noted, emphasizing a potentially treatment-nave status for this patient. The findings underscore the necessity for comprehensive clinical management and potential adjunct therapies given the advanced nature of the tumor."
720,TCGA-D3-A5GT-06Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation of the right inguinal and right iliac/obturator contents revealed an invasive melanoma of the superficial spreading type, classified as Clark level IV with a Breslow thickness of 10.0 mm. The tumor exhibited both radial and vertical growth phases, with a high mitotic rate and notable features such as ulceration, focal regression, vascular invasion, and microscopic satellitosis. Notably, the surgical margins were free of malignancy. Metastasis was identified in two of ten right inguinal lymph nodes and in two of seven iliac and obturator lymph nodes, with extracapsular extension present in the inguinal nodes. The largest metastatic tumor deposit in the right inguinal nodes measured 40.0 x 35.0 mm, while in the iliac and obturator nodes, it measured 12.0 x 10.0 mm. These findings underscore the aggressive nature of the melanoma and its propensity for lymphatic spread, highlighting the critical need for comprehensive therapeutic management."
721,TCGA-EB-A6QY-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed a diagnosis of malignant melanoma of the skin, located on the shoulder. The tumor exhibited ulceration and pigmentation with a Breslow thickness of 10 mm, indicating a significant depth of invasion. Importantly, the resection margins were clear of malignancy, showing normal tissue structure, which suggests that the excision was complete. There was no evidence of venous invasion, and details regarding lymphatic invasion, lymph node involvement, and the presence of satellite nodules were not specified. Overall, the findings highlight an ulcerated malignant melanoma with considerable invasion but clear surgical margins, which are crucial factors in guiding further treatment and prognosis."
722,TCGA-EB-A5SE-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathology findings reveal a diagnosis of nodular melanoma located on the trunk. The tumor is characterized by being multicentric with satellite nodules present. Histologically, the melanoma demonstrates two distinct levels of invasion: the larger nodule exhibits a fourth level of invasion, while the smaller nodule shows a second level of invasion. The Breslow thickness of the main tumor is noted to be 4.0mm. Although the margins and lymph node involvement are not specified, the presence of multicentric features and satellite nodules indicates a potentially aggressive behavior. No additional pathological findings were noted beyond these primary observations."
723,TCGA-BF-AAOX-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals an epithelioid melanoma diagnosed from a pigmented skin sample resected from the right hand of a male patient. The tumor displays a mushroom-shaped growth pattern with notable ulceration. It is classified as Clark level IV with a Breslow thickness of significant depth, corresponding to Stage IIC, with a T4 designation. Importantly, there is no evidence of lymph node involvement (N0) or distant metastasis (M0). The tumor margins, however, are not explicitly mentioned, necessitating potential further evaluation. The aggressive characteristics of the melanoma, including its depth and ulceration, indicate a higher risk profile and underscore the need for vigilant monitoring and management."
724,TCGA-EB-A24C-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings reveal a diagnosis of malignant melanoma located on the trunk of the skin. The tumor is characterized by ulceration and pigmentation, indicating an aggressive phenotype. Histological examination confirms the absence of venous invasion, suggesting the tumor has not infiltrated the local vasculature. Importantly, the surgical margins are uninvolved, indicating that the excision successfully removed the tumor with clear boundaries. These findings are crucial for determining the prognosis and guiding further treatment options."
725,TCGA-EB-A430-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological analysis of the excised skin lesion from the trunk reveals a diagnosis of nodular melanoma, characterized by its poorly differentiated and ulcerated appearance. The tumor is also pigmented and has invaded the reticular dermis, reaching Clark's level IV. Despite the significant depth of invasion indicated by a Breslow's depth of 1.8 cm, there is no evidence of venous invasion. Importantly, the surgical margins are uninvolved, suggesting complete excision of the tumor. No lymph node involvement was reported. This detailed assessment underscores the aggressive nature of the melanoma, while also highlighting the successful excision with clear margins."
726,TCGA-EB-A551-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination revealed an amelanotic melanoma of the skin on the leg, characterized by a mushroom-like, ulcerated tumor with a Breslow thickness of 10 mm, indicating extensive invasion into the subcutaneous tissue (Clark's level V). The melanoma exhibited perifocal lymphoid infiltration, suggesting an immune response. Notably, six lymph nodes were assessed, with two demonstrating metastatic involvement. The margins of the excised specimen were clear of tumor cells, and there was no evidence of venous invasion. The tumor is staged as pT4bN2bM0 according to the 7th edition of the TNM classification, reflecting the advanced local and regional spread of the malignancy."
727,TCGA-WE-A8K4-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings reveal the diagnoses of three distinct cases: a benign trichilemmoma of the right cheek, a malignant melanoma of the right arm, and an infiltrating adenocarcinoma of the prostate. The trichilemmoma, identified in an 8 mm punch excision, is benign, free of dysplasia or malignancy, and appears completely excised. In contrast, the right arm mass initially suggested a differential diagnosis between malignant melanoma and metastatic carcinoma, but definitive immunohistochemical staining confirmed it as malignant melanoma. This melanoma exhibited characteristics of a nodular type with a vertical growth phase, a Breslow thickness of 12.00 mm, and a mitotic rate of 4/mm. Notably, the tumor showed no signs of lymphovascular or perineural invasion, regression, micro-satellites, or coexisting naevus. Tumor-infiltrating lymphocytes were non-brisk, and the lesion was completely excised, with a deep margin of 0.3 mm and a circumferential margin of 20.0 mm, classified as stage pT4a. BRAF immunostaining was negative, and PCR analysis showed no mutations in the BRAF gene. Finally, microscopic examination of prostate chippings weighing 24 grams revealed infiltrating adenocarcinoma involving more than 90% of the tissue, characterized by a Gleason score of 4+4=8 with a tertiary pattern 5, correlating to a stage of pT1b. These comprehensive findings facilitate appropriate clinical management and therapeutic decision-making for each condition."
728,TCGA-XV-A9W5-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The essential pathological findings indicate a diagnosis of melanoma located on the left shoulder skin. The tumor is classified as an epithelial melanoma, presenting with a Clark level of 4 and a Breslow depth of 2 mm. Pathological examination revealed none of the surrounding margins were invaded by the melanoma, ensuring clear surgical margins. There was no evidence of metastatic involvement within regional lymph nodes upon examination, and no signs of distant metastasis were observed. Given the depth and cell layer infiltration, the melanoma is staged at I. These findings suggest a localized melanoma with no regional or distant spread, indicating an early-stage disease that has been excised with clear margins."
729,TCGA-BF-A5EQ-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient was diagnosed with melanoma, a primary skin tumor characterized by atypical melanocytic proliferation and significant cellular atypia. Histopathological examination revealed a malignant neoplasm with notable features including pleomorphism, high mitotic activity, and the presence of necrotic areas. Surgical margins were assessed, and the analysis demonstrated involvement of the resection margins, indicating that the tumor has not been entirely excised. Additionally, lymph node involvement was identified, signifying regional metastasis. The overall pathological findings suggest an aggressive melanoma with both local tissue invasion and evidence of metastatic spread. Blood samples analyzed for associated abnormalities were unremarkable, indicating no hematologic malignancies. These findings collectively highlight the advanced nature of the melanoma, underscoring the need for comprehensive therapeutic management."
730,TCGA-EB-A553-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of malignant melanoma of the skin, characterized by a pigmented lesion with a Breslow thickness of 10 mm and superficial ulceration. The excision reveals that the tumor extends beyond 4 mm, confirming its advanced stage. Importantly, there is no evidence of venous invasion, and the surgical margins are uninvolved, suggesting the excision was complete with clear borders. Additionally, a second skin fragment contains superficial melanoma of the malignant lentigo type. No lymph node involvement is noted. These findings confirm the presence of an aggressive melanoma with significant depth but without vascular invasion or residual tumor at the excision margins."
731,TCGA-EB-A5SF-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological examination reveals a diagnosis of nodular melanoma located on the skin of the extremity. The tumor exhibits ulceration, raised borders, and pigmentation. Microscopic analysis shows a significant level of invasion, categorized as the 5th level by Clark. The depth of invasion measured is considerable. The surgical margins are of particular concern, necessitating a careful evaluation to ensure the complete excision of tumor tissues. Lymph node involvement is a critical factor, though not detailed in this summary, and would require further investigation. The comprehensive pathological findings underscore the aggressive nature of the lesion, highlighting the importance of thorough clinical management and close follow-up."
732,TCGA-FW-A5DX-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological evaluation reveals a diagnosis of left anterior chest wall melanoma, characterized by residual melanoma and previously noted biopsy site changes. All surgical margins are confirmed to be negative for tumor infiltration, indicating complete excision at the primary site. Examination of the left axillary lymph nodes shows metastatic involvement in four out of eleven nodes, with evident extracapsular invasion in the largest positive node. Conversely, the level 3 left axillary lymph nodes excised were negative for melanoma, suggesting no further spread in those lymph nodes. These findings highlight the melanoma's local invasion and regional lymph node metastasis, with significant but contained extracapsular involvement. Additional histochemical analyses were conducted to support diagnostic accuracy and guide clinical management."
733,TCGA-XV-A9W2-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The patient has been diagnosed with melanoma located on the skin of the right forearm. The pathological examination reveals a Clark Level II invasion, indicating that the tumor has penetrated into the papillary dermis. The Breslow thickness is measured at 1 mm, categorizing the lesion as an early invasive melanoma. There is no evidence of regional lymph node involvement or distant metastasis, placing the disease at Stage I. The tumor exhibits clear surgical margins, indicating complete excision. Other relevant findings do not reveal additional pathological complexities, making the overall prognosis favorable with early-stage detection and clear margins."
734,TCGA-EB-A85J-01Z-00-DX1,SKCM,"Please generate a comprehensive and professional pathology report based on the provided slide from Skin, including key elements such as: (1) the histopathological diagnosis, (2) tumor morphology and growth patterns, (3) extent of invasion and involved structures, (4) lymphovascular or perineural invasion, (5) status of surgical margins, (6) TNM staging if possible, and (7) any additional pathological findings including non?neoplastic tissue alterations.","The pathological findings indicate a diagnosis of malignant melanoma located on the skin of the hip. The tumor exhibits prominent pigmentation and extends beyond 4 mm in thickness, with a measured Breslow depth of 5.5 mm. Microscopically, the tumor lacks superficial ulceration, and there is no evidence of venous invasion. The excision margins are free of tumor involvement, demonstrating adequate clearance. No signs of neo-adjuvant treatment are present in the specimen. The additional presence of fibrous, fatty, and bone tissue at the resection margin further supports the absence of residual disease, ensuring that the resection was comprehensive. Importantly, there is no mention of lymph node involvement, implicating that the focus remains on the primary tumor site and margins."
